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P-001
SERUM CA19-9 LEVEL ABOVE THREE 
THOUSANDS IN BENIGN BILIARY 
STRICTURE
Y. J. Ahn, H. S. Ahn, S. C. Heo, K. T. Hwang, 
J. K. Chung and I. M. Jung
Seoul National University College of Medicine, Seoul, 
Korea
Introduction: Although serum CA19-9 is main tumor 
marker in pancreaticobiliary malignancies, elevated value 
more than thousand can also be observed in benign condi-
tions. Here, we report upon a case of benign biliary stricture 
with concomitant rise of serum CA19-9 level more than three 
thousand.
Methods: A 72-year-old male who received laparoscopy 
assisted distal gastrectomy for early gastric cancer was 
referred for generalized jaundice with liver function abnor-
mality on fi fth postoperative day. MRCP demonstrated 
abrupt narrowing at distal CBD causing diffuse distension of 
IHD and EHD which was not shown in preoperative CT. 
Postoperative CT scan showed no defi nite mass in biliary 
system, neither PET-CT showed hypermetabolic lesion 
around distal CBD. Biliary stent was inserted for two months 
with liver function totally normalized. After removal of 
biliary stent, liver function altered again and serum CA19-9 
began to rise up to 3210 IU/ml during next 6 months of fol-
lowing up period. Percutaneous transhepatic biliary drainage 
was done and serum CA19-9 level decreased to 85 IU/ml for 
one month.
Results: We performed Roux-en Y hepaticojejunostomy for 
relieving biliary obstruction with tentative diagnosis of 
benign biliary stricture. The serum CA19-9 level after opera-
tion decreased to normal level (30 IU/ml). The patient is 
healthy without evidence of disease.
Conclusions: This case shows that benign biliary obstruc-
tion can lead serum CA19-9 level to more than three thou-
sand. In determining surgical method in the situation of distal 
bile duct obstruction with elevated serum CA19-9 level 
above thousand, judicious decision is necessary not to do 
unnecessary pancreaticoduodenectomy.
P-002
EMBOLIZATION COIL: A DOUBLE-
EDGED SWORD IN LIVER TRAUMA
J. J. Bong
Department of Surgery, Universiti Kebangsaan Malaysia 
(UKM) Medical Centre, Kuala Lumpur, Malaysia
Introduction: Transcatheter arterial embolization using 
microcoils is now considered a treatment option in arresting 
arterial bleed in liver trauma. However, complications arising 
from the use of embolization are seldom reported in the 
trauma literature. We herein report a case of a successfully 
embolization of hepatic arterial bleeding but complicated by 
persistent biliary fi stula secondary to biliary obstruction from 
the embolized microcoil.
Methods and Results: A 16-year-old male presented with 
abdominal pain and shock following a motorcycle accident. 
After brief resuscitation, an exploratory laparotomy was 
carried out and found a shattered right lobe of liver. Damage-
control surgery was performed with perihepatic packings. 
Post-operatively, a CT angiography showed an arterial blush 
at the right hepatic artery, to which a microcoil embolization 
was carried out via the percutaneous route. A second lapa-
rotomy was carried out and the devitalized posterior sector 
was excised. Post-operative recovery was uncomplicated 
except for persistent, large-volume bile leaks in the surgical 
drain. An ERCP showed extravasation of contrast from the 
biliary branch distal to the microcoil embolization site. A 
narrowing and distortion of right anterior duct was observed 
secondary to the presence of embolization microcoil. A 
guidewire was passed through the stricture with great diffi -
culty, and a long, plastic, endobiliary stent was inserted. The 
biliary fi stula eventually dried up in six weeks and the endo-
biliary stent was removed.
Conclusion: An embolized microcoil can cause biliary 
obstruction resulting in fi stula despite an initial success in 
arresting the hemorrhage.
P-003
WHITE GAUZE TEST: A SIMPLE AND 
RELIABLE METHOD IN PREVENTING 
POST-OPERATIVE BILE LEAK AFTER 
HEPATECTOMY
K. Yugasaravanan, R. Paul, Z. Zamri, A. Noraini, 
M. Krishna and J. J. Bong
Hepatobiliary Surgery Unit, Department of Surgery, 
Universiti Kebangsaan Malaysia Medical Center, Kuala 
Lumpur, Malaysia
Intoduction: Post-hepatectomy bile leak causes much mor-
bidity. The white gauze test is a simple yet reliable method 
in preventing this complication.
Methods: The white gauze test involved pressing the 
gauze gently onto the transected liver surface and looking 
for the presence of bile. If present, the leaking duct was 
repaired under loupe magnifi cation using Polydioxanone 
5–0 sutures. The process was repeated until there was no 
staining of the gauze. From January 2010 until March 2011, 
a total of 42 consecutive patients (28 males and 14 females) 
were recruited into the study. Patients who underwent lapa-
roscopic liver resections and open radiofrequency ablation 
were excluded. The operative site was routinely drained 
until 5th post-operative day. The presence of post-operative 
bile leak was defi ned as the presence of bile in the surgical 
drain.
Results: The types of hepatectomies performed included 3 
extended hepatectomies, 8 hemihepatectomies, 1 central 
hepatectomy, 11 sectionectomies, 1 bisegmentectomy and 18 
wedge resections. Three patients in this series underwent 
additional biliary reconstruction. Seven (16.7%) patients 
were cirrhotic with preserved liver function (Child’s A). Bile 
leaks were detected intraoperatively in 29 patients (70%) and 
repaired. As a result, there was no clinical evidence of post-
operative bile leak in all patients. There was one 30-day 
mortality in this series. This patient had concomitant resec-
tion of hilar lymph nodes but post-operatively recovery was 
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complicated by pancreatitis and fi stula, resulting in multi-
organ failure and death.
Conclusion: The white gauze test is a simple and fast, yet 
reliable, way to prevent post-operative bile leak.
P-004
INFLUENCE OF MAJOR HEPATIC VEIN 
INJURY ON TREATMENT OF BLUNT 
LIVER INJURY
K. M. Chae1, G. O. Jung1, D. E. Park1 and J. T. Oh
Department of Surgery, Wonkwang University Hospital, 
Wonkwang University College of Medicine 344-7 
Synyoung-dong, Iksan, JeunBuk, Korea
Purpose: Non-operative management of blunt liver injuries 
is highly successful in lower grade blunt liver injury (LI) 
patients. However, high grade blunt LI patients are shown 
higher rate of operation management. The purpose of this 
study was to analyze whether Major hepatic vein injuries 
affect on choice of therapeutic modality of blunt LI and 
prognosis of patients.
Patients and Method: From Jan. 2002 to Dec. 2009, 329 
patients were treated after diagnosis as blunt LI. 90 of 329 
patients were included to blunt LI from grade III to V accord-
ing to classifi cation of CT fi nding. We divided into three 
groups according to grade of LI. We reviewed medical 
record, retrospectively.
Result: Mean age of patients (n = 90) was 39.1 years 
old. 63 of 90 patients were managed by non-operative 
treatment and 27 were treated by operative method. Morbidity 
and mortality of patients were 7 (7.8%) and 9 (11%), respec-
tively. Initial systolic blood pressure, initial diastolic blood 
pressure, transfusion amount, amount of hemoperitoneum, 
injury of MHV, and leakage of dye in CT showed signifi cant 
difference between each group. However, injury of only 
MHV did not showed signifi cance in multivariate analysis 
for risk of operation and mortality. If hepatic artery or portal 
vein injury was associated with MHV injury, which showed 
increase of operation and mortality.
Conclusion: Only MHV injury did not infl uenced on risk of 
operation and mortality. However, MVH injury that was 
associated with other hepatric vessel injury may be consider 
as contributing factor that is increasing risk of operation and 
mortality.
P-007
EXTRACORPOREAL MEMBRANE 
OXYGENATION SUPPORT IN 
POTENTIAL ORGAN DONORS FOR 
BRAIN DEATH DETERMINATION
C-E. Hsieh, K-H. Lin, Y-L. Chen and Y-Y. Chang
Changhua Christian Hospital, Changhua, Taiwan
Introduction: Extracorporeal membrane oxygenation 
(ECMO) must be applied in early stages to perfuse organs 
before donation in order to expand the donor pool. The aim 
of this study was to examine the benefi ts of ECMO on poten-
tial organ donors with multiple complications.
Methods: A retrospective review was conducted in this 
study. All patients with ECMO support in this study were on 
the verge of brain death and therefore were potential subjects 
for organ donation.
Results: Six of the organ donors with severe neurological 
damage under ECMO support were completed organ dona-
tions, 2 women and 4 men, aged 19 to 58 years (mean, 32 
years). Three of the donors completed the brain death deter-
mination procedure, 1 failed the procedure, and 2 had cardiac 
asystole prior to the procedure and were unable to be declared 
dead even after resuscitation. Nine kidneys and 3 livers were 
successfully retrieved from 5/6 donors. These donated organs 
led to 11 successful transplants (8 kidneys, 2 livers, and 1 
simultaneous kidney-liver transplant). The transplanted 
organs functioned well and the organ recipients made a full 
recovery.
Conclusions: ECMO allows for the maintenance of abdom-
inal organ tissue perfusion without the need of warm isch-
emia until the organs are procured; provides for enough time 
for the organ donation procedure to be completed in a safe 
manner; and reduces the risk of unpredictable cardiac arrest 
that could result in the death of the donor and subsequently 
the loss of grafts.
P-008
FACTORS AFFECTING PROGNOSIS OF 
SMALL HEPATOCELLULAR 
CARCINOMA IN TAIWANESE PATIENTS 
FOLLOWING HEPATIC RESECTION
C.-J. Ko1, Y.-L. Chen1 and C.-T. Chou2
1Department of General Surgery, Changhua Christian 
Hospital, Changhua, Taiwan; 2Department of Radiology, 
Changhua Christian Hospital, Changhua, Taiwan
Introduction: Small hepatocellular carcinoma (HCC) 
affects millions of individuals worldwide. Surveillance of 
high-risk patients increases early detection of small HCC. To 
identify prognostic factors affecting the overall survival (OS) 
and recurrence-free survival (RFS) of patients with small 
HCC.
Methods: In this prospective study, 140 Taiwanese patients 
with small HCC stage I or stage II were enrolled. Clinical 
parameters of interest included operation type, tumor size, 
tumor histology, Child-Pugh class, presence of HbsAg and 
liver cirrhosis, HCV status, AFP, total bilirubin, serum 
albumin, and administration of antiviral and salvage 
therapies.
Results: Tumor size correlated signifi cantly with a poorer 
OS in patients with stage I small HCC (p = 0.014); however, 
patients with stage II small HCC experienced a signifi cantly 
poorer RFS (p = 0.033). OS rates did not differ signifi cantly 
between stage I and II small HCC. Tumor margins, tumor 
histology, and cirrhosis did not signifi cantly affect OS or 
RFS (p > 0.05). Increasing tumor size has generally been 
associated with poorer prognoses in cases of HCC. This 
study verifi ed the relationship between small HCC tumor 
size and OS; however, a reduction in OS with increasing 
tumor size was demonstrated for stage I, but not for stage II, 
small HCC.
Conclusion: Patients with stage II small HCC may benefi t 
from aggressive surveillance for tumor recurrence and 
appropriate salvage treatment. Further studies are needed for 
additional stratifi cation of stage I patients to identify those 
at increased risk of death.
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P-009
A CASE OF HEPATOCELLULAR 
CARCINOMA WITH DIFFUSE 
INTRADUCTAL TUMOR INFILTRATION 
INTO INTRA- AND EXTRA- HEPATIC 
BILE DUCT
B. G. Choi, H. J. Kim, H. H. Kim, E. K. Park, 
J. S. Seoung, Y. H. Hur, Y. S. Koh, J. C. Kim, H. J. Kim 
and C. K. Cho
Department of Surgery, Chonnam National University 
Medical School, Gwangju, South Korea
Introduction: Hepatocellular carcinoma (HCC) may 
involve the biliary tract in several different ways: tumor 
thrombosis, hemobilia, tumor compression, and diffuse 
tumor infi ltration. A diffuse intraductal tumor infi ltration into 
both intra- and extra hepatic bile duct in HCC is very rarely 
identifi ed.
Methods: The patient was a 38-year-old man who presented 
with painless jaundice. In laboratory tests, serum bilirubin 
level (total/direct) was 8.4/8.1 mg/dL, and serum AFP and 
CEA levels were 1353 IU/mL and 239 U/mL respectively. On 
abdominal CT and MRI, enhancing mass in and around the 
left intrahepatic bile duct (IHBD) was detected and which was 
extended into common hepatic duct (CHD). US guided liver 
biopsy was done, and the result was compatible with HCC.
Results: In operation, left hepatectomy and caudate lobec-
tomy was performed with extraction of intraluminal tumor 
thrombi from CHD. The result of frozen biopsy for cut 
margin of left IHBD was negative. On cross section of the 
liver, about 5 cm sized irregular multilobulated mass was 
found along left IHBD and soft yellow to brown colored 
mass were fi lled in left IHBD lumen, both central and periph-
eral IHBD. In microscopic and immunohistochemical exam-
ination, the tumor along left IHBD and intraductal mass were 
confi rmed by HCC.
Conclusions: A HCC with diffuse intraductal tumor infi ltra-
tion into both intra- and extra hepatic bile duct is very rare 
clinical condition which needs differential diagnosis with 
peripheral cholangiocarcinoma or hilar cholangiocarcinoma. 
We experienced an very unusual type of HCC and report the 
case here in.
P-010
SURGICAL ROLE FOR MULTIPLE 
HEPATOCELLULAR CARCINOMA WITH 
TWO OR THREE NODULES LESS THAN 
5 CM IN DIAMETER IN LIVER 
TRANSPLANTATION ERA
S. H. Choi1, G. H. Choi1, J. Y. Park2, D. J. Joo1, M. K. Ju1, 
M. S. Kim1, J. S. Choi1 and S. I. Kim1
Department of Surgery1 and Internal Medicine2, Yonsei 
University College of Medicine, Seoul, Korea
Introduction: Recently, surgical resection showed better 
overall survival than transarterial chemoembolization 
(TACE) for patients with multiple hepatocellular carcinomas 
(HCCs) although liver resection is not currently recom-
mended for multiple HCCs. We performed this study to 
clarify the role of liver resection for multiple HCCs.
Methods: From January 2003 to December 2008, 160 
Child-Pugh A patients who had two or three nodules without 
vascular invasion and tumor diameter ≤5 cm per radiologic 
study were enrolled in this study, retrospectively. Long-term 
outcomes were compared among three treatment modalities 
such as surgical resection (n = 36), TACE (n = 107) and liver 
transplantation (LT) (n = 17).
Results: Disease-control rates of surgical resection and 
TACE were 19.4% and 10.3%, respectively (p = 0.158). The 
5-year disease-free survival rates after surgical resection and 
LT were 11.2% and 87.5%, respectively (p < 0.001). The 
5-year overall survival rates after TACE, surgical resection 
and LT were 28.9%, 48.1% and 80.2%, respectively (p = 
0.447 at resection vs. LT, p = 0.005 at resection vs. TACE). 
In patients with surgical resection, sixteen patients who did 
not have cirrhosis showed higher 5-year disease-free and 
overall survival rates than those of patients who had cirrhosis 
(20.8% vs. 0%, p = 0.007; 69.9% vs. 26.5%, p = 0.023). 
Surgical resection of 20 patients who had cirrhosis did 
not show any survival benefi t compared to that of TACE 
(p = 0.280).
Conclusion: In multiple HCCs with radiologic two or three 
nodules, no radiologic vascular invasion and tumor diameter 
≤5 cm, surgical resection can be justifi ed only in patients 
without cirrhosis. LT showed the best oncologic outcomes in 
these patients.
P-011
EFFICACY OF TRANSARTERIAL 
CHEMOEMBOLIZATION FOR HCC IN 
WATERSHED SEGMENTS OF LIVER: 
COMPARISON OF UNILATERAL WITH 
BILATERAL CHEMOEMBOLIZATION
C. T. Chou1 and Y. L. Chen2
1Department of Radiology, Chang-Hua Christian Hospital, 
Chang-Hua, Taiwan; 2Department of Transplant Center, 
Chang-Hua Christian Hospital, Chang-Hua, Taiwan
Introduction: To evaluate the treatment effi cacy of unilat-
eral transarterial chemoembolization (TACE) in comparison 
to bilateral TACE for hepatocellular carcinoma (HCC) in 
watershed segments of liver.
Methods: Seventy-seven patients with 87 HCCs located in 
segment IV/V/VIII were included for our study. In the uni-
lateral TACE group, HCC with the feeding arteries solely 
came from the right or left hepatic artery. In the bilateral 
TACE group were HCC with the feeding arteries coming 
from both hepatic arteries or patients who had multiple 
tumors in both hepatic lobes. Embolization of all visible 
tumor feeding arteries on angiography was done for all 
patients.
Results: With regard to age, sex, Child-Pugh class, underly-
ing liver disease, alpha-fetal protein and mean tumor size, 
there were no statistically signifi cant differences between the 
two groups. Viable rate showed a statistically signifi cant dif-
ference between the two groups (p = 0.023). For HCC 
located across the watershed plane or not, the viable rate 
for watershed plane tumors was higher than other tumors 
(p = 0.048).
Conclusions: The viable rate in bilateral TACE group was 
lower than that of the unilateral TACE group for HCC in 
watershed segments. The viable rate of the HCC across the 
watershed plane was higher than that of the other lesions 
within watershed segments. In patients with HCC within 
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watershed segments of liver, especially across the watershed 
plane, post-TACE angiography for checkup of communica-
tion arteries from opposite side was recommended. 
Embolization of tumor feeding artery plus communication 
arteries from opposite hepatic artery might achieve better 
treatment effi cacy.
P-012
LAPAROSCOPIC LEFT HEPATECTOMY 
IN PATIENTS WITH INTRAHEPATIC 
STONES AND RECURRENT PYOGENIC 
CHOLANGITIS
K. Chun, B. Ahn and I. Song
Department of Surgery, Research Institute for Medical 
Sciences, College of Medicine, Chungnam National 
University, Daejeon, Korea
Purpose: To investigation whether totally laparoscopic left 
hepatectomy is worrisome to adapt intrahepatic stone disease 
with recurrent pyogenic cholagitis.
Method: From April 2008 to March 2010, twenty one 
patients visited for left intrahepatic stone with recurrent pyo-
genic cholangitis in Chungnam National University Hospital. 
During formal one year, eight patients were underwented 
laparoscopic assisted left hepatectomy and during latter year 
eleven patients were underwented totally laparoscopic left 
hepatectomy and two laparoscopic assisted heft hepatec-
tomy. Surgery type is decided preoperatively by intension to 
treatment. Clinical data were collected retrospectively and 
comparatively analyzed by surgery type.
Result: Mean age, sex ratio, preoperative ASA score, previ-
ous operation history, presence of acute cholangitis were not 
different in both laparoscopic assisted and totally laparo-
scopic left hepatectomy. Operation time was not different 
statistically (310.0 vs 309.5 min, p = 0.985). Intraoperative 
transfusion was more frequent in totally laparoscopic hepa-
tectomy patients but not statistically different (1 vs 3 times. 
p = 0.464) But postoperative complications were not differ-
ent in both patients group. Incision length was larger in 
lararoscopic assisted group (10.6 vs 8.5 cm, p = 0.07). 
Postoperative hospital stay was not different also.
Conclusion: In this study, we conclude totally laparoscopic 
left hepatectomy can be adapted in the patients with left IHD 
stones with RPC but more careful approach was necessary. 
More larger volume of prospective randomized study is need 
also.
P-013
EPITHELIAL TO MESENCHYMAL 
TRANSITION (EMT): A KEY 
MECHANISM OF TUMOR RESISTANCE
F. Theodora, N. Linh, C. L. Sam and D. Jurstine, 
M.-W. Caterina, M. Vijayaragavan and C. Christopher
The University of Melbourne, Department of Surgery, 
Austin Health, Heidelberg, Australia
Introduction: Colorectal cancer (CRC) results in over half 
a million deaths annually, with liver metastasis being the 
predominant cause. Apart from a small group amenable to 
surgery, the majority of patients are treated with palliative 
chemotherapy. We have shown that treatment of murine CRC 
liver metastases with Oxi4503 a novel vascular disruptive 
agent reduces tumor mass by 90%. However, a small popula-
tion of tumor cells persists at the tumor periphery, resulting 
in recurrence. The mechanisms by which these tumor cells 
resist treatment are poorly understood.
Methods: Using the same murine model of CRC liver 
metastases we investigated changes in tumor cell morphol-
ogy, hypoxia and pro-angiogenic growth factors at various 
time points post Oxi4503 treatment.
Results: Oxi4503 treatment caused acute hypoxia in the 
surviving tumors, induced signifi cant upregulation of pro-
angiogenic factors (HIF-1α, HGF, VEGF and TGF-β) and 
an extremely rapid and widespread EMT in all surviving 
tumor cells; characterized by almost total down regulation of 
E-cadherin, marked upregulation of the mesenchymal 
markers ZEB1 and vimentin and nuclear redistribution of 
β-catenin. In preliminary results we observed similar EMT 
in other cancer treatments including cytotoxic and anti-
angiogenic therapies.
Conclusions: This is the fi rst study to demonstrate in vivo 
EMT that involves essentially all surviving tumor cells fol-
lowing treatment. These fi ndings indicate that EMT may 
represent a common survival mechanism adopted by stressed 
tumor cells and as such may have signifi cant clinical implica-
tions in cancer therapy.
P-014
SPONTANEOUS REGRESSION OF 
HEPATOCELLULAR CARCINOMA
H. Fujikawa1, K. Ito1, N. Tsutusmi1, M. Inami1, 
M. Komatsu1, M. Setoguchi1, K. Mimatsu1 and H. Kano1, 
T. Oida1, S. Matsuoka2, M. Moriyama2 and H. Hasegawa3
1Social Insurance Yokohama Central Hospital, Yokohama, 
Japan; 2Nihon University School of Medicine, Tokyo, 
Japan; 3Matsumoto Dental University School of Dentistry, 
Shiojiri, Japan
Introduction: Spontaneous regression of malignant tumor 
is extremely rare. We report a case of spontaneous regression 
of hepatocellular carcinoma (HCC) with non alcoholic 
steatohepatitis.
Methods: A 72-year man was admitted because which in 
diameter of hepatic tumor 3 cm in segment 6 of the liver. 
Serum level of AFP was normal, and HBs Ag and hepatitis 
C antibody were negative. Enchanced ultrasonography and 
enchanced abdominal CT demonstrated no enchancement 
mass showing with extrahepatic growth in arterial phase. 
Angiography showed hypovasucular mass with peripheral 
enchancing rim. We assumed differential diagnoses includ-
ing cholangiocellular carcinoma, metastatic carcinoma and 
untypical HCC. Therefore, surgical resection was recom-
mended, and performed partial hepatic resection.
Results: Cut surface of the resected mass, measuring 3 cm 
in diameter, showed necrotic tissue with capsular structure. 
Microscopic examination showed that the central area of 
tumor completely developed coagulation necrosis but small 
nests of HCC remained in the periphery. Interestingly, middle 
perforating artery and some markedly dilated veins in tumor 
were occluded by thrombus, accompanied by recanalization 
of small vessels around the necrotic mass.
Conclusions: We suggested that regression of HCC resulted 
from ischemic changes by arterial thrombus.
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P-015
MORPHOLOGICAL STUDY OF 
INFILTRATING CELLS FOLLOWING 
SEVERE ACUTE CELLULAR REJECTION 
OF RAT LIVER ALLOGRAFT – IMPACT 
OF HYPERBARIC OXYGEN THERAPY
S. Gan1, C. Malcontenti-Wilson1, B. Howden1, I. Millar2, 
C. Christophi1 and V. Muralidharan1
1University of Melbourne, Department of Surgery Austin 
Health, Heidelberg, Australia; 2Hyperbaric Unit, Alfred 
Hospital, Prahran, Australia
Introduction: Acute cellular rejection is a common cause 
of post transplantation morbidity. Hyperbaric oxygen therapy 
(HBO) is indicated for treatment of ischemia reperfusion 
injury. However its safety and effi cacy has not been conclu-
sively studied in a rejection model of liver transplantation.
Methods: Male inbred Dark Agouti and Lewis rats were 
transplanted to create severe acute cellular rejection. HBO 
was administered twice daily for one, three and seven days 
following transplantation. A 14 day survival study was also 
conducted. T cell and Kupffer cell infi ltration was observed 
via immunohistochemistry for CD3 and ED2 antigen respec-
tively. Neutrophil infi ltration was observed via naphthol 
AS-D chloroacetate esterase staining.
Results: HBO conferred signifi cant survival advantage (p = 
0.01). It reduced infi ltrating T cell numbers (Day 3, 7) and 
total infi ltrating cells (Day 1, 7) in the perivenous (Zone 3) 
region. There was a trend for increasing Kupffer cell numbers 
after HBO in the periportal (Zone 1) region, Zone 3 and the 
area between (Zone 2). There was a trend to increase Kupffer 
cell percentage; this was not statistically signifi cant in all 
Zones at all timepoints. Increased neutrophil numbers were 
seen at Day 1 after therapy in both Zone 1 (p = 0.041) and 3 
(p = 0.046); there was no signifi cant effect at other timepoints.
Conclusions: HBO therapy was seen to have varied impact 
on the infi ltrating T cells, Kupffer cells and neutrophils. 
Further studies are required to clearly elucidate its mecha-
nisms of action.
P-016
THE EFFECT OF HYPERBARIC OXYGEN 
THERAPY ON ISCHEMIA, 
PRESERVATION AND REPERFUSION 
INJURY AFTER LIVER 
TRANSPLANTATION
A. Gin1, N. Q. Tran1, S. Hammoud1, 
C. Malcontenti-Wilson1, B. Howden1, I. Miller2, 
C. Christophi1 and V. Muralidharan1
1The University of Melbourne, Department of Surgery, 
Austin Health, Melbourne, Australia; 2Hyperbaric Unit, 
The Alfred Hospital, Melbourne, Australia
Introduction: Ischemia, preservation and reperfusion injury 
(IPRI) is a major cause of suboptimal donor organ function 
after orthoptic liver transplantation (OLT). This study inves-
tigates the effect of hyperbaric oxygen therapy (HBOT) after 
OLT on the severity of IPRI and hepatic microcirculation.
Methods: Syngeneic OLT was performed on male Lewis 
rats using organs stored in UW solution for 24 hours at 4°C. 
HBOT was administered twice daily. Animals were killed at 
12, 24 or 48 hours. Necrosis was quantifi ed using stereologi-
cal analysis of coagulative necrosis. Immunohistochemistry 
was used to measure apoptosis (caspase-3) and hepatocyte 
proliferation (Ki67). Microvascular casting was performed 
by intra-arterial infusion of acrylic resin (Mercox). Electron 
microscopy was used to assess the microvascular architec-
ture and hepatic endothelium.
Results: HBOT after OLT signifi cantly reduced necrosis 
and apoptosis, whilst increasing proliferation at 12, 24 and 
48 hours compared to untreated controls. HBOT after OLT 
improved the microvascular architecture and vessel diameter 
at 48 hours.
Conclusions: This study demonstrates that HBOT reduces 
the severity of IPRI after OLT and accelerates the rate of 
liver regeneration. HBO therapy may improve hepatic micro-
circulation by reducing the ultra-structural changes after 
transplantation.
P-017
THE EFFECT OF HYPERBARIC OXYGEN 
THERAPY ON ISCHAEMIA, 
PRESERVATION AND REPERFUSION 
INJURY AFTER LIVER 
TRANSPLANTATION: CELLULAR 
MECHANISMS
A. Gin1, N. Q. Tran1, N. F. A. Muin1, 
C. Malcontenti Wilson1, B. Howden1, I. Miller2, 
C. Christophi1 and V. Muralidharan1
1The University of Melbourne, Department of Surgery, 
Austin Health, Melbourne, Australia; 2Hyperbaric Unit, 
The Alfred Hospital, Melbourne, Australia
Introduction: Ischemia, preservation and reperfusion injury 
(IPRI) is a major cause of suboptimal donor organ function 
after orthoptic liver transplantation (ORT). This study inves-
tigated the effect of hyperbaric oxygen therapy (HBOT) after 
ORT on neutrophil (PMN) and Kupffer cell (KC) function.
Methods: Syngeneic OLT was performed on male Lewis 
rats using organs stored in UW solution for 24 hours at 4°C. 
HBOT was administered twice daily. Animals were killed at 
12, 24 or 48 hours. PMN and KC accumulation and distribu-
tion was assessed by immunohistochemistry.
Results: HBOT reduced PMN accumulation at all time 
points, achieving signifi cance at 12, 24 and 48 hours. HBOT 
reduced KC numbers signifi cantly at 12 and 48 hours.
Conclusions: Our previous study has demonstrated that 
HBOT reduces the severity of IPRI after ORT. This may in 
part be due to the immunomodulatory effects HBOT on PMN 
and KC accumulation.
P-018
CLINICAL IMPACT OF POSITIVE 
SURGICAL MARGIN STATUS IN 
PATIENTS WITH INTRAHEPATIC 
CHOLANGIOCARCINOMA AFTER 
HEPATECTOMY.
F.-J. Hsieh, T.-S. Yeh, C.-N. Yeh and Y.-Y. Jan
Deparment of General Surgery, Chang Gung Memorial 
Hospital, Chang Gung University, Taiwan 
Background: The clinical impact of positive surgical 
margin status in patients with intrahepatic cholangiocarci-
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noma (ICC) after hepatectomy and the prognostic factors 
have not yet been well investigated.
Patients and Methods: The clinical features of 296 patients 
with intrahepatic cholangiocarcinoma (ICC) who underwent 
resection with curative intention from 1977 to 2007 were 
retrospectively reviewed. Totally 103 patients had a positive 
resection margin, of which, 75 patients had a microscopically 
positive margin (R1) and 28 grossly positive margin (R2). 
The clinicopathological features were compared with 193 
patients with a negative resection margin and prognostic 
factors analyzed.
Results: ICC patients with intrahepatic stones, non-papil-
lary morphology and higher T stage tended to have more 
positive surgical margins. The median follow up duration 
was 7.3 months. The survival was better in the negative 
surgical margin group as compared with the positive surgical 
margin group. The survival difference between patients with 
a microscopically positive margin (R1) and grossly positive 
margin (R2) was not statistically signifi cant. The prognosis 
is determined by the grade of the tumor, nodal positivity and 
usage of chemotherapy.
Conclusion: Higher T stage, intrahepatic stones and non-
papillary morphology are the main contributing factors to a 
positive resection margin. Positive margin has an unfavor-
able impact on the Overall survival (OS) of ICC patients 
undergoing hepatectomy. In patients with a positive margin, 
prognosis was determined by the biology of the tumor and 
nodal positivity. Chemotherapy was useful in increasing the 
OS in these patients.
P-019
INFLUENCE ON TACROLIMUS TROUGH 
LEVEL CHANGES FROM TWICE DAILY 
TO ONCE DAILY IN LIVER 
TRANSPLANT RECIPIENTS
F. H. Huang2, C.-I. Wu1, C.-H. Chen1, K.-H. Lin2, 
C.-E. Hsieh3, S.-Y. Chien1 and Y.-L. Chen2
1The Department of Pharmacy, Changhua Christian 
Hospital, Changhua, Taiwan; 2General Surgery, Changhua 
Christian Hospital, Changhua, Taiwan; 3Department of 
Nursing, Changhua Christian Hospital, Changhua, Taiwan
Introduction: Tacrolimus once daily form can reduce dose 
frequency and improve patient’s compliance. But the trough 
level of once daily form was signifi cant decrease during 
formulation conversion. This study investigated the safety 
of tarcrolimus trough level changes and its correlative 
factor.
Methods: The open-label, observational, single-center 
study included 53 liver transplant recipients conversion from 
tacrolimus twice daily to once daily based on a 1 mg:1 mg 
proportion. Tacrolimus daily doses and concomitant trough 
levels, liver enzymes, renal function, HbA1c, adverse events 
were assessed every one month from 6 months before con-
version to 2011.04.30. The mean conversion time after trans-
plantation and follow-up duration were 51.4 (9–156) months 
and 8.3 (3–10) months respectively.
Results: According to this study of 41 males and 12 females 
enrolled, we observed the trough level of twice daily tacro-
limus was 4.65 ± 1.41 ng/ml at day 0, decreased to 2.72 ± 
1.35 ng/ml of once daily tacrolimus at day 30, 4.52 ± 1.96 ng/
ml at day 60 and 2.93 ± 1.11 ng/ml at day 300. Mean values 
of aspartate aminotransferase, alanine aminotransferase, cre-
atinine and HbA1c remained stable. One patient experienced 
acute rejection and one had headache during follow-up. By 
multiple regression, the tacrolimus trough level changes was 
correlated with sex, renal function and donor source.
Conclusion: Patient who are female, young age, living 
donor transplant and renal dysfunction may decrease tacro-
limus trough level at formulation conversion period. 
Therefore, we should monitor therapeutic drug concentration 
more frequent during early stage of conversion aimed at 
these populations.
P-020
THE EXPRESSION OF RENIN 
ANGIOTENSIN SYSTEM COMPONENTS 
IN HUMAN COLORECTAL LIVER 
METASTASES
K. Hung, V. Muralidharan and C. Christophi
Austin Health, Melbourne, Australia
Introduction: Colorectal cancer (CRC) is the second most 
common internal malignancy in developed countries. Liver 
metastasis is an important process in the progression of CRC, 
and is the leading cause of death. Despite best treatments, 
long-term survival remains poor. The local renin angiotensin 
system (RAS) has been implicated in functions of angiogen-
esis regulation, cellular proliferation, differentiation, migra-
tion, formation of extracellular matrix and apoptosis, thus 
has been targeted as potential novel therapy against tumori-
genesis. In this study, we characterize the expression of dif-
ferent RAS components in human colorectal liver metastases 
as compared to normal liver and tumor bearing liver, and 
relate this to the current understanding of RAS in the role of 
tumorigenesis.
Methods: Snap frozen and fi xed tissue from 15 resected 
colorectal liver metastases and 5 normal livers were used to 
determine the expression of various RAS components via 
quantitative real-time polymerase chain reaction (qRT-PCR) 
and immunohistochemistry (IH).
Results: Angiotensinogen, AT1R and ACE mRNA were 
expressed in varying levels across 3 different tissues types, 
however ACE mRNA not seen to translated into protein in 
some tumors. There was no difference in the expression of 
AT2R and MASR mRNA between tissue types.
Conclusions: The results demonstrate differential expres-
sion of RAS components in tumor, tumor bearing, and 
normal liver. The fi ndings offer possible explanation of the 
mechanisms underlying anti-tumorigenic effects of RAS 
blockade, which may be acting via disruption of paracrine 
interactions between tumor and host RAS components.
P-021
CONTRIBUTION OF INTERLEUKIN-28B 
VARIATION TO HEPATITIS C VIRUS 
CLEARANCE BY INTERFERON-BASED 
THERAPY
K. Ishii1, M. Kogame1, K. Kanayama1, M. Shiratori2, 
M. Shinohara1 and Y. Sumino1
Division of Gastroenterology and Hepatology1, Haneda 
Airport Clinic2, Toho University
Background/Aim: To elucidate the prevalence of sustained 
viral response (SVR) of interferon (IFN)-based therapy in 
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chronic hepatitis C (CHC) patients with genotype 1b and 
high viral load according to interleukin-28B variation.
Patients and Methods: Two hundred and eight patients 
with genotype 1b and high viral load (HCV-RNA by RT-PCR 
≥5.0 log copies/ml) were studied. All patients were treated 
with PEG-IFN-alpha 2a or PEG-IFN-alpha 2b in combina-
tion with ribavirin between January 2005 and January 2010 
in our hospital. PEG-IFNs were administered weekly for a 
median 48 weeks. Sustained virologic response (SVR) was 
defi ned as serum HCV-RNA being negative by RT-PCR 24 
weeks after fi nishing therapy. Of 208 patients, 95 consented 
to genetic testing, and genetic variations in IL-28B were thus 
analyzed. In this study, genetic variation near the IL-28B 
gene (rs 8099917) was investigated.
Results: SVR was obtained in 89 (43%) of 208 patients. In 
patients consented to genetic testing, SVR was obtained in 
37 (59%) of 63 patients with genotype TT in rs 8099917 
and in 5 (16%) of 32 patients with genotype TG in rs 
8099917. While genotype GG in rs 8099917 was not 
detected in patients studied. In multiple logistic regression 
analysis, genotype TT in rs 8099917 was independent 
factor of SVR.
Conclusion: Our results suggest that the SVR is strongly 
associated with IL-28B genotype in patients with genotype 
1b and high viral load who were diffi cult to treat.
P-022
BLOCKADE OF SONIC HEDGEHOG 
PATHWAY EFFECTIVELY INHIBITS THE 
GROWTH OF HEPATOMA IN MICE – AN 
“IN VIVO” STUDY
K-S. Jeng1, I-S. Sheen2, J-C. Su3, M-C. Yu3 and 
H.Y. Fang3
1Departments of Surgery, Far Eastern Memorial Hospital, 
Taipei, Taiwan; 2Department of Hepatogastroenterology, 
Chang-Gung Memorial Hospital, LinKou, Taiwan; 
3Department of Medical Research, Far Easten Memorial 
Hospital, Taipei, Taiwan
Introduction: Hepatocellular carcinaoma (HCC), the 
malignancy worldwide, is very prevalent in Taiwan and other 
Asian countries. These with unresectable status may need 
innovating other new target therapy. Sonic hedgehog (Shh) 
pathway activation may be essential for tumor growth and 
maintenance. We established an “in vivo” animal study to 
assess the treatment effect of mice HCC with Shh pathway 
inhibitor.
Methods: The mice were divided into 4 groups (control and 
A, B, C group) (n = 10 for each). We injected mouse hepa-
toma cells, ML-1 cells (5 × l06 cells) into left liver of 
C57BL/6 mice. At the 2nd week Group A received corn oil 
i.p. injection, Group B received cyclopamine 10 mg/kg/day 
i.p., and Group C received 30 mg/kg/day i.p. Each injection 
was given per day for 10 days. After an interval of 4 weeks, 
exploration was performed for each. Tumor size measure-
ment and RT-PCR examination of Shh pathway factors (Shh, 
Ptch-1, Gli-1, Smoh) for tumor and adjacent normal liver 
were undertaken.
Results: The decrease of tumor size of group C is statisti-
cally signifi cant (p = 0.013) when comparing with control 
group or group A. Among the change of the ratio of tumor/
non tumor liver, both shh mRNA of group B and group C 
have statistical signifi cance (p = 0.000, p = 0.000) comparing 
with group A. Only the difference of Shh mRNA of group C 
remains signifi cant after multivariate analysis.
Conclusions: Inhibition of Shh pathway may signifi cantly 
decrease tumor/liver Shh mRNA ratio and tumor size. We 
hope this study may contribute to the understanding of Shh 
pathway which may become an effective treatment target and 
be helpful the clinical application in the future.
(NSC 97-2314-B-418-008-MY3)
P-023
PHARMACOKINETICS OF TACROLIMUS 
MODIFIED RELEASE QD FOLLOWING 
LIVING DONOR LIVER 
TRANSPLANTATION: RESULT OF PILOT 
STUDY
D. H. Jung, S. G. Lee, S. Hwang, C. S. Ahn, D. B. Moon, 
T. Y. Ha, G. W. Song, G. C. Park, S. Yoon and S. Jung
Asan Medical Center, University of Ulsan College of 
Medicine, Seoul, Korea
Introduction: Data from phase II studies in stable trans-
plant patients indicate that the AUC0–24 for tacrolimus BID 
and tacrolimus modifi ed release QD formulations were 
within the equivalence range of 80–125% which supports the 
1:1 conversion from tacrolimus BID to tacrolimus QD. Study 
data indicate using the same therapeutic monitoring concepts 
for tacrolimus BID and tacrolimus QD and clinical data 
suggest similar safety and effi cacy for the two formulations. 
Data on the pharmacokinetics of tacrolimus QD inliving 
donor liver transplantation, however, have not yet been 
assessed. This phase 4 study was designed to describe the 
pharmacokinetics (PK) of tacrolimus QD in recipients of a 
living donor liver transplantation.
Methods: Patients received tacrolimus continuous infusion 
from days 0–5 (targeted trough levels 10–20 ng/ml). 
Conversion to tacrolimus QD was on day 5 with targeted 
trough levels of 10–20 ng/ml until day 30 then 5–15 ng/ml 
from day 30 onwards. Adjunct treatment with corticoste-
roids, MMF or basiliximab was permitted. Study duration 
was 12 weeks. The primary variable was AUC0–24h on days 6 
and 14. Secondary variables were Cmax, tmax, Cmin, incidence, 
severity, and time to acute rejection, patient and graft sur-
vival, and incidence of adverse events. The fi rst PK profi le 
(PK1) was obtained on day 2 after conversion (day 6 post 
transplantation) and the second (PK2) on day 9 after conver-
sion (day 14 ± 3 days post transplantation). Each PK profi le 
comprised 10 blood samples drawn before the fi rst QD dose 
(0 h) then at 1, 2, 3, 4, 6, 8, 12, 16, and 24 h after the QD 
dose. Effi cacy and safety analyses were based on the full 
analysis set (FAS) (patients with results attributed to treat-
ment) and PK analyses were based on the PK evaluable set 
(PKES) (patients in the FAS with PK1 and PK2 measure-
ments). AUC was calculated using the linear trapezoidal 
rule. Cmax, tmax, and Cmin were obtained directly from time-
concentration profi les.
Results: The FAS included 11 patients. One patient was 
excluded from the PKES because of a missing PK 2. One 
patient prematurely withdrew due to hypertension. 9 patients 
completed the study. Mean patient age was 52 years. Mean 
tacrolimus trough levels were slightly lower than targeted on 
day 6 but thereafter within targeted ranges. Mean AUC0–24h 
and Cmax were nearly doubled at PK2. No events of acute 
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rejection, graft loss, or patient death occurred. All patients 
experienced an adverse event and 3 a serious adverse event 
(none related to tacrolimus).
Conclusions: Conversion to tacrolimus QD was safe and 
effi cacious in this population. Mean AUC0–24h at PK2 was 
higher than previously reported but may refl ect cautious 
dosing by investigators.
P-024
SUCCESSFUL ABO-INCOMPATIBLE 
ADULT LIVING DONOR LIVER 
TRANSPLANTATION WITHOUT LOCAL 
INFUSION THERAPY UNDER 
RITUXIMAB PROPHYLAXIS
D. H. Jung, G. W. Song, S. Hwang, C. S. Ahn, D. B. 
Moon, T. Y. Ha, G. C. Park, S. Y. Yoon, S. W. Jung and S. 
G. Lee
Asan Medical Center, University of Ulsan College of 
Medicine, Seoul, Korea
Introduction: Since introduction of portal vein infusion 
therapy by Tanabe, et al., the patient’s survival rate of ABO-
incompatible (ABOi) adult living donor liver transplantation 
(ALDLT) was improved from 20% to 50%. And the adoption 
of anti-CD20 antibody (rituximab) has been brought on 
further improvement of outcome. Among those strategies, 
local infusion therapy (LIT) has made monumental turning-
point of clinical outcome of adult ABOi LDLT and its theo-
retical basis is that failed graft in ABOi LDLT has pathologic 
fi ndings of intravascular coagulation. But LIT accompanies 
substantial risk of morbidities such as bleeding, vascular 
injury or thrombosis. Since the introduction of Rit, the inci-
dence of AMR become nadir and LIT lacks intrinsic capacity 
for the prevention of AMR which is most dreadful complica-
tion in ABOi LDLT. Therefore, we postulated that the routine 
use of LIT was not essential component of strategies for 
overcoming ABO blood barrier. We have eliminated LIT 
from our protocol for adult ABOi LDLT after experience of 
20 cases of adult ABOi LDLTs with LIT.
Methods: December 2008 to March 2011, we have per-
formed 53 cases of adult ABOi LDLTs. Each patient received 
a single dose of rituximab (275 ∼ 375 mg/mm2) 2 weeks 
prior to LT. The frequency and timing of plasma exchange, 
depended on hemagglutinin titer, aiming at an antibody titer 
of 1:8 or less before LT. Spleen was preserved in all cases. 
LIT was employed in fi rst 20 cases (Group A) and no LIT in 
the rest (Group B). We retrospectively reviewed clinical data 
of all patients and compare the outcome between 2 groups.
Results: There was no difference in donor and graft factors 
such as age, sex ratio, body mass index, graft-to-recipient 
body weight ratio, steatosis. There was no difference in 
recipient factors such as age, sex ratio, MELD, original 
disease and ABO mismatch paring. The follow-up period 
was signifi cantly longer in Group A (17.8 ± 7.5 vs 6.7 ± 2.5 
month, p < 0.001). The only 1 in-hospital mortality caused 
by pneumonia occurred in group A. And the additional mor-
tality occurred on post-transplantation 4 month in Group A 
and the cause of death was biliary sepsis. The 3-month 
patient’s survival rate was 95.0% (Group A) and 100% 
(Group B), respectively. There was no signifi cant difference 
in the incidence of biliary complication, acute cellular rejec-
tion but infectious complication was more frequent group A. 
Total 7 episode of LIT-related complication occurred in 5 
patients (25%). Among those complications, 2 episodes were 
hepatic arterial injuries. By analysis of biochemical param-
eters between 2 groups such as serum AST/ALT, total bili-
rubin, prothrombin time, albumin showed no difference in 
peak level, day period for normalization. Two groups showed 
the similar pattern in the trend of post-LDLT anti-donor 
antibody titer and CD19 cell population. One case of AMR 
occurred in Group B which was successfully rescued by 
steroid pulse and PE.
Conclusion: In our result, the protocol without LIT can 
abolish the LIT-related complication and can be successfully 
applied to overcome ABO-blood barrier without any increase 
of immunologic risk.
P-025
EXTENDED CRITERIA FOR LIVING 
DONOR LIVER TRANSPLANTATION IN 
PATIENTS WITH ADVANCED 
HEPATOCELLULAR CARCINOMA
D. G. Kim, K. Y. Na, H. J. Choi, T. H. Hong and Y. K. Yoo
Department of Surgery, Catholic University of Korea, 
Seoul, Korea
Introduction: There have been many debates on extension 
of selection criteria for HCC from Milan criteria.
Methods: The 52 patients (36.4%) who underwent LDLT 
beyond Milan criteria among 143 patients with HCC from 
Oct., 2000 to May, 2010 at Department of Surgery, Catholic 
University of Korea were reviewed retrospectively. We eval-
uated the survival curve, prognostic factors for survival and 
compared survival between our new criteria and Milan 
criteria.
Results: Any tumor size and any level of serum AFP but no 
tumor number were infl uenced disease free survival and 
patient survival. The prognostic factor affecting to disease 
free survival included serum AFP level, tumor size, vascular 
invasion, tumor cell differentiation and pretransplant treat-
ment and the prognostic factors affecting to survival included 
serum AFP level, tumor size, vascular invasion and tumor 
cell differentiation on univariate analysis. In multivariate 
analysis, AFP (200 ng/ml), tumor size (7 cm) and vascular 
invasion had signifi cant infl uenced on survival and disease 
free survival. So according to our new criteria (size, <−7 cm, 
AFP, <200 ng/ml), 88.1% of our patients were included 
compare to 63.6% in Milan criteria. The survival, meet two 
factors in our new criteria was comparable to survival on 
Milan criteria. Survival on 3, 5 years who was meet one 
factor was 44% and 29.3%.
Conclusion: Tumor size <7 cm and AFP <200 ng/ml 
appeared the useful cut-off value in beyond Milan criteria. 
Analysis according to our criteria showed acceptable sur-
vival outcome.
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P-026
SURGICAL OUTCOME OF RIGHT 
LOBECTOMY FOR LIVING DONOR 
LIVER TRANSPLANTATION IN LARGE 
VOLUME SINGLE CENTER
D. G. Kim, S. J. Kim, K. Y. Na, H. J. Choi, T. H. Hong 
and Y. K. Yoo
Department of Surgery, Catholic University of Korea, 
Seoul, Korea
Introduction: Right lobe donation usually matched graft 
size in adult but safety of donor is major concerned regarding 
diffi cult surgical technique and surgical complications.
Methods: From May 1999 to February 2011, a total of 500 
adult-to-adult LDLTs using a right lobe were performed in 
our center. We divided the donor operations into 3 periods: 
period A (May 19, 1999 – Nov. 11, 2003; n = 100), period 
B (Nov. 14, 2003 – Jul. 10, 2007; n = 200), and period C 
(Jul. 13, 2007 – Feb. 7, 2011; n = 200). We reviewed clinical 
data on each period, surgical complications by Clavien’s 
classifi cation and it’s treatment, factors infl uenced surgical 
complications.
Results: Operative time, amount transfusion and postoper-
ative hospital stay were reduced in period C. There was no 
mortality and total complication rate was 28.2%, not related 
to period. Grade 1, 2, and 3 complications were 10.8%, 
7.8% and 9.6% respectively. Biliary complications were 
most common and progressively decreased without signifi -
cantly. The all biliary complications (n = 52) except one 
were successfully treated by percutaneous or endoscopic 
rout and both. Through multivariate analysis, readmission 
was identifi ed as a factor related with biliary complications. 
The degree of fatty change and remained liver volume were 
correlating factors with highest level of total bilirubin after 
operation.
Conclusion: Substantial proportion of donors suffered from 
donor complications and right liver donation require a metic-
ulous surgical technique to minimizing morbidity especially 
related to biliary complications
P-027
A HIGH-FLOW HEPATIC HEMANGIOMA 
MIMICKING HEPATOCELLULAR 
CARCINOMA ON GADOXETIC ACID–
ENHANCED MRI
H. J. Kim, B. G. Choi, E. K. Park, H. H. Kim, Y. H. Hur, 
Y. S. Koh, J. C. Kim, H. J. Kim and C. K. Cho
Chonnam National University Medical School, Gwangju, 
South Korea
Introduction: The hepatic hemangioma could be distin-
guished from hepatocellular carcinoma (HCC) in the point 
of bright signal intensity on T2-weighted image of MRI. 
However, some atypical hemangiomas, especially high-fl ow 
hemangiomas, may show rapid, intense homogeneous arte-
rial enhancement and iso-intense or slightly hyper-intense 
signal during equilibrium phase. These kinds of early enhanc-
ing hemangiomas can mimic hypervascular hepatic tumors, 
such as HCC.
Methods: A 65-year-old male admitted because of inciden-
tally detected liver mass. Abdominal CT showed well demar-
cated mass in left lateral segment with early enhancing and 
early wash out pattern. On liver MRI, the mass was detected 
as slightly low signal intensity on T1-weighed image and 
heterogeneous signal intensity on T2-weighted image. 
Moreover it was well enhanced at arterial phase and washed 
out at delayed phase. The diagnosis was made by HCC 
according to the fi ndings of imaging study.
Results: In operation, about 3 cm sized soft mass was found 
in S3 of liver, and wedge resection was performed. 
Microscopic examination and immunohistochemical study 
confi rmed that the mass was hemangioma instead of HCC 
fi nally.
Conclusions: The high-fl ow hemangioma, in case of 
showing pseudo washout sign on gadoxetic acid–enhanced 
MRI, is diffi cult to differentiate with HCC. High-fl ow hem-
angiomas should be considered when the following fi ndings 
are observed on gadoxetic acid–enhanced MRI; bright signal 
intensity on T2-weighted image, arterial-phase dominant 
enhancement, pseudo washout sign during the equilibrium 
phase, frequent perilesional arterioportal shunt, and iso-
intensity or slightly increased signal intensity on subtraction 
images between the unenhanced phase and the equilibrium 
phase.
P-028
THE EFFECTS OF AN 
ANTIHYPERTENSIVE DRUG, 
CAPTOPRIL, ON LIVER REGENERATION 
AND COLORECTAL CANCER LIVER 
METASTASES
S. L. Koh, E. I. Ager, C. Malcontenti-Wilson, 
V. Muralidharan and C. Christophi
The University of Melbourne, Department of Surgery, 
Austin Health, Heidelberg, Australia
Introduction: Liver regeneration (LR) following liver 
resection (PH) for colorectal cancer liver metastases 
(CRCLM) may be associated with high tumor recurrence. 
We have shown that the renin-angiotensin system (RAS) is 
up-regulated during LR and an inhibition of the angiotensin-
converting enzyme using captopril, signifi cantly inhibited 
CRCLM. This study investigated the effects of captopril on 
LR and CRCLM following PH.
Methods: 70% PH and CRCLM models have been well 
established in our department. CBA mice were randomized 
to 70% PH and 70% PH with CRCLM. Liver specimens 
were collected on days 1, 2, 4, 6, 8 post-PH and also on days 
16 and 21 (with CRCLM). The effects of captopril (750 mg/
kg) were measured by liver-to-body weight ratio (LBW) and 
hepatocyte proliferation, apoptosis and size. Further mea-
surements of liver stellate cell count and matrix metallopro-
teinase (MMP)-9 were also performed.
Results: Captopril did not inhibit liver regeneration. 
Captopril increased LBW on day 2 (0.57) compared to con-
trols (0.49) but by day 6, captopril decreased LBW (0.5 
compared to 0.73). LBW was similar between controls and 
treated by day 8. Interestingly on day 2, hepatocyte prolifera-
tion (3.4 compared to 53.7% for controls) and size (303.1 
compared to 406.3 μm2) were decreased by captopril, while 
stellate cells (65.39 cells/100 000 μm2) and liver MMP-9 
(0.68 units/mm2) were increased (controls having 48.08 
cells/100 000 μm2 and 0.12 units/mm2). Hepatocyte apopto-
sis was unchanged by captopril.
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Conclusion: Captopril-associated improvement in LR is 
possibly attributed to stellate cells and MMP-9, and not 
changes in hepatocyte proliferation, apoptosis or size.
P-029
LIVING DONOR LIVER 
TRANSPLANTATION IN A JEHOVAH’S 
WITNESS-CASE REPORT
G.-S. Choi, H.-C. Kim, J. C. Chung and H. J. Lee
Department of surgery, Soonchunhynang university 
Bocheon, Kyunggi-do, Repurblic of Korea
Purpose: Orthotopic liver transplantation is typically asso-
ciated with large volume blood loss. Technological and phar-
macological advances permit liver transplantation in patients 
who formerly were not candidates for this surgery because 
of strict limitations on blood product administration. We 
describe a liver transplant in a Jehovah’s Witness with liver 
cirrhosis related with HBV infection.
Clinical Features: A 52-year-old Jehovah’s Witness with 
liver cirrhosis related with HBV infection and end stage 
liver disease presenting with uncontrolled ascites underwent 
orthotopic liver transplantation. MELD score was 18. 
Recombinant human erythropoietin (10,000 IU sc every two 
days for four weeks, then 10,000 IU sc every day for one 
week) established a normal hemoglobin concentration pre-
operatively (>13.1 g/dl compared with 7.3 g/dl baseline). 
Intraoperatively, strategies for reducing risk of blood pro-
duct transfusion included avoidance of hypothermia (T > 
35°C), minimal blood sampling (four 1 ml samples), nor-
movolemic hemodilution (3 units) and return of blood 
(300 ml) scavenged from the operative fi eld. Estimated 
blood loss was 600 ml. The preoperative and postoperative 
hemoglobin concentration was 13.4 g/dl (hematocrit 0.38) 
and 11.4 g/dl (hematocrit 0.32), respectively. No blood 
products were required and he was discharged 15 days 
postoperatively without complication.
Conclusion: Technological and pharmacological advances 
allow patients to undergo surgery traditionally associated 
with large volume blood loss with reduced risk of blood 
product administration.
P-030
PROGNOSTIC ANALYSIS OF FIFTY-
FOUR CASES OF THE RISK 
HEPATECTOMY
H. Li and X. Wang
Tumor Hospital of XinJiang Medical University, Urmuqi, 
P.R.China
Objective: To explore the prognosis factors of the risk hepa-
tectomy for liver tumor.
Methods: The clinicopathologic data of 54 pathions who 
underwent the risk hepatectomy at Hepatobiliopancreatic 
Surgery of Tumor Hospital affi liated Xinjiang Medical 
University form January 2005 and June 2008 was analyzed 
retrospectively, Kaplan-Meier method and Cox regresstion 
model were used to analyze the survival and prognosis.
Results: The median survival time of patients underwent 
resection was 22.0 months. The survival rates of 1, 2, 3 year 
were 88.9%, 46.5%, 29.0% respectively. Univariate analysis 
showed that degree of cirrhosis, tumor with envelope, mul-
tiple tumor, tumor thrombus in portal vein or hepatic veins 
and the intraoperative quantity blooded was signifi cant por-
gnostic factors. The Cox multivariate analysis indicated that 
independent prognostic factors were degree of cirrhosis, 
tumor envelope, multiple tumor, tumor thrombus in portal 
vein, the intraoperative quantity blooded.
Conclusions: Actively risk hepatectomy for liver tumor 
offers the chance of long-term survival, especially for low 
degree of cirrhosis and tumor with envelope. However, risk 
hepatectmy for liver tumor coexisting multiple tumor and 
tumor thrombus in portal vein or hepatic veins also raise 
survival rate. To degree the intraoperative quantity blooded 
was the important factor for long-term survival. For coexist-
ing tumor thrombus in bile duct was not hepatectomy con-
traindication and porgnostic factors.
Key words: Liver tumor; Hepatectomy; Prognosis
P-031
THE PROGNOSTIC SIGNIFICANCE OF 
PREOPERATIVE SERUM LEVELS OF 
EXTRACELLULAR MATRIX PROTEIN 1 
IN PATIENTS WITH HEPATOCELLULAR 
CARCINOMA
J.-S. Li, W.-D. Jia, G.-L. Xu and H. Chen
Center for the Study of Liver Cancer and Department of 
Hepatic Surgery, Anhui Provincial Hospital, Anhui Medical 
University, No. 17 Lujiang Road, Hefei 230001, Anhui, 
China
Introduction: Extracellular matrix protein 1 (ECM1) is a 
glycoprotein involved in many biological processes. To eval-
uate the prognostic value of preoperative serum ECM1 levels 
in patients with hepatocellular carcinoma (HCC).
Methods: Preoperative serum levels of ECM1 were detected 
by enzyme-linked immunosorbent assay (ELISA) in 117 
patients with HCC and 53 healthy volunteers.
Results: We found that the median serum ECM1 level in 
HCC patients was signifi cantly higher than that in healthy 
volunteers (166.39 vs 108.06 pg/ml, P < 0.001). Median 
serum ECM1 levels were signifi cantly higher in patients with 
advanced TNM stage (P < 0.001), multiple nodule (P = 
0.028), vascular invasion (P < 0.001), severe liver cirrhosis 
(P < 0.001) and larger tumor size (P = 0.001). On the basis 
of the receiver operating characteristics curve, 180 pg/ml 
was defi ned as the critical value for the ECM1 levels, the 
sensitivity was 80.9%, and specifi city was 80.0%. The 
median for serum ECM1 levels of the HCC patients with 
recurrence was signifi cantly higher than those without recur-
rence (P < 0.001). On Cox proportional-hazard model mul-
tivariate analysis, high serum ECM1 level (>180 pg/ml) was 
an independent prognostic factor for overall survival and 
disease free survival of HCC patients.
Conclusions: Serum ECM1 levels are signifi cantly corre-
lated to the invasive phenotypes and survival rate. Thus, 
serum ECM1 level can be used as a predictive marker for 
recurrence and prognostic factor of HCC patients after 
surgery.
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P-032
FAVORABLE OUTCOME OF STEPWISE 
TREATMENT FOR MULTIPLE 
PYOGENIC LIVER ABSCESSES
K. Mimatsu1, T. Oida1, H. Kano1, N. Fukino1, 
A. Kawasaki1, K. Kida1, Y. Kuboi1 and S. Amano2
1Department of Surgery, Social Insurance Yokohama 
Central Hospital; 2Department of Surgery, Nihon 
University School of Medicine
Introduction: Percutaneous trans-hepatic drainage has 
become fi rst-line treatment for pyogenic liver abscess. 
However, treatment of multilocular or multiple liver 
abscesses are often diffi cult. This retrospective study was to 
assess the effi cacy of stepwise treatment of pyogenic liver 
abscesses.
Methods: Twenty-three patients with pyogenic liver 
abscesses in the single institute were prospectively enrolled 
to evaluate the clinical benefi ts of the stepwise treatment. All 
of eighteen cases were performed the stepwise treatment as 
follows; Step 1 is percutaneous trans-hepatic abscess drain-
age (PTAD) and systemic intravenous antibiotics. Step 2 is 
hepatic arterial infusion with antibiotics or administration of 
metronidazole. Step 3 is hepatic arterial infusion with anti-
biotics and administration of metronidazole.
Results: Step 1 therapy revealed effectiveness in 11 cases 
of all. Most of the patients with multilocular or multiple 
lesions and with mixed growths result of bacteriological 
culture in pus did not recover with step 1 treatment. Therefore, 
they were necessarily procedure step 2 and step 3. Eight 
patients with administration of metronidazole showed the 
effect in 6 patients. Especially, 2 of 3 patients with anaerobes 
result of bacteriological culture in pus were improved by 
administration of metronidazole. But methicilin resistant 
staphylococcus aureus (MRSA) enteritis as complication 
caused in 2 of 8 cases.
Conclusions: Abscess drainage with systemic intravenous 
antibiotics and hepatic arterial infusion with antibiotics were 
the most important initial procedure, but if this procedure is 
not effective, administration of metronidazole is useful treat-
ment for pyogenic liver abscess caused by anaerobes, 
regarded as bacterial translocation.
P-033
LAPAROSCOPY-ASSISTED 
HEPATECTOMY UNDER THE LIFTING 
METHOD FOR LIVER TUMOR
K. Mimatsu1, T. Oida1, H. Kano1, N. Fukino1, 
A. Kawasaki1, K. Kida1, Y. Kuboi1 and S. Amano2
1Department of Surgery, Social Insurance Yokohama 
Central Hospital, Yokohama, Japan; 2Department of 
Surgery, Nihon University School of Medicine, Tokyo, 
Japan
Introduction: Laparoscopy-assisted hepatectomy has not 
been become standard procedure due to some technical 
problems.
Introduction: We reviewed 5 cases of laparoscopy-assisted 
hepatectomy without Pringle maneuver under lifting method. 
The technical procedure is as below; Lifting method was 
performed and any patients were not required Pringle maneu-
ver. Before parenchymal resection of the liver, we decided 
the resection line at 2 cm distant from tumor edge using with 
laparoscopic ultrasonography. Precoagulation of the liver 
parenchyma was performed with the microwave coagulator 
(MC). After precoagulation of the resected line, resection of 
the liver parenchyma was performed using with the ultra-
sonically activated coagulating shears (LCS).
Introduction: The mean age was 64.8 years old, male in 2 
cases and female in 3 cases. Liver damage was A in 3 cases 
and B in two cases. The mean operation time was 
158.6 minutes and blood loss was 154.8 g. Wound burn was 
observed in 2 cases. There were no late hemorrhage, bile 
leakage, and port site or peritoneal metastases.
Conclusions: Laparoscopy-assisted hepatectomy using 
with MC and LCS under the lifting method is safe procedure 
in the tumor of the liver surface.
P-034
THE DYSFUNCTIONAL AREA AND 
CONGESTIVE AREA AFTER 
HEPATECTOMY WITH MAIN HEPATIC 
VEIN RESECTION
M. Han, A. Shunichi, K. Yoshihito, T. Yutaka, K. Takaaki, 
K. Satoshi, E. Hiroto and Y. Masakazu
Department of Surgery, Institute of Gastroenterology, 
Tokyo Women’s Medical University, Tokyo, Japan
Introduction: To evaluate the function of the congestive 
area after hepatectomy with main hepatic vein (HV) 
resection.
Methods: From November 2010 until May 2011, 8 patients 
underwent hepatectomy including the main hepatic vein 
(HV). Of these, left hepatectomy (LH) with middle hepatic 
vein (MHV) was performed in 4 patients, right hepatectomy 
(RH) with MHV in 3 patients, and posterior sectionectomy 
with right HV in 1 patient. Post-hepatectomy, all patients 
underwent gadoxetic acid disodium enhanced magnetic reso-
nance imaging (EOB-MRI) within 4 weeks. The congestive 
area appeared as a hyper-intense area on T2-weighted 
images. The function of the congestive area was evaluated 
on hepatobiliary phase images. After comparison with the 
intensity of normal liver, the area with low intensity was 
defi ned as dysfunction.
Results: Six of 8 patients showed a congestive area in the 
remnant liver on T2-weighted images, and the mean conges-
tive area was 10% of the remnant liver (range 5–14%). 
Nevertheless, all patients showed a dysfunctional area, and 
the mean dysfunctional area was 17% of the remnant liver 
(range 2–27%). In 7 of 8 patients the dysfunctional area was 
bigger than the congestive area. According to the surgical 
procedure, in 4 patients who underwent left hepatectomy 
with MHV the mean dysfunctional area was 12% of the 
remnant liver, but it was 24% in patients who underwent 
right hepatectomy with MHV.
Conclusions: The dysfunctional area was more extended 
than the congestive area after hepatectomy with HV.
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P-035
USEFULNESS OF THE COMBINATION 
PROCEDURE OF CRASH CLAMPING 
AND VESSEL SEALING FOR HEPATIC 
RESECTION
A. Nanashima, T. Abo, T. Sawai and T. Nagayasu
Division of Surgical Oncology, Nagasaki, Japan
Introduction: To reduce blood loss and transection time of 
hepatic parenchyma, the advanced forceps-style vessel 
sealing device was applied.
Methods: Control group was 59 patients undergoing hepa-
tectomy with crush clamp method between 2000 and 2007. 
Since 2008, forceps style vessel sealer was applied for 
hepatic transection in 55 cases including LigaSure precise or 
Harmonic Focus Curved sealer. A large hepatic vessels were 
cut by vascular linear stapler.
Results: In segmentectomy or sectionectomy, injured liver 
disease were more signifi cant in the LigaSure group and, 
however, intraoperative blood loss and use of transfusion 
were signifi cantly lower in comparison with control group 
(708 vs. 1579 ml, 13% vs. 41%; p < 0.05). Transection and 
operative time was lower in the vessel sealer group (33 vs. 
56 min, 341 vs. 491 min; p < 0.05). Incidence of abdominal 
infection was lower in the vessel sealer group (0 vs. 29%). 
In patients undergoing major hepatectomy, blood loss and 
transection time were signifi cantly lower in the vessel sealer 
group (1054 vs. 2000 ml, 39 vs. 48 min; p < 0.05). Incidence 
of abdominal infection and hospital stay period were lower 
in the vessel sealer group (0 vs. 21%, 21 vs. 36 days; p < 
0.05). In case of hepatectomy with lymphadenectomy, 
Harmonic Focus was quite useful to reduce blood loss. We 
showed combined resection of posterior sectionectomy and 
pulmonary, diaphragm and chest wall resection using 
LigaSure Impact by a video.
Conclusions: Forceps style vessel sealer is a useful device 
to achieve bloodless hepatectomy, which was associated with 
improvement of patient outcomes.
P-036
A NEW APPLICATION OF NEAR-
INFRARED FLUORESCENCE IMAGING 
FOR IMAGE-GUIDED HPB SURGERY_ 
INITIAL EXPERIENCE
H. Narasaki, E. Tanaka, J. Matsumoto, K. Kato, 
T. Tsuchikawa, T. Shichinohe and S. Hirano
Hokkaido University Graduate School of Medicine, 
Sapporo, Japan
Introduction: Near-infrared fl uorescence (NIR) imaging 
technology has been recently applied in the fi eld of human 
surgery. NIR imaging has some advantages over radiographic 
imaging. In the OR, NIR has no regulation and no need of 
protection. NIR imaging system is generally cheaper than 
roentgenographic imaging system. It is important to under-
stand fundamental facts for NIR imaging.
Methods: ICG was used for fl uorescent contrast agent. 
Photodynamic eye II (PDE) system (Hamamatsu Photonics, 
Hamamatsu, JAPAN) and mini-FLARE system (research 
product, Beth Israel Deaconess Medical Center, Boston, MA, 
USA) were used for fl uorescence detection system. These 
lead to showing real-time images during surgery. This makes 
image-guided surgery easy. The following two preliminary 
studies were done; 1. the intraoperative detection of lym-
phatic communication from hepatoduodenal ligament 
through para-aortic lymphatic basin; this study was also 
aimed for detection of “sentinel” para-aortic lymph nodes. 
ICG solution was injected in Calot’s triangle and the move-
ment of the ICG fl uorescence was observed. 2. intraoperative 
identifi cation of liver subsegment; ICG intravenous injection 
was performed after subsegmental Glissonian pedicle was 
identifi ed and clamped.
Results: 1; lymphatic anatomy was visualized in all patients, 
however, identifi cation of “sentinel” para-aortic lymph nodes 
was possible in 5 out of 13 patients. 2; Fluorescence defect 
in liver subsegment which should be resected was easily 
identifi ed in 1 of 4 patients.
Conclusion: NIR imaging should be suitable for real-time 
image-guided surgery. Lymphatic anatomy and liver blood 
perfusion can be visualized.
P-037
SPATIAL MORPHOLOGICAL AND 
MOLECULAR DIFFERENCES IN 
TUMORS: MAJOR CONTRIBUTORS TO 
DRUG RESISTANCE
L. Nguyen, T. Fifi s, C. Malcontenti-Wilson 
and C. Christophi
The University of Melbourne, Department of Surgery, 
Austin Health, Heidelberg, Australia
Introduction: Solid tumors are complex and heterogeneous 
in nature; composed of tumor and stromal cells embedded in 
an extracellular matrix and fed by vascular networks. Rapid 
proliferation of tumor results in constant vessel remodelling, 
ineffi cient perfusion and tumor regions characterized by 
hypoxia and acidosis. Hypoxia in the tumor centre results in 
localized necrosis while near the periphery it induces proan-
giogenic cell infi ltration and neovascularization. Using a 
vascular disruptive agent Oxi4503 we demonstrated tumor 
resistance in the periphery.
Methods: In murine model of colorectal (MoCR) liver 
metastases, spatial differences between the peripheral and 
central regions of untreated tumors and changes following 
Oxi4503 treatment were examined by H&E and 
immunostaining.
Results: We found signifi cant differences between the 
periphery and the tumor centre in proangiogenic factor 
(VEGF, AT1R and HIF1-α) expression, in infi ltration of 
immune cells (macrophages T-cells), and in tumor vessel 
maturity. In addition a small proportion of tumor cells in the 
periphery demonstrated mesenchymal morphology (high 
ZEB1 and Vimentin expression loss of E-cadherin and 
nuclear accumulation of β-catenin). Oxi4503 treatment 
destroyed the central tumor vessels but not the vessels in the 
periphery. A tumor kinetics study revealed higher apoptotic 
tumor cells in the tumor central region compared to the 
peripheral region.
Conclusions: We have demonstrated signifi cant molecular 
and morphological differences between the periphery and the 
bulk of the tumor and these may account for the drug resis-
tance observed.
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P-038
SUNITINIB/OXI4503 COMBINATION 
THERAPY ON A MURINE MODEL OF 
COLORECTAL CARCINOMA (CRC) 
LIVER METASTASIS
L. Nguyen, T. Fifi s, C. Malcontenti-Wilson 
and C. Christophi
The University of Melbourne, Department of Surgery, 
Austin Health, Heidelberg, Australia
Introduction: Tumor resection is the only potentially cura-
tive treatment of CRC liver metastasis. Chemotherapy is 
only used palliatevely and there is an urgent need for new 
effective treatments. In earlier studies we demonstrated that 
OXi4503, a vascular targeting agent, leads to widespread 
tumor necrosis but does not achieve complete eradication. 
Other studies have demonstrated the antiangiogenic drug 
Sunitinib, a multitargeted tyrosine kinase inhibitor, in com-
bination with cytotoxic drugs prolongs survival in experi-
mental and clinical studies. Here we investigate Sunitinib/
OXi4503 combination therapy on a murine model of CRC 
liver metastasis.
Methods: Male CBA mice were induced with CRC liver 
metastases. From day 14 post tumor induction mice received 
daily Sunitinib (40 mg/kg) intraperitoneal (IP) injections for 
the next 7 days. A single IP injection of OXi4503 (100 mg/
kg) was also administered at day 16 post tumor induction.
Results: The combined treatment signifi cantly reduced 
viable tumor compared to either single therapy alone. Tumor 
kinetics revealed signifi cantly increased tumor apoptosis and 
reduced tumor proliferation following combination treat-
ment. Upregulation of the mesenchymal markers ZEB1 and 
Vimentin and nuclear accumulation of E-cadherin and 
β-catenin indicate the surviving tumors may become resis-
tant to combination therapy by adopting a mesenchymal 
morphology.
Conclusions: Combination treatment is more effective in 
reducing tumor load than either treatment alone, however the 
tumor is not totally eradicated. Changes in cell morphology 
following combination therapy suggest that Epithelial 
to Mesenchymal Transition (EMT) may confer drug 
resistance.
P-039
US-GUIDED PERCUTANEOUS DRAINAGE 
TREATMENT FOR PYOGENIC LIVER 
ABSCESS
A. Nugroho, R. Y. Saunar, A. S. Putranto and B. Philippi
Digestive Division, Cipto Mangukusumo Hospital, Faculty 
of Medicine, University of Indonesia, Jakarta, Indonesia
Background: Percutaneous drainage has become the fi rst-
line treatment for pyogenic liver abscess although some 
centers still preferred surgical drainage as advised in the 
recent past. The aim of this retrospective study was to assess 
the effectiveness of percutaneous drainage, in terms of effi -
cacy, length of hospital stay and costs.
Methods: Patient’s outcomes, including the length of hos-
pital stay, procedure-related complications and treatment 
failure were recorded. Data of 12 patients (8 males; 4 
females; mean age, 50 yrs; range, 19–74 yrs) were retrospec-
tively analyzed.
Results: Eleven cases (10 with solitary and one with mul-
tiple abscesses) were successfully treated with US-guided 
percutaneous drainage using 10F-12F thoracic tube without 
surgical intervention, and one patient had conservative treat-
ment only. All of them received broad spectrum antibiotics. 
Most of our cases involving a large diameter abscess with 
symptoms of pain and infections, and no history of other 
pathology. All patients return home after a short period of 
hospital stay with no morbidity or death.
Conclusions: US-guided percutaneous drainage for pyo-
genic liver abscess carries a lower morbidity with a lower 
hospital cost.
P-040
THE CASE OF HEPATOCELLULAR 
CARCINOMA WITH LEFT-SIDED 
GALLBLADDER DUE TO AN 
ANOMALOUS PORTAL VEIN 
BRANCHING
A. Omori, S. Katagiri, Y. Kotera, S. Ariizumi, 
Y. Takahashi, T. Kato, J. Takasaki, G. Yoneda, H. Egawa 
and M. Yamamoto
Tokyo Women's Medical University, Tokyo, Japan
Introduction: A left-sided gallbladder is a rare congenital 
anomaly. But in many cases, this anomaly combined with an 
anomalous portal vein branching. We report a case of a 
patient with hepatocellular carcinoma (HCC), who has a 
left-sided gallbladder combined with an anomalous portal 
vein branching.
Patient: A 72 year-old woman has been treated for chronic 
hepatitis type C for 10 years. A liver tumor was detected on 
ultrasonography (US). Needle biopsy revealed this tumor is 
a well-differentiated HCC. US, Computed tomography (CT), 
3DCT shows an anomalous portal vein branching. At fi rst, 
the portal branch of posterior segment bifurcated from the 
portal trunk. The next a portal branch of anterior segment 
bifurcated from the portal trunk and the left portal vein did 
not have P4. The round ligament connected to the portal 
branch of an anterior segment.
An operation was performed. The gallbladder located in the 
ventral side of the round ligament. After we performed cho-
lecystectomy, tore the capsule of Glisson along the round 
ligament and recognized the portal vein branch of the lateral 
segment. We confi rmed that the tumor exists in the lateral 
segment of the liver, and we performed lateral segmentec-
tomy of the liver.
Conclusions: When we fi nd the patients with left-sided gall-
bladder, we need to think about there might be an anomalous 
portal vein branching is presented. Because sometimes liver 
surgery is complicated due to an anomalous portal vein 
branching.
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P-041
DE NOVO MALIGNANCY IN LIVER 
TRANSPLANT RECIPIENTS
H.-W. Park, S.-G. Lee, S. Hwang, K.-H. Kim, C.-S. Ahn, 
D.-B. Moo, T.-Y. Ha, G.-W. Song, D.-H. Jung 
and G.-C. Park
Department of Hepatobiliary Surgery and Liver 
Transplantation, University of Ulsan College of Medicine 
and Asan Medical Center, Seoul, South Korea
Purpose: De novo malignancy is a frequent complication 
after organ transplantation which requires immunosuppres-
sive therapy. Posttransplant immunosuppressive medications 
result in decreased immune surveillance against malignant 
cells and increase the risk of malignancies mediated by 
various viruses. In this study, we tried to investigate the 
incidence patterns and treatments of de novo malignancy 
after liver transplantation (LT), especially mainly after living 
donor liver transplantation.
Methods: Between August 1992 to December 2009, 2519 
LTs were performed, living donor liver transplantation cases 
were 2171 and deceased donor liver transplantation cases 
were 348. Medical records of these patients were retrospec-
tively reviewed.
Results: Among them, 57 patients (2.3%) revealed de novo 
malignancies. In this single-center series, the incidence rate 
of de novo malignancy was rather low. Common cancers 
were PTLD (post-transplant lymphoproliferative disorder) 
(n = 4) and poorly differentiated carcinoma of unknown 
origin (n = 3) at the fi rst year; colon cancer (n = 4) and gastric 
cancer (n = 4) at the second and third year; gastric cancer 
(n = 6) and colon cancer (n = 2) at the fourth and fi fth year; 
colon cancer (n = 4) and breast cancer (n = 2). The patterns 
of de novo malignancy were different from those in the 
western countries. The common malignancies were stomach 
cancer and colon cancer in this series, but skin cancer, lym-
phoma and lung cancer were much less frequent comparing 
with the results from western countries. Low compliance to 
routine screening checkup was observed in a majority of 
patients.
Conclusion: The incidence of de novo malignancy after LT 
requires special attention because their clinical course may 
determine the patient survival. The results of this study 
revealed that the common malignancies in Korean general 
society, such as gastric cancer, are also common in patient 
who underwent LT. To detect these de novo malignancies in 
time and to manage them not too late, periodic screening 
checkup should be performed. The screening protocol should 
follow that for general population. Reasonable and repeat 
education seems to be essential to solve the intractable 
problem of low compliance for routine cancer screening.
P-042
EPSTEIN-BARR VIRUS ASSOCIATED 
FULMINANT HEPATITIS REQUIRING 
LIVER TRANSPLANTATION (CASE 
REPORT)
H. W. Park, S. G. Lee, S. Hwang, K. H. Kim 
and Y. H. Park
Division of Liver Transplantation Surgery, Department of 
Surgery, University of Ulsan College of Medicine and Asan 
Medical Center, Seoul, Korea
Introduction: Epstein-Barr virus (EBV) is one of the most 
common viruses, infecting more than 90% of humans and 
persisting throughout life. Whereas most EBV primary infec-
tions of infants and children are asymptomatic or have non-
specifi c symptoms, infections of adolescents and young 
adults frequently result in symptomatic infectious mononu-
cleosis. More than 50% of these patients present with the 
triad of fever, generalized lymphadenopathy, and pharyngi-
tis. Approximately 10% of symptomatic patients have sple-
nomegaly, palatal petechiae, and hepatomegaly. Less 
commonly, severe complications occur such as hemolytic 
anemia, myocarditis, hepatitis, splenic rupture, meningitis 
and encephalitis. We report a case of fulminant hepatitis 
related to a primary EBV infection in an immunocompetent 
19-year-old male.
Case Report: A previously healthy 19-year-old male devel-
oped a fl u-like syndrome. He received conservative treatment 
including pyretics in a local clinics. A week after, the patient 
present nausea, myalgia, chilling, and whole body jaundice. 
He was admitted to a medical intensive care unit. On admis-
sion, he was noted to be febrile, weak, and icteric. The serum 
ALT level was 3083 IU/L (normal range: 0–40 IU/L) and 
AST level was 1796 IU/L (normal range: 0–40 IU/L) sug-
gesting an acute cytolytic hepatitis. The platelet count in 
peripheral blood was 31000/mm3. Abdominal CT revealed 
hepatosplenomegaly without biliary obstruction. The follow-
ing day, the patient showed loss of consciousness with acute 
renal failure. Mechanical ventilation and extra-renal support 
were urgently applied. Results of blood tests for hepatitis A, 
B, C, and E viruses were not indicative of prior or current 
infection. An HIV serum ELISA antibody test was non-reac-
tive. The results of Leptospirosis, Rickettsia, Hantan virus, 
Cytomegalovirus, Herpes simplex virus antibody tests were 
negative. Concerning Epstein-Barr virus, the serum 
EBV-VCA antibody were positive (IgG: 2.7, IgM: 1.8), the 
EBV nuclear antigen antibody IgG was also positive (IgG: 
4.7) which suggested recent primary EBV infection.
He was put on a liver transplant waiting list with absolute 
priority. Two days after, he underwent orthotropic liver trans-
plantation. The study of surgically extracted liver specimen 
showed positive for EBV by PCR. After liver transplantation, 
he recovered after an uneventful course of 26 days.
Conclusion: Sporadic cases of acute liver failure caused by 
primary EBV infection have been reported in the literature, 
with an overall mortality of 87%. We report the case of a 
young patient who developed fulminant hepatitis immedi-
ately following EBV primary infection. In addition to 
common blood tests, the detection of EBV antibody must be 
considered in any young boy developing an acute onset of 
hepatitis after a fl u-like syndrome, without obvious toxic or 
auto-immune cause. Our patient underwent emergent liver 
transplantation and he recovered well.
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P-043
THE EFFECTIVENESS OF 
PLASMAPHERESIS AS A LIVER 
SUPPORT FOR LIVER GRAFT 
DYSFUNCTION FOLLOWING ADULT 
LIVING DONOR LIVER 
TRANSPLANTATION
H.-W. Park1, C.-S. Park1, S. Hwang1, Y.-H. Park1, 
S.-W. Jung1, S.-Y. Yoon1, G.-C. Park1, G.-W. Song1, 
S.-W. Kwon2 and S.-G. Lee1
1Department of Surgery, Division of Hepatobiliary Surgery 
and Liver Transplantation, Asan Medical Center, University 
of Ulsan College of Medicine, Seoul, Korea; 2Department of 
Laboratory Medicine, Asan Medical Center, University of 
Ulsan College of Medicine, Seoul, Korea
Background: Severe graft dysfunction has been occasion-
ally encountered following adult living donor liver transplan-
tation (LDLT). This study intended to assess the effectiveness 
of plasmapheresis (PP) as a liver supportive measure in 
LDLT recipients showing severe graft dysfunction.
Methods: During two years from January 2007 to December 
2008, 517 adult LDLTs were performed in our institution. Of 
them 68 underwent PP therapy as a liver support.
Results: Fifty two underwent PP during the fi rst month fol-
lowing LDLT and another 16 underwent PP after that period. 
The underlying causes of such liver support were acute and 
chronic rejections, ischemic damage, viral hepatitis recur-
rence and unknown causes. A total of 944 sessions of PP 
were performed for these 68 patients, indicating 13.8 ± 8.2 
times per patient for 26.4 ± 31.7 days. Serum total bilirubin 
level was signifi cantly reduced following PP therapy: 24.93 
± 5.5 mg/dL before PP and 15.6 ± 4.2 mg/dL at 1 week after 
completion of PP (p < 0.001). Other biochemical parameters 
did not signifi cantly affected by PP. Overall 1-year patient 
survival rate was 58.6%. Six-month graft survival rate after 
completion of PP was 72.9% in 52 patients undergoing PP 
during the fi rst posttransplant month and 32.5% in 16 patients 
undergoing PP after 1 month (p = 0.021).
Conclusion: The results of this study implicate that PP has 
a benefi cial effect on the recovery of liver graft function, 
especially during the early posttransplant period. We suggest 
to perform active application of PP therapy for liver recipi-
ents showing severe graft dysfunction of total bilirubin 
greater than 10 mg/dL.
Keywords: Living donor liver transplantation, graft dys-
function, plasmapheresis
P-044
THE PROGNOSTIC IMPLICATIONS OF 
EGFR EXPRESSION IN PANCREATIC 
ADENOCARCINOMA AND LYMPH 
NODES
M. V. Perini, A. L. Montagnini, R. Patzina, R. Coudry, 
J. Jukemura, S. Penteado, A. Diniz, E. E. Abdo, 
T. Bacchella and I. Cecconello
Department of Gastroenterology, University of São Paulo 
Medical School (HC-FMUSP) and A.C. Camargo Hospital, 
Brazil
Introduction: Five year survival after resection of PA 
ranges from 10%–29% and EGFR expression has been 
related to its aggressiveness.
Aim: Analyze EGFR expression in pancreatic non-tumoral, 
tumoral and metastatic lymph node tissue and correlate it 
with clinicopathological fi ndings and survival after resection 
for PA.
Method: Between 1990–2006, 88 patients with PA were 
operated. Variables analyzed were: gender, differentiation, 
nodes, neural and vascular invasion, margin, TNM, mem-
brane EGFR (M-EGFR) and cytoplasmatic EGFR (C-EGFR) 
expression in tumor tissue, pancreatic non-tumor tissue and 
metastatic lymph node. TMA technique was used for imun-
nohistochemestry analysis.
Result: There were 47 females (53.4%) and 41 males 
(46.6%) with mean age of 59.1 y. Median survival and 5 y 
survival were 22.9 m and 18%. M-EGFR expression was 
positive in 35.5% of cases in tumor sample and in 23.8% in 
metastatic lymphnodes. M-EGFR expression was different 
in pancreatic non-tumor tissue when compared to tumor (p 
= 0.004) and nodes (p = 0.02). There was no difference 
between tumor and metastatic nodes. Only male gender was 
associated with M-EGFR expression in pancreatic tumor 
tissue. C-EGFR was positive in 11.3% of the tumor and 4.8% 
of metastatic lymph nodes. There were no differences in 
C-EGFR expression when tumor and metastatic nodes were 
compared. Gender, nodal and margin status, neural and vas-
cular invasion, TNM, peri-pancreatic invasion and positive 
tumor M-EGFR expression correlated with survival. On mul-
tivariate analysis, gender, neural invasion and portal vein 
resection were signifi cant.
Conclusion: Tumor M-EGFR expression has impact in sur-
vival in patients operated for PA and is related to its expres-
sion in metastatic lymph node.
P-045
COULD PRIOR SPLENECTOMY 
MODULATE HEAT SHOCK PROTEIN 70 
(HSP70) EXPRESSION DURING LIVER 
REGENERATION?
M. V. Perini, F. P. Lopasso, E. Sobrozza, R. H. Sayao, 
J. Requena, A. Cruz, A. C. D’Albuquerque 
and I. Cecconello
University of Sao Paulo Medical School, Department of 
Gastroenterology, São Paulo, Brazil
Background: Liver regeneration depends on the imbalance 
between the amount of residual liver and the infl ammatory 
response that occurs after hepatectomy. HSP70 is a chaper-
one over expressed in response to stress.
Objective: Analyze HSP70 expression in remain liver tissue 
in rats during liver regeneration.
Method: Male Wistar rats were divided in two groups: 1 – 
hepatectomy (H+) 2 – splenectomy and after three days 
hepatectomy (S+). N-acetilcystein (NAC) per os was admin-
istered for three days before hepatectomy and intravenous 
(20 mg/kg) deferoxamine and NAC (20 mg/kg) 1 hour 
before surgical procedure. Groups were then divided accord-
ing to post operative (PO) day: 1, 3 and 7. Imunnohistochemestry 
for HSP70 was performed and its expression in the liver and 
spleen were evaluated according to its intensity, percentage 
and location.
Results: There were 51 rats and group H+ has 26 rats and 
group S+ 25 rats. In the H+ group, splenic HSP70 expression 
was different regarding intensity (p = 0.04), cell type (p < 
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0.01) and percentage of cells (p < 0.01). Also, liver HSP70 
expression was different regarding intensity (p = 0.05), per-
centage (0.03) zone (p = 0.001). In the group S+, there was 
difference regarding intensity (p = 0.03), percentual (p = 
0.06) and zone (p = 0.03) expression. Linear regression 
regarding PO day and type of surgery, showed that prior 
splenectomy decreases HSP70 expression in the third PO day.
Conclusion: Prior splenectomy and NAC + DFX adminis-
tration does alter HSP70 expression in the remaining liver 
tissue.
P-046
LAPAROSCOPIC RESECTION OF 
HEPATIC ADENOMA: INDICATION, 
FEASIBILITY AND SAFETY
M. V. Perini, P. Herman, F. F. Coelho, R. M. Lupinacci, 
L. A. C. D’Albuquerque and I. Cecconello
Department of Gastroenterology, Hospital das Clínicas, 
University of São Paulo Medical School, São Paulo, 
Brazil
Background: Laparoscopic resection of benign liver dis-
eases has gained acceptance over conventional approach due 
to the ability to provide adequate surgical treatment associ-
ated to a superior cosmetic result. However, to date there are 
no studies reporting specifi cally the results of laparoscopic 
treatment of hepatocellular adenoma (HA).
Aim: The aim of this study is to discuss treatment strategy 
and assess feasibility, safety and outcomes of a series of pure 
laparoscopic resection (PLLR) for patients with HA.
Methods: Twenty-seven female patients submitted to PLLR 
were reviewed. Indications were: all lesions larger than 5 cm 
and selected lesions larger than 3 cm in a favorable anatomic 
position (anterior or lateral segments).
Results: The mean age was 34.5 years. Twenty-three 
patients had a single lesion, one had two, one had four and 
two had liver adenomatosis. Mean tumor size was 6.4 cm 
(±3.4 cm). Three right hepatectomies, 13 left lateral sectio-
nectomies, six wedge resections and fi ve segmentectomies 
were performed. There were no blood transfusions or conver-
sions. Post-operative complications occurred in two (7.4%) 
patients. Mean hospital stay was 3.8 days. All patients are 
alive and after a mean follow-up of 24 months (range 3 to 
42 months), no recurrences were observed.
Conclusions: PLLR is safe and feasible and should be con-
sidered as new standard of care for the treatment of HA when 
performed by surgeons with experience in liver and laparo-
scopic surgery.
P-047
TREATMENT OF UNRESECTABLE 
HEPATOCELLULAR CARCINOMA BY 
HEPATIC ARTERIAL INFUSION 
CHEMOTHERAPY COMBINED WITH 
RADIOTHERAPY
J. Tani, H. Miyoshi, H. Yoneyama, A. Deguchi 
and T. Masaki
Kagawa University, Miki-cho, Japan
Introduction: Hepatocellular carcinoma (HCC) with portal 
vein tumor thrombosis (PVTT), biliary invasion (BI) or infe-
rior vena cava invasion (IVCI) is associated with poor prog-
nosis. The aim of this study was to evaluate the effi cacy of 
hepatic arterial infusion chemotherapy (HAIC) with radio-
therapy for patients with these diseases.
Methods: Between January 2007 and December 2010, 
eleven patients were recruited. Eleven HCC patients with 
PVTT, BI or IVCI were treated with HAIC via a subcutane-
ously implanted injection port with radiotherapy. A course of 
chemotherapy consisted of cisplatin followed by 5-fl uoroura-
cil or 5-fl uorouracil with pegylated interferon. Radiotherapy 
was performed with a total of 45 gray (Gy) over 3 weeks. 
The prognostic factors associated with survival after treat-
ment were analyzed.
Results: Six patients exhibited partial response to this form 
of HAIC with radiotherapy (response rate = 54.5%). Median 
survival times for the Six responders and fi ve non-responders 
were 13.5 (range, 4–21) and 7.5 (range, 1–11) months from 
the start of radiation treatment, respectively (P = 0.041). The 
single factor that signifi cantly infl uenced survival was thera-
peutic effect. Treatment was well tolerated and severe toxic-
ity was infrequent.
Conclusions: HAIC with radiotherapy may be a useful 
alternative for the treatment of patients with advanced HCC 
complicated with PVTT, BI or IVCI. This treatment some-
times expected prolongation of the prognosis for hepatocel-
lular carcinoma with PVTT, BI or IVCI.
P-048
LIVER RESECTION FOR METASTATIC 
NEUROENDOCRINE TUMORS: 10 YEARS 
OF EXPERIENCE AT A SINGLE 
TERTIARY INSTITUTION
J. Y. Teo, S. Y. Tan and S. Y. Lee
Department of General Surgery, Singapore General 
Hospital, Singapore
Introduction: Gastrointestinal neuroendocrine tumors are 
rare, and have a strong predilection to metastasize to the 
liver. While liver resection for colorectal metastases is well 
established, the exact role of liver resections for metastatic 
neuroendocrine tumors is less well-defi ned. This is further 
complicated by the fact that a signifi cant majority of patients 
have diffuse, bilobar disease.
Methods: We retrospectively reviewed all patients who 
underwent liver resection for metastatic neuroendocrine 
tumors over a 10-year period at our institution, and compared 
the clinical, pathological and survival characteristics.
Results: 10 patients underwent liver resection for metastatic 
neuroendocrine tumors of the study period. 4 patients under-
went synchronous resection of the liver mets together with 
the primary, one patient underwent resection for presumed 
HCC followed by resection of the primary disease after 
further staging and investigations, while the remainder 
underwent resection of metastases with curative intent. The 
median overall survival was 45.5 months (range 1–138 
months) with fi ve of the ten patients still alive at the time of 
writing, after a mean and median of 64.4 and 67 months’ 
follow-up respectively. Of these, four remain disease-free. 
There was only one perioperative mortality in our series.
Conclusions: Liver resection for metastatic neuroendocrine 
cancer has a low mortality and morbidity and can confer 
excellent overall and disease-free survival in selected 
patients.
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P-049
BEVACIZUMAB PROTECTS AGAINST 
HEPATIC INJURY IN PATIENTS 
TREATED WITH FLUOROPRIMIDINE-
PLUS-OXALIPLATIN CHEMOTHERAPY 
FOR COLORECTAL LIVER METASTASIS
T. Hisaka1, H. Horiuchi1, S. Uchida2, H. Ishikawa1, 
R. Kawahara1, K. Mikagi1, Y. Kawashima1, 
H. Nogita1, R. Yamaguchi3, M. Kage4, H. Yano4, 
H. Kinoshita1 and K. Shirozu1
1Department of Surgery, Kurume University School of 
Medicine, Kurume, Japan; 2Department of Surgery, 
Kurume Medical Center, Kurume, Japan; 3Department of 
Pathology, Kurume Medical Center, Kurume, Japan; 
4Department of Pathology, Kurume University School of 
Medicine, Kurume, Japan
Introduction: Preoperative systemic chemotherapy has 
been used in patients with colorectal liver metastasis to 
downsize unresectable tumors and make hapatic resection 
possible.
Bevacizumab has recently been used in association with 
5-fl uorouracil, irinotecan, and oxaliplatin. In this study, we 
evaluated the effect of bevacizumab added to fl uoroprimi-
dine-plus-oxaliplatin (5FU/OX) chemotherapy for colorectal 
liver metastasis on the morphology of non-tumoral liver.
Methods: Resected liver specimens from patients treated 
with 5FU/OX chemotherapy with (n = 10) or without (n = 10) 
bevacizumab were analyzed. The response to chemotherapy 
was evaluated by pathologic analysis of hepatic injury.
Results: Bevacizumab decreased the severity of the sinusoi-
dal dilatation, hepatocellular necrosis, sinusoidal fi brosis.
Conclusions: This analysis shows that bevacizumab pro-
tects against liver injury and thus provides the histological 
explanation of the safe use of bevacizumab prior to liver 
resection.
P-050
PREDICTIVE FACTORS FOR SURVIVAL 
IN ELDERLY PATIENTS WITH 
HEPATOCELLULAR CARCINOMAS 
AFTER HEPATECTOMIES
L.-C. Tsao, Y.-L. Chen, K.-H. Lin and S.-J. Kuo
Changhua Christian Hospital, Changhua City, Taiwan
Introduction: With the improvement in technic of hepatec-
tomy, it was performed more frequently among elderly 
patients. The general healthy condition and the nature of the 
disease could be different in the elderly patients in compared 
with younger ones.
Methods: From Apr 2004 to Oct 2010, we enrolled the 
patients who had received hepatectomies for HCCs with 
detailed basic patient characteristics, peri-operative param-
eters, and pathologic fi ndings. The patients could not be 
followed up at out-patient department or by telephone inter-
view for recording of tumor recurrence and mortality would 
be excluded. We fi nally included the patients who were older 
than 70 years with the tumor size smaller than 5-cm in 
the largest diameter for further analysis. All the host, peri-
operative, and tumor characteristics were evaluated and 
compared for prognostic factors identifi cation.
Results: Total 51 patients were eligible for further analysis. 
The median follow-up period was 30.3 months (5.7 ∼ 104.5). 
Nineteen patients hade recurrent HCCs and 13 patients 
expired due to malignancy. Serum albumin, prothrombin 
time, INR, and hemoglobin level were statistically signifi -
cantly associated with disease-related mortality. The relative 
risk of mortality for the INR level higher than 1.1 times had 
only a statistic trend.
Conclusions: Although this study is not designed prospec-
tively randomizedly, the results shown in this study still 
imply us the basic liver capabilities and preserved liver func-
tions can play as predictive factors for mortality among 
elderly patients with HCCs underwent hepatectomies.
P-051
THE COUNTER-REGULATORY EFFECT 
OF AT1/AT2 RECEPTORS ON 
MACROPHAGE FUNCTION
S. W. Wen1, E. Ager1,2 and C. Christophi1
1The University of Melbourne, Department of Surgery 
(Austin Health), Heidelberg, Australia; 2Harvard 
University, Massachusetts General Hospital, Boston, USA
Introduction: Blockade of the renin-angiotensin system 
(RAS) inhibits tumor growth in several cancers, including 
colorectal liver metastases. The immunomodulatory poten-
tial of the RAS may, in part, be responsible for this anti-
tumor effect. A majority of the RAS effects are mediated by 
the AT1 receptor while activation of the alternative receptor 
(AT2 receptor) has counter-regulatory effects. This study 
investigates the direct effects of the RAS on macrophage 
function in vitro.
Methods: P338D1 cells, a murine macrophage cell line, 
were treated with angiotensin II with either AT1 receptor 
blockade (Irbesartan, 1 μm) or AT2 receptor blockade 
(PD123319, 1 μm) for 24 hours. The protein expression of 
VEGF, iNOS, MMP-9, TNF-α, CD14 and change in macro-
phage migration/invasion were assessed.
Results: The expression of key RAS components (AT1/AT2 
receptors) by P338D1 cells were confi rmed using immuno-
fl uorescence. AT1 receptor blockade decreased the expres-
sion of iNOS, MMP-9, VEGF and CD14 but increased 
TNF-α when compared to AT2 receptor blockade. Phalloidin 
staining showed higher fi lopodia and focal adhesion forma-
tion following AT1 receptor blockade compared to AT2 
receptor blockade by macrophages. However, the migration 
assay using fi bronectin coated transwells revealed no differ-
ence in migration.
Conclusions: Macrophages possess the ability to respond 
and produce RAS components. The RAS can alter the 
production of key growth factors important during tumor 
development by macrophages. This study confi rms the 
counter-regulatory role of AT1/AT2 receptor activation.
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P-052
OUTCOMES OF HEPATIC RESECTION 
FOR COLORECTAL CANCER LIVER 
METASTASIS
D. D. You, I. Y. Park, K. H. Kim, D. G. Kim and B. H. Kye
Department of Surgery, College of Medicine, The Catholic 
University of Korea, Korea
Purpose: The liver is a major site for the metastatic spread 
of primary colorectal cancers. Among the various modalities 
of treatment for hepatic metastasis of colorectal cancer, 
hepatic resection has been proven to be the most effective 
treatment. This analysis was intended to review our experi-
ence with hepatic resection for colorectal cancer liver 
metastases.
Materials and Methods: From 1989 to 2010, we retrospec-
tively analyzed the clinical experience of 40 patients who 
were underwent hepatic resection for 24 synchronous and 16 
metachronous hepatic metastases from colorectal cancer. The 
survival rate was calculated using the Kaplan-Meier method 
and the log rank test. The median follow up period was 60.8 
months.
Results: The median survival length of the patients was 133 
± 33.0 months. Resection mortality was not observed. Age, 
sex, the preoperative CEA level, location, differentiation, and 
the surgical method for the primary tumor did not infl uence 
the survival (p > 0.05). The number, largest size, sum of the 
largest size, and surgical method (wedge resection, segmen-
tal resection, lobectomy) for the hepatic metastasis did not 
infl uence the survival (p > 0.05). Considering the time from 
diagnosis of the primary tumor to detection of the metastatic 
lesion, patients that had metachronous lesions survived 
longer than patients that had synchronous lesions (p < 0.05). 
Patients that had a longer disease free interval after hepatic 
resection had a longer survival period (p = 0.04).
Conclusions: Our results suggest that hepatic resection for 
colorectal cancer liver metastasis is a safe procedure with a 
survival benefi t for the patients. We especially believe that 
hepatic resection for metachronous hepatic metastasis of 
colorectal cancer may offer a chance of longer survival to 
these patients.
P-053
IMPACT OF CLINICOPATHOLOGICAL 
FACTORS ON POSTOPERATIVE 
MORBIDITY, RECURRENCE AND 
SURVIVAL IN LIVER RESECTION 
PATIENTS
F. Zehra1 and R. Wilson2
1University of New South Wales, NSW, Australia; 
2Liverpool Hospital, NSW, Australia
Introduction: Surgery is considered the most effective 
method for treating primary liver cancer or colorectal metas-
tases. It is important to understand the prognostic factors 
associated with postoperative morbidity, recurrence and 
survival.
Methods: A single surgeon’s experience of liver resection 
was reviewed to identify postoperative morbidity, recurrence 
and survival. 41 patients with primary or secondary liver 
carcinoma or benign liver pathology from 2001 to 2010 with 
liver resection in Upper GIT Surgery Unit at Liverpool 
Hospital were included in the study. Fisher exact test, logistic 
regression and Kaplan Meier methods were used for analyses 
where appropriate.
Results: 22 patients had colorectal liver metastasis, 7 
primary liver cancers and 12 benign diseases. Median follow 
up was 2.5 years. 3 patients had major complications within 
30 days of operation with no postoperative surgical mortality. 
Age was the only factor (p = 0.05) that infl uenced postopera-
tive morbidity. Presence of synchronous tumour (p = 0.01) 
impacted survival after colorectal primary resection. No 
factors were found infl uencing survival after liver metastasis 
resection and recurrence.
Conclusions: Increasing age (>50 years) and presence of 
synchronous tumour are risk factors for post-operative mor-
bidity and survival respectively.
P-054
EXTRACORPOREAL SHOCK WAVE 
LITHOTRIPSY IN THE MANAGEMENT 
OF A LARGE, IMPACTED 
INTRAHEPATIC STONE ABOVE AN 
HEPATICO-JEJUNOSTOMY 
ANASTOMOTIC STRICTURE
J. J. Bong
Department of surgery, Universiti Kebangsaan Malaysia 
(UKM) Medical Centre, Kuala Lumpur, Malaysia
Introduction: Intrahepatic stone above an anastomotic 
stricture at the hepatico-jejunostomy site frequently requires 
revision surgery or percutaneous transhepatic cholangio-
scopic lithotripsy as a treatment of choice. However, both 
methods are invasive and not without risks. Extracorporal 
shock wave lithotripsy (ESWL) has recently been reported 
to be useful in the treatment of large, impacted, bile-duct 
calculus not amenable to conventional balloon or Dormia 
basket extraction. Not only does ESWL offers high stone-
clearance rates, it has the added advantage of being non-
invasive and carries minimum complication.
Methods and Results: We herein report a case of the use 
of ESWL in the management of a large, impacted intra-
hepatic stone above a hepatico-jejunostomy stricture. A 
41-year-old male presented with progressive jaundice and 
fever. He also gave a past history of open cholecystectomy 
complicated by iatrogenic bile-duct injury 1 year ago, and 
was treated by Roux-en-Y hepatico-jejunostomy reconstruc-
tion at another hospital. After initial resuscitation with 
intravenous rehydration and antibiotics, a percutaneous tran-
shepatic cholangiography was carried out and showed a tight 
anastomotic stricture at the hepatico-jejunostomy site, and 
an impacted, 3-cm, intrahepatic stone at the confl uence. 
Percutaneous balloon dilatation of the stricture was per-
formed followed by a single session of ESWL. The frag-
mented, smaller stones were subsequently extracted 
percutaneously by Dormia basket. The procedure was toler-
ated well by the patient without any complication. At 
10-month follow up, he remained well and asymptomatic.
Conclusion: ESWL can be a useful tool in the management 
of diffi cult, large biliary calculi, especially in combination 
with other endoscopic or percutaneous procedures.
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P-055
CHOLECYSTOLITHOTOMY: A USEFUL 
TECHNIQUE IN GALLSTONE ILEUS
J. S. Gundara, N. Williams, S. Roser and J. S. Samra
Department of Gastrointestinal Surgery, Royal North Shore 
Hospital, Sydney University, Australia
Introduction: Gallstone ileus is a heterogeneous and highly 
morbid condition that suffers from a lack of consensus 
regarding the timing and approach to management of the 
biliary tree and associated fi stula.
Methods: We report three cases that demonstrate the spec-
trum of gallstone ileus with classical examples of both 
Barnard’s and Bouveret’s syndromes. This is followed by a 
brief review of current literature.
Results/Conclusions: Following enterolithotomy, poten-
tially morbid, defi nitive one stage surgery in typically com-
promised, elderly patients needs to be weighed against the 
risk of recurrence and ongoing biliary pathology. We report 
for the fi rst time a safer and simpler approach involving open 
cholecystolithotomy when the patient is not suitable for 
defi nitive biliary surgery.
P-056
MANAGEMENT OF THE JUVENILE 
GALLBLADDER TORSION – 
CHARACTERISTIC CT FINDINGS AND 
EMERGENT LAPAROSCOPIC SURGERY
K. Hiramatsu1, T. Arai1, Y. Okada1, A. Tanano2, S. Saeki1, 
T. Amemiya1, H. Goto1, F. Sato1, K. Kimura1, H. Tanaka1 
and H. Ida1
1Department of Surgery, Anjo Kosei Hospital, Anjo, Aichi, 
Japan; 2Department of Pediatric Surgery, Anjo Kosei 
Hospital, Anjo, Aichi, Japan
Introduction: Torsion of the gallbladder is one of the causes 
of necrotic cholecystitis, where emergent operation is indi-
cated. A delayed diagnosis could lead to major morbidity and 
mortality. In addition to the congenital fl oating gallbladder, 
acquired factors, including turtle back, visceral ptosis and 
loosening of the connecting tissue, seem to be also involved 
in the occurrence of the volvulus. Thus most of the gallblad-
der torsion is presented in the elderly but rarely in the juve-
nile. We report two juvenile cases which were successfully 
diagnosed with computed tomography (CT) and treated with 
emergent laparoscopic cholecystectomy.
Case Reports: In either juvenile case, the diagnosis as gall-
bladder torsion was made with enhanced CT. Dislocation of 
the gallbladder to the left side of the gallbladder bed was 
recognized as a sign of the fl oating gallbladder. In addition, 
the gallbladder torsion was strongly suggested by the follow-
ing fi ndings: 1) narrow segment between neck (or cystic 
duct) and body of the gallbladder, 2) wall thickness without 
enhance of the gallbladder body and fundus, and 3) increased 
fl uid density in the content of the gallbladder body and 
fundus, but not in the neck. From these characteristic fi nd-
ings, we diagnosed these cases as acute necrotic cholecystitis 
due to gallbladder torsion. In both cases, emergent laparo-
scopic cholecystectomy was performed without any diffi cul-
ties. The patients were discharged from our hospital without 
any complications.
Conclusion: Precise CT examination is important to diag-
nose the gallbladder torsion. Laparoscopic cholecystectomy 
immediately after the diagnosis might result in a good 
outcome.
P-057
ADENOSQUAMOUS AND SQUAMOUS 
CELL CARCINOMA OF GALLBLADDER: 
ARE THEY BIOLOGICALLY DIFFERENT 
FROM ADENOCARCINOMA
A. Javed1, R. Kalayarasan1, H. H. Nag1, P. Sakhuja2 and 
A. K. Agarwal1
1Department of GI Surgery, GB Pant Hospital & MAM 
College, New Delhi; 2Department of Pathology, GB Pant 
Hospital & MAM College, New Delhi
Introduction: Adenosquamous carcinoma (ASC) and squa-
mous cell carcinoma (SCC) of gallbladder are rare histologi-
cal variants of gall bladder cancer (GBC). This study was 
undertaken to analyze the clinicopathological variables and 
surgical outcomes in patients with ASC/SCC of gallbladder 
and compare them with adenocarcinoma (AC).
Methods: Retrospective analysis of operated GBC patients 
between August 2009 & March 2011. Patients with ASC/
SCC on fi nal histopathology were compared with AC group 
for clinical presentation, tumor size, locoregional extent, 
lymph node involvement and survival.
Results: One hundred and forty one patients of GBC were 
taken up for surgery (excluding Incidental Gall bladder 
cancer) during the period. Of the 80 patients who underwent 
surgical resection with a curative intent, Nine patients had 
ASC (n = 6) or SCC (n = 3; group A) while 71 had adeno-
carcinoma (Group B). Abdominal pain was the most common 
symptom, vomiting was signifi cantly more common in group 
A compared to group B (55.56% vs. 15.49%, p = 0.01). The 
median tumor size was signifi cantly higher in group A 
(7.8 cm vs. 5.1 cm, p = 0.01). Extrahepatic adjacent organ 
involvement requiring adjacent organ resection was also 
more common in Group A (88.89% vs. 29.57%, p = 0.001). 
In spite of the higher T stage, the majority of patients in 
group A had a node negative disease (55.56% vs. 19.4%, 
p = 0.023). All the 52 patients found to have metastatic 
disease on laparoscopy/exploration had AC on histopatho-
logical examination. During median follow up period of 11 
months (range 2–21 months) there was no signifi cant differ-
ence in the overall survival between the 2 groups (77.78% 
(7/9) vs. 80.28% (57/71), p = 1.0).
Conclusions: ASC and SCC presented at an advanced T 
stage, however the incidence of nodal involvement and 
distant metastasis was less common compared to AC. Despite 
being locally advanced malignancy requiring more extensive 
resection survival in these patients was comparable to 
patients with adenocarcinoma.
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P-058
NUMERICAL CONVERSION OF 
SURGICAL DIFFICULTIES IN SINGLE 
INCISION LAPAROSCOPIC 
CHOLECYSTECTOMY
S. Kameyama, H. Motonari, H. Taniguchi, H. Koami, 
T. Ishimine, T. Matsumura and T. Isa
Urasoe general hospital, Urasoe, Japan
Introduction: Single incision laparoscopic cholecystec-
tomy (SILC) may be a comparable alternative to conven-
tional multiport laparoscopic cholecystectomy (CMLC). 
However, it has been recognized that the procedures were 
more diffi cult than CMLC, especially for residents. So we 
attempted to assess by numerical conversion of surgical dif-
fi culties of SILC to contribute to initial surgeon training.
Methods: We supposed that important factors associated 
with surgical diffi culties of SILC excluded infl ammatory 
change were body mass index (BMI), ventral wall thickness 
(VWT) and umbilicus-xyphoid distance (UXD) as substitu-
tion of the distance from umbilicus to gallbladder. Between 
November 2009 and May 2011, 30 of 46 patients who under-
went SILC were performed by a same surgeon. The above 
factors were measured by MRI images on 30 patients, and 
assessed a correlation between operation time (OT) and each 
factor.
Results: OT had a statistically signifi cant correlation with 
UXD (r = 0.64, p < 0.0001) and BMI (r = 0.64, p < 0.0001), 
whereas the correlation between OT and VWT was not good 
(r = 0.39, p = 0.03). But it might be added a learning bias to 
these results.
Conclusions: There was a possibility that UXD and BMI 
could be used to predict the surgical diffi culties of SILC for 
initial surgeon training.
P-059
A CASE OF SYNCHRONOUS DOUBLE 
PRIMARY CANCER WITH 
ADENOCARCINOMA OF DISTAL 
COMMON BILE DUCT AND 
INTRADUCTAL PAPILLARY MUCINOUS 
CARCINOMA OF PANCREAS
H. J. Kim, H. H. Kim, H. J. Kim, B. G. Choi, E. K. Park, 
Y. H. Hur, Y. S. Koh, J. C. Kim and C. K. Cho
Department of Surgery, Chonnam National University 
Medical School, Gwangju, South Korea
Introduction: In 10–52% of patients with intraductal papil-
lary mucinous neoplasm (IPMN) of pancreas, multiple 
cancer is identifi ed synchronously or metachronously. The 
exact etiology for the development of secondary malignan-
cies is unknown. Gastrointestinal tract is the most common 
site of secondary malignancy. Synchronous double primary 
cancer with intraductal papillary mucinous carcinoma 
(IPMC) and adenocarcinoma of distal common bile duct 
(CBD) has rarely been reported.
Methods: A 73-year-old man presented with abdominal 
pain and anorexia. Abdominal CT and MRI showed 1.8 cm 
sized ill-defi ned enhancing mass lesion in distal CBD and 
2 cm sized multilobulated cystic lesion in the pancreas head. 
The preoperative diagnosis was IPMC of pancreas invaded 
to distal CBD and the patient underwent pylorus-preserving 
pancreaticoduodenectomy.
Results: The histologic examination confi rmed two separate 
cancer with adenocarcinoma of distal CBD and invasive 
IPMC of pancreas without continuation with two mass 
lesion. After the operation, he had received gemcitabine-
based chemotherapy 3 times at a 3-week-interval. The patient 
is alived without evidence of recurrence in 1-year-follow up 
evaluation after surgery.
Conclusions: Synchronous double primary cancer is defi ned 
as two distinct primary malignant tumors in different organs 
with different histologic origins. In our case, the initial radio-
logic diagnosis was IPMC of pancreas head which has 
invaded to distal CBD. However, the pathologic results con-
fi rmed the synchronous double primary cancer with adeno-
carcinoma of distal CBD and invasive IPMC of pancreas 
head. Here in, we report the rare type of double primary 
cancer with distal CBD cancer and pancreas IPMC.
P-060
FEASIBILITY AND SAFETY OF THREE-
PORT LAPAROSCOPIC 
CHOLECYSTECTOMY USING 2 MM 
MINI-PORT
K. W. Kim and J. Park
Haeundae Paik Hospital, Inje University College of 
Medicine, Busan, Korea
Introduction: Since four-port laparoscopic cholecystec-
tomy (LC) was reported, there have been various surgical 
options for LC. Recently, single port LC has been increas-
ingly performed to improve cosmesis and post operative 
pain. Some surgeons thought that three-port LC could be 
safe, effective, economic and cosmetic as much as single port 
LC. For this reason, Data were prospectively collected to 
assess feasibility and safety of three-port LC using 2 mm 
mini-port (M-LC).
Methods: Between April 2010 and April 2011, 161 cases of 
LC were performed by single experienced surgeon who had 
experience more than 400 cases of LC. Among of 161, 130 
patients were enrolled this study. Patient selection for M-LC 
was decided by surgical view through umbilical port.
Results: There were 63 cases of conventional three-port LC 
(umbilical, epigastric, right subcostal port). Among of 63, 16 
cases were LC using 11, 10, 5 mm port, 47 cases were LC 
using 11, 5, 5 mm port. M-LC (11, 5, 2 mm) was 67 cases. 
Feasibility of M-LC was 51.5% (67/130). No patients in 
M-LC required conversion to open cholecysectomy but one 
case in M-LC needed additional port owing to cystic artery 
bleeding. The mean operative time (skin to skin) in M-LC 
was 30.75 ± 6.41 (± SD) minutes. There were no surgical 
related complications in M-LC.
Conclusions: M-LC is a feasible and safe procedure with 
nearly scarless wounds for selected patients. Also, M-LC can 
be another surgical option of various LC methods for expe-
rienced surgeon without learning curve.
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P-062
SINGLE FULCRUM LAPAROSCOPIC 
CHOLECYSTECTOMY – A VARIANT OF 
THE SINGLE INCISION AND MULTI-
PORT TECHNIQUE
K. K. Hwan1, S. H. Choi2, H. K. Hwang2, C. M. Kang2 
and W. J. Lee2
1Division of Hepato-Biliary-pancreas, Department of 
Surgery, NHIC Ilsan Hospital, Seoul, Korea; 2Division of 
Hepato-Biliary-pancreas, Department of Surgery, Yonsei 
University College of Medicine, Seoul, Korea
Introduction: Single-incision laparoscopic cholecystec-
tomy (LC) is still technically demanding, and usually requires 
specially designed instruments. This article describes our 
own technique, a single-fulcrum LC using only standard 
ports and instruments.
Methods: Between March 2009 and December 2010, 130 
consecutive patients underwent this single-fulcrum LC for 
benign gallbladder disease. Perioperative surgical outcomes 
were retrospectively evaluated.
Results: One hundred and ten patients (84.6%) underwent 
successful single-fulcrum laparoscopic cholecystectomy, and 
20 patients (15.4%) required additional trocar during the 
procedure due to severe infl ammation and adhesion around 
Calot area. As compared to conversion cases, it demonstrated 
shorter operating time (57.2 ± 14.3 min vs. 68.9 ± 3.1 min, 
p = 0.002), cost effectiveness (similar cost; 3,340.4 ± 690.5 
USD vs. 3,419.4 ± 412.0 USD, p = 0.410), and reasonable 
learning curve with no complication or mortality.
Conclusion: Single-fulcrum LC is feasible, safe, and quite 
reproducible. The surgical wound can be dramatically 
reduced at a similar cost to conventional LC. It may be an 
alternative procedure for most uncomplicated benign gall-
bladder disease.
P-063
SERUM BILE ACID – THE ALMOST 
FORGOTTEN SINGLE LIVER FUNCTION 
MARKER
T. J. M. Lalisang1 and M. Suryaatmadja2
1Digestive Surgery Division, Cipto Mangunkusumo 
Hospital, Faculty of Medicine, University of Indonesia, 
Jakarta, Indonesia; 2Departement of Clinical Pathologic, 
Cipto Mangunkusumo Hospital, Faculty of Medicine, 
University of Indonesia, Jakarta, Indonesia
Introduction: Serum bile acid (sBA) is the only simultane-
ous liver function marker which is often forgotten. The aim 
of this study is to confi rming the role of bile acid value, as 
single marker, compared to the conventional liver function 
tests.
Method: Before and after study on obstructive jaundice 
patients was performed. Bile duct decompression was used 
as a model to observe the changing markers. The liver func-
tion markers were measured with ACA TRX 7010 before, 
and after 7, 14 days bile duct decompression.
Result: Twenty-one patients were included. All patients had 
bile acid accumulation, and impairment of liver functions. 
After decompression, the average of bile acid serum 
decreased from 96.4 to 19.9 until 13.0 μmol/L, while bile 
acid in the bile fl uid increased from 987 to 1400 until 
2078 μmol/L. The serum total bilirubin decreased from 20.0 
to 13.3 until 6.2 mg/dL and serum ALP decreased from 908 
to 453 until 298 IU/L. The γ-GT reduced, from 431 to 222 
until 177 IU/L all of above data p < 0.05. Coagulation func-
tion improve by shortening of PT from 19.5 to 14.3 until 14.7 
second and APTT from 57.5 to 38.7 until 42.1 second. The 
albumin level increased slightly from 2.8 to 2.9 mg/dL while 
CHE activity was fi xed at low level after decompression, and 
only 3 patients reached the normal level. The average of AST 
activity decreased from 111.8 to 110.2 until 72.6 IU/L (p < 
0.05) and ALT from 66.7 to 72.8 until 54.3 IU/L.
Conclusion: Serum bile acid level follow the classic liver 
function markers changes, and can be used as a single marker.
P-064
INDICATIONS FOR PERI-OPERATIVE 
CHOLANGIOGRAPHY AND POST-
OPERATIVE OUTCOMES FOLLOWING 
LAPAROSCOPIC CHOLECYSTECTOMY
D. Z. J. Lee1 and P. Fisher2
1Aberdeen Royal Infi rmary, Aberdeen, United Kingdom; 
2Caithness General Hospital, Wick, United Kingdom
Introduction: There is divided opinion as to whether peri-
operative cholangiography (POC) should be performed on a 
routine or selective basis during laparoscopic cholecystec-
tomy. Our objectives were to analyze the use of POC in a 
rural hospital in Scotland and identify long-term post-oper-
ative outcomes of patients without POC during laparoscopic 
cholecystectomy.
Methods: We reviewed case notes for 86 patients operated 
on by one surgeon between 04/01/06–08/10/08 and assessed 
whether indications for POC were met. We also identifi ed 
any further admissions with recurrence of symptoms from 
the operation date to March 2011.
Results: Of 86 patients, POC was performed in 60, out of 
which 44 (70%) had recognized indications for the investiga-
tion. 12 (46%) of the 26 patients in whom POC was not 
undertaken had indications for POC. This included 1 patient 
who had a history of pancreatitis, raised amylase on admis-
sion and deranged LFTs, 10 with deranged LFTs only, and 1 
with deranged LFTs and dilated CBD on ultrasound. 6 (10%) 
patients had CBD stones identifi ed on POC, which was pre-
ceded by a history of jaundice in 2 patients and dark urine/
pale stools in 1 patient. Of the 6, 1 had MRCP, 1 had ERCP 
and the remaining 4 were managed expectantly. 4 (15%) of 
26 patients without POC had recurrence of symptoms requir-
ing admission post-operatively, none of which were found to 
have retained stones.
Conclusions: Our results suggest that POC may have a 
more justifi able role in identifying CBD stones when per-
formed selectively in high-risk patients compared to routine 
POC in all patients
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P-065
PROGNOSTIC SIGNIFICANCE OF MUC4 
EXPRESSION IN GALLBLADDER 
CARCINOMA
H. K. Lee1, S. K. Min1, M-S. Cho2 and T. H. Kim3
1Department of Surgery School of Medicine Ewha Womans 
University, Seoul, Korea; 2Department of Surgery School of 
Medicine Ewha Womans University, Seoul, Korea; 
3Department of Internal Medicine School of Medicine 
Ewha Womans University, Seoul, Korea
Introduction: Mucins (MUC) are high molecular glycopro-
teins and serve protective and lubricating roles in normal 
epithelium of gastrointestinal tract. Deregulated expression 
of mucins is involved in tumor biology (carcinogenesis or 
tumor invasion). MUC4 is a membrane-associated mucin, 
which is not expressed in normal biliary epithelium but 
expressed in cholangiocarcinoma cells. Recently, it has been 
reported that MUC4 expression is a poor prognostic factor 
in pancreatic and bile duct carcinoma. To date, relationship 
between MUC4 expression and prognosis in gallbladder 
(GB) carcinoma remains undocumented. Authors examined 
MUC4 expression in GB carcinoma and investigated its 
association with prognosis.
Methods: 63 patients with GB carcinoma undergoing surgi-
cal resection were selected and Immunohistochemical stain-
ing was performed to determine the expression of MUC1, 
MUC2, MUC4 protein.
Results: For GB carcinoma, positive staining of MUC1, 
MUC2, and MUC 4 was 81.0%, 28.6%, and 55.6%, respec-
tively. There was signifi cant positive correlation between 
MUC4 and MUC1 expression (p = 0.004), and signifi cant 
negative correlation between MUC4 and MUC2 expression 
(p = 0.009). In univariate analysis, survival of patient with 
MUC4 expression was signifi cantly worse than that without 
MUC4 expression (p = 0.047). T-stage (p < 0.05) and lymph 
node metastasis (p < 0.001) were signifi cantly associated 
with poor survival. Regarding MUC1 and MUC2, there was 
no signifi cant survival difference between positive group and 
negative group. In combined status of MUC4 and MUC2, 
MUC4 positive and MUC2 negative group showed signifi -
cantly worse survival rate compared to the other groups (p 
< 0.05). In multivariate analysis, MUC4 expression (p = 
0.02) and lymph node metastasis (p = 0.002) were signifi cant 
independent risk factors.
Conclusions: MUC4 expression in GB carcinoma is signifi -
cantly associated with poor prognosis and may predict 
outcome of patients with GB carcinoma.
P-066
SURGICAL TREATMENT FOR 
HEPATELITHIASIS IN CHANGHUA 
CHRISTIAN HOSPITAL: LONG TERM 
RESULT
C-C. Lin and Y-L. Chen
Division of General Surgery, Department of Surgery, 
Changhua Christian Hospital, Changhua City, Taiwan
Introduction: Hepatolithiasis was a relatively common 
disease in Asia countries, however, the incidence of this 
disease has decreased signifi cantly during recent years. 
There is no treatment of choice for hepatolithisis according 
to current literature. Some reports suggest that hepatic resec-
tion is associated with high stone clearance rate and low 
stone recurrence rate, however, the long term outcome is 
rarely mentioned. Herein, we present the long term result of 
patients with hepatolithiasis who underwent hepatic resec-
tion in Changhua Christian Hospital (CCH).
Methods: From 2000–01 to 2003–03, 66 patients with diag-
nosis of hepatolithiasis underwent hepatic resection in CCH. 
Choledochotomy with T-tube drainage were performed rou-
tinely, as well as postoperative choledochoscopic examina-
tion via T-tube tract. All interventions were carried out by 
the same hepatobiliary surgeon. The charts were reviewed 
and clinical information were collected retrospectively.
Results: The stone clearance rate was 98.48% (n = 65) after 
hepatic resection and postoperative choledochoscopic litho-
tripsy. The stone recurrence rate was 39.39% (n = 26), with 
a mean recurrence time of 42 (9–110) months postopera-
tively. The perioperative morbidity rate was 42.42% (n = 28), 
most of them were due to wound infection (n = 22), however, 
none of these patients died as a result of complication. The 
mean follow up time was 121 (101–139) months. Total 4 
(6.06%) patients developed cholangiocarcinoma after an 
average of 62.75 (19–117) months postoperatively.
Conclusions: Hepatic resection combined with postopera-
tive choledochoscopic lithotripsy is associated with high 
stone clearance rate, however, the stone recurrence and 
wound infection rate remain high according to our data.
P-067
AGE AND SEX DIFFERENCES IN 
COMPLICATIONS AND 
CONVALESCENCE AFTER 
LAPAROSCOPIC CHOLECYSTECTOMY
S. Lokman, M. R. S. Siddiqui, J. Barry, K. Lodha and F. 
Hasan
Benenden Hospital, Kent, UK
Introduction: Laparoscopic cholecystectomy is a common 
surgical procedure yet little is known about age and gender 
differences after surgery. We conduct a database review to 
analyze age and sex differences in complication and conver-
sion rates and infl uence on return to normal daily activities 
and work after laparoscopic cholecystectomy (LC).
Methods: 58 patients had a laparoscopic cholecystectomy 
for proven gallstones between 9/4/2001 and 15/2/2006.
Results: We had a 65.5% response rate with 431 replies at 
a mean follow up of 22.4 months (2.3–52.8). There was a 
male to female ratio of 5 : 23 with a mean age of 54.2 years 
(22–83). Using linear regression we found no signifi cant 
correlation with operative time and variables of age and sex 
(df = 2, 251 R2 = 0.03, F = 0.574, p < 0.564). No signifi cant 
correlation with number of complications and age or sex (df 
= 2, 334 R2 = 0.004, F = 1.615, p < 0.200). Age (Exp(B) = 
1.040, p < 0.51) and sex (Exp(B) = 0.863, p < 0.855) had no 
effect on conversion. No difference was found in relation to 
age and sex with return to normal daily activities (df = 2, 
307, F = 0.904, p < 0.406). Age was a non-signifi cant predic-
tor of return to work (Beta = 0.040, p < 0.572) however men 
return to work signifi cantly sooner (Beta = 0.191, p < 0.007).
Conclusions: Operative time, number of complications, 
conversion to open and return to normal daily activities may 
not be affected by age or sex of patients. Hospital stay may 
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be longer in older patients. Men appear to return to work 
sooner. Further analysis with validated questionnaires are 
required.
P-068
ACUTE PANCREATITIS. A MORE 
COMMON COMPLICATION OF 
GALLSTONES IN MALES
A. M. Malik, K. Altaf Hussain Talpur, H. Ali, S. Imam, 
J. Naeem Qureshi and N. A. Sheikh
Department of Surgery, Liaquat University of Medical and  
Health Sciences, Jamshoro, Pakistan
Objective: Gallstone pancreatitis is reported to be more 
common in females. This study focuses on the prevalence of 
gallstone pancreatitis in male subjects.
Methodology: This is an observational comparative study 
conducted over 7 years from June 2004 to June 2011, includ-
ing 186 patients of symptomatic gallstone disease. The 
patients were mostly diagnosed on ultrasonography. There 
was however normal pancreas sonographically in almost all 
the cases. A number of elderly patients had co-morbidities 
which were taken care of and after prerequisite investigations 
majority were operated by laparoscopic surgery and a minor 
proportion by conventional open surgery. A detailed history 
revealed attacks of acute pancreatitis in a number of patients 
while some of them develop acute pancreatic after cholecys-
tectomy. Demographics and other variables are studied and 
statistical analysis done on SPSS version 17.
Results: A total number of 1863 mixed population with 
symptomatic gallstone disease.
With a mean age of 46.42 years and Std of 20.457, range 
of 82 (11–93) were admitted and treated in a teaching unit 
with full facility of laparoscopic surgery. Of the total number, 
there were 198 (10.53%) while female comprised 1665 
(89.36%). There was a history of acute pancreatitis before 
admission in 103 (52.02%) males while only 39 (2.34%) 
females had a previous history of acute pancreatitis. Of the 
total number, 1645 (88.29%) patients were operated laparo-
scopically while remaining (11.70%) were operated by open 
laparoscopic cholecystectomy due to one or the other reasons. 
Post operative complications were more commonly seen in 
male subjects as cholecystitis and distorted Callot’s triangle 
was more commonly found in male subjects. Post opera-
tively 13 (6.56%) male patients developed acute pancreatitis 
with jaundice while only 3 (0.180%) female patients devel-
oped acute pancreatitis.
Conclusion: Contrary to the belief, gallstone associated 
acute pancreatitis is getting more common in our society. 
Alcohol consumption may be a contributing factor in west 
in association with gallstones causing acute pancreatitis.
Key Words: Gallstones, male subjects, female subjects, 
acute pancreatitis.
P-069
A CASE OF AMPUTATION NEUROMA OF 
THE COMMON BILE
K. Mimatsu1, T. Oida1, H. Kano1, N. Fukino1, 
A. Kawasaki1, K. Kida1, Y. Kuboi1 and S. Amano2
1Department of Surgery, Social Insurance Yokohama 
Central Hospital, Yokohama, Japan; 2Department of 
Surgery, Nihon University School of Medicine, Tokyo, 
Japan
Introduction: Amputation neuroma is a tumor-like second-
ary hyperplasia that may be developed after accidental or 
surgical trauma. Amputation neuroma of the bile duct has 
occasionally been reported which occurred in the cystic duct 
stump late after the cholecystectomy. However, the differen-
tial diagnosis from a malignancy is diffi cult preoperatively. 
We report a rare case of the amputation neuroma of common 
bile duct.
Case Report: 75-year-old woman was admitted to our hos-
pital because of hyperbililubinemia. She had undergone cho-
lecystectomy 40 years ago and choledochotomy 20 years 
ago, respectively. Abdominal enhanced computed tomogra-
phy showed heterogenous tumor 2 cm in diameter in the 
common bile duct. We performed resection of the middle 
segment of the common bile duct and bilio-digestive Roux-en 
Y anastomosis because the tumor was diagnosed as common 
bile duct neulerimoma by intraoperative pathological exami-
nation. Gross inspection showed an intramural lesion under 
the mucosa. Histological fi ndings showed spindle shaped 
cells with palisading forming and the tumor growing from 
peripheral nerve sheath. Immunohistochemicaly, cytoplasm 
and nuclei of the spindle-shaped tumor cells appear reactive 
for S-100 protein, but were negative for smooth muscle actin, 
desmin, CD34 and c-kit. The histological diagnosis was 
amputation neuroma of the common bile duct. The postop-
erative course was uneventful. The patient has remained 
asymptomatic without evidence of recurrence for 1 year 
since her resection.
Conclusion: We must be kept in mind of amputation 
neuroma in the different diagnosis of common bile duct 
tumor.
P-070
ADVANTAGES OF LASERPHYRIN 
COMPARED WITH PHOTOFRIN IN 
PHOTODYNAMIC THERAPY FOR BILE 
DUCT CARCINOMA
A. Nanashima, T. Abo, T. Nonaka, T. Sawai and 
T. Nagayasu
Division of Surgical Oncology, Nagasaki, Japan
Introduction: The aim of this study was to compare the 
effects of laserphyrin-PDT (L-PDT) on biliary cancer with 
those of the conventional photosensitizer, photofrin-PDT 
(P-PDT).
Methods: An animal tumor model was established by inoc-
ulation of NOZ cells in 4-week-old male BALB/c mice. The 
laser light wavelength was set at 630 nm for P-PDT and 
660 nm for L-PDT, at a frequency of 10 Hz. Each group 
received a total energy fl ux of 60 J/cm2. The proportion of 
TUNEL (terminal deoxynucleotidyl transferase-mediated 
dUTP-biotin nick-end labeling)-positive cells, expression of 
VEGF (vascular endothelial growth factor) and the PCNA 
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(proliferating cell nuclear antigen)-labeling index (LI) were 
assessed after PDT.
Results: L-PDT had signifi cantly more potent apoptotic 
effects at 48 and 72 h after light exposure compared with 
P-PDT (P\0.001). The mean PCNA-LI was signifi cantly 
lower in the L-PDT group than the P-PDT group and the 
index was signifi cantly lower at several time points after 
PDT (6, 12, 24, 48 and 72 h after laser light exposure) in the 
L-PDT than P-PDT (P < 0.001 vs. control). The cell prolif-
erative activity was signifi cantly decreased at 12 and 24 h 
after P-PDT compared with the control (P < 0.001). VEGF 
expression was signifi cantly higher at 3 h after L-PDT com-
pared with the control (P < 0.05), whereas it was signifi cantly 
higher at many time points after P-PDT (3, 6, 48 and 72 h; 
P < 0.05 vs. control).
Conclusions: L-PDT is a better approach for biliary cancer 
than the conventional P-PDT, based on its potent apoptotic 
and cytostatic effects.
P-072
PREOPERATIVE RISK ASSESSMENT IN 
OBSTRUCTIVE JAUNDICE PATIENTS
A. Nugroho, T. J. M. Lalisang, Y. Mazni, A. Simanjuntak 
and B. Philippi
Digestive Surgery Division, Cipto Mangunkusumo 
Hospital, Faculty of Medicine, University of Indonesia, 
Jakarta, Indonesia
Introduction: Obstructive jaundice carries a signifi cant 
morbidity and mortality in patients undergoing surgery. 
Preoperative assessment helps surgeons to decide appropri-
ate treatment plan in order to reduce morbidity and 
mortality.
Methods: Demographic, clinical and laboratory data of 38 
obstructive jaundice patients undergone biliary drainage 
were analyzed with regards to the operative morbidity and 
mortality.
Results: Eleven out of thirty-eight patients (28%) died after 
the surgery. Similar to other studies, male gender, old age 
and malignancy were associated with higher mortality rate. 
All of these cases had 6 risk factors according to Pitt’s cri-
teria. The serum bile acid level in these patients were range 
from 4.7 to 8.7 mg/dl, comparing to total serum bilirubin 
level of 21 to 45 mg/dl, suggesting a better predictive value 
of serum bile acid over bilirubin, in term of its sensitivity to 
predict mortality. As in any surgery, clinical conditions such 
as high ASA status and sepsis might also increase the risk of 
death in obstructive jaundice.
Conclusions: Preoperative factors are associated with peri-
operative outcome in obstructive jaundice patients. Certain 
demographic, clinical and laboratory data may be used to 
provide information for the surgeon for the purpose of tailor-
ing perioperative care as well as for the patients during 
informed consent process.
P-073
METASTATIC SMALL BOWEL 
PERFORATION CAUSED BY 
INTRAHEPATIC 
CHOLANGIOCARCINOMA IN A PATIENT 
WITH COMBINED 
HEPATOCELLULAR-
CHOLANGIOCARCINOMA
J. T. Oh1, G. D. Kim2, H. J. Jo3 and D. B. Kang1
1Department of Surgery, Wonkwang Gunsan Medical 
Center, Gunsan, South Korea; 2Department of Radiology, 
Wonkwang Gunsan Medical Center, Gunsan, South Korea; 
3Department of Pathology, Wonkwang Gunsan Medical 
Center, Gunsan, South Korea
Advances in chemotherapy and radiation therapies for malig-
nant tumors have resulted in the identifi cations of various 
novel features of intestinal metastasis. The common causes 
of small bowel metastasis are malignant melanoma and lung 
cancer, and this has also been rarely reported to uterine cervi-
cal cancer, malignant lymphoma of the larynx, malignant 
lymphoma of soft palate, and epatocellular carcinoma 
(HCC). The Combined HCC-cholangiocarcinoma (HCC-
CC) is a rare primary liver malignancy, and is composed of 
cells with the histopathological features of both HCC and 
CC, but metastatic small bowel perforation by CC in a 
patient with combined HCC-CC has not been reported previ-
ously. The authors report the case of a 51-year-old man with 
a metastatic small bowel perforation caused by an intrahe-
patic CC in combined HCC-CC.
P-074
SMALL CELL CARCINOMA OF 
GALLBLADDER
I-Y. Park, Y-K. Lee, H-Y-M. Lee and D-D. You
Bucheon St. Mary Hospital, The Catholic University of 
Korea, Republic of Korea
Introduction: Small cell carcinoma of gallbladder consti-
tutes 4% of all gallbladder cancers. Despite aggressive and 
various treatments, its prognosis is poor. In the process of 
treating pneumonia of 70-year-old female patient, who had 
a gallstone, a gallbladder mass was detected incidentally. 
Operation was performed and the pathology revealed small 
cell carcinoma.
Case: 70-year-old female patient was admitted without any 
symptom but had a history of a gallstone 2 years ago, the 
mass in the gallbladder was found by computed tomography 
(CT). MRCP and PET CT were done. 3 cm mass in the 
gallbladder with an enlarged lymph node at hepatic hilum 
was found. The blood chemistry was nonspecifi c, and tumor 
markers (CEA and CA19-9) were not elevated. After opera-
tion, gross fi nding showed 3 × 3 cm mass on the fundus of 
gallbladder. The frozen section of cystic lymph node and GB 
mass were malignant. Radical cholecystectomy was per-
formed. Mass was a poorly differentiated small cell carci-
noma of gallbladder. There were metastases in 2 lymph 
nodes, scoring T2N1M0, Stage IIIB (AJCC 7th). Patient was 
discharged 10 days after operation without any complica-
tions and 6 Cycles of etoposide with cisplatin chemotherapy 
were done. After 12 months from operation, patients are well 
without recurrence.
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Conclusions: Small cell carcinoma of gallbladder has poor 
prognosis. However, concurrent treatment with chemother-
apy or radiation therapy could be able to increase survival 
rate of patients.
P-076
CONGENITAL AGENESIS OF THE 
GALLBLADDER WITH THE 
HYPOGENETIC CYSTIC DUCT 
DEFINITELY DIAGNOSED BY PERORAL 
CHOLANGIOSCOPY
K. Sasaki
National Health Insurance Kawasaki Hospital, Kawasaki, 
Japan
Introduction: Congenital agenesis of the gallbladder 
(CAGB) is a rare anomaly serendipitously detected at 
autopsy or laparotomy in most adult cases. Though usually 
poses no problems, it sometimes complicates cases exhibit-
ing biliary symptoms, defying diagnosis.
Methods: A 59-year-old spinster presented with a few-day 
history of abdominal pain, nausea, vomiting and fever. Her 
past and family histories were non-contributory. Laboratory 
data showed elevated hepatic and pancreatic enzymes, 
hyperbilirubinemia and leukocytosis. Computed tomography 
(CT) demonstrated the dilated biliary tree obstructed by a 
stone in the distal part and the swollen pancreas with the 
enhanced peripancreatic adipose tissue. No ectopic or entopic 
gallbladder was detected by ultrasonography, CT or mag-
netic resonance cholangiopancreatography. Though failed to 
visualize the gallbladder, endoscopic retrograde cholangiog-
raphy showed a stone in the distal and a short, thin, blind 
tube arising from the mid extrahepatic biliary tree.
Results: She underwent endoscopic sphincterotomy and 
choledocholithotomy under the diagnosis of CAGB with the 
hypogenetic cystic duct complicated with choledocholithia-
sis triggering pancreatitis. Peroral cholangioscopy revealed 
the tube to be a crescentic folded cul-de-sac running parallel 
with and draining into the common hepatic duct, the vesti-
gigial primordium of the cystic duct and gallbladder, con-
fi rming the diagnosis. She kept an uneventful postoperative 
course.
Conclusions: This is the fi fth case of CAGB with the hypo-
genetic cystic duct and the fi rst in the world, in which the 
diagnosis is established by peroral fi ndings fulfi lling Frey’s 
diagnostic criteria. Emphasized are the importance of aware-
ness of the anomaly and the crucial role of peroral cholan-
gioscopy in diagnosing CAGB and obviating unnecessary 
exploration.
P-077
EARLY GALLBLADDER CANCER: OUR 
EXPERIENCES OF 23 PATIENTS
K. Yabuki, S. Kanemitsu, N. Minagawa, T. Torigoe, 
A. Higure and K. Yamaguchi
Department of Surgery, School of Medicine, University of 
Occupational and Environmental Health, Japan
Introduction: Despite the recent advances of imagings, pre-
operative diagnosis of early gallbladder cancer is often dif-
fi cult. We retrospectively reviewed our experiences of 23 
patients with early gallbladder cancer.
Methods: From September 1981 to May 2011, we experi-
enced 23 patients with early gallbladder cancer in our hos-
pital and one of our affi liated hospitals. 17 patients were 
diagnosed as having suspected early gallbladder cancer by 
fi ndings of clinical imagings. On the other hand, the remain-
ing six patients were not diagnosed preoperatively.
Results: The former 17 patients were eight men and nine 
women, with the mean age of 65.8 years (32–85). We per-
formed laparoscopic cholecystectomy (n = 9), and open cho-
lecystectomy (n = 8). They were papillary type (n = 16), and 
nodular type (n = 1) macroscopically. 11 patients were doing 
well without recurrence of from 2 months to 186 months 
after the surgical resection and the remaining six patients 
were lost to follow-up. The latter six patients were two men 
and four women with the mean age of 68.1 years (57–83). 
Preoperative diagnosis was cholecystolithiasis (n = 4), unex-
plained swelling of the gallbladder wall (n = 1), and HCC 
(n = 1). We performed laparoscopic cholecystectomy (n = 4), 
and open cholecystectomy (n = 2). They were fl at type (n = 
4) and papillary type (n = 1), macroscopically. 5 patients 
were doing well without recurrence from 14 months to 70 
months after the surgical resection and the other died from 
HCC.
Conclusions: Preoperative diagnosis of early gallbladder 
cancer is often diffi cult especially in fl at type. The clinical 
course of early gallbladder cancer is favorable, even after 
cholecystectomy.
P-078
THE PROGNOSTIC SIGNIFICANCE OF 
PREOPERATIVE CE-US IN PATIENTS 
WITH PANCREATIC DUCTAL 
ADENOCARCINOMA
G. Akasu, K. Fukuyo, Y. Kawashima, H. Ishikawa, 
T. Hisaka, M. Yasunaga and H. Kinoshita
Kurume University School of Medicine, Kurume, Japan
Introduction: The purpose of this study was to investigate 
the prognostic signifi cance of preoperative CE-US in patients 
with pancreatic ductal adenocarcinoma.
Methods: Between 2008 and 2009, 10 patients were under-
went curative resection for pancreatic ductal adenocarci-
noma and performed preoperative CE-US with Sonazoid 
(Daiichi-Sankyo, Tokyo, Japan). All patients were treated 
with neither chemotherapy nor radiotherapy before surgery. 
Using the digitally stored data of the CE-US, we prepared a 
time-signal intensity curve of the pancreatic ductal adenocar-
cinoma and measured the signal intensity (SI). Disease free 
survival was analyzed with the Kaplan-Meiyer method.
Results: The SI ranged from 6.6 to 143 dB (mean ± SD, 
54.6 ± 42.9) and divided into two subgroups: group A = 
poorly enhanced (≤50 dB) or group B = well enhanced 
(>50 dB). Patients with group A had a mDFS of 7 months vs 
24 months for those with group B (p = 0.018).
Conclusions: Poorly enhanced (≤50 dB) CE-US predict for 
a shorter DFS in patients with pancreatic ductal adenocarci-
noma after surgery.
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P-079
PREOPERATIVE MALNUTRITION IS 
ASSOCIATED WITH PROGNOSIS OF 
PANCREATIC CANCER
H. Baba, T. Sanada and N. Goseki
Shuwa General Hospital, Kasukabe, Japan
Introduction: Continuing treatment for pancreatic cancer is 
closely associated with the performance status of the patients. 
Moreover, malnutrition may associate with performance 
status. We aimed to investigate the relation between malnu-
trition and the prognosis of the pancreatic cancer patients.
Methods: 16 consecutive pancreatic cancer patients were 
enrolled for the study. Preoperative nutrition status was 
grouped as good (48 or more), fair (43 to 48) and poor (less 
than 43) according to the prognostic nutrition index (PNI) 
proposed by Onodera in 1984. PNI is easily calculated by 
serum albumin and peripheral lymph cell count (PNI = 10 × 
serum albumin + 0.005 × peripheral lymph cell count). All 
patients underwent pancreaticduodenectomy and continued 
their treatment with chemotherapy. Enteral nutrition was 
started on the fi rst post operative day.
Results: Despite positive nutrition support after operation, 
serum albumin decreased 10% after three weeks and body 
weight decreased 11% after three months. All patients 
received Gemcitabine (700 mg/m2 ∼ 1000 mg/m2) as adju-
vant chemotherapy. Chemotherapy was discontinued when 
Grade 3/4 adverse events were experienced (three patients). 
Survival curve among the three groups were signifi cantly 
different (p < 0.05).
Conclusion: In our study, nutrition status of the patients 
gradually fell and fi xed, despite our positive nutrition 
support. The longer period of the adjuvant chemotherapy, the 
better prognosis is achieved. Relatively malnutrition in pan-
creatic cancer patients have poor prognosis.
P-080
GROOVE PANCREATITIS – A CASE 
REPORT
V. D. Borgaonkar, D. Sushil and B. Viraj
HPB Services, Department of Surgery, Seth Nandlal Dhoot 
Hospital, Aurangabad, India
Introduction: Groove Pancreatitis is a rare clinical condi-
tion. It presents as pancreatic head mass with duodenal and 
ductal obstruction. This benign condition should be kept in 
mind in differential diagnosis of pancreatic head mass.
Methods: This is a case report of singular patient presented 
to us with anorexia, weight loss, vomiting after food and 
dyspepsia. MDCT revealed pancreatic head mass with 
dilated Intra-Hepatic Biliary Radicles, Common Bile Duct 
and Pancreatic duct with multiple pancreatic calculi and atro-
phic pancreas. At exploration stomach was grossly dilated 
with pancreatic head mass causing a duodenal obstruction. 
Whipple’s pancreatico-duodenectomy was not feasible due 
to dense adhesions at porta hepatis and portal vein. Fine 
needle aspiration cytology was performed to rule out malig-
nancy. Pancreatic head coring with lateral pancraetico-
enteric bypass with anticolic gastro-enterosomy was done.
Results: Patient had uneventful recovery and is asymptom-
atic since last nine months. He has been counseled about the 
role of alcohol in his ailment and has been advised to stop 
consuming alcohol.
Conclusions: Groove pancreatitis is a rare clinical condi-
tion. It should be kept in mind in differential diagnosis of 
Pancreatic head mass. All efforts should be made to exclude 
carcinoma. Though Whipple’s Pancreatico-duodenectomy 
should ideally be done, many times due to technical diffi cul-
ties only surgical bypass can also prove to be a good option. 
Long term symptom free period can be achieved by quitting 
alcohol.
P-081
SURGICAL TREATMENT OF 
PANCREATIC BODY AND TAIL CANCER 
USING RAMPS PROCEDURE
Y. R. Chang1, S.-S. Han2, S.-J. Park2, S. H. Kim2, 
T. H. Kim2, S. M. Woo2 and W. J. Lee2
1Department of Surgery, Seoul National University College 
of Medicine, Seoul, Korea; 2Center for Liver Cancer, 
National Cancer Center, Goyang-si, Korea
Background: Radical antegrade modular pancreatosplenec-
tomy (RAMPS) procedure is known as a feasible procedure 
to achieve negative tangential margin compared to traditional 
approach. The purpose of this study is to evaluate the surgical 
outcome of RAMPS procedure.
Methods: Twenty six patients underwent surgical resection 
with curative intent using RAMPS procedure from January 
2005 to June 2009 in National Cancer Center, Korea. 
Clinicopathologic data were collected retrospectively.
Results: Negative tangential margin was achieved in 24 
patients (92%). Mean number of retrieved lymph nodes was 
23.1 and node positivity was seen in 73%. Median survival 
of 26 patients was 16.9 months. Patients with negative 
margin had median survival of 18.2 months and positive 
margin had 6.5 months.
Conclusion: Negative tangential margin was achieved in 
92% and the survival was longer in the patients with negative 
margin. RAMPS procedure is a feasible procedure to achieve 
negative tangential margin in pancreatic body and tail cancer.
P-082
ISOLATED PANCREATIC 
TUBERCULOSIS: CASE REPORT AND 
REVIEW OF THE LITERATURE
A. Chiow, R. Wijaya, C. K. Chong and S-M. Tan
Department of General Surgery, Changi General Hospital, 
Singapore
Introduction: While tuberculosis is still a very prevalent 
disease in developing countries, isolated intra-abdominal 
organ involvement is rare. We report on a case of pancreatic 
tuberculosis mimicking pancreatic cystadenoma/adenocarci-
noma and review the latest published literature.
Case Study: A 26-year-old migrant lady from a developing 
country presented to the hospital with complains of epigas-
tric pain for 4 days and obstructive jaundice. Examination 
was unremarkable except for scleral icterus and epigastric 
tenderness.
Blood investigations revealed a markedly raised bilirubin 
with deranged LFTs. Acute hepatitis markers, serum Ca 19–9 
and CEA were unremarkable. A CT abdomen and pelvis and 
subsequent MRI pancreas/MRCP revealed a 3 × 4 cm heter-
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ogenous, multicystic, septated mass lesion at the head of 
pancreas suggestive of pancreatic mucinous cystadenoma/
carcinoma with upstream biliary dilatation and CBD stones. 
EUS/FNAC subsequently confi rmed an obstructing complex 
mixed cystic/solid mass lesion however cytology revealed 
granulomatous tissue suspicious of tuberculosis.
ERCP papillotomy and stone clearance was performed 
with good relief of biliary obstruction.
The patient was started on tuberculosis treatment and with 
subsequent cultures confi rming tuberculosis.
Discussion: The diagnosis and current management of pan-
creatic tuberculosis will be discussed with a review of the 
current literature. A suggested diagnostic algorithm will be 
presented.
Conclusion: Although rare, pancreatic tuberculosis should 
be considered in patients with risk factors presenting with 
pancreatic mass lesions. FNAC is a useful diagnostic tool 
and taken together with careful clinical assessment allows 
for an accurate diagnosis to be made sparing patients unnec-
essary invasive surgery.
P-083
RETROPERITONEAL CASTLEMAN 
DISEASE DIAGNOSED AFTER 
LAPAROSCOPIC RESECTION
C. K. Cho, H. H. Kim, E. K. Park, J. S. Seoung, Y. H. Hur, 
Y. S. Koh, J. C. Kim and H. J. Kim
Chonnam National University Medical School, Gwangju, 
South Korea
Introduction: Castleman disease (CD) is a rare benign dis-
order that may grow in any area where lymphoid tissue is 
normally present. Clinical diagnosis of CD is diffi cult and 
the diagnostic certainty is obtained only by histologic exami-
nation. Laparosopic resection of retroperitoneal CD has been 
seldom reported in the literatures until now.
Methods: A 46-year-old female visited for surgery because 
of progressively increased mass in retroperitoneal space on 
abdominal computed tomography (CT). On abdominal CT, 
about 4 cm sized well-defi nted nodular mass with iso-splenic 
enhancement was detected in the area around upper border 
of pancreas tail, and the preoperative impression was pre-
sumed to accessory spleen.
Results: The laparoscopic resection was performed and the 
retroperitoneal mass was well-marginated and removed 
uneventfully with the operation time of 135 minutes. The 
resected specimen was confi rmed by CD, an hyaline-vascu-
lar varient on microscopic examination.
Conclusions: Two forms of CD are established by clinical 
classifi cation; the unifocal, localized, pseudoneoplastic form 
with a good prognosis, and the multifocal form with a more 
aggressive course. And three histological types have been 
identifi ed; hyaline vascular, plasma cell and mixed type. 
Although there is no standard therapy for CD, because of it’s 
rarity and heterogeneity, surgical removal could be the cura-
tive treatment, especially in localized form, and irradiation 
is an effective alternatives if surgical resection is not avail-
able. Most of the reported case of surgically removed retro-
peitoneal CD were performed by laparotomy, we report a 
case of a CD presenting as a retroperitoneal nodular mass 
diagnosed histologically after laparoscopic resection.
P-084
A CASE OF PANCREATIC 
ADENOSQUAMOUS CARCINOMA 
TREATED WITH 
PANCREATICODUODENECTOMY AFTER 
CHEMORADIATION THERAPY
B. G. Choi, E. K. Park, H. H. Kim, Y. H. Hur, Y. S. Koh, 
J. C. Kim, H. J. Kim and C. K. Cho
Chonnam National University Medical School, Gwangju, 
South Korea
Introduction: Adenosquamous carcinoma (ASC) of pan-
creas is a rare tumor and is characterized by the presence of 
variable proportion of mucin-producing glandular elements 
and squamous components account for at least 30% of tumor 
tissue. The prognosis of pancreatic ASC has been known to 
be very poor, and the effect of chemoradiation on the respect-
ability is not certain.
Methods: A 41-year-old man presented vomiting and epi-
gastric pain, and imaging studies demonstrated a ill-defi ned 
retroperitoneal mass measuring 5.4 × 3.7 cm compressing 
duodenal 3rd portion. An exploratory laparotomy was 
performed under the impression of retroperitoneal tumor.
Results: In operation, hard irregular mass was found in ret-
roperitoneal space which infi ltrated into duodenum and sur-
rounding retroperitoneal tissue tightly. The tumor was 
determined to be unresectable and palliative gastrojejunos-
tomy with incision biopsy was performed. The pathologic 
results were metastatic squamous cell carcinoma. After the 
operation, systemic evaluation for identifying the primary 
focus including PET-CT failed to fi nd any other malignant 
lesion except known retroperitoneal malignancy. The patient 
received 3 cycles of 5-fl uorouracil and low-dose cisplatin (FP) 
based chemoradiation, and additional 2 cycles of FP chemo-
therapy. Follow-up CT scan revealed that tumor deceased in 
size (2.8 cm from 5.4 cm). Pancreaticoduodenectomy was 
performed with successful dissection of the tumor. The fi nal 
results of microscopic and immunochistochemical study was 
ASC of pancreas. The patient received postoperative FP che-
motherapy and is alive without evidence of recurrence 8 
months after surgery.
Conclusions: We successfully resected pancreatic ASC 
after chemoradiation which was initially unresectable due to 
retroperitoneal infi ltration.
P-085
A CASE OF PRIMARY PANCREATIC 
LYMPHOMA MIMICKING PANCREATIC 
ADENOCARCINOMA
K. Chun, B. Ahn and I. Song
Department of Surgery, Research Institute for Medical 
Sciences, College of Medicine, Chungnam National 
University, Daejeon, Korea
Introduction: Ductal adenocarcinoma accounts for 90% 
of pancreatic tumor. PPL is quite rare, less than 0.5% of 
pancreatic tumors and less than 1% of cases of non-Hodg-
kin’s lymphoma. PPL is diffi cult to differentiate from pan-
creatic adenocarcinoma. Correct diagnosis is important 
because PPL has differing management and usually better 
prognosis.
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Here we report a case presenting PPL of a small mass 
in the pancreatic tail portion mimicking pancreatic 
adenocarcinoma
Case: 67 year old male was admittied the hospital with 
complaint of right upper abdominal pain presenting biliary 
colic. Computed tomography, MRI of the abdomen showed 
cholecystitis with gallstone and incidentally 1.5 cm sized 
hypodense round mass located at the tail of pancreas, sug-
gesting pancreatic adenocarcinoma. FDG PET imaging 
revealed round, intense FDG uptake in the tail of pancreas.
Patient underwent the laparosopic cholesystectomy and 
distal pancreatectomy with splenectomy. Pancreatic mass 
ultimately proved to be PPL.
Permanent pathology of pancreatic mass revealed diffuse 
large cell lymphoma.
The postoperative course was complicated by a pancreatic 
fi stula, which closed with conservative therapy. Patient is 
doing well at the follow up after 6 month.
Conclusion: PPL should be considered in the differential 
diagnosis of pancreatic carcinoma.
P-086
HYPERBARIC OXYGEN DOES NOT 
IMPROVE SURVIVAL IN SEVERE ACUTE 
PANCREATITIS
C. M. Cuthbertson, S. L. Koh, M. Nikfarjam, 
V. Muralidharan and C. Christophi
Austin Hospital, Melbourne, Australia
Introduction: Hyperbaric oxygen therapy (HBO) may 
simultaneously modify several pathways involved in the 
local and systemic infl ammatory response in acute pancre-
atitis and reduce disease severity and mortality. It improves 
mortality in limited animal studies and is safely administered 
in humans.
Methods: 350 male Wistar rats were induced with severe 
pancreatitis by retrograde bile duct injection. Rats were ran-
domized to 12-hourly HBO or control treatment. All animals 
had their time of induction and death recorded. Animals 
killed for assessment of tissue for other studies were included 
as censored data.
Results: After the initial 64 rats, there was a survival benefi t 
with hyperbaric oxygen therapy. However, at the end of 
further studies, the cumulative study population showed no 
difference in survival (p = 0.9). The control animals had a 
median survival time of 29.2 (18.7, 39.8) hours. Treated 
animals survived 28.7 (23.9, 33.6) hours.
Conclusions: Despite promising early results, hyperbaric 
oxygen did not affect mortality in a rat model or severe acute 
pancreatitis.
P-087
HYPERBARIC OXYGEN IMPROVES 
CAPILLARY MORPHOLOGY IN SEVERE 
ACUTE PANCREATITIS
C. M. Cuthbertson, K. H. Su, V. Muralidharan 
and C. Christophi
Austin Hospital, Melbourne, Australia
Introduction: Hyperbaric oxygen (HBO) is a potential 
treatment for severe acute pancreatitis. This paper aims to 
investigate the effect of hyperbaric oxygen on pancreatic 
capillary morphology.
Methods: Sixty-seven male Wistar rats were induced with 
severe pancreatitis by retrograde bile duct injection. Rats 
were randomized to 12-hourly HBO or control treatment. 
Two rats in each group were killed at baseline and 24, 48 
and 72 hours post induction, and a cast of the pancreatic 
microvasculature was examined using scanning electron 
microscopy.
Results: Normal pancreatic vasculature is a dense network 
with a consistent capillary diameter. In acute pancreatitis, 
mean capillary diameter is increased at 24 hours, p < 0.001, 
and further increased at 48 hours, p = 0.007. From 24 hours, 
diameter heterogeneity is increased (p < 0.001), and capillary 
density is reduced (p < 0.001). HBO has a signifi cant effect 
on vascular morphology changes from 48 hours after induc-
tion. Capillary diameter and heterogeneity of diameter are 
decreased by HBO (both p < 0.001). Capillary density is 
increased by HBO at 48 and 72 hours (p < 0.001).
Conclusions: In acute pancreatitis, structural capillary 
diameter and heterogeneity of diameter increase, and capil-
lary density decreases. These parameters are all improved by 
HBO treatment. HBO treatment normalizes the pancreatic 
microvasculature following acute pancreatitis, and may have 
a role in the treatment of this disease.
P-088
THE MANAGEMENT FOR THE 
HEPATOCELLULAR CARCINOMA CASES 
COMPLICATED WITH PORTAL 
HYPERTENSION
A. Deguchi1, Y. Suzuki2 and T. Masaki1
1Department of Gastroenterology and Neurology, Faculty 
of Medicine, Kagawa University, Kagawa, Japan; 
2Department of Gastroenterological surgery, Kagawa 
University Hospital, Kagawa, Japan
Introduction: Hepatocellular carcinoma (HCC) is the car-
cinoma that the recurrence rate is extremely high and com-
plicated with portal hypertension. Liver residual function is 
exacerbated by retreatment. In HCC recurrence patients, 
poor hepatic functional reserve and thrombocytic decrease 
disturb the treatment. On the other hand, it is already reported 
that improvement of the hepatic functional reserve is obtained 
with thrombocytic increase by splenectomy. This study was 
undertaken to evaluate the effectiveness of splenectomy for 
HCC patients with portal hypertension and the prognosis 
after received splenectomy.
Methods: 25 patients (Child-Pugh B/C: 15/10; CLIP score 
1/2: 15/10) with hepatocellular carcinoma who underwent 
splenectomy at our hospital from in 2005 to 2008 were 
enrolled. We also examined the prognosis in 12 patients with 
HCC (Child-Pugh B/C: 7:5; CLIP score 1/2: 7/5) which did 
not receive splenectomy as control group.
Results: In splenectomy group, improvement of albumin, 
T-Bil, platelets, Child-Pugh score were obtained. Furthermore, 
the induction of IFN therapy was enabled in 13 of 25 HCV-
positive patients after treatment for HCC, and SVR was 
obtained in two patients. Overall survival rate was 83% at 3 
years in splenectomy group. On the other hand, the survival 
rate was 56% at 3 years in control group.
Conclusions: Splenectomy improved hepatic functional 
reserve and might contribute to the prolongation of the sur-
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vival period in patients with hepatocellular carcinoma with 
portal hypertension.
P-089
PANCREATIC STELLATE CELLS (PSCS) 
ENHANCE PANCREATIC CANCER 
INVASION IN HYPOXIA VIA 
CONNECTIVE TISSUE GROWTH 
FACTOR (CTGF) SECRETION
D. Eguchi1, N. Ikenaga1, S. Kozono1, L. Cui1, H. Fujita1, K. 
Ohuchida1,2, T. Ohtsuka1, K. Mizumoto1,3 and M. Tanaka1
1Departments of Surgery and Oncology, Kyushu University, 
Japan; 2Advanced Medical Initiatives Kyushu University, 
Japan; 3Kyushu University Hospital Cancer Center, Japan
Introduction: Pancreatic cancer is a hypovasucular tumor 
and exists under hypoxic condition. Pancreatic stellate cells 
(PSCs) promote the progression of pancreatic cancer by 
secreting several soluble factors. However, the biological 
functions of PSCs in hypoxia are little known. The aim of 
this study was to clarify the impact of PSCs on pancreatic 
cancer cells under hypoxic condition.
Methods: We isolated human PSCs from fresh pancreatic 
ductal adenocarcinoma tissues, and cultured in normoxia 
(21%O2) or hypoxia (1%O2). We assessed the expression of 
various factors related to the tumor-stromal interaction in 
both conditions by quantitative RT-PCR and western blotting 
analysis. We analyzed the effect of overexpressed molecules 
in PSCs under hypoxic condition on the invasiveness of 
pancreatic cancer cells using RNA interference technique.
Results: The expression levels of SDF-1, VEGF, 
TGF-β, MMP3, collagen type 1 and CTGF in PSCs were 
higher under hypoxic condition than under normoxic condi-
tion. CTGF in the supernatant of PSCs was higher in hypoxia 
than in normoxia. Conditioned media of PSCs in hypoxia 
enhanced the invasiveness of pancreatic cancer cells more 
intensively than conditioned media of PSCs in normoxia. 
The invasion of cancer cells decreased when CTGF secretion 
from PSCs in hypoxia was reduced by silencing CTGF 
expression using small interfering RNA.
Conclusions: PSCs in hypoxia secrete CTGF more abund-
untly, and enhance the invasion of pancreatic cancer cells.
P-090
METACHRONOUS METASTASES OF 
PANCREATIC CANCER. MUST WE SAY 
ALWAYS “NOT RESECTABLE”? A CASE 
REPORT
D. Fernandez Luengas, I. Pascual Miguelañez, 
R. Fernandez Sanchez, M. A. Vaquero Perez 
and J. Torres Jimenez
Department of General and Digestive Surgery, HPB Unit, 
Hospital Infanta Sofi a, Complutense University, Madrid, 
Spain
Introduction: Bad oncological results on pancreatic cancer 
surgery have lead to search for new treatment strategies. We 
present the case of a 39 year-old female with pancreatic 
adenocarcinoma and metachronous metastases who under-
went surgery of both.
Methods: The patient presented an obstructive jaundice 
due to a 5 cm tumor on the head of the pancreas. No 
vascular involvement was documented on CT scan and 
extrahepatic disease was ruled out with a PETscan. 
Pancreaticoduodenectomy was performed without postop-
erative complications. Histological analysis revealed a 
pT3N0 (0/23) adenocarcinoma with moderate differentiation 
and perineural. Adjuvant therapy with gemcitabine plus RT 
was administered. Two metachronous hepatic metastases 
were detected on MR after adyuvant treatment, eight months 
after surgery: 2 cm sized in segment II, close to the left 
suprahepatic vein, and 1 cm sized in segment VI. 
“Neoadyuvant” QT was administered with FOLFOXIRI 
schedule. After QT, partial response was observed on MR, 
and left lateral sectionectomy plus resection of lesion in 
segment VI was performed, 11 month after initial pancreatic 
surgery. Histologic analysis revealed a metastase of pancre-
atic adenocarcinoma in segment II, and fi brous changes with 
no malignancy in segment VI. The patient was discharged 
on day 5 and she is currently alive with no evidence of 
recurrent disease.
Conclusions: Decreasing mortality and morbidity in major 
procedures as pancreaticoduodenectomy and liver resec-
tions permits more aggressive strategies in poor prognosis 
cancers as pancreatic adenocarcinoma, specially in young 
patients. Neoadjuvant treatments and new protocols of che-
motherapy may contribute to improve results of this chal-
lenging disease.
P-091
A CASE OF NON FUNCTIONING 
METASTATIC NEUROENDOCRINE 
TUMOR TREATMENT WITH 
OCTREOTIDE LAR
H. Fujikawa1, M. Ishibashi2, Y Tukune2, K. Ito1, 
N. Tsutusmi1, M. Inami1, M. Komatsu1, K. Mimatsu1, 
H. Kano1, T. Oida1, H. Sasano3, S. Matsuoka4 
and M. Moriyama4
1Social Insurance Yokohama Central Hospital, Miyagi, 
Japan; 2Tukune Clinic, 3 Tohoku University School of 
Medicine, Tokyo, Japan; 4Nihon University School of 
Medicine, Tokyo, Japan
Introduction: The development of a long-acting formula-
tion of octreotide long-acting release (LAR®) signifi cantly 
improved the quality of life for patients with nonfunctioning 
neuroendocrine tumors (NETs).
Methods: A 75-years old man was admitted in our hospital 
because of dynamic abdominal CT showed metastatic mul-
tiple masses. His serum level of tumor markers were normal, 
and HBs Ag and hepatitis C antibody were negative. We 
decided to perform an exploratory laparoscopy because we 
could not fi nd out a primary origin of malignancy by con-
ventional diagnostic techniques. Histopathological fi ndings 
showed cribriform pattern that was expressed on CD56, syn-
aptophysin, and chromogranin, and he was diagnosed with 
NETs. But he discharged without therapy. He was readmitted 
because of complaining of fever. CT showed multiple masses 
without abscess. His serum level of C-reacitve protein was 
positive and He was improved by antibiotic drug. Somatostatin 
receptors, 1, 2A, 2B, 3 (SSTRs) expressed on liver tissue, 
therefore he was started on octreotide 300 μg/day to octreo-
tide LAR 20 mg im/4 week.
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Results: At of 36 months after diagnosis on Jun 2011, his 
performance status and survival benefi ts were obtained by 
Octreotide LAR.
Conclusions: Octreotide LAR was particularly useful for 
the patient who did not hope for chemotherapy.
P-092
LONG SURVIVAL CASE OF ADVANCED 
PANCREATIC CANCER THAT GEM 
SUCCEEDS
H. Fujikawa1, K. Ito1, N. Tsutusmi1, M. Inami1, 
M. Komatsu1, N. Fukino1, K. Mimatsu1, H. Kano1, 
T. Oida1, S. Matsuoka2 and M. Moriyama2
1Social Insurance Yokohama Central Hospital, Yokohama, 
Japan; 2Nihon University School of Medicine, Tokyo, 
Japan
Introduction: We report the case of a patient who has 
survived for 36 months without any signs of recurrence 
following a course of chemotherapy with gemcitabine 
(GEM).
Methods: A 75-years old man was complaining of weight 
loss and pointed out tumor on abdominal ultrasonography at 
nearest hospital. He was referred to our hospital for further 
evaluation. He had history of asthma, diabetes and BPH. The 
laboratory on admission, his serum tumor marker (CA19-9) 
was 517 IU/L. Dynamic CT showed low density lesion 3 cm 
in diameter on the pancreatic body. Abdominal angiography 
showed infi ltration of the superior mesenteric artery and 
portal vein. He was diagnosed with unresectable pancreatic 
cancer stage IV, therefore he was started on chemotherapy 
with GEM (1,000 mg/m2 i.v. over 30 minutes) on days 1, 8, 
and 15 every 28 days.
Results: After the end of the 10th course, tumor size had 
reduced from 30 mm to 20 mm and his CA19-9 level was 
markedly reduced to 91 U/mL. At of 36 months after diag-
nosis on May 2011, his performance status and survival 
benefi ts were obtained by undergoing chemotherapy with 
GEM (total 38th course).
Conclusions: This is a case of unresectable pancreatic 
cancer, treated GEM chemotherapy, in which the patient 
survived 36 month after diagnosis.
P-093
THE CD271 POSITIVE RATE OF 
PANCREATIC STELLATE CELLS IS 
CORRELATED WITH THEIR 
MIGRATION ACTIVITIES ENHANCED 
BY CO-CULTURED PANCREATIC 
CANCER CELLS
K. Fujiwara1, K. Ohuchida1,2, K. Shindo1,3, S. Kozono1, 
N. Ikenaga1, L. Cui1, S. Aishima3, M. Nakamura1, 
K. Mizumoto1,4, Y. Oda3 and M. Tanaka1
Departments of Surgery and Oncology1, Advanced Medical 
Initiatives2, and Department of Anatomic Pathology3, 
Graduate School of Medical Sciences, Kyushu University, 
Fukuoka, Japan; Kyushu University Hospital Cancer 
Center4, Fukuoka, Japan
Introduction: CD271, a nerve growth factor receptor, has 
been reported to be one of the markers of mesenchymal stem 
cell. However, the biological functions of CD271 in pancre-
atic cancer are unknown. Pancreatic cancer is characterized 
by abundant desmoplasia, and the interaction of cancer cells 
and pancreatic stellate cells (PSCs) plays an important role 
in the progress of pancreatic cancer. In the present study, we 
investigated the function of CD271 in pancreatic cancer cells 
and PSCs.
Methods: CD271 expression was assessed in 9 pancreatic 
cancer cell lines and 9 primary cultures of PSCs derived from 
pancreatic cancer tissues by fl ow cytometry. Next, we com-
pared ability of invasion and migration of PSCs co-cultured 
with cancer cells. Immunohistochemical analysis of CD271 
was performed for 6 normal pancreatic tissues, 45 pancreatic 
cancers, and 32 intraductal papillary mucinous neoplasms 
(IPMNs) of the pancreas.
Results: The positive rates of CD271 expression were 0.2–
6.8% in pancreatic cancer cell lines, and 0–3.9% in PSCs. In 
vitro co-culture experiments showed that the CD271 positive 
rates in PSCs were correlated with the migration activities 
of PSCs enhanced by co-culture with cancer cells. In immu-
nohistochemical analysis, pancreatic cancer cells were not 
stained. The CD271 positive rates of PSCs in normal pan-
creas, pancreatic cancer, and IPMNs were 0%, 45%, and 
84%, respectively. In pancreatic cancer, the positive rates of 
CD271 in PSCs were higher on the edge of tumors than in 
the center of tumors.
Conclusions: These data suggest that CD271 + PSCs may 
be function-specifi c subpopulation to be recruited by neo-
plastic cells.
P-094
A SURGICAL CASE OF DUODENAL 
NEUROENDOCRINE CARCINOMA
K. Fukuyo, G. Akasu, Y. Kawashima, H. Ishikawa, 
T. Hisaka, M. Yasunaga and H. Kinoshita
Kurume University School of Medicine, Kurume, Japan
A 75-year-old woman visited a local clinic with the chief 
complaint of nausea and anorexia. Upper gastrointestinal 
endoscopy showed a swollen, eroded the papilla of Vater. 
Biopsy revealed adenocarcinoma. Subsequently, she devel-
oped jaundice, and was admitted to our hospital for treat-
ment. ERCP showed an 11-to 20-mm tumor (exposed type) 
at the papilla of Vater, a papilliform elevation in the lower 
bile duct (Bi), and stenosis confi ned to the Bi. CT showed a 
15-mm tumor with gradual weak enhancement at the papilla 
of Vater, and enlarged lymph nodes at the head and uncinate 
process of the pancreas. After biliary decompression by 
endoscopic retrograde biliary drainage, subtotal stomach-
preserving pancreaticoduodenectomy with D2 lymph node 
dissection was performed. Immunohistochemically, the 
lesion was positive for chromograninA, synaptophysin, and 
CD56, and the Ki67 labeling index was 70%, with at least 
20 mitotic fi ngures per 10 high-power fi elds, leading to a 
diagnosis of large cell neuroendocrine carcinoma (NEC).
Neuroendocrine carcinomas arising from the papilla of 
Vater are rare, high-grade malignant tumors, and are prone 
to vascular invasion and distant metastasis at an early stage. 
Therefore, it has been reported the majority of them are 
advanced when detected, and follow a rapid clinical course. 
Herein, we report a surgical case of neuroendocrine carci-
noma of the papilla of Vater, with a review of the 
literature.
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P-095
CLINICOPATHOLOGIC FEATURES AND 
PROGNOSIS OF MUCINOUS CYSTIC 
NEOPLASMS (MCNS) WITH OVARIAN 
STROMA
E. M. Gil, S. H. Choi, D. W. Choi, J. S. Heo, M. J. Kim, 
H. J. Park and K. K. Choi
Samsung Medical Center, Gangnam-gu, Seoul, Korea
Introduction: Intraductal papillary mucinous neoplasms 
(IPMNs) and mucinous cystic neoplasms (MCNs) are 
included in mucin-producing pancreatic tumors. The reports 
about the MCNs are relatively few. The aim of this study was 
to elucidate the clinicopathological features and prognosis of 
MCN.
Methods: By using the presence of ovarian stroma as a 
requisite criterion for diagnosis of MCN, medical records of 
46 MCN patients among 285 mucin-producing neoplasms 
were reviewed. All the patients underwent curative resection 
in Samsung Medical Center between 1994 and April 2011.
Results: MCN was confi rmed in 46 cases, including 37 
low-grade (80.4%), 4 intermediate-grade (8.7%), 1 high-
grade dysplasia (2.2%) and 4 invasive carcinomas (8.7%). 
Patients with MCN were exclusively women (91.3%) with 
the mean age of 48.1 years. Most tumors were located in the 
pancreatic body/tail (89.1%) with a mean size of 52.4 mm. 
The most frequent presenting symptom was abdominal pain 
(23.9%). More than half were asymptomatic. None of the 42 
patients with non-invasive MCNs recurred. However 2 out 
of 4 patients with invasive MCNs recurred and 1 died within 
5 years. The 53-year-old female had additional pancreatec-
tomy due to local recurrence in 2 years, and currently under-
going chemotherapy after detection of pleural metastasis. 
The 52-year-old male patient, whose cancer size was up to 
7 cm, was found to have liver metastases 1 year after the 
operation, and expired another 1 year later.
Conclusions: The prognosis of the non-invasive MCN is 
excellent when curative resection was performed. Early cura-
tive surgical resection is recommended even in the cases of 
recurrence.
P-096
RESECTION OF A SOLITARY 
PANCREATIC METASTASIS OF 
MALIGNANT MELANOMA: REPORT OF 
A CASE
H. Goto, T. Arai, S. Saeki, Y. Okada, K.  Hiramatu, 
T. Amemiya, F. Sato, K. Kimura, H. Tanaka, H. Ida and 
R. Kawada
Department of Surgery, Anjo Kosei Hospital, Japan
Introduction: Most metastatic pancreatic tumors are 
detected at an advanced stage and are not considered suitable 
for surgery; however, resection is sometimes indicated for a 
solitary pancreatic metastasis and improves the prognosis.
Case Reports: We report such a case of a 71-year-old 
woman, in which the malignant melanoma of nasal cavity 
was resected with maxillary antrum 8-months ago, and this 
time sub-stomach preserved pacreatoduodenectomy was 
performed.
Conclusion: We also discuss the relevant literature, includ-
ing all the reports of pancreatic metastasis from malignant 
melanoma found in Medline. Only 15 cases were reported, 
and half of the cases, addition to ours, were able to resect. A 
good prognosis can be expected once the pancreatic meta-
static lesions are surgically excised, especially if it is a soli-
tary metastasis. Therefore, surgical resection of pancreatic 
metastases is recommended to achieve the best chance of 
long-term survival.
P-097
MULTIVISCERAL RESECTION OF 
PANCREATIC NEUROENDOCRINE 
TUMORS
J. S. Gundara, N. Williams, R. Alvarado-Bachman, 
S. Gananadha, T. J. Hugh and J. S. Samra
Department of Surgery, Royal North Shore Hospital, 
Sydney University, Australia
Introduction: Pancreatic neuroendocrine tumors (PNET) 
are rare and surgical resection offers the only possibility of 
cure for localized disease. The role of surgery in the setting 
of metastatic disease is more controversial.
Methods: We report two cases of synchronous, one stage 
multivisceral resections for PNET and associated reconstruc-
tion. This is followed by a brief review of current 
literature.
Results/Conclusions: Emerging data suggests that synchro-
nous surgical resection of pancreas and liver may be associ-
ated with increased survival. We highlight the technical 
issues involving such an extensive resection and demonstrate 
that one stage multivisceral operations can be achieved 
safely.
P-098
PHASE I TRIAL OF ORAL S-1 PLUS 
GEMCITABINE AND CONCURRENT 
RADIOTHERAPY FOR T3–4 AND M0 
PANCREATIC CANCER
G. Honda, M. Kurata, S. Kobayashi, Y. Okuda 
and K. Tsuruta
Tokyo Metropolitan Komagome Hospital, Tokyo, Japan
Introduction: The primary objective of this phase I trial 
was to determine recommended doses of gemcitabine (GEM) 
with full-dose oral S-1 and concurrent radiotherapy in 
patients with T3–4 and M0 pancreatic cancer.
Methods: Eighteen patients consented to receive this treat-
ment. Weekly GEM (200–300 mg/sq for 6 weeks) was 
administered with oral S-1 (80 mg/sq/day) synchronized 
with concurrent radiotherapy (50.4 Gy in 28 fractions). 
Restaging evaluation was performed 4 weeks after the fi nal 
irradiation.
Results: Two consecutive patients receiving 300 mg/sq of 
GEM demonstrated dose-limiting toxicities (DLT) involving 
neutropenia, while only 1 of 6 patients at doses of 200 mg/
sq demonstrated DLT. Therefore, 200 mg/sq of GEM was 
determined as recommended dose and 10 additional patients 
were assigned to this dose level. DLT was observed in 2 of 
these 10 patients. Grade 3/4 toxicities were neutropenia in 
11, anorexia in 8, pneumonitis in 2 and thrombopenia in 1 
patient. The median tumor size decreased to 2.3 cm (range: 
0.3–3.5) in diameter. Nine patients achieved a partial 
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response, giving an overall response rate of 50%, while the 
other 9 patients showed stable disease.
Conclusions: This treatment regimen can obtain a high 
response rate. However, stringent management is required to 
prevent adverse events, especially hematological toxicities 
and anorexia.
P-100
A CASE OF UNUSUAL TYPE OF 
AMPULLA OF VATER CANCER; 
UNDIFFERENTIATED CARCINOMA 
WITH PLEOMORPHIC LARGE CELLS
H. J. Kim, H. H. Kim, E. K. Park, B. G. Choi, H. J. Kim, 
Y. H. Hur, Y. S. Koh, J. C. Kim and C. K. Cho
Chonnam National University Medical School, Gwangju, 
South Korea
Introduction: Undifferentiated carcinoma with pleomor-
phic large cells in the ampulla of Vater is very rare with a 
incidence of less than 5% of all ampullary tumors. The tumor 
is composed with pleomorphic cells and giant cells.
Methods: An 80-year-old man presented with intermittent 
epigastric pain beginning about one month ago. Abdominal 
CT and MRI revealed a 2.4 cm sized peripheral enhancing 
mass in the ampulla of Vater and several enlarged lymph 
nodes (maximum 1.7 cm) in the portocaval space and around 
celiac axis. Endoscopic examination revealed a irregular 
tumoral infi ltration of the ampullary orifi ce. Pylorus-
preserving pancreaticoduodenectomy was performed under 
the impression of ampulla of Vater cancer.
Results: Grossly 2.4 × 2 cm sized hard mass was found in 
the ampulla of Vater, which invaded into the pancreas. 
Microscopically, the tumor cells were round to polygonal 
and presented in groups without any higher architectural 
features. The nuclei were large and round with prominant 
nucleoli. Immunohistochemical examination showed posi-
tive staining for vimentin, CK7, and CK19. Pathological 
diagnosis was confi rmed by undifferentiated carcinoma with 
pleomorphic large cells of ampulla of Vater (T3N1M0). The 
patient is alive without evidence of recurrence in 1-year-
follow up after surgery.
Conclusions: Undifferentiated carcinoma with pleomorphic 
large cells in the ampulla of Vater is a rarely encountered 
disease. The prognosis is poorer than ‘conventional’ adeno-
carcinoma. The treatment option is only curative surgical 
resection. Here in, we present a rare case of surgically 
resected undifferentiated carcinoma with pleomorphic large 
cells in the ampulla of Vater.
P-101
POSTERIOR APPROACH FOR THE 
SURGICAL TREATMENT OF 
PANCREATIC PSEUDOCYST USING 
LAPAROSCOPIC CYSTOGASTROSTOMY
K-H. Kim1, Y-K. You2, C-H. An1, J-S. Kim1, I-Y. Park3 and 
D-G. Kim2
1Uijeongbu St. Mary’s Hospital, Uijeongbu, Korea; 2Seoul 
St. Mary’s Hospital, Seoul, Korea; 3Bucheon St. Mary’s 
Hospital, Bucheon, Korea
Introduction: Pancreatic pseudocysts are common sequelae 
of pancreatitis and pancreatic trauma. The management is 
based upon the pseudocyst size and presence of symptoms. 
For the large cyst and symptomatic cyst, the treatment of 
choice has been internal drainage using several available 
options. With the advent of advanced laparoscopic tech-
nique, laparoscopic cystogastrostomy is a less morbid 
method, alternative to open drainage.
Methods: From September 2006 to July 2010, We present 
our experience with two man and one woman aged 38 and 
65 years with pancreatic pseudocyst that were successfully 
performed cystogastrostomy laparoscopically by using a 
stapler.
Results: Average operation time was 315 minutes (range 
220–410). All patients had an uneventful recovery, with no 
major morbidity. All patients were discharged from 5th to 
6th postoperative day.
Conclusions: The Posterior approach of laparoscopic cys-
togastrostomy is a feasible and secure method for large ret-
rogastric pancreatic pseudocyst and facilitates debridement 
of the necrotic pancreas.
P-102
PREDICTIVE FACTOR OF LYMPH NODE 
METASTASIS IN INTRADUCTAL 
PAPILLARY MUCINOUS NEOPLASMS OF 
THE PANCREAS
I. Kitazono1, T. Komokata1, Y. Shimamoto1, H. Motodaka1, 
K. Yoshikawa1, H. Kawamura1, Y. Imoto1, M. Osako2, 
J. Kadono2, N. Ishizaki2 and M. Tabata2
1Department of Cardiovascular, Thoracic, and Hepato-
Billiary-Pancreatic Surgery, Kagoshima University 
Graduate School of Medical and Dental Science; 
2Department of Surgery, Kagoshima Medical Association 
Hospital
Background: Little is known about the frequency of lymph 
node metastasis (LNM) in intraductal papillary mucinous 
neoplasms (IPMN). Our aim of this study was to investigate 
the predictive factors for the LNM in IPMN.
Material and Methods: Between January 2000 and 
December 2010, 75 patients with IPMN underwent surgical 
resection. Of these, 13 patients with double cancer were 
excluded. LNM was observed in 6 patients. We retrospec-
tively reviewed the differences of clincopathologic features 
between {LNM(+) n = 6} and {LNM(−) n = 56} groups of 
patients with IPMN and analyzed the LNM- related factors.
Results: Univariate analysis revealed that the preoperative 
elevation of carbohydarte antigen 19–9 (CA19-9) (>38 U/
ml) (83% vs. 16% p = 0.00018), intraductal papillary muci-
nous carcinoma (IPMC) (100% vs. 32%, p = 0.001) were 
signifi cant predictive factors for the LNM. Multivariate 
analysis demonstrated that the independent risk factors of 
LNM were elevated CA 19–9 (p = 0.03, odds ratio = 16.3, 
95%CI = 1.319–201.521). The 3-year cumulative survival of 
LNM(+) groups was signifi cantly lower than the LNM(−) 
group (survival rate 26% vs. 94%, p < 0.001).
Conclusion: The risk factors associated with LNM in IPMN 
were elevated CA19-9. In these patients, regional lymph 
node dissection would be recommended.
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P-103
CASE REPORT: CONCURRENT 
LYMPHOMA AND PANCREATIC 
ADENOCARCINOMA
J. M. Lai1, P. Crowley2 and M. Nikfarjam1
Department of 1Surgery and 2Anatomic Pathology, 
University of Melbourne, Austin Health, Melbourne, 
Victoria, Australia
Introduction: Retroperitoneal lymph node enlargement in 
patients with pancreatic cancer is sometimes treated as incur-
able disease. Non-metastatic causes of lymphadenopathy 
should however be considered
Case Reports: Two cases of signifi cant retroperitoneal 
lymphadenopathy in the setting of pancreatic cancer, treated 
by pancreaticoduodenectomy and lymph node dissection are 
described. Both cases had a fi nal diagnosis of concurrent 
pancreatic cancer and lymphoma with no evidence of pan-
creatic lymph node metastasis on histopathology.
Discussion: We discuss the patterns of normal lymph node 
involvement in pancreatic cancer and lymphoma.
Conclusions: Interpretation of staging imaging is important 
in patients with pancreatic cancer. Not all enlarged lymph 
node should be attributed to pancreatic cancer.
P-104
PANCREATODUODENECTOMY FOR 
PERIAMPULLARY TUMOR: 
INDONESIAN ONE TEAM EXPERIENCE
T. J. M. Lalisang, A. Nugroho, Y. Mazni, A. Simanjuntak 
and B. Philippi
Digestive Surgery Division, Cipto Mangunkusumo 
Hospital, Faculty of Medicine, University of Indonesia, 
Jakarta, Indonesia
Introduction: Pancreaticoduodenectomy (PD) is the only 
hope for prolong survival in periampullary cancer. Developing 
countries face a more complex problems, regarding the 
majority of patients presented with prolong jaundice and 
nutrition impairment. This study reviews the outcome of PD.
Methods: A Retrospective data analysis of 120 PD in the 
last ten years was performed, in the last 3 year the resection 
rate was more than 15 cases per year around several Jakarta 
hospital.
Results: 53% male were operated which age average 51.3 
(17–73) years. More than on month jaundice was the common 
symptoms and more than half suffer for under nutrition. 
Preoperative bile duct decompression were done on 85% 
cases due to the high level of total bilirubin. Pre operatively 
15% of cases, already were proven malignant tumor by 
biopsy. Pylorus preserving PD were performed on 57% 
cases, classic Whipple 40% cases and total pancreatecduo-
denectomy was done on 3 cases. Pathologic result 48% were 
Head Pancreas Carcinoma, 37% were Ampula Vater malig-
nancy and nine cases were benign tumor, Overall 73% cases 
were on State II and III, state I only in 7% and state IV 20% 
of cases. The overall morbidity was 56% and the post opera-
tive mortality were 20%, but the last twenty case there were 
no mortality. Over all survival 50% die after 12 moth, there 
were 10 cases alive more than 60 moths especially the 
ampula Vater tumor. In they surviva average 24 moths.
Conclusions: Perioperative selection infl uenced the result. 
Aggressive against the complications overcome the destruc-
tive effect. Adequate drainage prevent the mortality due to 
pancreatic leak.
P-105
LARGE CELL NEUROENDOCRINE 
CARCINOMA OF THE AMPULLA OF 
VATER: A CASE REPORT
H. J. Lee, H. C. Kim, J. C. Chung and G. S. Choi
Department of surgery, Soonchunhyang University 
Bucheon Hospital, Bucheon, Reperblic of Korea
Introduction: Primary neuroendocrine carcinoma of the 
ampulla of Vater is very rare. The clinical course presents an 
appearance of extremely aggressive behavior and frequent 
liver metastasis. The effective adjuvant chemotherapy for 
large cell neuroendocrine carcinoma (LCNEC) is not estab-
lished as yet. We report a rare case of LCNEC of the ampulla 
of Vater.
Methods: A 58 year old man presented with epigastric dis-
comfort and dyspepsia. All laboratory fi ndings were within 
normal limits. PET-CT scan showed a focal FDG uptake in 
the head of pancreas. Endoscopic biopsy specimen of 
duodenal papilla revealed a diffuse infi ltration of atypical 
cell, consistent with poorly differentiated malignant 
tumor. The patient underwent pylorus preserving 
pancreaticoduodenectomy.
Results: Histopathologic fi ndings were suitable for LCNEC. 
Immunohistochemical studies revealed positivity for chro-
mogranin A, synaptophycin. The patient was undertaken 
chemotherapy (cisplatin and etoposide). Six months after 
surgery, a metastatic hepatic nodule was found at segment 7 
and was treated by radiofrequency abration. The patient was 
received six courses of additional chemotherapy (cisplatin, 
doxorubicin and cyclophosphamide; CAP). Fifteen months 
after the surgery, the patient is alive and no other metastatic 
lesion is found.
Conclusions: CAP chemotherapy was effective. For early 
detection of liver metastasis, short term follow up by using 
radiologic imaging is essential.
P-106
CASE REPORT: ACINAR CELL 
CARCINOMA OF THE PANCREAS, A 
RARE PANCREATIC TUMOR
L. S. Lee, S. S. Tan and S.-M. Tan
Changi General Hospital, Singapore
Introduction: Acinar cell carcinoma of the pancreas (ACC) 
is a rare tumor, accounting for only 1% of all pancreatic 
tumors. This tumor is usually sizeable, with its’ size ranging 
from 2 to 30 cm. They are commonly located in the pancre-
atic head, neck and uncinate process.
Case History: We report a case of ACC of the pancreas who 
presented with vague abdominal distension. His CT scan 
showed a lobulated hypodense mass located posterior to the 
body of the pancreas. CA 19–9 and CEA were normal. 
Endoscopic ultrasonography guided fi ne needle aspiration of 
the tumor showed adenocarcinoma. He underwent distal pan-
createctomy and splenectomy. Morphology and staining is 
consistent with ACC.
Results: Post-operative recovery was uneventful.
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Conclusions: ACC is a rare pancreatic tumor, the defi nitive 
diagnosis of this tumor requires a histopathology and immu-
nohistochemical studies.
P-107
COMPARISON BETWEEN CONTINUOUS 
CLOSED SUCTION DRAINAGE AND 
PASSIVE DRAINAGE OF THE 
PANCREATIC DUCT IN 
PANCREATICOGASTROSTOMY
K. Mimatsu1, T. Oida1, N. Fukino1, H. Kano1, 
A. Kawasaki1, K. Kida1, Y. Kuboi1 and S. Amano2
1Department of Surgery, Social Insurance Yokohama 
Central Hospital, Yokohama, Japan; 2Department of 
Surgery, Nihon University School of Medicine, Tokyo, 
Japan
Introduction: Temporary external drainage of the pancre-
atic duct is one of the surgical options to prevent the develop-
ment of a pancreatic fi stula. This retrospective study was 
comparison between suction drainage and passive drainage 
of the pancreatic duct tube.
Methods: After a modifi ed subtotal stomach-preserving 
pancreaticoduodenectomy reconstruction with pancreatico-
gastrostomy was performed, a pancreatic duct tube was 
inserted and fi xed into the remnant pancreatic duct with-
drawn through the anterior gastric wall and totally external-
ized. The pancreatic tube was then connected to the aspiration 
bag of a 200-cc Silicone Bulb Evacuator® or to a closed 
system drainage bag for natural drainage. 13 patients were 
enrolled to the suction drainage (SD group) and 11 patients 
to the passive drainage (PD group) in this study.
Results: Volume of pancreatic drainage content was tend to 
be more in the SD group than in the PD group. Pancreatic 
fi stula is not signifi cant difference between in SD group (3 
of 13 cases) and in the PD group (3 of 11 cases). According 
to ISGPF, grade A, B, C were observed in 1, 1, 1 case in SD 
group and 0, 2, 1 case in PD group, respectively. Late intra-
abdominal hemorrhage and abdominal abscess observed in 
1 case of each groups, respectively.
Conclusions: Although the volume of pancreatic duct drain-
age content was more in the closed suction drainage than in 
the passive drainage, it is not signifi cantly difference of the 
incidence of pancreatic leakage. Prospective randomized 
study is necessary to confi rm whether each drainage provide 
a better option to prevent pancreatic leakage.
P-108
SURGICAL MANAGEMENT FOR TWO 
TIMES DELAYED MASSIVE INTRA-
ABDOMINAL HEMORRHAGE 
FOLLOWING 
PANCREATICODUODENECTOMY
K. Mimatsu1, T. Oida1, H. Kano1, N. Fukino1, 
A. Kawasaki1, K. Kida1, Y. Kuboi1 and S. Amano2
1Department of Surgery, Social Insurance Yokohama 
Central Hospital, Yokohama, Japan; 2Department of 
Surgery, Nihon University School of Medicine, Tokyo, 
Japan
Introduction: Delayed massive hemorrhage is one of the 
major life-threatening complications following pancreatico-
duodenecotomy. Surgical treatment is recommended for 
massive hemorrhage because surgery obtained hemostasis in 
high rate and low mortality. However, re-bleeding from 
ruptured pseudoaneurysm is high mortality. We experienced 
successfully surgical treatment for twice delayed massive 
intra-abdominal hemorrhage after pancreaticoduodenectomy.
Case Report: A 57-year-old man admitted our hospital 
because of chronic pancreatitis. We had undergone panctre-
aticoduodenectomy with pancreaticogastrostomy for impres-
sion of malignancy. Delayed massive hemorrhage from drain 
was developed 11 days after surgery. Although angiography 
was done, the bleeding location was not clearly detected. 
Therefore, open abdominal surgery was performed. Surgical 
fi ndings showed the site of bleeding from the common 
hepatic artery. Surgical ligation of the bleeding point was 
performed using with suture technique. However, re-bleed-
ing from drain was developed 7 days after initial hemor-
rhage, and surgical ligation using with surgical ligation and 
absorbable hemostatic cotton was done. After second surgery 
for hemorrhage, there is no hemorrhage and fatal hepatic 
failure. He left from our hospital 64 days after initial surgery.
Conclusions: We should be kept in mind of re-bleeding 
after surgical management for delayed hemorrhage after 
pancreaticoduodenectomy.
P-109
SURGICAL MANAGEMENT OF THE 
RESECTED PLANE OF THE REMNANT 
PANCREAS TO REDUCE THE 
INCIDENCE OF PANCREATIC LEAKAGE 
FOLLOWING DISTAL 
PANCREATECTOMY
K. Mimatsu1, T. Oida1, H. Kano1, N. Fukino1, 
A. Kawasaki1, K. Kida1, Y. Kuboi1, H. Miyake2 
and S. Amano2
1Department of Surgery, Social Insurance Yokohama 
Central Hospital, Yokohama, Japan; 2Department of 
Surgery, Kasukabe Municipal Hospital, Saitama, Japan; 
3Department of Surgery, Nihon University School of 
Medicine, Tokyo, Japan
Introduction: Pancreatic leakage is the most major compli-
cations after distal pancreatectomy. Some technique such as 
staple closure and pledgetted suture due to reduce pancreatic 
leakage has been described. To date, a randomized control 
trial that was comparison between stapler and hand-sewn 
closure after distal pancreatectomy was reported. It con-
cluded that stapler closure did not reduce the pancreatic 
fi stula compared with hand-sewn closure. This retrospective 
analysis described better standard technique of pancreatic 
resection and closure following distal pancreatectomy.
Methods: Medical record of 41 patients who underwent 
distal pancreatectomy between 1998 and 2010 in two institu-
tions were reviewed in this retrospective study. Patients 
having distal pancreatectomy were divided into a pancreatic 
leakage group (n = 14) and a non-leakage group (n = 27). 
These groups were compared in terms of technique of closure 
of the pancreatic stump.
Results: Characteristics of patients including age, gender, 
disease and were not signifi cant deference between the pan-
creatic leakage group and the non-leakage group. Fish-mouse 
cutting of the pancreas is performed in the leakage group 
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more than the non-leakage group. Ligation of the main pan-
creatic duct and closure of the pancreatic stump was per-
formed in the non-leakage group more than the leakage 
group. Stapling closure was more incidence of pancreatic 
leakage than the hand suturing technique.
Conclusions: Precise square mattress suturing ligation of 
the main pancreatic duct and closure of the resection plane 
of the remnant pancreas make more reduced the incidence 
of pancreatic leakage following distal pancreatectomy.
P-110
NONFUNCTIONING PANCREATIC 
NEUROENDOCRINE TUMORS WITH 
SYNCHRONOUS HEPATIC METASTASIS: 
THREE CASE REPORTS
H. Motonari, H. Taniguchi, H. Koami, S. Kameyama, 
T. Ishimine, F. Kohakura, Y.  Nagamine, T. Matsumura 
and T. Isa
Urasoe General Hospital, Okinawa, Japan
Pancreatic neuroendocrine tumors (PNETs) are rare and 
often malignant. However, unlike most neoplasms, malig-
nant PNETs may grow slowly and can be treated by several 
concentrative therapies such as radiofrequency ablation 
therapy (RFA), transcatheter arterial chemoembolization 
(TACE), somatostatin analogs, anticancer agents, and recent 
molecular targeting agents. Therefore, aggressive surgical 
treatment for PNETs with hepatic metastasis may lead to 
long-term survival. Herein, we report 3 cases of resected 
nonfunctioning PNETs with synchronous hepatic metastasis. 
In all the 3 cases, preoperative images obtained using ultra-
sonography (US) and computed tomography (CT) revealed 
nonfunctional PNETs with hepatic metastasis, and the 
patients underwent surgical resection. We performed distal 
pancreatectomy for primary lesion and partial hepatectomy 
for hepatic metastasis; 2 patients were treated at the same 
time and the remaining patient underwent the procedure 6 
months after the surgery. All of them had recurrences, but 
their treatment on an outpatient basis is still ongoing. The 
postoperative treatment approach varied with each case. Two 
patients underwent RFA; 1 patient underwent systemic and 
transcatheter arterial chemotherapy and was subsequently 
treated with molecular targeting agents. The duration after 
surgery for the fi rst patient is 4 years 8 months, for the second 
is 3 years 4 months, and for the third is 1 year 9 months. Our 
fi ndings may indicate that surgical resection with hepatec-
tomy for nonfunctioning PNETs may lead to a favorable 
outcome.
P-111
TWO CASES OF RETROPERITONEAL 
SCHWANNOMA MIMICKING 
PANCREATIC TUMOR
H. Motonari, H. Taniguchi, H. Koami, S. Kameyama, 
T. Ishimine, T. Matsumura, K.  Kobashigawa and T. Isa
Urasoe General Hospital, Okinawa, Japan
Introduction: Pancreatic tumors are highly diverse and dif-
fi cult to distinguish. Endoscopic ultrasonography (EUS) 
plays a signifi cant role in the diagnosis of these tumors; 
recently, EUS-guided fi ne needle aspiration (EUS-FNA) has 
been performed frequently for cytological confi rmation. 
Herein, we report 2 cases of retroperitoneal schwannoma that 
mimicked pancreatic tumors.
Case 1: A cystic mass (diameter, 15 mm) in the pancreas 
head was detected in a 53-year-old woman by US and CT. 
Endoscopic retrograde cholangiopancreatography (ERCP) 
showed a normal main pancreatic duct without connection 
to the cyst. EUS-FNA revealed spindle cell proliferation in 
palisading patterns. Immunohistochemically, the spindle 
cells were positive for S-100 protein. Thus, the tumor was 
diagnosed as a schwannoma. She is currently under observa-
tion with her consent.
Case 2: A solid tumor (diameter, 23 mm) without cystic 
component was detected in the pancreas head of a 34-year-
old woman by US and CT. EUS fi ndings suggested that an 
oval solid tumor compressed a common bile duct and portal 
vein. We performed resection because the tumor had common 
bile duct stenosis. Operative fi ndings suggested that the 
tumor was located between the hepatoduodenal ligament and 
the dorsal pancreas and could be separated from the pancreas 
and bile duct. Simple enucleation of the tumor was per-
formed. Histological examination of the resected specimen 
revealed schwannoma.
Conclusions: Although schwannomas in peripancreas are 
common, distinguishing schwannomas from pancreatic 
tumor is diffi cult, some cases are diagnosed only by surgical 
excision.
P-112
A CASE OF INTRADUCTAL PAPILLARY 
MUCINOUS CARCINOMA OF PANCREAS 
WITH MULTIPLE FISTULAS INTO 
STOMACH AND DUODENUM
E. K. Park1, H. J. Kim1, B. K. Choi1, H. J. Kim1, 
J. S. Seoung2 and C. K. Cho1
1Chonnam National University Medical School, Gwangju, 
South Korea; 2Saint Carollo Hospital Dept. of Surgery, 
Suncheon, South Korea
Introduction: Since the fi rst report of intraductal papillary 
mucinous neoplasm (IPMN) of pancreas with pancreatobili-
ary fi stula in 1980, several cases of IPMN with fi stula have 
been reported. The organs most commonly affected by fi stula 
formation are duodenum, common bile duct and stomach, 
and the number of fi stula is usually single and rarely multiple 
according to reported cases.
Methods: A 71-year-old woman was admitted for abdomi-
nal discomfort and jaundice. In laboratory tests, serum total 
and direct bilirubin was 14.9 mg/dL/10.8 mg/dL and CA19-9 
was 146.8 U/mL. Abdominal CT and MR cholangiogram 
showed marked dilatation of pancreatic duct and biliary tract, 
with multifocal papillary or solid enhancing portion within 
pancreatic duct. The image studies and gastroduodenoscopy 
revealed two fi stulas between cystic mass and stomach 
antrum, and cystic mass and duodenum. The patient under-
went operation under the impression of intraductal papillary 
mucinous carcinoma (IPMC) with fi stula into stomach and 
duodenum.
Results: In operation, about 3.5 × 3 cm sized mass was 
found in pancreas head and fi rm fi brous tissue was demon-
strated between pancreas neck and stomach antrum. 
Whipple’s operation was performed for complete removal of 
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both pancreas mass and fi stula. On examination of resected 
specimen, two fi stulous openings were found, one at the 
posterior wall of stomach antrum in 1.5 cm diameter, and 
the other at the duodenal 2nd portion in 1.3 cm diameter. The 
pathologic diagnosis was invasive IPMC with fi stula into 
stomach and duodenum.
Conclusions: We report here a case of invasive IPMC with 
atypical manifestation of multiple fi stula into stomach and 
duodenum.
P-113
PANCREATIC TUBERCULOSIS 
MASQUERADING AS A SOLID-CYSTIC 
NEOPLASM OF THE HEAD OF 
PANCREAS
G. Srikanth, G. Shenoy1, S. Kumar and N. Shetty
BGS Global Hospitals, Institute of Gastroenterology, 
Bangalore, India
Introduction: Tuberculosis affecting the pancreas is rare. 
Differentiation between tuberculosis and malignancy in a 
patient presenting with pancreatic headmass is diffi cult. 
Herein, we describe a young lady presenting with pancreatic 
head mass, who underwent a pancreaticoduodenectomy and 
fi nal histology revealed tuberculosis.
Methods: 17 year old lady presented with recurrent epi-
sodes of pain abdomen and weight loss. A CECT of the 
abdomen showed 5 × 4 × 3 cm solid cystic mass lesion in 
the pancreatic head with and bile duct dilatation. Pancreatic 
duct not dilated. CA 19–9, CEA were within normal limits. 
Per-operatively there was a large mass in the pancreatic head 
6 × 5 × 4 cm tethered to IVC posteriorly over a small area 
and tethered to small area of portal vein. There were necrotic 
nodes in the retropancreatic region, the frozen Section of 
which showed reactive Hyperplasia. Incidentally she had a 
replaced right hepatic artery. She underwent Whipples 
Pancreaticoduodenectomy.
Results: The post operative course was uneventful except 
for a low output chylous fi stula which settled and she was 
discharged on 8th postoperative day. Histopathology showed 
necrotic mass in the head of the pancreas with granulomatous 
infl ammation. Acid fast bacilli were seen in smears from the 
necrotic mass.
Conclusions: Pancreatic tuberculosis is rare but needs to be 
considered in the differential diagnosis of patients presenting 
with solid-cystic lesion in the pancreas. Establishing diagno-
sis by less invasive preoperative means may avoid major 
surgical intervention.
P-114
INFLUENCE OF DAIKENCHUTO ON 
PATIENT’S PORTAL BLOOD FLOW 
AFTER PANCREATODUODENECTOMY
H. Sunagawa and N. Oshiro
Department of surgery, Nakagami Hospital, Okinawa-city, 
Japan
Introduction: Daikenchuto is a traditional herbal medicine 
that is used for treating postoperative ileus. Daikenchuto is 
known to increase portal blood fl ow after administration. But 
there is no report about effect of Daikenchuto on portal blood 
fl ow in patients after pancreatoduodenactomy. The aim of 
this study is to clarify the infl uence of Daikenchuto on portal 
blood fl ow of patients after pancreatoduodenectomy.
Methods: Twenty-two patients scheduled pancreatoduode-
nectomy were quasi-randomly assigned to two groups: group 
A and group B. 5.0 g of Daikenchuto with 20 ml water were 
given via jejunostomy tube three times a day in group A from 
the fi rst operative day. In group B, 20 ml of water were given 
same times. Portal blood fl ow volume (L/min) were mea-
sured using an ultrasonic doppler method on pre-operative 
day, post-operative day 1, day 3, day 7, respectively. 
Furthermore, pre and post clinical data were examined 
between two groups.
Results: Portal blood fl ow in the group A tended to increase 
much more than that in group B. But there was no signifi cant 
difference. Complication rate of the group A was lower than 
that of the group B signifi cantly.
Conclusions: Daikenchuto tended to increase portal blood 
fl ow after pancreatoduodenectomy, but there was no signifi -
cant differences.
P-115
TRANSDUODENAL LOCAL EXCISION 
FOR BENIGN AND EARLY-STAGE 
MALIGNANT NEOPLASMS OF THE 
AMPULLA OF VATER
H. Taniguchi, T. Isa, H. Motonari, H. Koami, 
S. Kameyama, T. Ishimine and T. Matumura
Center for Gastroenterology, Urasoe General Hospital, 
Okinawa, Japan
Background: Because ampullary tumors are rare neoplasms 
and accurate preoperative histological diagnosis and staging 
is often diffi cult and inconclusive, less invasive surgical pro-
cedures to treat such tumors are necessary. We report 4 cases 
of benign or early-stage malignant neoplasms of the ampulla 
of Vater treated by transduodenal local excision (TDE).
Patients: Between 2006 and 2008, 4 patients with ampul-
lary tumors underwent TDE. Preoperative diagnosis was 
confi rmed using endoscopy and biopsy. Tumor extension 
was evaluated by endoscopic ultrasonography (EUS). TDE 
was indicated for patients having adenomas or carcinomas 
limited within the common pancreaticobiliary channel (Ac).
Results: Three and 1 patients were diagnosed as having 
adenocarcinoma and adenoma, respectively. All patients 
were suspected of having ampullary tumors limited to Ac by 
EUS and underwent TDE. Postoperative pathology revealed 
3 well-differentiated tubular adenocarcinomas and 1 tubular 
adenoma. One patient having adenocarcinoma in situ with 
microscopically positive surgical margin had local recur-
rence 6 months after the operation and underwent pylorus-
preserving pancreaticoduodenectomy and survived for 3 
years. The remaining patients had mucosal lesions and sur-
vived for 3 to 5 years without recurrence.
Conclusions: In patients with adenoma or adenocarcinoma 
in situ without intraductal growth, TDE was an adequate 
surgical treatment choice. Although TDE is justifi ed in these 
patients, surgical procedures should be selected cautiously in 
patients having positive surgical margins.
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P-116
NOVEL METHOD FOR INVAGINATED 
PANCREATOJEJUNOSTOMY AFTER 
PANCREATODUODENECTOMY
I. Yasufuku, S. Osada, Y. Sasaki, S. Imai and K. Yosida
Surgical oncology, Gifu University, Japan
Introduction: To reduce pancreatic fi stula after pancreato-
duodenectomy (PD), we have tried invaginated pancreatoje-
junostomy. Our procedure is the entirely invaginated 
pancreatojejunostomy. We would like to introduce this pro-
cedure with fi gures.
Methods: The internal drainage catheter, cut to length of 
5 cm, is used as a stent for pancreatojejunostomy. Put the 
remnant pancreatic edge into the jejunal proximal edge, 
mucosa-on-capsule, end-to-end, external suture rows are 
created as a single suture between seromuscular tissue and 
remnant pancreatic capsule. Then suture the edge of jejunum 
with the remnant pancreatic capsule as a series suture around.
Results: we have no data as this procedure yet, so we will 
collect data, and report.
Conclusions: we expect that pancreatic fi stula would be 
reduced by this procedure.
P-117
DETECTION OF CIRCULATING TUMOR 
CELLS IN THE PERIPHERAL BLOOD 
INDEPENDENTLY PREDICT SURVIVAL 
IN PATIENTS WITH ADVANCE 
MALIGNANT BILIARY TRACT 
DISEASES: A NEW GUIDE FOR 
SELECTION OF STENTS
K. Chaiyabutr1,2 and K. Leelawat1,2
1Department of Surgery, Rajavithi Hospital, Bangkok, 
Thailand; 2College of Medicine, Rangsit University, 
Bangkok, Thailand
Introduction: To determine the role of circulating tumor 
cells (CTCs) in prediction of the overall survival of patients 
diagnosed with advanced malignant biliary tract obstruction 
diseases.
Methods: We investigated the prognostic value of circulat-
ing tumor cells (CTCs) by examining two markers (cytokera-
tin [CK] 19 and telomerase reverse transcriptase [hTERT] 
mRNA) in 40 patients diagnosed with advanced malignant 
biliary tract diseases. Quantitative real-time reverse tran-
scription (RT-PCR) was used to detect CK19 and hTERT 
mRNA in the peripheral blood of these patients. Overall 
survival was analyzed using the Kaplan-Meier method and 
Cox regression modeling.
Results: Positive CK19 and hTERT mRNA expression was 
detected in 45% and 60%, respectively, of the 40 patients 
sampled. Univariable analysis indicated that positive CK19 
mRNA expression was signifi cantly associated with worse 
overall survival (p = 0.009). Multivariable analysis deter-
mined that positive CK19 mRNA expression, patient’s age 
and serum bilirubin were each independently associated with 
overall survival.
Conclusions: CK19 mRNA expression levels in peripheral 
blood appear to provide a valuable marker to predict overall 
survival in patients with advanced malignant biliary tract 
obstruction.
P-118
ENDOSCOPIC – ASSISTED LIVER 
HANGING MANEUVER: A SAFER 
APPROACH
R. Chanwat, T. Khuhaprema and P. Rujanavej
Sumetchotimaytha Wutthi Khunpugdee Saipan, Surgical 
Oncology Unit, National Cancer Institute, Bangkok 10400, 
Thailand
Introduction: To establish a safer and technically easier 
retrohepatic dissection for the liver hanging maneuver with 
the assistance of endoscope.
Methods: During the dissection of the cranial and caudal 
parts of the liver, the space between the right and middle 
hepatic veins and the anterior surface of the infra-hepatic 
IVC are carefully exposed. A fl exible choledocoscope was 
gently moved through the retrohepatic tunnel from the caudal 
to the cranial end instead of blind dissection, and then tape 
can be passed around the liver parenchyma to elevate the 
liver away from the anterior surface of the IVC.
Results: This procedure has been employed in fourteen 
right hepatectomies for a huge hepatic tumor. In all cases, 
the taping was easily accomplished without any problems. 
The mean dissecting time was 12.3 minutes (range, 
8–38 minutes).
Conclusions: The most important step during the liver 
hanging maneuver is to develop the avascular space without 
any complication. This modifi cation of liver hanging maneu-
ver allows direct vision along the plane between the liver and 
the IVC, thus avoiding injury to the retrohepatic veins or 
IVC.
Key words: Liver hanging maneuver, Liver resection, 
Endoscopy
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ADJUVANT TRANSARTERIAL 
CHEMOEMBOLIZATION AFTER 
CURATIVE HEPATECTOMY IN 
HEPATOCELLULAR CARCINOMA – AN 
INITIAL EXPERIENCE
Y. S. Cheung1, Y. F. E. Cheung1, K. W. Ma1, 
C. N. C. Chong1, S. W. J. Wong1, J. Wong1, W. Y. J. Hui2, 
C. H. S. Yu2, K. F. Lee1 and B. S. P. Lai1
1Division of Hepatobiliary and Pancreatic Surgery, 
Department of Surgery; 2Department of Imaging and 
Interventional Radiology, Prince of Wales Hospital, The 
Chinese University of Hong Kong, Hong Kong, China
Introduction: Curative hepatectomy for hepatocellular car-
cinoma (HCC) is associated with high recurrence rate. A 
signifi cant proportion of recurrences arise from undetectable 
intrahepatic metastases at time of surgery. We aim to evaluate 
the safety and effi cacy of adjuvant transarterial chemoembo-
lization (TACE) in HCC after hepatectomy.
Methods: Retrospective review in HCC patients receiving 
adjuvant TACE was performed. TACE using lipiodol-cispl-
atin mixture and gelfoam embolization was performed 3 to 
10 weeks after hepatectomy. Survival and recurrence data of 
these patients were compared to patient-cohort with compa-
rable tumor characteristics where no adjuvant TACE was 
given.
Results: Twenty-seven patients (Male = 23, Female = 4), 
with a median age of 53, receiving adjuvant TACE from 
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April 2006 to October 2010 were recruited. Fifteen patients 
were cirrhotic. AJCC Staging distribution of the series was: 
I = 3, II = 8, III = 18, IV = 3. One patient developed liver 
abscess and 7 other patients experienced transient minor side 
effects. There was no mortality in our series. Sixteen patients 
developed disease recurrence, whereas 9 patients died at the 
time of evaluation. The median disease-free and overall sur-
vival was 9.2 (0.5 to 52.5) months and 16.8 (4.7 to 52.5) 
months respectively. The overall survival, disease-free sur-
vival and 1-year recurrence rate were better in patients with 
adjuvant TACE, but did not reach statistical signifi cance.
Conclusion: Adjuvant TACE is feasible and safe in HCC 
patients after hepatectomy. Further evaluation by prospective 
studies with larger sample size is warranted.
P-120
STAGED WOUND MANAGEMENT WITH 
MESH CLOSURE IN PATIENT WITH 
INTRA – ABDOMINAL HYPERTENSION 
AFTER LIVER TRANSPLANTATION: 
EVALUATION AND CRITICAL CARE
S-F Chuang1, C.-E. Hsieh2 and Y.-L. Chen1
1Attending Physician, General Surgery, Changhua 
Christian Hospital; 2Nurse Practitioner of liver 
transplantation, Changhua Christian Hospital
Introduction: This paper aims to discuss the application of 
mesh in liver transplantation (LT) complicated by intra-
abdominal hypertension (IAH) or abdominal compartment 
syndrome (ACS) with decreasing intra-abdominal pressure 
(IAP) and postoperative care.
Methods: According to patient’s of Changhua Christian 
Hospital, from 2002 to 2010, there were 80 liver transplanta-
tions that had been completed, nine cases of IAH/ACS were 
observed. Among them, 4 patients received wound closure 
with mesh. We use a mesh as an intervention at the time of 
wound closure when the central venous pressure increases 
more than 5 mmHg. The timing for the synthetic mesh 
removal depends on the recovery condition (decreased intra-
abdominal pressure) of hepatic and bowel edema after the 
transplantation; also, in order to prevent infections, the 
exploratory laparatomy procedure is performed 7–14 days 
after the surgery to remove the mesh.
Results: This paper describes the application of mesh for 
wound closure when LT is complicated by IAH/ACS; this 
technique decreased IAP events, improved and relieved 
intra-abdominal organ.
Conclusions: This paper records the keypoints for physio-
logical evaluation to assist early detection and prevention 
of IAH/CAS complications. Patients received emergency 
surgery to prevent further organ failure or infections.
P-121
SPONTANEOUS PORTOBILIARY 
FISTULA: TWO CASES
N. Dash, J. George and V. Mangla
All India Institute of Medical Sciences, New Delhi, India
Introduction: Hemobilia due to fi stulation between biliary 
and portal venous system is a grave complication that is 
diffi cult to manage even if the cause is known. We describe 
two cases of spontaneous porto-caval fi stula managed 
successfully.
Methods: Case1: A 54 year male of NHL on chemotherapy 
presented with massive hemobilia with hypotension and drop 
in hemoglobin. Endoscopy showed bleeding from one of the 
sites in duodenum. Laparotomy, duodenotomy and choledo-
chotomy revealed a fi stulous opening with bleed in D1 pos-
terior wall and a 5 mm fi stula in the posterior wall of CBD 
with brisk bleeding. He underwent Cholecystectomy, CBD 
exploration and suturing of the lower end, distal gastrectomy, 
tube duodenostomy and tube Choledochostomy. After fi ve 
months he underwent hepaticojejunostomy.
Case2: A 22 year renal transplantation recipient presented 
with hemobilia, hemodynamic instability and a drop in 
hemoglobin to 3.3 g/dl. USG and CT angiography revealed 
no pseudoaneurysm. Endoscopy showed hemobilia. 
Laparotomy revealed a dilated CBD with three 2 mm size 
openings on the posterior wall of distal CBD with bleed. He 
underwent cholecystectomy with suture ligation of lower end 
of CBD and tube choledochostomy. After four months he 
underwent Roux en y hepaticojejunostomy.
Results and Conclusions: Bilio arterial and biliovenous 
fi stula are rare causes of hemobilia. Anecdotal cases of bilio-
portal fi stula describe causes including aneurisms due to 
trauma and erosions due to stone disease. Spontaneous fi stu-
lae, like in our cases, have not been reported. Their occur-
rence in immunosuppressive cases made the management 
diffi cult. Prompt diagnosis and timely surgical intervention 
could save both of them.
P-122
DEBUT EXPERIENCE OF AN EMERGING 
LIVER TRANSPLANT PROGRAM IN 
SOUTH EAST ASIA
V. De Villa, A. Concejero, D. Ang, A. Yap, E. Arcilla, 
C. Asedillo, G. Herbosa, C. Ancheta, K. Calixto-Mercado, 
M. V. Samonte, N. Batayola and J. Ong
Center for Liver Disease Management and 
Transplantation, The Medical City, Pasig City, Metro 
Manila, Philippines
Introduction: Liver disease is common in the Philippines 
and there has long been a dearth of treatment options for end 
stage liver disease. The Medical City Liver Program was 
established in answer to the pressing need to provide a wide 
range of therapeutic options for liver diseases including liver 
transplantation. This report describes the initial experience 
in liver transplantation in this private medical center in the 
country.
Methods: The recipient was a 3.7-year-old 10-kg girl with 
biliary cirrhosis secondary to idiopathic neonatal cholestasis 
who had recurrent GI bleeding from extensive varices and 
severe chronic malnutrition. Her PELD score was 18. The 
donor was her 18-year-old maternal uncle. Pretransplant 
evaluation was completed, hospital ethics committee 
approval was granted and the operation was performed in 
January 2011 using standard techniques for pediatric live 
donor liver transplantation with a left lateral segment graft.
Results: The operation was successfully carried out and the 
recipient was discharged after a 4-week hospital stay. She 
received Tacrolimus-based immunosuppression. Infection in 
the early postoperative period was controlled with appropri-
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ate antibiotics. The preoperative total bilirubin of 23.2 mg/
dl was down to 1.0 mg/dl in 2 weeks. To date she remains 
well, is catching up with growth and has good graft function 
6 months after transplantation. Her donor likewise recovered 
with no complications.
Conclusion: This case represents the fi rst successful live 
donor liver transplantation in the Philippines. It confi rms that 
liver transplantation is now a feasible and viable treatment 
option for end stage liver disease in the country.
P-123
POSTOPERATIVE MORTALITY 
FOLLOWING LIVER RESECTION: A 
SYSTEMATIC REVIEW
N. Easwaralingam1, J. Laurence1, E. Johnston1,2, 
M. Hollands1, H. Pleass1,2, A. Richardson1,2 and V. Lam1,2
1Department of Upper Gastrointestinal Surgery, Westmead 
Hospital, Sydney, Australia; 2Discipline of Surgery, Sydney 
Medical School
Introduction: Postoperative mortality after liver resection 
was as high as 25% 25 years ago. With the evolution in 
patient selection, surgical technique and postoperative care, 
liver resection can now be performed safely. The aim of this 
systematic review was to document the postoperative mortal-
ity rate in the 21st century.
Materials and Methods: Medline and PubMed databases 
were searched for studies from January 2000 to December 
2010 using keywords “hepatectomy or liver resection” and 
“survival”. Additional papers were identifi ed by a manual 
reference search. Case reports and case series of less than 
twenty patients were excluded.
Results: Three hundred and fi fty nine articles met the inclu-
sion criteria of which thirty six reported a zero percent mor-
tality rate. Total number of patients was 76,729 with 2126 
postoperative deaths. This corresponds to a postoperative 
mortality rate of 2.8%. Postoperative mortality rates were 
2.5% and 2.6% in patients who underwent liver resection for 
hepatocellular carcinoma and colorectal liver metastases 
respectively.
Conclusion: Postoperative mortality rate following liver 
resection have fallen. However, the true rate is almost cer-
tainly higher than those reported.
P-124
A CASE OF GRANULOCYTE-COLONY 
STIMULATING FACTOR-PRODUCING 
HEPATOCELLULAR CARCINOMA
N. Fukino, T. Oida, H. Kano, K. Mimatsu, K. Kida, 
A. Kawasaki and Y. Kuboi
Department of Surgery, Social Insurance Yokohama 
Central Hospital, Yokohama, Japan
Introduction: Granulocyte-colony stimulating factor 
(G-CSF) is a naturally occurring glycoprotein secreted by 
macrophage etc. This protein combines the receptors of 
granulocyte precursor cells, and stimulates the proliferation 
and maturation of precursor cells in the bone marrow into 
fully differentiated neutrophils. Only four cases as G-CSF-
producing HCC were reported in English literature, includ-
ing in our case.
Methods and Results: A 52-year-old man suffering from 
general fatigue and pyrexia was referred to our hospital. The 
patient with diabetes mellitus was administered insulin by an 
injection, and had non hepatitis C virus and hepatitis B virus. 
The serum level of α-fetoprotein and protein induced by 
vitamin K antagonist-II increased 303 ng/ml, 441 AU/ml 
respectively. Enhanced computed tomography, abdominal 
ultrasonography and angiography revealed a hepatic tumor 
(8 cm in diameter) that showed hypovascular tumor in the 
right lateral sector. We diagnosed hepatocellular carcinoma, 
and performed liver partial resection of segment six. The 
pathological fi ndings showed a poorly differentiated adeno-
carcinoma. Moreover, the immunohistochemical examina-
tion revealed that the tumor cells were positive for antibodies 
against G-CSF. Postoperatively, we performed a transcathe-
ter arterial infusion twice for recurrence of the hepatic 
remnant. Our patient died of tumor progression 9 months 
after the surgery, and serum level of G-CSF at the time of 
death was 7500 ng/ml.
Conclusions: Although G-CSF-producing HCC is extremely 
rare, a differential diagnosis should be performed when a 
patient shows a high leukocyte count with no evidence of 
systemic infection or hematological disease.
P-125
HEPATECTOMY WITH MINIMAL 
INCISION BASED ON MEASUREMENT 
OF THE TO-BE-RESECTED SPECIMEN
N. Fukino1, T. Oida1, K. Mimatsu1, H. Kano1, A. Kawasaki1, 
K. Kida1, Y. Kuboi1, H. Miyaka2 and S. Amano3
1Social Insurance Yokohama Central Hospital, Yokohama, 
Japan; 2Kasukabe Municipal Hospital, Kauskabe, Japan; 
3Nihon University School of Medicine, Tokyo, Japan
Abstract not available at time of publication.
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PREVENTION OF EARLY DELAYED 
GASTRIC EMPTYING AFTER HEPATIC 
LATERAL SEGMENTECTOMY
N. Fukino1, T. Oida1, K. Mimatsu1, A. Kawasaki1, 
H. Kanou1, Y. Kuboi1, K. Kida1 and S. Amano2
1Department of Surgery, Social Insurance Yokohama 
Central Hospital, Yokohama, Japan; 2Department of 
Surgery, Nihon University School of Medicine, Tokyo, Japan
Introduction: Left-sided hepatectomy occasionally leads to 
early delayed gastric emptying (EDGE). We developed a 
new fi xation procedure of the round ligament to the perito-
neum to prevent EDGE after hepatic lateral segmentectomy 
and evaluated its effi cacy.
Methods: We retrospectively studied 42 patients who 
underwent hepatic lateral segmentectomy. They were divided 
into two groups: a fi xation group (N = 15) and a nonfi xation 
group (N = 27). The round ligament of the liver was divided 
at the umbilicus and detached from the abdominal wall from 
the umbilicus to the liver. The cut surface of the liver was 
wrapped by the round ligament, and the distal part of the 
round ligament was then fi xated to the peritoneum.
Results: EDGE was found to be 0% in the fi xation group 
versus 15% in the nonfi xation group.
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Conclusions: Fixation of the round ligament to the perito-
neum is a useful technique to prevent EDGE after hepatic 
lateral segmentectomy.
P-127
SUCCESSFULLY CONCOMITANT 
SURGERY OF ABDOMINOPERINEAL 
RESECTION AND RIGHT HEPATIC 
LOBECTOMY WITH THROMBECTOMY
N. Fukino, T. Oida, K. Kida, K. Mimatsu, A. Kawasaki, 
Y. Kuboi and H. Kano
Department of Surgery, Social Insurance Yokohama 
Central Hospital, Yokohama, Japan
Introduction: Macroscopic tumor thrombosis occupying 
the main portal branch is rare in patients with liver metasta-
ses. The incidence of macroscopic portal vein tumor throm-
bosis is rare from 0.4% to 2.8%. We reported successful 
operation which was concomitantly performed abdomino-
perineal resection and right hepatic lobectomy with throm-
bectomy for the right portal vein tumor thrombosis in a 
patient with advanced rectal carcinoma. To the best of our 
knowledge, this case was no report.
Methods: A 70-year-old man who was detected a hepatic 
mass in the right hepatic lobe by abdominal ultrasonography 
examination. The result of examination revealed a hepatic 
tumor with a tumor thrombosis in the right portal vein and 
rectal carcinoma. Therefore, we performed a concomitant 
surgery which was abdominoperineal resection and right 
hepatic lobectomy with tumor thrombectomy. Each of patho-
logical fi ndings of resected specimen of the rectum and right 
hepatic lobe showed a moderately differentiated adenocarci-
noma. Consequently, we diagnosed the rectal carcinoma 
and metastatic hepatic tumor with the portal vein tumor 
thrombosis.
Results and Conclusions: Our patient remains healthy with 
no evidence of recurrence 4 months after the surgery, and 
have been commuted to us hospital to treat adjuvant chemo-
therapy. Furthermore, CEA and CA 19–9 decrease to normal 
range 4 months after the surgery. We argue that operating 
simultaneously them should be selected for preventing cav-
ernous transformation of the veins, intestinal bleeding, and 
ascites, if the patient does not present multiple metastases. It 
is necessary to receive early adjuvant chemotherapy to 
prevent metastatic tumor of the lung.
P-128
COMPARISON OF CELLULAR 
INFILTRATE BETWEEN MODERATE 
AND SEVERE MODELS OF REJECTION 
IN A MURINE MODEL OF LTX – EFFECT 
OF HBO THERAPY ON MODERATE ACR
S. Gan1, C. Malcontenti-Wilson1, B. Howden1, I. Millar2, 
C. Christophi1 and V. Muralidharan1
1University of Melbourne, Department of Surgery Austin 
Health, Heidelberg, Australia; 2Hyperbaric Unit, Alfred 
Hospital, Prahran, Australia
Introduction: Acute cellular rejection (ACR) is a common 
cause of post transplantation morbidity. Hyperbaric oxygen 
therapy (HBO) has been shown to affect various components 
of the immune response, and to be effective in treating isch-
emia reperfusion injury. However its safety and effi cacy has 
not been conclusively studied in a rejection model of liver 
transplantation.
Methods: Male inbred Dark Agouti and Lewis rats were 
transplanted to create moderate acute cellular rejection. HBO 
was administered twice daily for seven days following trans-
plantation. T cell and Kupffer cell infi ltration was observed 
via immunohistochemistry for CD3 and ED2 antigen respec-
tively. Neutrophil infi ltration was observed via naphthol 
AS-D chloroacetate esterase staining.
Results: There was a trend for reduction in T cell number, 
total infi ltrating cells and T cell percentage after HBO in the 
periportal (Zone 1) and perivenous (Zone 3) regions. There 
was a trend of reduction after therapy in Kupffer cell number, 
total infi ltrating cells and percentage of Kupffer cells in Zone 
1, 3, and the liver in between (Zone 2) at Day 7. However 
this did not achieve statistical signifi cance in all Zones. There 
was a reduction in the number of neutrophils in both Zones 
1 and 3 following treatment which did not reach statistical 
signifi cance.
Conclusions: HBO therapy appears to have an impact on 
the infi ltrating T cells, Kupffer cells and neutrophils. Further 
studies are required to clearly elucidate its mechanisms of 
action.
P-129
THE INDICATION AND SURGICAL 
OUTCOME OF REDUCTION 
HEPATECTOMY FOR MULTIPLE 
ADVANCED HEPATOCELLULAR 
CARCINOMA
N. Gotohda, M. Konishi, S. Takahashi, T. Kinoshita, 
K. Yuichiro and T. Kinoshita
National Cancer Center Hospital East, Chiba, Japan
Introduction: The prognosis of bilobar multiple hepatocel-
lular carcinomas remains poor. We evaluated the surgical 
outcome of reduction hepatectomy for multiple advanced 
HCCs with large tumor.
Methods: From May 2001 to April 2010, 18 patients (17 
men, 1 woman) diagnosed as having multiple advanced 
HCCs with large tumor underwent reduction hepatectomy at 
our hospital. We estimated these surgical outcomes of them.
Results: Mean age was 51 years, mean diameter of main 
tumor was 142 mm. Ten patients underwent major hepatec-
tomy (>1 segment of the liver). The median survival time 
(MST) was 1.5 years, 1- and 3-year survival rates were 56 
and 26%. The characteristic of over 2-year survivors was that 
the size and the number of residual tumors were controllable 
by transcatheter chemoembolization (TACE) after reduction 
hepatectomy. Most patients could receive TACE on several 
times for residual HCCs in the remnant liver after reduction 
hepatectomy. The strong prognostic factor was the presence 
of portal vein invasion (Vp). Each MST was 204 and 952 
days in Vp+ and Vp− groups. Compared with the operation 
time and volume of blood loss in the fi rst 5-year, those surgi-
cal outcomes have improved in the second 5-year.
Conclusions: Safety improvement of reduction hepatec-
tomy for multiple advanced HCC with large tumor was rec-
ognized, but we should carefully consider the indication of 
reduction hepatectomy for advanced HCC patients with Vp.
214 Poster Presentation Abstracts
HPB © 2011 International Hepato-Pancreato-Biliary Association, HPB, 13 (Suppl. 3), 174–244
P-133
OBJECTIVE DETECTION FOR BILIARY 
CANCER USING AUTOFLUORESCENCE 
IMAGING
H. Nogita1, K. Ota2, T. Hisaka1, Y. Kawashima1, 
H. Ishikawa1, M. Yasunaga1, H. Horiuchi1, H. Kinoshita1 
and K. Shirouzu1
1Kurume University School of Medicine Department of 
Surgery, Kurume City, Japan; 2Kurume University School 
of Medicine Department of Anatomy, Kurume City, Japan
Introduction: The prognosis of bile duct cancer is poor and 
is the disease that the patients with approximately a little less 
than 20,000 people a year die.
Early diagnosis of carcinoma in itself having diffi culty with 
the cause of the poor biliary cancer treatment outcome, the 
degree of diffi culty of the method to treat being high is 
thought about for a cause.
We give the horizontal direction invasion depth that 
required directbile duct cancer such as ERCP or PTC, EUS/
IDUS, cholangioscope for perioperative bile duct isolation 
line decision of the bile duct cancer a diagnosis, but it is 
perioperative, and there is sometimes what we cannot but 
rely on in an operation for the bile duct stump quickly.
In late years it is said that bronchoscopy using autologous 
fl uorescence observation Auto FluorescenceImaging (fol-
lowing AFI) is useful in a localized diagnosis in lung cancer, 
and, by the way, effi cacy of the AFI needs a report in the 
alimentary canal region.
There is not yet the report of the autologous fl uorescence 
observation about. biliary cancer.
Methods: We examined the perioperative isolated organ of 
11 biliary cancer cases this time whether we could recognize 
the tumor deep regional nature of the biliary tract cancer 
stump by AFI.
Results: As for the carcinoma, autologous fl uorescence 
tended to diminish by AFI as compared with normal mucosa. 
We could depict the regional nature of the cancer by AFI, 
and, for the cholangiocarcinoma stump, it was suggested that 
it was effective.
Conclusions: As for the carcinoma, autologous fl uores-
cence tended to diminish by AFI as compared with normal 
mucosa.
For the biliary tract cancer, it was suggested that the 
regional nature of the cancer was recognizable and was effec-
tive in AFI.
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SURGICAL OUTCOMES AFTER 
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PORTAL HYPERTENSION IN THE 
CIRRHOTIC PATIENTS
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1Kyungpook National University School of Medicine, 
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Introduction: Hepatic resection for HCC is potentially 
curative treatment for selected patients and the outcome of 
hepatectomy in cirrhotic patients has improved remarkably 
in the recent year. However, the roles of portal hypertension 
(PH) on the postoperative course are still uncertainis. The 
aim of this study was to evalulate surgical outcomes of hepa-
tectomy in these patients with portal hypertension.
Methods: Data of 256 cirrhotic patients who underwent 
hepatectomy for HCC from 1998 to 2010 were collected 
retrospectively. Patients were divided into two groups 
according to preoperative presence of PH; 103 patients with 
PH and 153 without it.
Results: Operative morbidity and mortality did not differ 
between two groups (36.9% vs. 47.1%; P = 0.123, 3.3% vs. 
5.8%; P = 0.358). The 5-year survival rate was higher in 
patients without PH but showed no statistical difference 
between the two groups (46.5% vs. 36.2%; P = 0.757). Also, 
the 5-year disease free survival rate was no signifi cant dif-
ference according to the presence of PH (41.2% vs. 40.5%; 
P = 0.426). The predictive values of postoperative hepatic 
insuffi ciency were extent of hepatectomy, plasma transfu-
sion, number of tumor in multivariate analysis. Multivariate 
analysis identifi ed size of tumor, RBC transfusion as inde-
pendent predicting factors for survival.
Conclusions: Child–Pugh A and B patients with PH have 
surgical outcomes similar to patients without PH. In selected 
cirrhotic patients with PH, hepatic resection could be safely 
preformed and also potentally curative treatment.
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A SINGLE CENTER EXPERIENCE OF 
LIVING DONOR LIVER 
TRANSPLANTATION (LDLT) FOR 
PRIMARY BILLIARY CIRRHOSIS (PBC)
S. W. Jung1, S. G. Lee1, S. Hwang1, K. H. Kim1, 
C. S. Ahn1, D. B. Moon1, T. Y. Ha1, G. W. Song1, 
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Introduction: Primary biliary cirrhosis (PBC) is a chronic 
cholestatic liver disease involving immune-mediated destruc-
tion of interlobular and septal bile ducts. Recurrent PBC, as 
diagnosed by standard histologic characteristics, has been 
shown to occur in 11∼34% of transplanted patients. Liver 
transplantation remains the gold standard for treatment of 
end-stage liver disease with greater than 80% 5-year sur-
vival. The aim of this study is to describe our experience of 
liver transplantation for patients with PBC and to correlate 
peritransplant factors associated with disease recurrence.
Methods: Between Feb. 1998 and Jul. 2009, A total of 14 
(0.61%) patients with PBC underwent liver transplantation 
at Asan Medical center, and 2282 patients underwent liver 
transplantation for PBC at same period. Peritransplant data 
were collected by reviewing the medical records retrospec-
tively. Cases of recurrent PBC were defi ned by histologic 
classifi cation on liver biopsy. Statistical analyses were per-
formed in SPSS ver.12.0K for windows.
Results: Median recipient age was 48.3 years and 13 
(92.9%) were female. Median follow up period was 46.5 
months. Major postoperative complications were 5 (35.7%) 
biliary stricutures, 2 (14.3%) vascular stenosis, 2 (14.3%) 
bleedings, and 1 (7.1%) pneumonia. Disease recurrence 
occurred in 4 (28.6%) patients, and mean time to recurrence 
was 47.7 months. Retransplantation for recurrent PBC from 
the deceased donor was performed in 2 (14.3%) patients. 
Three patents died of chronic rejection, and sepsis. The 
5-year survival rate of recipients who underwent LDLT was 
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83.6%. However, there were no signifi cant factors related to 
recurrence of PBC statistically.
Conclusions: Living donor liver transplantation is a feasible 
treatment option for PBC with end-stage liver disease. 
Recurrent rate of PBC after LDLT is not negligible. Therefore, 
clinical suspicion of disease recurrence should be warranted 
whenever patient shows abnormal fi nding in liver function 
tests. Timely biopsy must be performed if indicated.
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INCIDENCE AND MANAGEMENT OF 
POSTOPERATIVE ABDOMINAL 
BLEEDING AFTER LIVER 
TRANSPLANTATION
S. W. Jung, S. G. Lee, S. Hwang, K. H. Kim, C. S. Ahn, 
D. B. Moon, T. Y. Ha, G. W. Song, D. H. Jung 
and G. C. Park
Asan Medical Center, Seoul, Korea
Introduction: Most of liver transplantation (LT) recipients 
have serious coagulation disorders at the time of LT opera-
tion, thus postoperative bleeding complications occur much 
more frequently than in other major abdominal surgery. The 
objective of this study is to assess the incidence and manage-
ment of postoperative abdominal bleeding after LT operation 
and to identify its risk factors.
Methods: During a study period of 36 months between 
January 2008 and December 2010, 1,039 patients underwent 
LT operations at our institution. Medical records were retro-
spectively reviewed focused on posttransplant abdominal 
bleeding. Postoperative abdominal bleeding were defi ned as 
any hemorrhage requiring radiologic intervention or lapa-
rotomy bleeding control within the fi rst posttransplant month. 
Bleeding itself was identifi ed as drainage of blood from the 
abdominal drains in all patients and was also confi rmed with 
dynamic phase enhanced computed tomography or percuta-
neous selective angiography. When extravasation of the con-
trast media was identifi ed on imaging studies, transcatheter 
microcoil embolotherapy or surgical intervention was per-
formed depending on the situation.
Results: Of these 1039 patients, 94 (9%) (62 men and 32 
women; mean age 49 years) showed suffered from abdomi-
nal bleeding after LT operation. Posttransplant abdominal 
bleeding occurs after a mean of 6.1 days after LT (range: 
1–21 days). Active bleeding was completely controlled by 
endovascular interventional techniques in 37 (39%), by sur-
gical ligation or vascular reconstruction in 43 (46%), and by 
sequential combinations of endovascular intervention and 
surgery in 14 (15%). The bleeding sites indicated for endo-
vascular radiologic intervention were the right inferior 
phrenic artery (n = 14), right and left epigastric artery (n = 
7), intercostal artery (n = 5), and right renal capsular artery 
(n = 4). The bleeding sites requiring laparotomy were the 
hepatic artery (n = 9), diaphragm (n = 8), inferior vena cava 
(n = 5), abdominal drain insertion site (n = 4), portal vein 
anastomosis site (n = 4), abdominal wall (n = 3), liver graft 
cut surface (n = 3), hilar plate (n = 3), and greater omentum 
(n = 3). To fi nd out the risk factor of posttransplant bleeding, 
we compared the clinical and hematologic parameters 
between patients groups showing posttransplant bleeding or 
not. Bleeding episodes were more likely to have more 
impaired preoperative coagulation profi les, history of prec-
edent major abdominal surgery and prolonged operation 
time. There was no signifi cant association with recipient age, 
body mass index, model for end-stage liver disease score, 
amount of perioperative transfusion, hypertension, presence 
of ascites.
Conclusions: Serious coagulopathy persists even after LT 
until the liver graft regain function suffi ciently. The risk 
of spontaneous bleeding from both coagulopathy and 
iatrogenic mechanical bleeding is very high during the early 
posttransplant period, which can lead to worsening of recipi-
ent outcomes. To minimize the risk of posttransplant bleed-
ing, meticulous surgical dissection and bleeding control 
should be emphasized.
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RETRANSPLANTATION FOR 
RECURRENCE OF CLINICALLY 
SIGNIFICANT HEPATITIS A FOLLOWING 
LIVER TRANSPLANTATION FOR 
FULMINANT HEPATITIS A
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and G. C. Park
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Introduction: Hepatitis A virus (HAV) is a self-limiting, 
usually asymptomatic infection that occurs predominantly 
among children. Adults affl icted with this virus often have 
clinically apparent disease with jaundice. There are, however, 
some reports of relapsing hepatitis resulting with liver 
failure. A relapse may be associated with a fulminant clinical 
course with rapid decompansation where a retransplantation 
may be inevitable.
Methods: Here we report 3 cases who underwent living 
donor liver transplantation (LDLT) for fulminant hepatic 
failure (FHF) due to HAV infection and required retransplan-
tation due to recurrence of HAV infection in the allograft 
causing liver failure. To elucidate the reason for acute hepatic 
dysfunction a liver biopsy was performed that revealed 
severe degenerative changes of hepatocytes with ductular 
cholestasis and apoptotic bodies. A computerized tomogra-
phy (CT) ruled out any vascular etiology. Detection of posi-
tive Anti-HAV IgM and genomic HAV-RNA by polymerase 
chain reaction (PCR) in the serum at the time of graft dys-
function led to the diagnosis of recurrent HAV infection.
Results: Case1: 40-year-old, otherwise healthy man who 
had hepatitis A virus (HAV) infection underwent LDLT for 
FHF. After postoperative day (POD) 35 his serum bilirubin 
level increased to 40 mg/dL. At 51 days after fi rst transplan-
tation, he underwent orthotopic liver transplantation. After 
liver transplantation patient recovered after an uneventful 
ICU course of 20 days.
Case2: 39 year old, previously healthy male who had HAV 
infection underwent cadaveric OLT for FHF. Patient was 
discharged uneventfully however readmitted 2 months later 
for CMV hepatitis. Serum CMV titers returned to baseline 
after a 3 weeks course of iv Gancyclovir treatment. His graft 
function gradually worsened and radiological evaluation 
didn’t reveal any condition. Further evaluation showed that 
his serum HAV-PCR was positive. Patient developed pro-
gressive kidney disfunction and diagnosed with hepatorenal 
syndrome. He underwent cadaveric OLT postoperative 4 
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months due to progressive liver failure. His explant pathol-
ogy revealed submassive hepatic necrosis with fi ndings sug-
gestive of viral infection.
Case 3: 27 year old female underwent LDLT due to FHF. 
She had recurrence of HAV infection resulting with graft 
failure and neurologic dysfunction. Her HAV PCR was found 
to be positive after 6 months and liver biopsy showed sinu-
soidal lymphocytosis consistent with hepatitis and negative 
immunostaining for CMV infection. She had progressive 
neurologic dysfunction accompanying graft failure. She 
underwent cadaveric OLT and postoperative explants 
revealed portal infl ammation with fi ndings suggestive of 
viral infection. Unfortunately after 2 days of retransplanta-
tion, liver function was worsened very quickly. She was 
passed away because of primary non-functioning graft 
(PNF).
Conclusions: We suggest that the risk of HAV reinfection 
after liver transplantation may be far higher than expected as 
results may be misinterpreted as rejection episodes. In our 
experiences, HAV reinfection came down to death of patient 
and other centers reported poor prognosis of recurred HAV 
hepatitis. we performed 3 cases of retransplantations and 2 
patients are alive now. So we suggest that the best way to 
treat HAV reinfection after liver transplantation is liver 
retransplantation.
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A COMPARATIVE ANALYSIS OF 
SURGICAL RESECTION BETWEEN 
LAPAROSCOPIC AND OPEN LIVER 
RESECTION IN A SINGLE, LESS THAN 
3 CM SIZED HEPATOCELLULAR 
CARCINOMA
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medicine, Daegu, Republic of Korea
Introduction: The purpose of this study is to compare the 
perioperative and long term outcomes of laparoscopic and 
open liver resections in single and small (<3 cm) sized hepa-
tocellular carcinoma.
Methods: From March 2006 to December 2010, 314 
patients underwent liver resection (42 cases of laparoscopy 
and 272 cases of open liver resection) for various diagnosis. 
Among these patients, 62 patients (24 patients of laparosco-
poic liver resection; [LAP group] and 38 patients of open 
liver resection; [Open group]) who had a single and less than 
3 cm sized hepatocellular carcinoma were selected for this 
study. We analyzed characteristics of tumor retrospectively; 
perioperative and long term result in two groups.
Results: The mean age of the patients was 56.3 (± 9.8) 
years. Tumor size, level of AFP, mean operative time and 
amount of blood loss was similar in two groups. However, 
in patients of LAP group, postoperative hospital stay was 
shorter (8.8 ± 5.0 day vs. 14.5 ± 10.0 days, P = 0.004) and 
rate of postoperative complication was fewer (P = 0.039) 
than those of Open group. The cost of operative material 
(equipment, instrument) was higher in LAP group 
(1,026,049 KRW vs. 710,619 KRW, P = 0.000). However the 
pharmaceutical expenditure was higher in Open group 
(620,763 KRW vs. 1,042,916 KRW, P = 0.011). The 3 year 
disease free survival were 56.9% and 63.5% respectively 
(P = 0.371). Overall survival rate were also not different 
signifi cantly in two groups (P = 0.303).
Conclusions: Laparoscopic hepatic resection is superior to 
open procedure for the treatment of single and small sized 
(<3 cm) HCC in terms of hospital stay and postoperative 
complication rate. The overall hospital cost was similar 
between two groups.
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PREDICATOR FOR SURVIVAL 
OUTCOMES OF YOUNG ADULT 
PATIENTS AFTER HEPATECTOMY FOR 
HEPATOCELLULAR CARCINOMA
T.-Y. Ko1, K.-H. Lin1, P.-Y. Lin2, Y.-L. Chen1,3 
and S.-J. Kuo1
1Department of General Surgery, Changhua Christian 
Hospital, Changhua, Taiwan; 2Laboratory of Cancer 
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Introduction: Hepatocellular carcinoma (HCC) ranks fi rst 
two cancer in Taiwan for decades. Several studies showed 
that younger HCC patients, especially those with age equal 
to or younger than 40 years old, do not have better prognosis. 
Even they had preserved liver function and were eligible for 
surgery, their prognosis of survival and recurrence seemed 
about the same in comparison to the average patients. We 
tried to analyze the risk factors and clarifi ed signifi cant 
results from our database.
Materials and Methods: A retrospective analysis included 
45 resectable younger HCC patients from March 1997 to 
November 2010 in Changhua Christian Hospital. Those 
patients were equal to or younger than 40-year-old at the 
diagnosis of HCC. We analyzed patients’ data as well as 
immunobiochemical reports, tumor histopathology, the 
disease free survival and overall survival, perioperative pro-
fi les and divided tumor size in to groups for initial correlation 
survey.
Results: During the follow-up period, 23 (53.49%) patients 
developed a recurrence of HCC. In the univariate analysis of 
clinical pathological variables, the tumor size, HCV infec-
tion, recurrence within 12 months and specimen margin less 
than 1 cm showed the most signifi cant differences in overall 
survival. On concerning cases with recurrence within one 
year, tumor size, serum alpha fetoprotein, the operation type 
and tumor stage signifi ed statistically.
Conclusion: Tumor size larger than 5.5 centimeter stands 
for early tumor recurrence and undesirable survival among 
this young aged group. Early screening for diagnosis 
and periodic follow-up for these younger patients are 
warranted.
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CLINICAL CHARACTERISTICS OF 
PATIENTS WITH ACUTE HEPATITIS B 
GENOTYPE A
M. Kogame, K. Ishii, K. Kanayama, M. Shinohara, 
N. Wakui and Y. Sumino
Department of Gastroenterology and Hepatology, Toho 
University School of Medicine, Tokyo, Japan
Introduction: Recently, an association between hepatitis B 
virus (HBV) genotype and clinical characteristics has been 
identifi ed. Of special interest is the recent increase of acute 
hepatitis B (AHB) genotype A observed in urban areas of 
Japan.
Methods: To determine the clinical characteristics associ-
ated with AHB genotype A, we compared admission serum 
levels of alanine aminotransferase, total bilirubin, and HBV 
markers for patients infected with AHB genotype A (A 
group) and AHB genotypes B or C (non-A group).
Results: Serum level of total bilirubin tended to be higher 
in the A group than in the non-A group. Serum titers of 
HBV-DNA and HBe antigen tended to be higher in the A 
group, and these may be related to the production of certain 
types of HBe antigen in genotype A HBV while the other 
genotypes produce only a single variant of the antigen. 
Serum titers of IgG-HBc antibody tended to be higher in 
the A group than those in non-A group. Serum titers of 
IgM-HBc antibody and serum levels of ALT in both group 
were similar.
Conclusions: Although patients in the non-A group did not 
develop to chronic hepatitis, 3 of 20 patients in the A group 
progressed to chronic hepatitis, suggesting that serum HBe 
antigen promotes immunologic tolerance to persistent viral 
infection.
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PREOPERATIVE TRANS-ARTERIAL 
CHEMO-EMBOLIZATION (TACE) AS A 
BRIDGING THERAPY TO 
HEPATECTOMY: TWO DIVERGING 
CLINICAL CASE SCENARIO IN A 
SINGLE INSTITUTION PRACTICE
P. S. Koh and B. K. Yoong
Division of Hepato-Pancreato-Biliary Surgery, Department 
of Surgery, Faculty of Medicine, University of Malaya, 
Kuala Lumpur, Malaysia
Introduction: The use of preoperative TACE prior to liver 
resection has been widely reported. In our institution, 
patients diagnosed with hepatocellular carcinoma (HCC) 
and amenable to surgery are usually operated within 2 to 4 
weeks upon diagnosis. Occasionally, surgery could not be 
offered within the expected timeframe due to lack of oper-
ating theatre (OT) time and TACE is used as a bridging 
therapy.
Methods: We present two cases of HCC that could not be 
operated early due to lack of OT time and were subjected to 
preoperative TACE. Case ONE had segment 2 and 3 HCC, 
who was given a single course of preoperative TACE and 
was operated 6 weeks after diagnosis. Case TWO had 
segment 4, 5 and 8 HCC and was given two courses of TACE 
with surgery performed 10 weeks after diagnosis. The clini-
cal outcomes of both patients were vastly different following 
preoperative TACE.
Results: The fi rst case showed tumor progression in size 
with associated subcapsular rupture on CT scan despite pre-
operative TACE. The second case did not show tumor pro-
gression on CT scan despite two courses of preoperative 
TACE and a delay of 10 weeks to surgery. Final HPE in the 
second case also showed that tumor size was smaller than 
initially reported.
Conclusions: The use of preoperative TACE as a bridging 
therapy in liver resection still needs further evaluation as can 
be seen in the two diverging clinical case scenarios.
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OF TUMOR RECURRENCE AND 
SURVIVAL OUTCOMES IN YOUNG 
ADULT PATIENTS FOLLOWING 
HEPATECTOMY
K.-H. Lin1, P.-Y. Lin2, C.-J. Ko1, S.-J. Kuo1 
and Y.-L. Chen1,3
1Department of General Surgery, Changhua Christian 
Hospital, Changhua, Taiwan; 2Laboratory of Cancer 
Research, Changhua Christian Hospital, Changhua, 
Taiwan; 3College of Medicine, Chung Shan Medical 
University, Taichung, Taiwan
Introduction: Hepatocellular carcinoma (HCC), it is one of 
the most common malignant neoplasm worldwide. In 
Taiwan, a high rate of HBV carrier status and tend to develop 
HCC within younger age. In such specifi c group, the recur-
rence of HCC is one of main reasons in terms of poor prog-
nosis in long-term survival. Hence, the research purpose was 
to determine the prognosis outcomes of young adults HCC 
patients according to different recurrence intervals.
Methods: Patients with age younger or equal than 40 years 
were included in this study. All of them were with preopera-
tive diagnosis of HCC and received hepatectomy at Changhua 
Christian Hospital. Clinical characteristics as well as opera-
tion and surgical outcomes were analyzed and indentifi ed the 
infl uences of tumor recurrence.
Results: From 1997 to 2009, 43 patients were enrolled in 
this study. A number of 23 patients developed HCC recur-
rence during the period of following up. The signifi cant 
differences were found in the variables of AFP, stage, and 
vascular invasion in disease free survival (DFS). Regarding 
overall survival (OS), in intervals of 6 months and 12 months 
revealed statistical signifi cant.
Conclusions: The recurrence of HCC is the major risk 
factor of poor prognosis after hepatectomy in our study. 
Young adults with HCC received curative resection devel-
oped tumor recurrence in 53.49% among them. The recur-
rence interval is a signifi cant factor to predict survival 
outcomes of young adults with HCC received curative resec-
tion. Thus, we suggested aggressive treatment and closely 
follow up in the fi rst year after hepatectomy.
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PROLONGED OVERALL SURVIVAL OF 
PATIENTS WITH COLORECTAL LIVER 
METASTASES TREATED WITH 
MULTIDISCIPLINARY APPROACH
T. Mizuno, H. Kanemoto, T. Sugiura and K. Uesaka
Department of Hepato-Biliary-Pancreatic Surgery, 
Shizuoka Cancer Center Hospital, Shizuoka, Japan
Introduction: Multidisciplinary approach using both che-
motherapy and surgical resection has improved survival of 
metastatic colorectal liver cancer patients. Even though 
recurrent disease occurred, repeat resection with re-induction 
of perioperative chemotherapy might re-induce cancer free 
status.
Objective: To investigate postoperative recurrence free-, 
overall survival and consequent cancer free status rate (more 
than 2 years) after multidisciplinary approach of initially 
resectable colorectal liver metastases patients.
Methods: We retrospectively analyzed the clinical data for 
131 consecutive patients undergoing initial liver resection for 
metastatic colorectal cancer between January 2003 and 
March 2009. Of the 131, 126 patients undergone R0/1 resec-
tion were examined.
Result: Median follow-up duration was 40.0 months. R 
number: R0/1/2 = 114/12/5. Synchronism: Synchronous/
Metachronous = 71/60. Preoperative CEA level (median): 
11.0 ng/ml. Ninety of 126 (71.4%) received postoperative 
adjuvant chemotherapy. The 3- and 5-year recurrence free 
survival after initial liver resection was 30.3% and 29.2%, 
respectively. Eighty fi ve of 126 patients recurred, experi-
enced a total of 42 times re-metasectomy in combination 
with systemic chemotherapy. Consequently, 22 of 85 (25.9%) 
recurred patients were re-induced cancer free status and 15 
(17.6%) maintained it more than 2 years. In addition to 41 
recurrence free patients, 56 of 126 (44.4%) patients obtained 
consequent cancer-free status at the last follow-up. The 3- 
and 5-year overall survival after initial hepatectomy was 
79.2% and 63.2%, respectively.
Conclusions: Though recurrence free survival after initial 
liver resection for colorectal liver metstases was still unsat-
isfying, multidisciplinary approach, such as repeat metasec-
tomy with postoperative systemic chemotherapy provided 
44.4% of consequent cancer-free status and better overall 
survival.
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CLINICOPATHOLOGICAL 
EXAMINATION OF THE SIMPLE 
NODULAR TYPE OF WELL-
DIFFERENTIATED HEPATOCELLULAR 
CARCINOMA WITH EXTENSIVE 
PELIOTIC CHANGE
Y. Nomura1, 2, O. Nakashima1, T. Kumabe3, H. Kinoshita2 
and M. Kage1
1Department of Diagnostic Pathology, Kurume University 
Hospital, Kurume, Japan; 2Department of Surgery, Kurume 
University School of Medicine, Kurume, Japan; 3Kumabe 
Hospital, Japan
Peliosis hepatis-like blood-fi lled cavities are frequently 
observed in the tumors of hepatocellular carcinoma (HCC). 
HCCs with PC usually consist of moderately differentiated 
HCC, but are rarely seen in well-differentiated HCC. In well-
differentiated HCC with PC, it is diffi cult to make a defi nite 
pre-operative daiganosis on imagings including Ultrasound 
(US), Computed Tomography (CT) and Magnetic resonance 
imageing (MRI). We examined 9 cases of the simple nodular 
type of well-differentiated HCCs with extensive PC that 
were resected in our University and related hospitals from 
1992 to 2011. The most of tumor showed prolonged enhance-
ment and capsule-like structure on delayed phase of dynamic 
CT. These tumors demonstrated high signal intensity of Fat 
Sat T2 weighted image of MRI, and various degree of low 
signal intensity of hepatobiliary phase of Gd-EOB-MRI. 
Grossly PC area of the tumor was occupied with extensive 
blood clots and was black in color. We report the clino-
copathological characteristics of these tumors comparing 
imaging and pathological features.
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HAND-ASSISTED LAPAROSCOPIC 
HEPATECTOMY FOR PRIMARY CLEAR-
CELL HEPTOCELLULAR CARCINOMA 
OF THE LIVER
T. Oida, K. Mimatsu, H. Kano, A. Kawasaki, N. Fukino, 
K. Kida and Y. Kuboi
Department of Surgery, Social Insurance Yokohama 
Central Hospital, Yokohama, Japan
Introductions: Hepatocellualar carcinoma (HCC) often 
develops against a background of chronic viral hepatitis. 
However, primary clear-cell heptocellular carcinoma of the 
liver (PCCL) is a specifi c and rare subtype of primary HCC. 
Here we report a case of PCCL underwent hand-assisted 
laparoscopic hepatectomy.
Methods and Results: A 75-year-old woman was presented 
with a hepatic tumor and gall bladder stone. She had hepatitis 
C virus infection. Abdominal US and CT showed a tumor of 
about 30 mm diameter in S5 of the surface of the liver. 
Imaging results suggested HCC and underwent, hand-
assisted laparoscopic partial hepatectomy following laparo-
scopic cholecystectomy. Operative time was 120 min and the 
blood loss was 142 ml, blood infusion was not required. She 
showed good recovery without complications. Histological 
fi ndings showed clear-cell heptocellular carcinoma.
Conclusions: The prognosis of PCCL is generally consid-
ered better than that of the common type HCC, hand-assisted 
laparoscopic hepatectomy is minimally invasive procedure 
for relatively small PCCL.
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IMPLANTATION OF DENVER SHUNT 
BEFORE PARACENTESIS
T. Oida1, K. Mimatsu1, A. Kawasaki1, H. Kano1, Y. Kuboi1, 
N. Fukino1, K. Kida1 and S. Amano2
1Department of Surgery, Social Insurance Yokohama 
Central Hospital, Yokohama, Japan; 2Department of 
Surgery, Nihon University School of Medicine, Tokyo, 
Japan
Introduction: The Denver peritoneovenous shunt is useful 
in the resolution of refractory ascites, because it alleviates 
symptoms and allows effective palliation. However, this 
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shunt did not prolong the life expectancy of patients with 
decompensated liver cirrhosis. Therefore, when deciding 
whether or not to implant a Denver shunt, it is important to 
determine the condition of the patient with refractory ascites. 
Here, we determined the appropriate time for Denver shunt 
implantation.
Methods: We retrospectively studied 21 patients who 
underwent Denver shunt implantation for hepatic failure-
related ascites. The patients were divided into 2 groups: the 
PC group in which paracentesis was performed before 
implantation of the Denver shunt and the WPC group in 
which paracentesis was not performed before implantation 
of the Denver shunt, respectively.
The patients were divided into PC and WPC groups 
depending on whether or not paracentesis was performed 
before implantation of the Denver shunt, respectively.
Results: The mean interval from hospital admission to 
Denver shunt implantation was signifi cantly shorter in the 
WPC group (9.0 ± 2.2 days) than in the PC group (25.9 ± 
5.9 days) (p < 0.0001). The mean survival time was signifi -
cantly longer in the WPC group (8.4 ± 2.5 months) (p < 
0.0071) than in the PC group (5.6 ± 1.7 months).
Conclusions: Early implantation of a Denver shunt should 
be considered for the treatment of ascites that is resistant to 
conservative medical therapy.
P-149
INTENSIVE PULMONARY SUPPORT 
USING EXTRACORPOREAL MEMBRANE 
OXYGENATION FOR ADULT LIVER 
TRANSPLANT RECIPIENTS WITH 
RESPIRATORY FAILURE
Y. Park, H-W. Park, S. Hwang, J-M. Namgoong, 
S-W. Jung, S-Y. Yoon, G-C. Park, G-W. Song, 
D-H. Jung and S-G. Lee
Department of Surgery, Division of Hepatobiliary Surgery 
and Liver Transplantation, Asan Medical Center, 
University of Ulsan College of Medicine, Seoul, Korea
Background: Adult liver transplantation (LT) recipients 
occasionally show serious acute pulmonary failure refractory 
to conventional treatments, which is closely associated with 
patient death, thus leading to application of very aggressive 
intensive care. We have assessed the feasibility of extracor-
poreal membrane oxygenation (ECMO) support in adult LT 
recipients facing acute pulmonary failure and refractory to 
conventional mechanical ventilation and concurrent nitric 
oxide gas inhalation.
Method: From January 2008 to August 2010, 14 adult LT 
recipients required ECMO support due to pneumonia (n = 8) 
and adult respiratory distress syndrome (n = 6). Mean age 
was 53 ± 6 years and mean model for end-stage liver disease 
score was 26 ± 9. Nine patients underwent living-donor LT 
and fi ve underwent deceased-donor LT.
Results: Veno-venous access mode was used and continu-
ous veno-venous hemodiafi ltration was performed concur-
rently in all 14 patients. No procedure-related complications 
occurred. Successful ECMO weaning was achieved in 7 
patients (50%) at the fi rst attempt, after mean ECMO support 
of 9 ± 7 days, but the other seven died due to overwhelming 
infection prior to ECMO weaning. The clinical sequences of 
two liver transplant recipients with pneumonia who survived 
and did not survive after ECMO support for each 8 days are 
depicted at the Figure. Univariate analysis revealed no sig-
nifi cant risk factors for failing ECMO support before ECMO 
start. We observed no signifi cant differences between the 
survivor and non-survivor groups in any clinical or demo-
graphic parameters.
Conclusions: ECMO is a technique for providing life 
support in patients experiencing pulmonary and cardiac 
failure by maintaining oxygenation and perfusion until 
native organ function is restored. As a rescue therapy, ECMO 
was benefi cial to be considered as a fi nal option in liver 
transplant recipients with refractory pulmonary dysfunction 
who would otherwise die due to hypoxemia.
P-150
RIGHT GASTROEPIPLOIC ARTERY: THE 
FIRST ALTERNATIVE INFLOW FOR 
HEPATIC ARTERIAL ANASTOMOSIS IN 
LIVING DONOR LIVER 
TRANSPLANTATION
Y. Park, C. S. Ahn, S. G. Lee, S. Hwang, K. H. Kim, 
D. B. Moon, T. Y. Ha, G. W. Song, D. H. Jung 
and G. C. Park
Liver Transplantation and Hepatobiliary Surgery, Asan 
Medical Center, Seoul, Korea.
Body: Suffi cient arterial fl ow after living donor liver trans-
plantation (LDLT) is closely related to the graft survival and 
post operative complication. But some obstacles preclude 
good arterial anstomosis such as multiple graft arteries, arte-
rial injuries during dissection or previous pathologic condi-
tion (TACE, atherosclerosis) and size discrepancy between 
graft and recipient arterial stumps. Right gastroepiploiec 
artery (RGEA) has many good reasons to use for alternatives 
of destroyed hepatic arteries. RGEA has always compera-
tively healthy nature even its small size can get suffi cient 
blood fl ow. It is easy to mobilize, easy to get suffi cient length 
and easy to modulate its size to anastomosis.
From January 2006 to December 2008, we performed 767 
cases of LDLT in Asan Medical Center. 28 RGEA were used 
in 849 arterial anastomosis from 767 LDLT. The arterial 
anastomosis was done by single surgeon under the surgical 
microscope. End to end interrupted suture technique was 
applied. Arterial sump was selected according to its blood 
fl ow. healthiness by inspection and size matching. All graft 
arterial sumps are reconstructed if possible. The RGEA was 
mobilized from greater curvature of stomach and greater 
omentum with neighboring tussue more than 15 cm in 
length. The suture material was 9.0 nylon or 10.0 nylon 
according to arterial diameter. The indications for using 
RGEA were severe arterial injury from previous TACE in 14 
cases, additional infl ow from dual graft LDLT in 13 cases, 
poor blood fl ow from recipient stumps in 3 cases, and arterial 
injury during hilar dissection in 3 cases. Mean diameter of 
RGEA was 2.0 mm (1.0–2.5 mm). Most of anastomosis were 
done with size discrepancy more than two fold. But all recon-
structed hepatic arteries work well and no complication was 
detected during whole follow up period.
In conclusion, using the RGEA in simple and easy proce-
dure for alternative hepatic arterial infl ow in the case of insuf-
fi cient graft hepatic artery or multiple donor graft arteries.
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HALF PRINGLE MANEUVER: A USEFUL 
TOOL IN LAPAROSCOPIC LIVER 
RESECTION
M. V. Perini, P. Herman, F. F. Coelho, R. M. Lupinacci, 
L. A. C. D’Albuquerque and I. Cecconello
University of Sao Paulo Medical School, Department of 
Gastroenterology, São Paulo, Brazil
Background: Laparoscopic liver resections are becoming a 
routine procedure in many centers however bleeding remains 
the major concern during parenchymal transection. Total 
vascular infl ow occlusion can be performed but ischemic 
reperfusion injuries can lead to postoperative morbidity. On 
the other hand, hemi hepatic infl ow occlusion, leading to 
hemi-liver ischemia, decreases the amount of liver paren-
chyma submitted to reperfusion damage and offers the 
advantage of reduced blood loss.
Objective: Describe the authors´ experience with laparo-
scopic half Pringle maneuver for segmentectomies, 
bisegmentectomies or nonanatomical liver resections.
Patients and Methods: Ten patients submitted to laparo-
scopic liver resection in a single tertiary center.
Results: There were six women and four men with a mean 
age of 40.2 y (26 y–54 y). There were four liver adenomas, 
three hepatocellular carcinomas, one metastatic melanoma, 
one metastatic colorectal carcinoma and one peripheral col-
angiocarcinoma. Mean tumor size was 4.1 cm (2.6–6.0). No 
postoperative complications or mortality were observed. 
Mean hospital stay was 3.1 days (1–5).
Conclusion: Laparoscopic liver resection with half Pringle 
maneuver is feasible and safe and may be included in the 
technical armamentarium of laparoscopic liver resections for 
a selected group of patients.
P-153
A RESECTED CASE OF INITIALLY 
UNRESECTABLE HILAR 
CHOLANGIOCARCINOMA BY LEFT 
HEPATIC TRISECTIONECTOMY, 
CAUDATE LOBECTOMY WITH 
SIMULTANEOUS PORTAL AND HEPATIC 
ARTERIAL RESECTION AND 
RECONSTRUCTION AFTER SYSTEMIC 
CHEMOTHERAPY
T. Sano1, Y. Shimizu1, Y. Senda1, K. Hara2, K. Yamao2 and 
Y. Nimura1
1Department of gastroenterological surgery, Aichi Cancer 
Center Hospital, Nagoya, Japan; 2Department of 
gastroenterology, Aichi Cancer Center Hospital, Nagoya, 
Japan
Introduction: Despite advanced imaging diagnosis for hilar 
cholangiocarcinoma (HC), the precise determination of 
tumor extent remains diffi cult. Thus, the resectability for HC 
is controversial in some locally advanced cases necessitating 
extensive hepatobiliary resection with complex vascular 
resection and reconstruction for R0 resection.
Case: A 72-year-old woman was diagnosed with a locally 
advanced HC involving both the portal vein and the common 
hepatic artery in terms of perineural invasion. After two 
courses of systemic chemotherapy using gemcitabine 
(1000 mg/m2), CT showed an involution of the soft tissue 
density revealing possible perineural invasion around the 
portal vein and the common hepatic artery. Then, we judged 
R0 resection to be potentially achievable. After left trisec-
tional portal vein embolization, the tumor was curatively 
resected by left trisectionectomy with caudate lobectomy and 
combined hepatic arterial resection and reconstruction with 
negative surgical margins. The operation time and intropera-
tive blood loss was 497 minutes and 1550 g, respectively. 
Liver infl ow occlusion time was 91 minutes. Histologically, 
a moderately-differentiated adenocarcinoma invaded the 
liver parenchyma, the media of the left portal vein. Although 
the right hepatic artery was closely surrounded by cancer 
cells, the direct histological invasion was absent. The viable 
cancer cells were evident, and the effect of chemotherapy 
was partly documented. Pathologically, the tumor was diag-
nosed as T3N0M0, stage IIA (UICC 7th). Postoperative 
recovery was uneventful, and the patient is alive 18 months 
after surgery with no evidence of tumor recurrence.
Conclusion: The neoadjuvant chemotherapy followed by 
re-staging might be a potential therapeutic choice for locally 
advanced HC with a marginal resectability.
P-154
PREOPERATIVE EMBOLIZATION OF 
THE COMMON HEPATIC ARTERY FOR 
RADICAL SURGERY OF EXTRAHEPATIC 
CHOLANGIOCARCINOMA
Y. Sasaki1, S. Osada1, H. Kondo2, S. Goshima2, 
Y. Tokumaru1, I. Yasufuku1, M. Kanematsu2 
and K. Yoshida1
1Department of surgical oncology, Gifu University, 
Graduate School of Medicine, Gifu, Japan; 2Department of 
radiology, Gifu University, Graduate School of Medicine, 
Gifu, Japan
Introduction: To perform radical surgery for hilar bile duct 
cancer, preoperative management of the common hepatic 
artery (CHA) is proposed.
Methods (Case Report): A patient was diagnosed as having 
bile duct cancer invading the CHA arising anomalously from 
the superior mesenteric artery. Subsequently, chemoradio-
therapy with 36 Gy radiation and S-1 administration at 
120 mg/day for 4 weeks with 2 weeks rest was performed. 
Six months later, lymph nodes metastasis had disappeared 
along with reduction of the primary tumor, and radical 
surgery was indicated for possible except the CHA manag-
ing. On angiography, after confi rming safety by temporary 
occlusion of the proper hepatic artery, the CHA was 
embolized.
Results: Hepatopancreatoduodenectomy with resection of 
the CHA were then safely performed, and the postoperative 
course was free of complications.
Conclusions: Preoperative hepatic artery embolization may 
increase the possibility of radical therapy and allow simpler 
surgical procedures for bile duct or pancreatic cancer com-
plicated by hepatic arterial invasion.
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ADIPOSE TISSUE-DERIVED 
MESENCHYMAL STEM CELLS 
TRANSPLANTATION PROMOTES 
HEPATIC REGENERATION FOLLOWING 
HEPATIC ISCHEMIA-REPERFUSION AND 
SUBSEQUENT HEPATECTOMY IN RATS
T. Seki1, Y. Yokoyama1,2, H. Nagasaki1, T. Kokuryo1, 
M. Uno1 and M. Nagino1 
1Nagoya University Graduate School of Medicine, Nagoya, 
Japan; 2Fujita Health University School of Medicine, 
Toyoake, Japan
Introduction: Adipose tissue-derived mesenchymal stem 
cells (ADSCs) are attractive source of regenerative medicine, 
because of their high accessibility with low invasiveness. We 
investigated the effi cacy of ADSC transplantation on the 
outcome of hepatic ischemia-reperfusion and subsequent 
hepatectomy in rats.
Methods: ADSCs were isolated from subcutaneous adipose 
tissues of rats. After clamping the hepatoduodenal ligament 
for 15 min, the rats were subjected to 70% partial hepatec-
tomy. After releasing the clamp, 2 × 106 cells of ADSCs per 
rat were injected through the penile vein. PBS was injected 
as a control. The parameters of hepatic regeneration, such as 
hepatic regeneration rate, mitotic index, and PCNA levels 
were examined. Furthermore, hepatic regeneration-associ-
ated protein and gene expression levels in the regenerating 
liver were determined.
Results: The hepatic regeneration rate on the day 2 was 
signifi cantly greater in the ADSCs transplanted group com-
pared with the Sham group. Some hepatic regeneration-
associated proteins and genes were signifi cantly up-regulated 
in the ADSCs transplanted group on day 1.
Conclusions: These results indicate that ADSCs transplan-
tation provides benefi cial effects in the process of liver 
regeneration following hepatic ischemia-reperfusion and 
subsequent hepatectomy.
P-156
EFFICACY OF FIBRIN GLUE AND 
POLYGLACTIN ACID SHEET FOR PIG 
LIVER RESECTION MODEL
S. Mitsugi, K. Masato, I. Yoshimi and K. Keiichi 
(presented by T. Shimizu)
Second Department of Surgery, Dokkyo Medical University
Aim: Fibrin glue is commonly used to prevent bile leakage 
and bleeding after hepatectomy in clinical cases. Recently, 
several liver centers try to use polyglactin acid sheet for 
preventing bile leakage and bleeding in Japan. However, 
there is no evidence of its effi cacy and safety when applied 
to cut liver surface after surgery. Therefore we evaluated the 
effi cacy of fi brin glue and polyglactin acid sheet using pig 
liver resection model.
Materials and Methods: A chevron incision was performed 
under general anesthesia, followed by the left hemi-hepatec-
tomy (approximately 40%), using pig liver. Pigs were sub-
sequently allocated randomly into 2 groups (n = 5 in both); 
in group A, a fi brin glue (Bolheal) with polyglactin acid sheet 
(Neoveil) was applied to the cut surface and in group B only 
Bolheal was applied. After one month, we evaluated histo-
logical fi ndings and incidence of biloma or infl ammatory 
change at the cut surface.
Results: All of the 5 pigs in group A had fi brotic capsulated 
cavity at the cut surface. Inside of those cavities included 
necrotic liver tissues, Bolheal, and peace of Neoveil with bile 
juice. Histologically, Neoveil and Bolheal remained in the 
fi brotic tissue in normal liver tissue. In group B, only one 
pig had abscess at cut surface. Other four pigs showed no 
histological problems; Bolheal was completely integrated 
into the normal liver parenchyma.
Conclusion: Bolheal was very effective for liver cut surface 
in this experimental study. Neoveil should not be applied for 
cut surface.
P-157
CLINICAL STUDY ON BILE LEAKAGE 
AFTER HEPATECTOMY
Y. Taguchi, T. Ebata, Y. Yokoyama, T. Kokuryo, 
N. Tsunoda, G. Sugawara, T. Igami, M. Fukaya, Y. 
Takahashi, K. Uehara and K. Itatsu
Department of Surgery, Nagoya University Graduate 
School of Medicine, Japan
Introduction: Bile leakage is a troublesome complication 
often facing after hepatectomy. The aim of this retrospective 
study is to clarify surgery-related predictors for bile leakage.
Methods: A total of 380 patients who consecutively under-
went hepatectomy between 2007 and 2010 were enrolled in 
this study. During the study period, total bilirubin concentra-
tion of the drain output was routinely measured on postop-
erative day 1, 4, and 7. According to the system proposed by 
ISGLS, 146 (38.4%) patients had bile leakage (grade A in 
77, B in 68, and C in 1). Surgery-related factors were ana-
lyzed to predict bile leakage of grade B or more.
Results: Univariate analysis showed that bile leak was sig-
nifi cantly associated with the following factors: anatomic vs 
nonanatomic resection (21% vs 6%, p = 0.002), with vs 
without bile duct resection (22% vs 11%, p = 0.007), with 
vs without vascular resection (26% vs 15%, p = 0.012), and 
major (2/3 or more) vs minor resection (25% vs 9%, p < 
0.001). According to types of anatomic hepatectomy, bile 
leakage was most common in left trisectionectomy (28/66, 
42%), followed by right hepatectomy (21/105, 20%), left 
hepatectomy (10/75, 13%), right trisectionectomy (4/37, 
11%) and the other anatomic hepatectomy (1/19, 5%). Thus, 
type of hepatectomy was classifi ed into left trisectionectomy 
or others. Stepwise logistic regression analysis demonstrated 
that only left trisectionectomy was an independent predictor 
of postoperative bile leakage (p = 0.001).
Conclusion: Left trisectionectomy is a high risk procedure 
of postoperative bile leakage. As the risk possibly results 
from the partial remnant of the right anterior sector, liver 
transection in left trisectionectomy should be advanced along 
the accurate anatomic plane.
222 Poster Presentation Abstracts
HPB © 2011 International Hepato-Pancreato-Biliary Association, HPB, 13 (Suppl. 3), 174–244
P-158
OUTCOME OF VASCULAR 
RECONSTRUCTION WITH CRYO-
PRESERVED VEIN GRAFT IN HEPATIC 
RESECTION FOR COLORECTAL 
METASTASIS
S. Tamura3,4, Y. Sugawara4, J. Kaneko4, T. Aoki1, 
K. Hasegawa1, Y Sakamoto1, A. Saito2,4, N. Motomura2,4, 
M. Makuuchi5 and N. Kokudo1,4
1Department of Surgery, Hepato-Biliary Pancreatic Surgery 
Division, Tokyo University, Tokyo, Japan; 2Department of 
Cardiothoracic Surgery, Tokyo University, Tokyo, Japan; 
3University of Tokyo Tissue Bank, Tokyo, Japan; 
4Department of Surgery, Artifi cial Organ and 
Transplantation Division, Tokyo University, Tokyo, Japan; 
5Japanese Red Cross Medical Center, Tokyo, Japan
Introduction: Resectability of hepatic colorectal metastasis 
[CR-mets] is a signifi cant factor affecting outcomes. 
However, the procedure is often hindered by its anatomical 
location adhering to major vessels. We have aggressively 
applied the use of cryo-preserved vein [CP-v] grafts for 
various types of abdominal surgery including liver transplan-
tation and extensive hepato-biliary surgery. CP-v grafts do 
not require anticoagulation and therefore considered valu-
able in major hepatic surgery. Studying the outcome of 
radical resection for CR-mets with CP-v may suggest useful 
approach in the coming era of advanced adjuvant therapy.
Method: Outcomes of surgical removal of CR-mets with 
cryo-preserved vein grafts were studied.
Results: Between 1994–2010, total of 402 patients with 
CR-mets underwent hepatic resection. Among them, 7 
underwent extended resection requiring extensive vascular 
reconstruction with CP-v grafts. Anticoagulation was unnec-
essary and none experience thrombosis. Post operative 
course was uneventful in all cases. During follow up, three 
died from recurrent disease at median interval of 15 months 
[mo] (5–23 mo), other three are alive with recurrent disease 
and are under chemotherapy at median interval of 22.4 mo 
(11–44 mo). Finally, one patient remains recurrence free 
after 49 mo. One, two, and three year survival rates were, 
85.7%, 45.7%, and 45.7% respectively.
Conclusion: Outcome of radical resection with reconstruc-
tion of major vessel is not dismal. Use of CP-v graft for 
venous outfl ow reconstruction in CR-mets is feasible and 
may enhance the rate of resectable cases. Further application 
is warranted.
P-159
SECURING DONOR SAFETY AND 
OPTIMIZING RECIPIENT OUTCOMES IN 
LIVING DONOR LIVER 
TRANSPLANTATION: SYSTEMATIC 
SELECTION OF GRAFT TYPES AND USE 
OF CRYO-PRESERVED VEIN GRAFT
S. Tamura1, Y. Sugawara1, J. Kaneko1, T. Aoki1, 
K. Hasegawa1, Y. Sakamoto1, M. Makuuchi2 
and N. Kokudo1
1Tokyo University, Tokyo, Japan; 2Japanese Red Cross 
Medical Center, Tokyo, Japan
Introduction: In our adult to adult living donor liver trans-
plantation [LDLT] program, we have continued to apply 
systematic selection of graft types and use of cryo-preserved 
vein graft for outfl ow reconstruction of the middle hepatic 
vein [MHV]. In the current study, we evaluate the outcomes 
of our approach.
Methods: Outcomes of 100 consecutive LDLT were studied. 
Donor complication was assessed with Clavien system.
Results: Among the 100 donors, right liver graft [RL] was 
procured in 67 cases (67%), and left liver graft [LL] in 33 
cases (33%). LL with the caudate lobe [LL + C] was selected 
in 24 cases of LL (73%). In the RL group, 9 (14%) were with 
the MHV [RL/MHV+], and 54 (86%) were without the 
MHV[RL/MHV−]. No grade IV or mortality was observed. 
Overall, complications were observed in 89%, 52%, and 57% 
of the donors who were retrieved RL/MHV+, RL-MHV− and 
LL + C, respectively. The severity of complications were, 
Grade I–II; 78%, 39%, 44%, Grade IIIa; 11%, 13%, 9%, and 
Grade IIIb; 0%, 0%, 4%, respectively. No complications were 
reported in 11%, 48%, and 48% of each group. Five year 
survival of the recipients with RL/MHV+, RL/MHV− and 
left L + C were, 78%, 88%, and 92%, respectively.
Conclusions: Use of cry-preserved vein graft for venous 
outfl ow reconstruction under algorithm based systematic 
selection of graft types may be effective in securing donor 
safety and optimizing recipient outcomes in LDLT.
P-160
EXTRACORPOREAL HEPATIC 
RESECTION FOR ADVANCED HCC WITH 
DIFFICULT ANATOMY, THREE CASE 
REPORTS
P. H. Wen, Y. L. Chen, K. H. Lin and C. E. Hsieh
Department of General Surgery, Changhua Christian 
Hospital, Changhua, Taiwan
Introduction: Extracorporeal hepatic resection and hepatic 
autotransplantation allow treatment of hepatobiliary tumors 
located in critical sites and expand the role of liver surgery. 
In the literature there were only a few series of studies avail-
able, which included even fewer cases of hepatocellular car-
cinoma. We reported three cases receiving combination of 
extracorporeal hepatic resection and autotransplantation for 
otherwise untreatable hepatocellular carcinoma.
Methods: In 2011 in our center, three patients with hepato-
cellular carcinoma received extracorporeal hepatic resection 
with autotransplantation. Conventional liver surgery was 
considered impossible or dangerous because of the advanced 
disease or the critical sites at which the tumor was located. 
All the three patients were male, in their mid age.
Results: The three patients received extracorporeal right 
extended hemihepatectomy, left extended hemihepatectomy, 
and central segmentectomy (segment I, IV, V, VIII) respec-
tively. The anhepatic periods were no longer than 3 hours 
and 22 minutes. A temporary portocaval shunt was per-
formed to tide over this period. The venous outfl ow system, 
portal system, biliary tract and hepatic artery were recon-
structed in order. There was no early postoperative mortality 
or recurrence. All are still alive.
Conclusion: The combination of curative extracorporeal 
hepatic resection provided an alternative of treatment in 
selected patients. It could also be extended to the patients 
with hepatocellular carcinoma in experienced transplantation 
centers. However, a long-term follow-up for the incidence of 
recurrence or mortality should be further reported.
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MACROPHAGE PLASTICITY DURING 
THE PROGRESSION OF COLORECTAL 
LIVER METASTASES
S. W. Wen1, E. Ager1,2 and C. Christophi1
1The University of Melbourne, Department of Surgery 
(Austin Health), Heidelberg, Australia; 2Harvard 
University, Massachusetts General Hospital, Boston, USA
Introduction: Macrophages play an important role in 
tumorigenesis. These cells are heterogeneous in nature and 
are capable of either inhibiting or supporting tumor growth 
in response to changing microenvironment signals and the 
stage of tumor development. This study investigates the pos-
sible functional changes by macrophages in a murine model 
of colorectal (CRC) liver metastases.
Methods: Following induction with CRC liver metastases, 
macrophages were depleted by two successive doses (6 to 24 
hours apart) of gadolinium chloride (GdCl3, 20 mg/kg) at 
either day 0, 10, 14 or 18. Experimental endpoints for day 0 
GdCl3 treatment were days 7, 16 and 21 after tumor induc-
tion. The endpoint for mice treated with GdCl3 at day 10, 14 
and 18 were at day 21. The effect of macrophage depletion 
on liver tumor burden, iNOS expression, apoptosis, prolif-
eration, VEGF-infi ltrating cells and CD3+ cells was 
investigated.
Results: Early macrophage depletion increased tumor load 
at the exponential tumor growth phase (day 16) while late 
stage depletion (day 18) decreased tumor load by day 21. 
Late macrophage depletion was associated with increased 
numbers of CD3+ and iNOS expressing infi ltrating cells in 
tumors while decreasing the number of VEGF-expressing 
infi ltrating cells. The number of apoptotic non-parenchymal 
cells in the liver also increased.
Conclusions: Macrophages have divergent effects on tumor 
growth; results suggest a switch to a pro-tumor function at 
the late stages of tumor development. Alterations in key 
growth factors such as iNOS and VEGF, and T-cell response 
may be responsible for this change.
P-162
THE FEASIBILIY AND THERAPEUTIC 
EFFECT OF LAPAROSCOPIC LIVER 
RESECTION
M. Yasunaga, K. Okuda, H. Sakai, T. Ogata, H. Kinoshita 
and K. Shirouzu
Kurume University School of Medicine, Kurume, Japan
Background and Aim: Liver resection has dramatically 
evolved over the years. Laparoscopic liver resection (LLR) 
is especially a recognized alternative to open surgery. 
However the safety and the effi cacy of the techniques are 
still unknown. This study explored the feasibility and thera-
peutic effect of LLR.
Patients and Methods: Between April 2002 and May 2011, 
patients suitable for liver resection were carefully assessed. 
Data were collected prospectively to assess the outcome 
including, size of tumor, intra-operative blood loss, operation 
time, duration of hospitalization, blood transfusion require-
ment. Laparoscopic liver resection in our technique is as 
follows. The left lobe was mobilized by laparoscopically, 
followed by applying a small incision, and the left Glisson 
was handled integrally by the Endo-linear stapler. 
Subsequently, under direct vision, a liver resection was 
carried out with the SonoSurge or CUSA using a hanging 
maneuver. The lateral segmentectomy was performed under 
Pure laparoscopic Surgery. In the partial liver resection, 
Radiofrequency ablation (RFA) was used on Parenchymal 
transection line for pre-coagulation, followed by resection of 
the liver.
Results: Forty-one patients underwent LLR. The mean size 
of tumor was 23.0 ± 1.70 mm, mean operation time and 
blood loss was 303 ± 10.2 min and 242 ± 34.2 g. The mean 
duration of hospitalization was 10.8 ± 3.24 days. No patients 
had blood transfusion and major complication.
Conclusion: Laparoscopic liver resection can be done 
safely and effectively with applying a small incision for 
appropriately selected patients.
P-163
EXPERIENCE BEFORE ESTABLISHING 
TOTALLY LAPAROSCOPIC LEFT 
LATERAL SECTIONECTOMY AS A 
STANDARD OPERATION
S. S. Yun, D. S. Lee, D. H. Lee and H. J. Kim
Yeungnam University Hospital, Daegu, Korea
Introduction: The aim of this study is to present our experi-
ence before establishing laparoscopic left lateral sectionec-
tomy (LLLS) of liver as a standard operation and to show 
effi cacy of totally LLLS compared to open left lateral sec-
tionectomy (OLLS).
Methods: We retrospectively analyzed and compared the 
clinical outcomes (operation time, blood loss, hospital stay, 
complication rate etc) in 31 patients who underwent LLLS 
and 27 patients who underwent OLLS between January, 
2002 and December, 2009. To see the learning curve of 
LLLS, we arbitrarily divided fi rst and second half period 
(before and after December, 2007) depending on case number 
15.
Results: Mean operative time in the LLLS group were 275 
± 67.4 min (fi rst half), 269.7 ± 102.6 min (second half) and 
195.2 ± 48.2 min in the OLLS group. Mean operative time 
was shorter in the second half LLLS compared to that of 
the OLLS group. (p < 0.05) Mean intra-operative blood 
loss was not different in the three groups (298 ± 389 ml, 
3410.7 ± 709.5 ml and 167.6 ± 231.1 ml) and neither was 
the complication rate (14.2%, 5.8% and 14.8%). There 
were two open conversions in the fi rst half LLLS group and 
no deaths in the three groups within 90 postoperative days. 
Post-operative hospital stay was shorter in the second half 
LLLS compared to the OLLS group (9.9 ± 4.0 versus 16.9 
± 9.1, p = 0.007).
Conclusion: The totally LLLS was safe, feasible treatment 
option that can be a standard procedure in selected patients 
after initial learning curve.
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VALUE OF THREE-DIMENSIONAL 
DIRECT MULTI-DETECTOR ROW CT 
CHOLANGIOGRAPHY IN BILIARY 
DUCTAL EVALUATION FOR PERIHILAR 
CHOLANGIOCARCINOMA
T. Ajiki, K. Ueno, H. Sawa, I. Ohtsubo, Y. Yoshida, 
S. Murakami, K. Shinozaki, M. Kido, I. Matsumoto, 
T. Fukumoto, Y. Hori and Y. Ku
Department of Surgery, Division of Hepato-Biliary-
Pancreatic Surgery, Kobe University Graduate School of 
Medicine, Kobe, Japan
Introduction: Accurate diagnosis of ductal cancer spread in 
hilar cholangiocarcinoma is diffi cult, and recent progress of 
3-dimensional (3D) CT cholangiography may improve this 
problem. We assessed preoperative biliary ductal evaluation 
using 3D-CT cholangiography compared with endoscopic 
retrograde cholangiography (ERC) and magnetic resonance 
cholangiopancreatography (MRCP) in this malignancy.
Methods: Of 24 patients diagnosed as perihilar cholangio-
carcinoma, 11 patients had jaundice (T-bilirubin ≥4.0 mg/dl) 
and had undergone preoperative biliary drainage (5 PTBD, 
6 ENBD), and 13 patients did not require preoperative biliary 
drainage. Conventional multi-detector-row CT (MDCT), 
ERC and MRCP were planned in all patients. Direct cholan-
giography was performed via biliary drainage tubes or via 
temporary endoscopic biliary tubes that lay at ERC examina-
tion. Biliary ductal evaluation was based on visualization of 
the peritumoral biliary tree and attempted assessment of the 
tumor invasion, and graded into 3 categories (Grade A; com-
plete visualization and clear diagnosis of tumor invasion, B; 
incomplete visualization and rough diagnosis of tumor inva-
sion, C; incomplete visualization and diffi cult to diagnose 
tumor invasion).
Results: In biliary ductal evaluation, the rates of Grade 
A/B/C were 13/52/35% in ERC, 13/42/46% in MRC, and 
42/21/38% in 3D-CT cholangiography, respectively. The 
clearest evaluation of the biliary tree was provided by 3D-CT 
cholangiography in patients with obstructive jaundice (p = 
0.044), and by ERC in patients without obstructive jaundice 
(p = 0.018). Based on the 3D-CT cholangiography fi ndings, 
the accuracy of tumor invasion diagnosis was 67% in Grade 
A and 60% in Grade B, and R0 resection was achieved in 
73% of resected cases.
Conclusions: 3D-CT cholangiography can satisfactorily 
delineate the biliary tree and tumor invasion of perihilar 
cholangiocarcinoma, especially in patients with obstructive 
jaundice.
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LAPAROSCOPIC FUNDECTOMY AND 
ARGON CHOLECYSETOMY
A. Aldohayan, H. Alqahtani and F. Bamihrz
College of Medicine King Saud University, Saudi Arabia
Background: Laparoscopy is the best way to manage 
gallbladder disease. How ever in acute infl ammation and 
there is no plane of cleavage of biliary structure, also open 
technique is required. We devolved a technique to be 
managed and applied to all patients need laparoscopic 
cholecysetomy.
Method: After establishment of pneumoperitonium. The 
cystic duct is dissected. In case of acute infl ammation and 
absence of line cleavage. The dissection of fundus started 
fi rst up to the narrowing of gallbladder to form the cystic 
duct.
The gallbladder caudal to cystic duct is open and resected 
and stones removed for Hartman pouch and cystic duct argon 
diathermy is applied to mucosa of Hartman pouch and cystic 
duct and closed by 20 absorbable suture and drain placed in 
gall bladder fossa.
The procedure was done for and patient. All patient has 
smooth post operative recovery and drains removes in 2 days 
and discharge in average 3.4 days.
The procedure is safe and can be used as replaced open 
cholecysetomy.
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PROGNOSTIC IMPACT OF THE NUMBER 
OF LYMPH NODE METASTASIS IN 
PERIHILAR CHOLANGIOCARCINOMA
T. Aoba, T. Ebata, Y. Yokoyama, T. Kokuryo, N. Tsunoda, 
G. Sugawara, T. Igami, M. Fukaya, Y. Takahashi and 
K. Uehara
Nagoya University Graduate School of Medicine, Japan
Introduction: To verify an appropriate assessment of nodal 
metastasis for prognostic stratifi cation in perihilar 
cholangiocarcinoma.
Methods: A total of 4092 lymph nodes from 311 patients 
with perihilar cholangiocarcinoma who underwent surgical 
resection between 2000 and 2009, were re-reviewed. Of 
them, 163 (52%) patients had nodal metastasis (N+), while 
the remaining did not (N−). The number of involved nodes 
was 1 to 3 (limited metastasis) in 103 patients and 4 or more 
(extensive metastasis) in 45; the anatomic location was clas-
sifi ed into three: nodes in the hepatodudodenal ligament 
(group A, n = 65), nodes around the pancreatoduodenum 
(group B, n = 58), and the other nodes (group C, n = 25).
Results: The 3- and 5-year survival rates were 64% and 
59% in patients with N− and 27% and 23% in patients with 
N+, respectively (P < 0.001). Grouped according to the 
number of involved node, 3- and 5- year survival rates were 
35% and 26% in patients with limited metastasis and 18% 
and 12% in patients with extensive metastasis, respectively 
(P = 0.010). Patients with limited metastasis showed statisti-
cally better survival than those with extensive metastasis and 
worse than those with N−. In contrast, there was no signifi -
cant difference among the group A, B and C patients.(5-year 
survivals of 21%, 33%, and 16%, respectively.)
Conclusion: The number of involved nodes provides a 
better prognostic stratifi cation in perihilar cholangiocarci-
noma. Patients with nodal metastasis can be divided into 
limited or extensive subsets.
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MISIDENTIFICATION OF DUODENUM 
AS GALL BLADDER DURING 
LAPAROSCOPIC CHOLECYSTECTOMY 
– DISASTROUS CONSEQUENCES
G. S. Brar, S. S. Virk, S. Budhiraja and S. Kumar
Department of Surgery, Dayanand Medical College & 
Hospital, Ludhiana, India
Introduction: Laparoscopic cholecystectomy has become 
the procedure of choice for the management of gall stone 
disease. Although bile duct injury is the commonest reported 
complication, bowel injuries are infrequent and duodenal 
perforation is rare. Duodenal perforation is either caused 
during dissection of duodenum away from the gall bladder 
or as a result of thermal injury. We here describe a case where 
descending duodenum was misidentifi ed as gall bladder 
leading to disastrous consequences.
Material & Methods: A case of symptomatic cholelithiasis 
was planned for laparoscopy cholecystectomy elsewhere in 
a near by hospital. After a prolonged and diffi cult attempt at 
dissection, bile was seen coming from one of the orifi ce, 
procedure was abandoned and patient was referred to our 
institute for further management.
Patient was reexplored through right subcostal incision. 
Intra operatively small, contracted gall bladder was found to 
be densely adherent to hepatoduodenal ligament forming a 
single unit and there was no evidence of dissection around 
it. Descending part of duodenum was completely separated 
from pancreas including disruption of ampulla of vater and 
devitalized duodenum was hanging from fi rst part of duode-
num. Lower end of duodenum was closed with multiple 
clips. Due to the extensive nature of injury pancreaticoduo-
denectomy was done. Patient had uneventful recovery and 
was discharged on 7th post operative day. On communication 
with the primary surgeon it was found that in absence of 
normal gall bladder, duodenum was misidentifi ed as gall 
bladder and continued dissection upwards till he encountered 
bile leak from ampulla of vater.
Conclusion: Duodenal injury is a rare complication of lapa-
roscopic cholecystectomy with very high mortality. Poor 
depth perception coupled with limited tactile feedback in 
laparosocopic surgery can lead on to misidentifi cation of 
disease and distorted anatomy. Early diagnosis and interven-
tion can result in a favorable outcome.
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STUDY OF LOW PRESSURE 
PNEUMOPERITONEUM IN PATIENTS 
UNDERGOING LAPAROSCOPIC 
CHOLECYSTECTOMY
S. Budhiraja, S. Kumar and N. P. Jain
Department of Surgery & Medicine, Dayanand Medical 
College & Hospital, Ludhiana, India
Aim: This study aimed to evaluate the effi cacy of a low- 
pressure (LP) (7 mmHg) pneumoperitoneum as compared 
to standard-pressure pneumoperitoneum (SP) (12 mmHg) 
during laparoscopic cholecystectomy in reducing the inci-
dence of post operative shoulder tip pain and analgesic 
consumption
Materials and Methods: 100 consecutive patients qualifi ed 
for laparoscopic cholecystectomy (LC) due to uncomplicated 
symptomatic gallstones were randomized to either SPLC or 
LPLC. The statistical analysis included sex, mean age, body 
mass index, ASA grade, operative time, complication rate, 
conversion rate, postoperative pain assessed by the Visual 
Analogue Scale of Pain (VAS) including the incidence of 
shoulder-tip pain, postoperative hospital stay, recovery time, 
complication rate, conversion rate from LP to SP following 
the operation. p < 0.05 was considered as indicative of 
signifi cance.
Results: Neither conversion to an open procedure nor major 
complications occurred in either group. The operative time 
was similar in both groups (LP 55.7 ± 8.6 min vs SP 51.9 ± 
8.3 min). The mean postoperative pain score was 6.18 ± 3.48 
lower after LP than SPLC and the difference amounted to 
22.2% (p < 0.005). The incidence of shoulder-tip pain was 
2.1 times lower after LP than SPLC (p < 0.05). QOL within 
7 days following the operation was remarkably better after 
LPLC than after SPLC (p < 0.01).
Conclusions: LP pneumoperitoneum is superior to SP pneu-
moperitoneum in terms of lower postoperative pain, a lower 
incidence of shoulder-tip pain, and a better QOL within 7 
days following the operation.
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CHOLECYSTITIS OR CHOLESTASIS 
AFTER GASTROESOPHAGECTOMY
N. Fukino1, T. Oida1, K. Mimatsu1, H. Kano1, 
A. Kawasaki1, K. Kida1, Y. Kuboi1, H. Miyake2 and 
S. Amano3
1Department of Surgery, Social Insurance Yokohama 
Central Hospital, Yokohama, Japan; 2Department of 
Surgery, Kaukabe Municipal Hospital, Kasukabe, Japan; 
3Department of Surgery, Nihon University School of 
Medicine, Tokyo, Japan
Introduction: Increased incidences of gallbladder disorders 
after esophagectomy and gastrectomy have been reported. 
Moreover, several researchers have reported increased inci-
dences of gallbladder diseases in patients receiving long-
term total parenteral nutrition. We studied the incidence of 
cholecystitis or cholestasis and determined its relationship 
with total parenteral nutrition; further, we compared the inci-
dence after esophagectomy and after total gastrectomy.
Methods: We retrospectively studied 109 patients who 
underwent total gastrectomy or esophagectomy. These 
patients were divided into 2 groups those who underwent 
total gastrectomy (TG group) and those who underwent 
esophagectomy (E group).
Results: The 2 groups did not signifi cantly differ with 
respect to the mean duration of perioperative administration 
of total parenteral nutrition and the incidence rate of chole-
cystitis or cholestasis after esophagectomy.
Conclusion: Postoperative hyperbilirubinemia after esoph-
agectomy may not contribute to the development of gallblad-
der complications. We suggest that parenteral modalities 
such as tube feeding be initiated immediately after surgery 
for preventing gallbladder complications after esophagec-
tomy. Further, a short duration of administration of total 
parenteral nutrition and immediate postoperative initiation of 
oral feeding may prevent gallbladder complications after 
esophagectomy and total gastrectomy.
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IMPACTION OF A LITHOTRIPSY 
BASKET BY A GIANT COMMON BILE 
DUCT STONE
N. Fukino, T. Oida T, K. Kida, A. Kawasaki, K. Mimatsu, 
Y. Kuboi and H. Kano
Department of Surgery, Social Insurance Yokohama 
Central Hospital, Yokohama, Japan
Introduction: The treatment for common bile duct (CBD) 
stone is continually being. Impaction of the lithotripsy basket 
during endoscopic removal of CBD stone was seen in 5.9%. 
We reported a case of surgery for impacted biliary basket.
Methods: A 66-year-old woman was admitted to our hospi-
tal complaining right upper abdominal pain. Magnetic reso-
nance cholangiopancreatography revealed a defect (15 × 
20 mm in diameter) of CBD. We diagnosed the choledocho-
lith and performed endoscopic retrograde cholangiopancrea-
tography to remove the CBD stones. But unfortunately the 
retrievable basket around a stone was impacted in Vater 
ampulla. It was impossible to treat an endotriptor for the 
forceps. So diagnosis was the incarseration of basket and an 
urgent surgery performed. At the operation, cholecystectomy 
was performed and the bile duct was explored. The basket 
and stones were removed through a longitudinal choledo-
chotomy. The wires leading to the basket were cut, and 
the basket and stone were extracted via the incision. 
Choledochoscopy revealed no residual stone and fragment. 
A T-tube was inserted, and the choledochotomy was closed.
Results and Conclusions: The postoperative course was 
uneventful. We evaluated that if the size of CBD stone is 
over 20 mm in diameter, the risk of impacted basket increase. 
In these cases surgery might be selected as an initial treat-
ment of CBD stone.
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POSTCHOLECYSTECTOMY COMMON 
BILE DUCT DILATATION: OPEN VERSUS 
LAPAROSCOPIC CHOLECYSTECTOMY
N. Fukino1, T. Oida1, K. Mimatsu1, H. Kano1, 
A. Kawasaki1, Y. Kuboi1, K. Kida1 and S. Amano2
1Department of Surgery, Social Insurance Yokohama 
Central Hospital, Yokohama, Japan; 2Department of 
Surgery, Nihon University School of Medicine, Tokyo, 
Japan
Introduction: Cholecystectomy as a factor causing common 
bile duct (CBD) dilatation has been debated. The aim of this 
study was to investigate CBD dilatation after cholecystec-
tomy in patients with a preoperative CBD diameter of 
<6 mm.
Methods: We retrospectively analyzed the cases of 101 
patients who underwent cholecystectomy. These patients 
were divided into 2 groups – the open cholecystectomy 
group (OC group) and the laparoscopic cholecystectomy 
group (LC group).
Results: The postoperative mean CBD diameter was 5.80 ± 
0.49 mm in the OC group and 5.75 ± 0.47 mm in the LC 
group; the diameters were not signifi cantly different between 
the 2 groups (p < 0.6699). With regard to the change in body 
weight after surgery, gained, in the OC group, 71.1%, patients 
gained weight, 20%, showed no change, and 8.9% lost 
weight; the corresponding numbers in the LC group were 
75%, 23.2%, and 1.8% patients, respectively, thus, there 
were no signifi cant differences in terms of weight changes 
between the 2 groups (p < 0.6607, p < 0.6973, and p < 
0.1690, respectively).
Conclusion: Thus, for patients with preoperative CBD 
diameters of <6 mm, no compensatory dilatation occurs after 
open or laparoscopic cholecystectomy.
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THROMBOCYTOSIS FOLLOWING 
SPLENECTOMY
N. Fukino1, T. Oida1, K. Mimatsu1, K. Kano1, 
A. Kawasaki1, K. Kida1, Y. Kuboi1, H. Miyake2 
and S. Amano
1Department of Surgery, Social Insurance Yokohama 
Central Hospital, Yokohama, Japan; 2Department of 
Surgery, Kasukabe Municipal Hospital, Kasukabe, Japan; 
3Department of Surgery, Nihon Univercity School of 
Medicine, Tokyo, Japan
Introduction: Splenectomy is one of the main causes of 
reactive thrombocytosis. In most cases, thrombocytosis 
found incidentally is harmless and resolves spontaneously; 
however, extreme thrombocytosis may resuit in thrombotic 
events such as acute myocardial infarction, mesenteric vein 
thrombosis, and pulmonary embolism. Thus, there are no 
clear indications for determining which patients with reac-
tive thrombocytosis require treatment. In this study, we 
evaluated reactive thrombocytosis that developed after sple-
nectomy with or without additional organ resection.
Methods: We retrospectively studies 70 patients who under-
went splenectomy. These patients were divided into 2 groups: 
the only splenectomy group (group A) and the splenectomy 
with additional organ resection group (group B).
Results: Both the platelet count at 1 week and 1 month after 
the operation (p < 0.01 and p < 0.001, respectively) and the 
incidence rate of thrombocytosis at 1 week and 1 month (p 
< 0.4089 and p < 0.0007, respectively) were signifi cantly 
higher in the group A than in the group B. All the patients in 
both the groups recovered from thrombocytosis without any 
platelet reduction therapy, and there was no postoperative 
thrombosis.
Conclusion: Splenectomy often results in reactive thrombo-
cytosis; however, platelet reduction therapy is not required 
for treating postsplenectomy reactive thrombocytosis.
P-173
PERIOPERATIVE NUTRITIONAL 
SUPPORT FOR BILIARY CANCER 
SURGERY
G. Sugawara, T. Ebata, Y. Yokoyama, T. Igami, 
Y. Takahashi and M. Nagino
Division of Surgical oncology, Department of Surgery, 
Nagoya University Graduate School of Medicine, Nagoya, 
Japan
Introduction: Bacterial translocasion (BT) is considered to 
be one of the causes of postoperative infectious complica-
tions (POICs) in patients undergoing hepatobiliary resection 
for biliary cancer.
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Methods: From 2000 to 2005, we conducted 2 randomized 
controlled trials (RCT) to establish nutritional support for 
hepatobiliary resection. Based on positive results of RCTs, 
we made three nutritional strategies to prevent BT; 1) 
replacement of bile drained externally from the biliary drain-
age catheter, 2) perioperative administration of synbiotics, 3) 
postoperative early enteral feeding. All the bile drained 
externally from the biliary drainage catheter in patients with 
obstructive jaundice was replaced orally to maintain the 
intestinal integrity. Preoperative symbiotic treatments were 
administered orally for at least 2 weeks before operation. 
During surgery, an 8-Fr catheter was placed through a jejunal 
limb for postoperative enteral feeding. The enteral feeding 
was initiated on postoperative day 1. Postoperative symbiotic 
treatments were administered through the feeding catheter 
for 2 weeks. POICs were recorded for up to 30 days after 
surgery.
Results: Before establishment of nutritional protocol, 
between 1990 and 1999, 194 patients underwent combined 
liver and extrahepatic bile duct resection with intrahepatic 
cholangiojejunostomy. Of the 194 patients, 76 (39%) had 
wound infection, 64 (33%) intra-abdominal abscess, and 43 
(22%) bacteremia. After establishment of protocol, between 
2006 and 2010, 307 patients underwent hepatobiliary resec-
tion. Of the 307 patients, 31 (10%) had wound infection, 58 
(19%) intra-abdominal abscess, and 18 (6%) bacteremia.
Conclusion: The frequency of POICs certainly decreased 
after establishment of nutritional support. These results 
support our perioperative nutritional management.
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HEPATIC RESECTION OF PERIPHERAL 
CHOLANGIOCARCINOMA OTHER THAN 
INTRADUCTAL PAPILLARY TYPE
Y.-Y. Jan, C.-N. Yeh, T.-S. Yeh and M.-F. Chen
Department of General Surgery, Chang Gung Memorial 
Hospital, Chang Gung University, Taiwan
Aim: Peripheral cholangiocarcinoma (PCC) can be grossly 
classifi ed into mass-forming (MF), periductal-infi ltrating 
(PI), and intraductal papillary (IP) types. IP-PCC should be 
distinguished from others type of PCC due to a favorable 
prognosis. However, non IP-PCC patients undergoing hepa-
tectomy needs to be well clarifi ed due to limited number of 
cases.
Methods: This study retrospectively reviewed prospec-
tively collecting data of 224 histologically proven PCC, 
including 172 non-IP type patients who underwent hepatec-
tomy between 1977 and 2007. Non-IP PCC was further clas-
sifi ed into mass-forming (MF), mass-forming mixed with 
periductal infi ltative (MF-PI), and periductal infi ltrative PCC 
(PI) for comparison.
Results: Two hundred and twenty four PCC patients (95 
men and 116 women) underwent hepatic resection from 
1977 to 2007. Among them, 52 had IP PCC (23.2%) and 
172 non IP PCC (76.8%) patients underwent hepatectomy. 
101 out of 172 non-IP PCC had curative resection (curative 
resection rate: 58.7%). The follow-up duration ranged from 
1.1 to 193.1 months (median: 13.4 months). Overall sur-
vival (OS) rates for non-IP PCC at 1, 3, and 5 years were 
58.4%, 23.6%, and 15.1%, respectively. Abscence of symp-
toms, lower alkaline phosphatase, normal CEA, and MF 
PCC independently and favorably affected OS for non-IP 
PCC after hepatectomy. Subgroup analysis revealed 
abscence of symptoms, normal CEA, curative hepatectomy, 
and negative lymph node metastasis independently and 
favorably affected OS for MF PCC patients after heptec-
tomy. Curative hepatectomy independent and favorably 
affected OS for MF-PI PCC patients after heptectomy. 
Normal albumin level and negative lymph node metastasis 
independent and favorably affected OS for PI-PCC patients 
after heptectomy.
Conclusion: PCC patients other than IP type do have dis-
tinct characters and outcomes after hepatectomy. Correct 
subclassifi cation is important for tailored treatment.
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MANAGEMENT OF COMMON BILE 
DUCT STONE AFTER FAILED 
ENDOSCOPIC RETROGRADE 
CHOLANGIOPANCREATOGRAPHY
W. S. Jeo, T. M. J. Lalisang and A. B. H. Simanjuntak
Digestive Division Department of Surgery Cipto 
Mangunkusumo Hospital, Jakarta, Indonesia
Introduction: Common bile duct stone (CBDS) is one of 
the medical conditions which need to intervene. CBDS 
develops in about 10%–20% of patients with gallbladder 
stones. Many options and techniques have been applied to 
manage this problem. Endoscopic Retrograde Cholangio-
pancreatography (ERCP) is usually perform to extract the 
stones, but if it’s fail need surgical intervention. It’s impor-
tant to choose appropriate management. This study evaluated 
the intervention of CBDS to improve for better outcome.
Methods: A retrospective review of the patients with defi ni-
tive diagnosis of CBDS after failed ERCP over period from 
January 2007 to December 2010. Data were collected from 
hospital records, including surgical interventions and results.
Results: Over a 4-year period, 29 patients out of 38 CBDS 
presented failed ERCP. Male in 17 (58.6%) and female 12 
(41.4%). Age above 40 year-old is about 60%. Treatment is 
mostly in 27 patients (93.1%) by open common bile duct 
exploration (CBDE), which inserted T-tube in 17 (62.9%) 
with 2 retained stones and choledochoenterostomy bypass in 
12 (37.1%). Laparoscopic CBDE with choledoscope in 2 
patients (6.9%) had successfully performed with good duct 
clearance. No perioperative mortality was recorded.
Conclusions: Surgical CBDE is effi cacious procedure 
dealing with unsuccessful endoscopic stone extractions. 
Failure after ERCP mostly intervene by open CBDE and 
T-tube, in some cases have to directly to surgery. Laparoscopic 
CBDE is possible to manage CBDS with good clearance.
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CHOLEDOCHAL CYST – A 10 YEAR 
EXPERIENCE IN HOSPITAL SELAYANG
T. V. Kandasamy1, K. F. Lim1, M. S. Subramaniam2, 
K. Raman1 and H. Singh1
1HPB Department, Hospital Selayang, Selangor, Malaysia; 
2Surgical Department, Hospital Sultanah Bahiyah, Alor 
Star, Kedah, Malaysia
Introduction: Cystic dilatation of the biliary tree is a rare 
condition. Although most large series on choledochal cysts 
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(CC) originate from East Asian countries, the presentation 
and natural history of CC in Malaysia is not well studied.
Methods: Retrospective data was collected from a central-
ized database system from 2000 to mid 2010 with total of 71 
patients who underwent surgery for CC.
Results: There were 7 males and 64 females with a mean 
age of 30.4 years. 9 patients were pregnant. The common 
presentation in control group was either epigastric or right 
hypochondriac pain (43.6%). In pregnant group, 6/9 had 
fever and jaundice (66.7%). Complete cyst excision with 
Roux en Y hepaticojejunostomy in 57 patients. 10 patients 
in addition, had liver resection. Excision and choledocho-
plasty done for 1 patient for type II CC. 2 patients needed 
whipple’s operation due to malignancy at the distal margin 
of the cyst. One patient had double bypass for advanced 
cancer. Peri operative morbidity was 26.8%. The commonest 
being surgical site infection (SSI). 8/14 patients (57.1%) with 
SSI had undergone pre- operative biliary decompression. 
Average hospital stay for this group was 16.5 days compared 
to 9.2 days for the non decompressed group. There was one 
mortality due to heart and renal failure. Malignancy was 
noted in 7 patients (9.9%).
Conclusion: In the non pediatric population, choledochal 
cysts occur more frequently in women, and pregnancy seems 
to predispose to cholangitis in this group. Pre operative 
biliary decompression should be performed only in the 
setting of cholangitis.
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BENIGN STRICTURE OF THE COMMON 
HEPATIC DUCT MIMICKING KLATSKIN 
TUMOR
S. K. Kee, J. O. Kim, S. Y. Nam and J. D. Seo
CHA Gumi Medical Center, CHA University, Gumi, Korea
Benign solitary stricture of the extrahepatic bile duct without 
a history of pancreatitis or biliary surgery is extremely rare 
and diffi cult to discriminate from malignant stricture. Usually 
its diagnosis is made from histologic examination of the 
resected specimen postoperatively. We encountered a case of 
benign solitary stricture of the common hepatic duct (CHD) 
presented by septic cholangitis.
A 58-year-old man presented to the emergency room with 
a 1-day history of dyspnea, fever and chill. He had been 
experiencing intermittent epigastric discomfort and dyspep-
sia for 2 weeks before presentation. The medical history was 
unremarkable and he had no history of operation and trauma. 
His liver test were as follow: total bilirubin 7.4 mg/dL, direct 
bilirubin 5.0 mg/dL, AST 219 IU/L, ALT 185 IU/L, ALP 
153 IU/L and r-GGT 540 IU/L. Hepatitis B surface antigen 
and hepatitis C virus antibody were negative and tumor 
markers of CEA and CA19-9 were in normal range. Enhanced 
computed tomography and ultrasonography of the abdomen 
showed moderate dilatation of the intrahepatic bile duct and 
short-segmental wall thickening of the proximal CHD. ERCP 
showed mild dilatation of intrahepatic bile duct and short-
segmental luminal narrowing at the level of proximal CHD. 
After conservative treatment, he underwent a laparotomy 
through an extended right subcostal incision under the 
impression of cholangiocarcinoma of the CHD. Laparotomy 
revealed a collapsed gallbladder and a short, ring-like steno-
sis at the CHD just below the junction of the left and right 
hepatic ducts, but no mass was palpated along the biliary 
tract. A cholecystectomy and resection of the extrahepatic 
biliary tract was performed. Examination of frozen section 
of the resected CHD revealed no evidence of malignancy. 
Anastomosis of the CHD to a Roux-en-Y jejunal limb was 
performed. The postoperative period was uneventful and the 
patient was discharged on the 15th postoperative day. The 
microscopic fi ndings of the resected specimen revealed 
chronic infl ammation of the bile duct.
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WHICH SURGICAL STRATEGY IS 
OPTIMAL IN PATIENTS WITH T2 
GALLBLADDER CANCER?
S. H. Kim, G. H. Choi, C. M. Kang, K. S. Kim, 
J. S. Choi and W. J. Lee
Department of Surgery, Yonsei University College of 
Medicine, Seoul, Korea
Backgrounds: The presentation symptoms of GBCA are 
non-specifi c and most patients have been diagnosed as an 
advanced stage. However, because of the expansion of lapa-
roscopic cholecystectomy, incidental fi nding of GBCA is 
dramatically increased as initial presentation. The manage-
ment of incidental GBCA is debate issue. Therefore, we 
compared between our 10-year experience and consensus 
based surgical strategy of GBCA.
Methods: 155 patients underwent operation because of 
GBCA with stage more than T2 from Jan. 2000 to Dec. 2009 
at Severance Hospital, Yonsei University Health System, 
Seoul, Korea. The medical records of 70 patients with T2 
GBCA were retrospectively reviewed.
Results: Cholecystectomy, lymph node (LN) dissection and 
liver resection as like NCCN or AJCC recommendation were 
performed in only 32 (45.8%) patients. In T2 GBCA with 
positive LN, OS between cholecystectomy with LN dissec-
tion and radical cholecystectomy or between D1 and D2 LN 
dissection did not show a signifi cant difference. Twenty 
patients experienced recurrence during follow-up period. 
Among eleven patients underwent cholecystectomy with 
liver resection, only two (18.2%) patients had intrahepatic 
recurrence. Among nine patients underwent cholecystectomy 
without liver resection, three (33.3%) patients had intrahe-
patic recurrence. However, Recurrences at gallbladder bed 
were one and two patients, respective and it was not signifi -
cant difference (p = 0.438).
Conclusions: There was a large gap between clinical prac-
tices and treatment guidelines. Though patients to enroll in 
this study and experience recurrence were a small, cholecys-
tectomy and LN dissection without liver resection showed a 
similar survival and recurrence patterns compared with that 
of radical cholecystectomy. To be accordance between clini-
cal practices and treatment guidelines, the roles of limited 
resection in T2 lesion will be needed to evaluate more.
Key Words: Gallbladder cancer, surgical strategy, radical 
cholecystectomy
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DIFFERENT CD133 EXPRESSION 
PATTERN OF INTRADUCTAL 
PAPILLARY NEOPLASMS OF BILE DUCT 
(IPNB) AND BILIARY TRACT 
ADENOCARCINOMAS
S. Murakami, T. Ajiki, K. Ueno, H. Sawa, I. Ohtsubo, 
Y. Yoshida, K. Shinozaki, M. Kido, I. Matsumoto, 
T. Fukumoto, Y. Hori and Y. Ku
Department of Surgery, Division of Hepato-Biliary-
Pancreatic Surgery, Kobe University Graduate School of 
Medicine, Kobe, Japan
Introduction: Recently, cancer stem cells (CSCs) have 
been reported to play important roles in various kinds of 
cancer. CD133 was originally reported to be one of the 
surface markers of hemopoietic stem cells and progenitor 
cells, and is known to be an important cancer initiating cell 
marker. We previously reported that the CD133 expression 
pattern distinguishes intraductal papillary mucinous neo-
plasms (IPMN) from ductal carcinomas of the pancreas. 
Although intraductal papillary neoplasms of bile duct (IPNB) 
are recognized as counterparts of IPMN because of mucin 
production and papillary growth, there is little knowledge 
about their characteristics as compared with bile duct cancers. 
In this study, we sought to determine the expression pattern 
of CD133 in IPNB compared with bile duct cancers.
Methods: CD133 expression was examined by immunohis-
tochemical methods in IPNB (n = 7), intrahepatic cholangio-
cellular carcinomas (IHCCC, n = 24) and hilar bile duct 
cancers (HBDC, n = 10).
Results: The IPNB group included more females than the 
other groups (p = 0.006) and was characterized by longer 
survival. All patients showed strong expression of MUC5AC. 
Four of 7 (57%) patients showed MUC1+/MUC2− expres-
sion, 2 of 7 (29%) showed MUC1−/MUC2+ expression and 
1 of 7 (14%) showed MUC1-/MUC2- expression. No CD133 
expression was observed in patients with IPNB. In contrast, 
CD 133 expression was observed in 11.0% of cancer cells in 
IHCCC and in 13.7% in HBDC.
Conclusions: These results demonstrate that CD133 expres-
sion is downregulated in IPNB, suggesting that loss of CD133 
expression might be a useful clinicopathological marker dis-
tinguishing IPNB from bile duct adenocarcinomas, and indi-
cates that IPNB is a counterpart of pancreatic IPMN.
P-181
AGGRESSIVE SURGERY FOR LOCALLY 
ADVANCED GALLBLADDER CANCER 
WITH OBSTRUCTIVE JAUNDICE
Y. Nasu, E. Tanaka, T. Tsuchikawa, J. Matsumoto, K. Kato, 
T. Shichinohe and S. Hirano
Department of Surgical Oncology, Hokkaido University 
Graduate School of Medicine, Sapporo, Japan
Introduction: Gallbladder cancer (GBC) is frequently diag-
nosed only at an advanced stage. Obstructive jaundice is 
generally regarded as an indicator of far advanced disease 
and poor prognosis. The aim of this study was to identify the 
patients benefi ting from surgical intervention.
Methods: Sixty-fi ve patients of GBC with UICC T2 or 
more tumors underwent surgical resection between 1998 and 
2008. Clinicopathologic features, extents of resection, and 
survival rates were investigated retrospectively. Obstructive 
jaundice was defi ned that serum Total-bilirubin (T-bil) level 
was more than 2.0 mg/dl. GBC patients with jaundice might 
underwent curative resection after biliary drainage and the 
adequate relief of jaundice below the 2.0 mg/dl of T-bil level. 
Para-aortic lymphadenectomy and intraoperative frozen 
section pathology were performed because the status of para-
aortic lymph nodes should be examined during the operation 
prior to radical resection.
Results: The 5-survival rates were 29%. Univariate analysis 
demonstrated that the 5-year survival rates for patients with 
(n = 37) and without (n = 28) obstructive jaundice were 27%, 
31%, respectively (p = 0.74), which was not statistically 
signifi cant?, whereas blood loss, portal vein invasion, lym-
phovascular invasion, liver metastasis, distant lymph node 
metastasis including para-aortic lymph node metastasis, 
regional lymph node metastasis, and residual tumors were 
signifi cant factors for poor prognosis (p < 0.05). Multivariate 
analysis demonstrated that liver metastasis and distant 
lymph node metastasis were signifi cant independent factors 
(p < 0.05).
Conclusions: Aggressive surgery might improve long-term 
survival in patients with advanced GBC even in those with 
obstructive jaundice if distant metastasis is excluded.
P-182
SUBGROUPS OF LYMPH NODE 
METASTASIS INCLUDING EXTRA 
CAPSULAR LYMPH NODE 
INVOLVEMENT HAD NO SURVIVAL 
IMPACT IN PATIENTS WITH EXTRA-
HEPATIC BILE DUCT CANCER.
T. Noji1, M. Miyamoto1, K. C. Kubota2, T. Shinohara4, 
Y. Ambo3, S. Hirano1, Y. Matsuno2, N. Kashimura3 
and S. Kondo1
1Surgical Oncology, Hokkaido University, Sapporo, Japan; 
2Department of Surgical Pathology, Hokkaido University 
Hospital, Sapporo, Japan; 3Department of Surgery, 
Teine-Keijinkai Hospital, Sapporo, Japan; 4Department of 
Pathology, Teine-Keijinkai Hospital, Sapporo, Japan
Background: Lymph node metastasis (LNM) is one of the 
most important prognostic factors for extra-hepatic bile duct 
carcinoma (ExHBDC). However no data is available about 
the prognostic signifi cance of a subgroup of LNM including 
extra-capsular lymph node involvement (ExCLNI) in resect-
able ExHBDCs. The aim of the present study is to determine 
the prognostic impact of ExCLNI as a subgroup of LNM in 
patients with surgically treated ExHBDCs.
Methods: A total of 228 patients with resectable ExHBDCs 
were included in this retrospective study. The existence of 
ExCLNI and its prognostic value were analyzed as a sub-
group of LNM. The rate of LNM and ExCLNI as well as the 
location of LNM were assessed.
Results: ExCLNI was detected in 22% of patients with 
LNM. The presence of ExCLNI correlated signifi cantly with 
the middle-distal bile duct (p = 0.002). The overall 5 year 
survival rate was 40%. A multivariate analysis revealed that 
the presence of LNM was an independent prognostic factor 
but ExCLNI as a subgroup of LMN had no survival impact 
in resectable ExHBDCs.
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Conclusion: ExCLNI was detected in a signifi cant portion 
of patients who had resectable ExHBDCs. While ExCLNI 
was detected in 22% of our patients with LNM in resectable 
ExHBDCs, the presence of ExCLNI had no survival impact 
on patients with resectable ExHBDCs. LNM itself was the 
most important prognostic factor regardless of any subcate-
gorization of LNM based on ExCLNI, location, or number 
of LNM.
P-183
DUODENAL SWITCH OPERATION VS 
CHOLEDOCHOJEJUNOSTOMY FOR 
JUXTAPAPILLARY DUODENAL 
DIVERTICULA
T. Oida1, K. Mimatsu1, H. Kano1, A. Kawasaki1, Y. Kuboi1, 
N. Fukino1, K. Kida1 and S. Amano2
1Department of Surgery, Social Insurance Yokohama 
Central Hospital, Yokohama, Japan; 2Department of 
Surgery, Nihon University School of Medicine, Tokyo, 
Japan
Introduction: Since the fi rst case of juxtapapillary diverti-
clum reported by Lemmel, several reports have demonstrated 
an association between periampullary diverticulum and 
gallstone disease. Thus, we compared the effi ciency of the 
duodenal switch operation and choledchojejunostomy for 
patients who underwent surgery for cholangitis with juxta-
papillary duodenal diverticula.
Methods: We retrospectively studied 17 patients who had 
cholangitis associated with juxtapapillary duodenal diver-
ticula. These patients were divided into 2 groups on the basis 
of the operative procedure: the duodenal switch operation 
group (DS group) and the choledochojejunostomy group (CJ 
group).
Results: The mean operative time and blood loss were sig-
nifi cantly lesser in the DS group than in the CJ group (p < 
0.0001 and p < 0.0005, respectively); however, the duration 
of nasogastric suction requirement and time after which oral 
ingestion of solid diet could be safely resumed after surgery 
were signifi cantly longer in the DS group than in the CJ 
group (p < 0.0001 and p < 0.0001, respectively). Gallstone 
formation after the surgery did not occur in both groups.
Conclusion: Duodenal switch operation is useful and less 
invasive for cholangitis associated with juxtapapillary duo-
denal diverticula, and for preventing cholangitis for a long 
period after the operation; however, gastric stasis still 
remains a problem with this procedure.
P-184
A RESECTED CASE OF HILAR 
CHOLANGIOCARCINOMA BY LEFT 
HEPATIC TRISECTIONECTOMY, 
CAUDATE LOBECTOMY WITH 
SIMULTANEOUS PORTAL AND HEPATIC 
ARTERIAL RESECTION AND 
RECONSTRUCTION USING THE LEFT 
HEPATIC ARTERY
T. Sano1, Y. Shimizu1, Y. Senda1, K. Hara2, K. Yamao2 
and Y. Nimura1
1Department of gastroenterological surgery, Aichi Cancer 
Center Hospital, Nagoya, Japan; 2Department of 
gastroenterology, Aichi Cancer Center Hospital, Nagoya, 
Japan
Introduction: Although major hepatobiliary resection for 
hilar cholangiocarcinoma has been a widespread curative 
treatment, combined hepatic arterial resection and recon-
struction still remains a challenging surgical procedure.
Case: A 70-year-old woman was diagnosed with an 
advanced hilar cholangiocarcinoma involving both the left 
portal vein and the right hepatic artery. After left trisectional 
portal vein embolization, the tumor was curatively resected 
by left trisectionectomy with caudate lobectomy and com-
bined hepatic arterial resection and reconstruction with nega-
tive surgical margins. The hepatic arterial reconstruction 
between the posterior branch of the right hepatic artery and 
left hepatic artery was performed under the microscopic 
technique in end-to-end fashion. Histologically, a well-dif-
ferentiated adenocarcinoma invaded the media of the left 
portal vein and the adventitia of the right hepatic artery. 
Pathologically, the tumor was diagnosed as T4N0M0, stage 
IVA in terms of UICC 7th. Postoperative recovery was 
uneventful, and the patient is alive 17 months after surgery 
with no evidence of tumor recurrence.
Conclusion: The left hepatic artery can be available for 
hepatic arterial reconstruction even in case of a left-sided 
hepatectomy in terms of a tumor extension.
P-185
EFFICACY OF ENDOSCOPIC 
TRANSPAPILLARY GALLBLADDER 
DRAINAGE FOR PATIENTS WITH 
SURGICAL RISKS
S. Yusuke, S. Manabu and K. Shoichi
Internal Medicine Unit, Iwate Prefectural Isawa Hospital, 
Oushu, Japan
Introduction: Early cholecystectomy is usually needed for 
patients with acute cholecystitis. It is, however, diffi cult for 
some patients to perform emergency cholecystectomy 
because of surgical risks. Recently, there have been few 
reports on the effi cacy of endoscopic transpapillary gallblad-
der drainage (ETGBD) for initial treatment of acute chole-
cystitis. We report here the effi cacy of ETGBD for the 
treatment of patients with acute cholecystitis who have surgi-
cal risks for early cholecystectomy.
Methods: The patients treated with ETGBD for acute cho-
lecystitis between July 2008 and November 2010 were 
included in this study. The diagnosis of acute cholecystitis 
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was made by their clinical and radiological features. Success 
rate, complications and clinical course after ETGBD were 
investigated.
Results: A total of fi fteen cases in which ETGBD was tech-
nically successful were included in this study (79%). The 
mean age of the patients (male 6, female 9) was 74 ± 14 
years. Cystic duct perforation as a complication of ETGBD 
occurred in one case. All fi fteen patients successfully treated 
with ETGBD had become asymptomatic within a few 
days, and fi ve patients underwent late laparoscopic 
cholecystectomy.
Conclusions: ETGBD is an effective treatment of acute 
cholecystitis for patients with surgical risks or high aged 
patients. Although technical diffi culty suggests that the lower 
success rate in ETGBD than in percutaneous transhepatic 
gallbladder drainage (PTGBD), ETGBD would have the 
advantage of avoiding complications associated PTGBD 
tube and keeping activities of daily living.
P-186
LAPAROSCOPIC SURGERY FOR 
CONGENITAL BILIARY DILATATION IN 
ADULTS
S. Takahata, T. Otsuka, M. Nakamura, S. Shimizu 
and M. Tanaka
Department of Surgery and Oncology, Kyushu University, 
Fukuoka Japan
Introduction: Since we fi rst reported in 1996, we have 
experienced 26 laparoscopic surgery of congenital biliary 
dilatation in adult patients. We report about our operative 
methods and review the results especially focused on com-
plications and safety.
Methods: All the cases were divided into three groups by 
the time surgery was performed; former period (1996 to 1999, 
9 cases), intermediate period (1999 to 2003, 8 cases) and the 
late period (2004 to 2010, 9 cases) Surgical parameters 
including operation time, blood loss, complications, rate of 
open conversion were compared between the three groups.
Results: In the early period, all the operative procedures 
including hepatico-jejunostomy was performed laparoscopi-
cally. During the intermediate period, mini-laparotomy was 
made to facilitate biliary reconstruction. There was a decrease 
in operation time and Blood loss during intermediate period. 
The procedure was converted to open in 3 patients in early 
(40%) and 1 patient in intermediate period (10%). In the late 
period, we completely perform all surgical procedure under 
laparoscope. Operation time got longer however, blood loss 
was minimal. There was no case converted to open laparot-
omy in recent 9 patients.
Conclusions: Laparoscopic surgery of congenital biliary 
dilatation is now becoming the comparatively safe 
procedure.
P-187
INTRAOPERATIVE 
CHOLANGIOGRAPHY IS VALUABLE 
FOR CHOLECYSTECTOMY IN PATIENTS 
TREATED BY PREOPERATIVE 
ENDOSCOPIC STONE REMOVAL FOR 
CHOLEDOCHOLITHIASIS
K. Ueno, T. Ajiki, H. Sawa, I. Ohtsubo, Y. Yoshida, 
S. Murakami, K. Shinozaki, M. Kido, I. Matsumoto, 
T. Fukumoto, Y. Hori and Y. Ku
Department of Surgery, Division of Hepato-Biliary-
Pancreatic Surgery, Kobe University Graduate School of 
Medicine, Kobe, Japan
Introduction: Intraoperative cholangiography (IOC) as a 
routine workup during cholecystectomy is controversial. The 
aim of this study is to evaluate the value of IOC during 
cholecystectomy performed at our institute during a 12-year 
period.
Methods: A total of 425 consecutive patients who under-
went IOC during cholecystectomy (laparoscopic cholecys-
tectomy: LC, n = 344, open cholecystectomy: OC, n = 56, 
OC converted from LC, n = 25) were evaluated. Magnetic 
resonance cholangiopancreatography (MRCP) were per-
formed for bile duct evaluation before surgery. If common 
bile duct (CBD) stones were detected, endoscopic removal 
of CBD stones was performed before the operation.
Results: The success rate of IOC was 93.8% (399/425). 
The rate was similar in LC (93.9%) and in OC (93.8%). 
Abnormal biliary systems were detected in 10 cases (2.5%) 
who were diagnosed as having normal biliary systems by 
preoperative MRCP. IOC detected CBD stones in 8 cases 
(2.0%), of which seven were status after removal of CBD 
stones. The detection rate of CBD stones in cases with 
endoscopic removal of CBD stones (10.8%) was signifi -
cantly higher than in those without removal of CBD stones 
(0.3%) (p < 0.05). Seven out of 8 patients having residual 
CBD stones underwent surgery more than 2 weeks after 
endoscopic removal of CBD stones. Biliary injury occurred 
in 1 patient (0.2%) who underwent LC due to the misiden-
tifi cation of a cystic duct and CBD.
Conclusions: Our results suggest that IOC should be per-
formed for patients with choledocholithiasis whose stones 
were removed endoscopically prior to surgery.
P-188
TGFB1-DEPENDENT EPITHELIA-
MESENCHYMAL TRANSITION INDUCES 
CHOLANGIOCARCINOGENESIS AND 
REPRESENTS AN INDEPENDENT 
PROGNOSTIC FACTOR OF PATIENTS 
WITH INTRAHEPATIC 
CHOLANGIOCARCINOMA AFTER 
HEPATECTOMY
T-S. Yeh1 and T. C. Chen2
Department of Surgery and Pathology, Chnag Gung 
Memorial Hospital, Chang Gung University, Taipei
Backgrounds: Several lines of evidence indicate that epi-
thelia-mesenchymal transition (EMT) pivotally affects tumor 
invasion, progression and metastasis of several solid cancers; 
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whereas the role of EMT in cholangiocarcinoma needs to be 
investigated in depth.
Materials and Methods: Thioacetamide-induced cholan-
giocarcinoma rat model was established, and at different time 
periods the rats were sacrifi ced to represent dysplasia, early 
cancer and advanced stage of cholangiocarcinoma, respec-
tively. Three cholangiocarcinoma cell lines (HuCCT1, TFK 
and TGBC) were used. The cancer cell lines were treated 
with TGFβ1, TGFβ1 + TGFβRII, and vehicle, respectively. 
Epithelial phenotypes (E-cadherin and β-catenin) and mes-
enchymal phenotypes (Snail, Twist and vimentin) were 
determined using imminohistochemistry and immunocyto-
chemistry, respectively on the rat model and cell lines in 
vitro, respectively. A total of 143 patients with intrahepatic 
cholangiocarcinoma undergone intended curative hepatec-
tomy were enrolled. The clinicopathological parameters and 
long-term outcomes were reviewed. Expression of Snail and 
vimentin on these 143 surgical specimen were determined 
using immunohistochemistry. Univariate and multivariate 
analysis of the prognostic factors including clinicopathologi-
cal parameters, and Snail and vimentin, were performed.
Results: EMT was consistently observed in cholangiocarci-
noma rat model in steps. TGFβ1 promotes EMT of three 
cholangiocarcinoma cell lines; whereas TGFβ1 antagonist, 
TGFβRII, effectively inhibits EMT. Finally, Snail and 
vimentin emerged as an independent prognostic factor 
of patients with intrahepatic cholangiocarcinoma after 
hepatectomy.
Conclusion: TGFβ1-dependent EMT is strongly associated 
with development and invasiveness of cholangiocarcinoma. 
Expression of Snail and vimentin in intrahepatic cholangio-
carcinoma indicated poor prognosis.
P-189
BILIARY RE-RECONSTRUCTION IN 
PATIENTS WITH BILIARY DISEASE
Y. Yoshida, T. Ajiki, K. Ueno, H. Sawa, I. Ohtsubo, 
S. Murakami, K. Shinozaki, M. Kido, I. Matsumoto, 
T. Fukumoto, Y. Hori Y and Y. Ku
Department of Surgery, Division of Hepato-Biliary-
Pancreatic Surgery, Kobe University Graduate School of 
Medicine, Kobe, Japan
Introduction: Performing repeated biliary reconstruction in 
patients with biliary disease is complicated because of the 
possibility of increased intraoperative blood loss resulting 
from adhesions around the hepatic portal region, as well 
as anastomotic leakage caused by bile duct ischemia. We 
report our experience with cases who underwent biliary re-
reconstruction to examine its feasibility and describe their 
postoperative courses.
Methods: Between 2000 and 2010, eight patients under-
went biliary re-reconstruction in our institute. The male/
female ratio was 2/6, and the mean age was 61 years (30–77). 
The reasons for the 1st surgery were as follows, 4 congenital 
biliary dilatation, 3 cholangiocarcinoma and 1 bile duct stric-
ture. The reasons for the secondary surgery were as follows; 
2 hilar cholangiocarcinoma, 1 distal cholangiocarcinoma, 1 
recurrent IPNB, 2 intrahepatic gallstones and 2 bile duct 
strictures.
Results: Hepatectomy (1 right hx, 2 left hx) was performed 
in 3 cases, and re-hepatico or re-choledo-jejunostomy 
without hepatectomy was performed in 5 cases. Mean opera-
tive time was 519 ± 133 min (237–781), mean blood loss 
was 1296 ± 555 ml (205–2291) and mean hospital stay was 
26 ± 8.3 days (18–98). Postoperative complications included 
2 anastomotic leakages, 1 intra-abdominal abscess, 3 SSI and 
3 cholangitis, and all cases improved with conservative 
therapy. All cases are still doing well without any recurrence 
of anastomotic stenosis.
Conclusions: A second surgery in patients with biliary 
reconstruction is likely to result in longer operative time and 
increased blood loss because of the complexity of the surgi-
cal procedure. However, it may be safe without serious 
complications.
P-189a
COMPARISON OF CLINICAL RESULT 
BETWEEN EARLY LAPAROSCOPIC 
CHOLECYSTECTOMY AND DELAYED 
LAPAROSCOPIC CHOLECYSTECTOMY 
AFTER PERCUTANEOUS 
TRANSHEPATIC GALLBLADDER 
DRAINAGE (PTGBFD) IN MORE THAN 70 
YEARS OLD PATIENTS WITH ACUTE 
CHOLECYSTITIS
K. M. Chae, G. O. Jung, J. T. Oh and D. E. Park
Department of Surgery, Division of Hepatobiliary Surgery, 
Wonkwang University School of medicine
Background: operative management of acute cholecytitis 
in old age patients has been showed relatively higher morbid-
ity and mortality. Aim of This study was to analyze appropri-
ate management for an acute cholecystitis in more than 70 
years old.
Patients and Method: From May. 2003 to Dec. 2009, we 
performed this study with more than 70 years old patients 
that was diagnosed acute cholecystitis. (n = 257). We 
excluded patients that have a hepatobilliary malignancy, pre-
viously laparotomy history, secondary cholecystitis, and high 
operative risk factor (n = 78). We divided into two groups 
according to the fi rst management of an acute cholecystitis. 
One hundred two of 179 (group A) had undergone a laparo-
scopic cholecystectomy (LC) or open cholecystectomy (OC) 
within 48 hr after arrived emergency room and 77 of 179 
(group 2) was performed PTGBD as fi rst management. We 
divided group 2 into group C (n = 47) and D (n = 30) accord-
ing to trying cholecystectomy or not. We compared to clini-
cal outcome with two groups.
Result: The mean age of patients was 77.5 years old. Group 
A and B were 102 and 77, respectively. Univariant analysis 
of pre-operative clinical fi nding between group A and B 
showed only statistically difference in age, type of acute 
cholecystitis, However, pre-operative co-morbidity of group 
B showed signifi cantly higher than group A. In postoperative 
results between group A and C, a postoperative complica-
tions and open conversion rate, mortality after cholecystec-
tomy were not difference.
Conclusion: PTGBD could be considered as appropriate 
management in old age patients with acute cholecystitis. 
Moreover, PTGBD could be reducing unnecessary 
cholecytectomy
Key word: Acute cholecystitis, old age patients, percutane-
ous transhepatic cholecystostomy, early laparoscopic chole-
cystectomy, delayed laparoscopic cholecystectomy
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EARLY RESULTS OF BINDING 
PANCREATICOJEJUNOSTOMY
S. Ahn, K. Lee and W. Shin
Department of Surgery, Inha University hospital, Incheon, 
Korea
Introduction: The post-operative complication and clinical 
course of the pancreaticoduodenectomy largely depend on 
the pancreaticojejunostomy. The several methods of pancre-
aticojejunostomy are clinically used. We analyzed the early 
results of binding pancreaticojejunostomy.
Method: The 21 binding pancreaticojejunostomy were per-
formed at Inha university Hospital from 2006 to 2009. We 
analyzed the clinical result of binding pancreaticojejunos-
tomy retrospectively.
Result: The sex of the 21 patient were 11 male and 10 
female. The average age the patient was 61 years old. The 
bindig pancreaticojejunostomy were applied to 4 Whipple’s 
procedures and 17 pylorus preserving pancreaticoduodenec-
tomies. The causative diagnosis were 3 pancreatic head 
cancer, 5 distal common bile duct cancer, 8 Ampulla of Vater 
cancer, 2 duodenal tumor, 2 chronic pancreatitis and 1 duo-
denal trauma. The consistency of the pancreatic parenchyme 
was soft in 15 cases and hard from chronic pancreatitis in 6 
cases.
According to the post-operative course, 16 cases recovered 
well and didn’t experience any complication. But, 5 cases 
(23.8%) suffered leakage from pancreaticojejunostomy. 2 
cases of them received distal pancreatectomy due to sustained 
pancreatic fi stula and bleeding. 1 case of them expired 
because of intraperitoneal abscess and multi-organ failure.
Conclusion: The binding pancreaticojejunostomy seems to 
be a relatively safe procedure, but the further study is 
required for validating the safety.
P-191
NOVEL PANCREATO-ENTERIC 
RECONSTRUCTION WITH 
BIOABSORBABLE POLYMER SHEET 
AND BIOCOMPATIBLE BOND
A. Masayasu, M. Mitsuo, O. Katsuya, T. Yasuko, O. Kojun 
and K. Isamu
Saitama Medical University International Medical Center, 
Gastrointestinal Center 1397–1 Yamane Hidaka, Saitama, 
Japan
Introduction: Pancreato-enteric reconstruction (PER) often 
induces severe complications because of pancreatic juice 
leakage. The leakage of pancreatic juice is mostly caused by 
pancreatic damage by the suture needle. Our group invented 
a novel method for PER by sutureless anastomosis using a 
bioabsorbable polymer sheet (BAPS) and biocompatible 
bond (BCB). In this study we used animals to investigate 
whether this method is available for clinical use.
Methods: Hybrid pigs were laparotomized under general 
anesthesia. The body of the pancreas was divided and the 
cranial stump was closed by suture. A BAPS coated with 
BCB was rolled and fi xed around the caudal pancreatic 
stump into a cylinder and anastomosed to the duodenal side 
wall without suturing the pancreas. The BCB was composed 
of a cross-linking agent synthesized from organic acid and a 
biological polymer confi rmed to be of high-strength and low 
toxicity in clinical use. The BAPS was composed of poly-
lactic acid and polycaprolactone. Ten weeks after the opera-
tion, the pigs were re-laparotomized.
Results: All of the operated pigs survived until sacrifi ce 
without pancreatic juice leakage or intra-abdominal infec-
tion. The pancreatic stump was tight on the duodenum. Part 
of the pancreas was observed in the duodenal lumen. The 
histological study revealed that the pancreatic stump and 
duodenal wall were continuous and that the main pancreatic 
duct opened into the lumen of the duodenum in spite of the 
profuse infi ltration of infl ammatory cells.
Conclusion: We propose that our method of sutureless PER 
with BAPS and BCB may be feasible for clinical use.
P-192
THE FEASIBILITY OF LAPAROSCOPIC 
RESECTION WITH PANCREATIC 
NEUROENDOCRINE TUMORS (PNETS): A 
SINGLE INSTITUITIONAL EXPERIENCE
S. H. Choi, D. W. Choi, J. S. Heo, M. J. Kim, H. J. Park 
and K. K. Choi
Samsung Medical Center, Seoul, Korea
Introduction: Pancreas neuroendocrine tumors (PNETs) 
are usually small, benign or low-grade malignant neoplasms 
with good prognosis. Laparoscopic approach has been 
increasingly used in the treatment of pancreatic diseases, 
though its actual effectiveness and feasibility remains 
debated. This study was aimed to determine the role of lapa-
roscopic operation for PNETs.
Methods: From Jan. 2007 to Mar. 2010, 36 patients with 
PNETs who underwent curative pancreatic resection in 
Samsung Medical Center were reviewed retrospectively. 
Operative procedures in this study were limited to enucle-
ation and distal pancreatectomy. The patients’ clinicopatho-
logic characteristics, operative outcomes, and follow-up data 
were analyzed based on medical records and telephone 
survey.
Results: Laparoscopic pancreatic resection was performed 
in 17 patients and open surgery in 19 patients. Post-operative 
and long term results were similar in the patients who under-
went laparoscopic and open surgery; sex, age, pre-operative 
symptom, hormonal status and tumor marker. The tumor was 
located more distal part in the laparoscopic operation group 
(p = 0.008). And the tumor size was more larger in the lapa-
roscopic group (p = 0.022). Nevertheless post-operative 
complication and long term results did not different between 
two groups. One 5 cm sized tumor with a malignant PNET 
in laparoscopic surgery group suffered recurrence. However, 
this patient remain alive with radiofrequency ablation 
treatment.
Conclusions: Laparoscopic pancreatic resection is a safe 
and effective for well-selected benign PNETs. Tough if the 
tumors larger than 5 cm or has malignant features, more 
extensive open surgery is recommended.
Keywords: Pancreatic neuroendocrine tumor, Pancreas, 
Laparoscopic operation
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HEMATOLOGICAL CONSEQUENCES OF 
CYTOKINES OVEREXPRESSION IN 
SEVERE ACUTE PANCREATITIS
S. Chooklin and A. Pereyaslov
Medical University, Lviv, Ukraine
Introduction: Hematological changes and overexpression 
of various cytokines are typical for the severe course 
of pancreatitis. The goal of this study was to evaluate the 
hematological changes with the relation to cytokines’ 
expression.
Materials and Methods: The plasma levels of IL-17, 
IL-18, and ICAM-1 were measured at the time of admission, 
3rd, and 7th day in 43 patients with severe acute 
pancreatitis.
Results: During fi rst week the levels of IL-17 and IL-18 
gradually increased in patients with severe pancreatitis, 
while peaked levels of ICAM-1 were observed at the time of 
admission with the subsequent decrease during all period of 
observation. The IL-17 levels clear correlated with the quan-
tity of total leukocyte, polymorphonuclear leukocytes and 
hemoglobin level. The clear strong correlation was observed 
between IL-18 and quantity of circulating granulocytes in 
patients with necrotizing pancreatitis. Serum ICAM-1 cor-
related number of band neutrophils and hematocrite.
Conclusions: IL-17 and Il-18 have prominent proinfl amma-
tory properties due to the induction numerous genes that 
associated with infl ammation, such as IL-1β, IL-6, TNF-
alpha, and GM-CSF. Hematological effects of IL-17 and 
IL-18 may connect with its ability induced the GM-CSF 
expression which also enhanced in severe pancreatitis.
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INFECTED NECROTIZING 
PANCREATITIS
S. Chooklin and O. Hranat
Bihalskyy Medical University, Lviv, Ukraine
Objectives: Among a wide spectrum of acute pancreatitis 
problem, the special value gets fi nding-out of the infectious 
factor, which result to development of the infected 
pancreatonecrosis.
Materials and Methods: We studied 34 patients with 
severe acute pancreatitis. We investigated a microbial spec-
trum in tissues and fl uid formations.
Results: In frame of the verifi ed microfl ora the basic place 
occupied aerobic enterobacter, and also anaerobic bacteria. 
Analysis of presence of monocultures show, that domination 
aerobic-anaerobic associations, what in a combination of two 
bacteria and aerobic monoculture. In signifi cant part of the 
patients observed a fl ora polyresistance to antibiotics. From 
the moment of apposition of the infectious factor and 
throughout all period of disease the microfl ora with aerobic 
metabolism and aerobically-anaerobic associativity prevails. 
For the tissue was typical contaminative gram-negative 
agent, mainly on the third week of disease with Escherichia 
coli, Pseudomonas aeruginosa and Enterobacter aerogenes 
domination. The becoming infected of not mature fl uid col-
lections descended mainly aerobic gram-negative fl ora, 
however in short terms – on the second week of acute pan-
creatitis. The infectious factor of the mature fl uid collections 
was represented by aerobic-anaerobic associations with 
domination of gram-negative. Composition of aerobic-anaer-
obic associations of microfl ora is presented in overwhelming 
quantity by two bacteria.
Conclusion: Index of frequency of revealing of anaerobic 
associativity Enterococcus spp. and Enterobacter aerogenes 
allows estimating them as microbes-indicators of aerobic-
anaerobic becoming infected.
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BILIARY INTRADUCTAL PAPILLARY 
MUCINOUS NEOPLASIA: A REVIEW
M. Devadas1, M. Stilianos1, J. Laurence1,2, A. Richardson1,2, 
E. Johnston1, M. Hollands1, V. Lam1,2 and H. Pleass1,2
1Department of Surgery, Westmead Hospital, Sydney, 
Australia; 2Discipline of Surgery, Sydney Medical School, 
Sydney, Australia
Introduction: Biliary intraductal papillary mucinous neo-
plasm (B-IPMN) is a rare tumor that is characterized by 
growth within the bile ducts and increased production of 
thick mucinous fl uid by the tumor cells. The purpose of this 
research was to review the current literature to gain an under-
standing of the presentation, prognosis, pathology and treat-
ment of this tumor.
Methods: Databases such as PubMed and Medline were 
searched. Relevant papers were identifi ed and assessed with 
relevant information extracted.
Discussion: Clinically, the most common presenting com-
plaint is right hypochondralgia. However it may also be 
discovered incidentally or with obstructive jaundice with or 
without biliary sepsis. Biliary IPMN often occurs in the 
context of chronic biliary disease and/or previous biliary 
surgery. Radiological studies demonstrate that often 
biliary dilatation is usually the only imaging fi nding in 
biliary IPMN. Prognosis seems to be determined, and as is 
the case in other tumors, by size, location and resectability4. 
Factors associated with a worse median survival included 
depth of invasion, R1 vs R0 resection, MUC1 expression 
(shorter survival if positive), and CEA expression (shorter 
survival if positive)5. Barton et al. reported the 5 year sur-
vival rate for B-IPMN is 38% after resection2.
Conclusion: Biliary intraductal papillary neoplasm is a rare 
tumor. Its presentation can vary widely from abdominal pain, 
jaundice, fevers, disseminated disease or be found inciden-
tally. Research tends to indicate early complete surgical 
resection is the currently accepted treatment however this 
may be challenged by the fact that early B-IPMN is not a 
malignant process and expectant management may be more 
appropriate.
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SAFETY OF EXTENSIVE RESECTIONS IN 
PATIENTS WITH BORDER-LINE 
RESECTABLE PANCREATIC CANCER
V. I. Egorov, V. A. Vishnevsky, T. V. Shevchenko, 
O. V. Melekhina, R. V. Petrov, I. A. Kozyrin 
and Z. A. Kovalenko
Vishnevsky Institute of Surgery, Moscow, Russia
Introduction: The safety of extensive pancreatic resection 
in patients with locally advanced malignant pancreatic 
tumors is still being studied.
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Objective: To estimate the safety of total duodenopancre-
atectomy (TDP) and corporocaudal resection with celiac axis 
and its branches excision (modifi ed Appleby operation) in 
patients with locally advanced malignant pancreatic tumors.
Method: Analysis of complications and mortality rates after 
16 TDPs and 5 modifi ed Appleby operations in patients 
(mean age 54 ± 4.4∼52 ± 3.2 years) with locally advanced 
for malignant pancreatic tumors (2009–2010).
Results: According to CT and endoUS data tumors were 
considered borderline-resectable in 16 cases (76.1%). The 
resections of portal and/or superior mesenteric vein with 
direct veno-venous anastomosis or autovenous prosthesis 
were performed in 43.7% of TDPs and 40% of Appleby 
procedures, marginal vein excision in 12.5% and 60% 
respectively. Average operating time was 544 ± 152 vs 530 
± 120 min, average blood loss-1150 ± 152 ml vs 880 ± 
560 ml, complication rate – 37.5% and 40% respectively. 
Relaparotomy was performed in 3 patients (18.7%) for 
wound dehiscence (2) and autovenous prosthesis thrombosis 
after TDP and in 1 patient (20%) with arrosive hemorrhage 
after Appleby operation. Average hospital stay were 30.7 ± 
12.6 and 32 ± 10 days. One patient died of sepsis on the 65th 
day after Appleby operation.
Conclusion: TDP and modifi ed Appleby operation showed 
acceptable complication and mortality rates in patients with 
border-line resectable pancreatic malignancy, which allow 
using these modalities as a radical and palliative treatment.
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SHORT-TERM RESULTS OF TOTAL 
DUODENOPANCREATECTOMIES, 
STANDARD AND EXTENSIVE 
PANCREATICODUODENECTOMIES IN 
PATIENTS WITH MALIGNANT 
PANCREATIC TUMORS
V. I. Egorov, O. V. Melekhina, V. A. Vishnevsky, 
T. V. Shevchenko, R. V. Petroff, I. A. Kozyrin, 
Z. A. Kovalenko and S. O. Zagagov
Vishnevsky Institute of Surgery, Moscow, Russia
Introduction: To estimate short-term results of total duode-
nopancreatectomies (TDP), standard (SPD) and extended 
pancreatoduodenectomies (EPD) for malignant pancreatic 
tumors.
Methods: Prospective analysis of the short-term results of 
114 pancreatectomies for malignant pancreatic tumors 
(2005–2010).
Results: 16 TDP, 50 SPD and 48 EPD were performed for 
ductal adenocarcinoma (96), neuroendocrine cancer (9), 
intraductal papillary mucinous carcinoma (8) and renal cancer 
metastases (1). All the TDPs were undertaken for tumor 
involvement of more than one anatomical part of the pancreas. 
Portal and/or superior mesenteric vein resection were per-
formed in 4 SPDs (8%), 15 EPDs (31.2%), and 9 TDPs 
(56.2%), average amount of removed lymph nodes was 16, 
28 and 34, R0-resection was done in 30 (60%), 39 (81%) and 
14 (87.5%) cases. The average blood loss was 1225 ± 818 ml, 
1445 ± 1043 ml and 1150 ± 952 ml, mean operating time 
−405 ± 115 min, 511 ± 73 min and 544 ± 152 min respec-
tively, hospital stay was 21.8 ± 10.9, 21.9 ± 6.9 and 30.7 ± 
12.6 days. Overall complication and mortality rates were 60% 
and 6%, 54% and 6%, 37.5% and 0% correspondingly.
Conclusions: TDPs and EPDs performed in specialized 
department are as safe as SPD and can be standard modalities 
for malignant pancreatic tumors treatment to achieve the 
level of R0-R1 resection.
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EFFECT OF PANCREATIC STENT 
REMOVAL TIME ON PANCREATIC DUCT 
PATENCY IN DILATED PANCREATIC 
DUCTS
N. Fukino1, T. Oida1, K. Mimatsu1, H. Kano1, 
A. Kawasaki1, Y. Kuboi1, K. Kida1 and S. Amano2
1Department of Surgery, Social Insurance Yokohama 
Central Hospital, Yokohama, Japan; 2Department of 
Surgery, Nihon University School of Medicine, Tokyo, 
Japan
Introduction: Anastomotic stenosis develops after pancre-
aticoduodenectomy (PD) performed along with pancreatico-
gastrostomy (PG), and this stenosis is attributed to acute 
infl ammation and fi brosis around the anastomosis. We evalu-
ated the early postoperative changes in the diameter of the 
remnant pancreatic duct in patients with a mildly dilated 
pancreatic duct in terms of the time of removal of the pan-
creatic stents.
Methods: We retrospectively analyzed the cases of 70 
patients with a mildly dilated pancreatic duct (diameter, 
4–7 mm) who had undergone PD with PG. They were 
divided into 2 groups depending on the time of removal of 
the pancreatic stents: early removal group (Group E) and late 
removal group (Group L).
Results: The mean and the rate of change in the pancreatic 
duct did not show a signifi cant differences between the 2 
groups.
Conclusions: Development of post-PG pancreatic anasto-
motic strictures in patients with a mildly dilated pancreatic 
duct is independent of the time of removal of the pancreatic 
stents.
P-199
NOTES CHOLECYSTECTOMY
S. Gupta, S. Kumar and G. S. Brar
Departments of Surgery & Gynaecology, Dayanand 
Medical College and Hospital, Ludhiana, Punjab, India
Introduction: Natural orifi ce transluminal endoscopy 
surgery is a ideal technique that aim at reducing skin incision 
and post operative care. The purpose of this study was to 
analyze operative and long term results of a series of hybrid 
transvaginal cholecystectomy.
Methods: Between May 2007 & March 2011, transvaginal 
NOTES cholecystectomy for symptomatic cholelithiasis was 
performed using conventional instruments by a hybrid tech-
nique in 45 women. Mean age was 52 years.
Results: There was no major complication during transvagi-
nal approach with 3 conversions. The overall mean duration 
of the procedure was 70 minutes. The mean follow up was 
12 months ranging from 3–24 months and none of the 
patients have complained of dyspareunia or other vaginal or 
pelvic complication.
Conclusion: Hybrid Transvaginal cholecystectomy is a safe 
and cosmetically better approach with minimal post opera-
tive discomfort. It can be performed in surgical setting where 
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laparoscopy is practised regularly, using conventional 
instruments.
P-200
A RARE CASE: SOLID VARIANT 
MALIGNANT SEROUS CYSTADENOMA 
OF THE PANCREAS
S. S. Han, S. D. Lee, S. J. Park, Y. K. Kim, T. S. You, 
S. H. Kim, Y. H. Ko and E. K. Hong
Center for Liver Cancer, National Cancer Center, Republic 
of Korea
Introduction: We report a fi rst case of the solid variant 
subtype of the pancreas serous cystadenoma with invasive 
growth.
Method: The tumor presented in 56-year-old man without 
symptom. Computed tomography revealed 2.1 cm sized 
hypervascular mass in the tail of the pancreas. Laparoscopic 
distal pancreatectomy was performed.
Results: Gross examination of the resected specimen 
showed a 2.5 × 2.0 × 1.3 cm sized solid mass with peripan-
creatic infi ltration including splenic vein. The tumor was 
composed of thick fi brous bands without hemorrhage and 
necrosis. Histologic examination of the pancreas showed a 
solid neoplasm composed of compactly arranged glandular 
structures of cuboidal or polygonal cells, many of which had 
clear cytoplasm. A periodic acid Schiff’s (PAS)-glycogen 
stain was weakly positive in the cytoplasm. Nuclei were 
small and round, darkly stained by hematoxylin. Mitoses, 
cytologic atypia, or papillary growth pattern were not identi-
fi ed. However, there was aggressive invasion into the peri-
pancreatic tissue including perioneural area and splenic vein. 
Immunohistochemical staining revealed that tumor cells 
were positive for CK7, CK19, MUC-6 and negative for 
synaptophysin.
Conclusions: Solid serous adenoma of the pancreas is the 
rarest subtype with only 11 cases published and all of them 
revealed benign lesion. However, oncologic surgeons should 
be aware of the possibility of malignant transformation like 
this case.
P-201
PREDICTORS OF MORTALITY IN 
SEVERE ACUTE PANCREATITIS
M. K. Hinduja, T. D. Yadav, R. Kochhar, R. Singh 
and P. Sinha
PGIMER, Chandigarh, India
Introduction: Mortality in patients with severe acute pan-
creatitis (SAP) is associated various clinical, investigational 
and treatment factors.
Methods: 66 patients of SAP were studied prospectively 
between January 2009 and June 2010 for clinical features, 
lab parameters, Ranson’s and APACHE II scores and CT 
severity index. Factors affecting mortality were analyzed. All 
patients were managed with prophylactic antibiotics, nasoje-
junal/parenteral nutrition and supportive care. Necrosectomy 
was done for persistent organ failure, infected necrosis and 
clinical deterioration.
Results: Of the 66 patients (45 males, age 13–84 years, 
etiology: 31 alcohol, 24 gallstones and 9 others), 21 under-
went percutaneous catheter drainage and 16 underwent 
necrosectomy. 16 patients died, of whom 12 had been oper-
ated. On univariate analysis factors associated with mortality 
were: obesity (p = 0.001), number of comorbidities (p = 
0.001), duration of pancreatitis (p = 0.001), serum bilirubin 
(p = 0.001), base defi cit, (p = 0.001) CT severity index of 
>7 (p = 0.001), extent of necrosis (p = 0.001) at admission, 
Ranson’s score at 48 h (p = 0.001), APACHE II score at 
admission (p = 0.001), number of organ failures (p = 0.001), 
need of surgery (p = 0.001) and post-operative enteric fi stula 
(p = 0.001). On multivariate analysis, base defi cit, serum 
bilirubin and need for surgery at admission were found to be 
independent predictors of mortality.
Conclusions: Factors at admission correlating with mortal-
ity were comorbidities, APACHE II and CTSI scores, multi-
organ failure, high serum bilirubin and high base defi cit. 
Patients managed conservatively survived more often than 
those operated.
P-202
SIMPLIFIED CRITERIA TO PREDICT 
THE SEVERITY OF GALL STONE 
PANCREATITIS
N. P. Jain, S. Budhiraja and R. pal Babra
Dayanand Medical College & Hospital, Ludhiana, India
Introduction: Multiple criteria have been suggested to 
predict the severity of gall stone pancreatitis. We have 
studied RBS >150 at the time of admission as the single 
criteria to predict the severity of pancreatitis and as a guide 
for intensive monitoring of the patient.
Material & Methods: The prospective study was per-
formed on 81 patients with gall stone pancreatitis. The 
random blood sugar levels at the time of admission was 
considered as criteria to study the prognosis. To validate the 
role of RBS, white blood cell count, blood urea nitrogen and 
pulse rate were also recorded in predicting the severity of 
gall stone pancreatitis at admission. Biliary Ranson ≥3, mod-
ifi ed Imrie ≥3, and APACHE II score, and new criteria of 
RBS >150 were studied and compared using Z-test. P < 0.05 
was considered statistically signifi cant.
Results: APACHE II >5 and RBS >150 had sensitivity of 
88.4%, which was comparable to Biliary Ranson ≥3, modi-
fi ed Imrie ≥3 sensitivity of 96.15 and 96.4 respectively.
Conclusion: RBS >150 can be used as a simplifi ed indicator 
at admission with gall stone pancreatitis and is comparable 
to Biliary Ranson ≥3, modifi ed Imrie ≥3, and APACHE II 
score.
P-203
AN EXAMPLE OF METASTATIC 
PANCREAS CANCER FROM KIDNEY 
CANCER
Y. Kawashima, T. Hisaka, H. Nogita, H. Ishikawa, 
M. Yasunaga, H. Horiuchi, H, Kinoshita and K. Shirouzu
Kurume University School of Medicine Department of 
Surgery, Kurume City, Japan
The patient was 71-years old woman. There is no main 
complaint. We have a pancreas tumor pointed out in CT 
during follow-up for diabetes with internal secretion internal 
medicine.
Two places of masses were detected in a pancreas 
body and tail and, in abdominal contrasting CT, were a mass 
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contrasted faintly. It was not typical pancreatic cancer 
views.
There is no paraaortic lymph node swelling, too. The supe-
rior mesenteric artery permeation is absent, too. An ascitic 
pear. An examination for ERCP showed the stoppage of the 
pancreatic duct in a pancreas body. It was classII by pancre-
atic juice paratripsis cytodiagnosis. There were negative spot 
by the examination of PET. The rise of the pancreatic cancer 
tumor marker was absent, too.
There were not abnormal fi ndings by upper and lower 
digestive tract endoscopy.
A systemic close inspection showed light mass shadow in 
lower right lung fi eld. However, in July, 2006, the right 
cancer of kidney has history of right kidney extraction, but 
is followed up without increase of the size to date for approx-
imately four years from the time. A neuroendocrine tumor 
pancreatic was diagnosed.
We performed Distal pancretaomy (splenic merger exci-
sion) D2 on October 21, 2010.
Tumor showed two places in a pancreas body and a 
tailpiece in pathology results after an operation. We 
were histopathological, and pancreatic metastasis from 
cancer of kidney was diagnosed. The lymph node which we 
resected did not have the metastasis. The postoperative 
course is good and becomes the discharge after an operation 
in 18 days.
A summary: We experienced 1 excision case of the pancre-
atic metastasis after cancer of kidney technique.
In the distant metastasis of the cancer of kidney, there are 
many lungs, a bone, a soft tissue, pancreases. We relatively 
take a pause after kidney enucleation, and, like this case, a 
metastatic focus may come out. Furthermore, we seem to 
often worsen relatively gently even if metastasis develops.
The pulmonary mass is CT, and this case is regarded as 
cancer of kidney metastases to lung for four years because 
there is hardly size increase. If the metastatic site is resect-
able in the cancer of kidney practice guidelines, excision is 
recommended. Therefore, will examine surgery in the metas-
tases to lung in future,; but a target agent molecular in the 
cancer of kidney metastatic recurrence: Sorafenib was very 
effective, and at fi rst it became treatment with sorafenib.
Discussion: We experienced 1 cancer of kidney metastases 
to pancreas excision this time. When a past includes a cancer 
of kidney history, we must examine treatment after metasta-
ses to pancreas were considered enough. A cancer of kidney 
implication, we report it including discussion from literatures 
in metastases to pancreas.
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PROGNOSTIC FACTORS AFTER 
PANCREATICODUODENECTOMY IN 
PERIAMPULLARY ADENOCARCINOMA: 
NODAL METASTASIS MORE 
INFLUENCING PROGNOSTIC FACTOR 
THAN CANCER LOCALIZATION
T. Komokata, Y. Shimamoto, H. Motodaka, I. Kitazono, 
K. Yoshikawa, S. Motoi and Y. Imoto
Kagoshima University, Kagoshima, Japan
Introduction: Adenocarcinomas of the distal bile duct, 
ampulla of Vater, and pancreatic head are known to have 
dismal prognosis. Pancreatic head cancer is considered to 
have more aggressive relative to the other periampullary 
carcinomas. We investigated prognostic factors after pancre-
aticoduodenectomy for periampullary adenocarcinomas to 
identify biologic behavior.
Methods: The records of all patients who underwent pan-
creaticoduodenectomy for periampullary adenocarcinoma 
between May 1984 and March 2011 at our department were 
reviewed. Demographics, treatment, and outcome/survival 
data were analyzed. Kaplan-Meier survival curves were 
created and compared by log-rank test. Multivariate analysis 
was undertaken using Cox proportional-hazards model.
Results: 80 consecutive periampullay adenocarcinomas (30 
distal bile duct, 18 ampulla of Vater, 32 pancreatic head) 
treated by pancreaticoduodenectomy were identifi ed. Overall 
5-year survival was 29.2% with a median survival of 24 
months. Pancreatic cancer histology showed the shortest 
median survival (16 months), followed by distal bile duct 
cancer (46 months) and ampullary carcinoma (56 months) (P 
< 0.0001). Potential predictors of decreased survival on uni-
variate analysis included site of origin, portal vein resection, 
intraoperative blood transfusion, nodal metastasis, micro-
scopic positive margin, lymphatic invasion, vascular inva-
sion, and neural invasion. Only nodal metastasis signifi cantly 
predicted outcome on multivariate analysis [median 19 
versus 57 months, hazard ratio (95% CI): 1.58 (1.10–2.29), 
P = 0.012].
Conclusion: Presence of lymph node metastasis predicts 
poor survival following pancreaticoduodenectmy in patients 
with periampullary adenocarcinoma, regardless of the site of 
origin.
P-205
FEASIBILITY STUDY OF S-1 IN 
RESECTED BILIARY TRACT CANCER
M. Konishi and K. Nkachi
National Cancer Center Hospital East, Japan
Background: There is no establish standard adjuvant che-
motherapy following surgery for biliary tract cancer (BTC). 
Some phase 2 studies of S-1 for advanced BTC showed high 
response rates, which are anticipated to be better perfor-
mance than GEM. The purpose of this study is to assess the 
feasibility of chemotherapy with S-1 following surgery for 
BTC.
Methods: A multicenter phase 2 study was designed. The 
criteria for eligibility were histologically proven BTC of 
stage 1B ∼ 3 and accomplishment of macroscopically cura-
tive resection. Administration of S-1 was started within 10 
weeks after surgery and continued for 6 months. The treat-
ment regimen consisted of 6-week cycles in which, 80 mg/
m2/day was given for 4 weeks. Primary end point was treat-
ment compliance. When rate of treatment completion (actual 
S-1 dose/intended S-1 dose >75%) is over 50%, this treat-
ment is recognized as feasible.
Results: Thirty three patients enrolled in this study until 
February, 2011. The primary tumor sites were as follows; 
gallbladder (n = 5), intrahepatic bile duct (n = 4), extrahe-
patic bile duct (n = 16), and ampulla of Vater (n = 8). 
Operative procedures consisted of pancreatoduodenectomy 
(n = 20), major hepatectomy (n = 8), and minor hepatectomy 
(n = 5). Curability and tumor stage were as follows; R0 (n = 
29), R1 (n = 4), stage1B (n = 7), stage2A (n = 5), stage2B 
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(n = 15), and stage3 (n = 6). The last patient is going to fi nish 
the treatment on August, 2011. We will soon analyze the 
primary end point and present the results.
P-206
CLINICAL OUTCOME OF PANCREATIC 
NECROSECTOMY IN PATIENTS OF 
NECROTIZING PANCREATITIS
S. Kumar, S. Budhiraja and N. P. Jain
Departments of Surgery & Medicine, Dayanand Medical 
College and Hospital, Ludhiana, Punjab, India
Introduction: Acute necrotizing pancreatitis is a cause of 
signifi cant morbidity and mortality. It represents a severe 
form of acute pancreatitis. 20%–30% patients with acute 
pancreatitis will progress to a stage of acute necrotizing 
pancreatitis. Early phase of systemic infl ammatory response 
is followed by infective complicated phase.
Methods & Results: 124 patients with established diagno-
sis of acute necrotizing pancreatitis were treated from 
January 2003 to March 2011. There were 89 males and 35 
females, with median age of 32 years (17–76). Ethanol abuse 
was (69%) the commonest cause, followed by gallstones 
(17%) and other causes (17%). Surgical procedure consisted 
of pancreatic necrosectomy with post-operative closed 
lavage. In 16% patients necrosis was sterile. Following com-
plications were encountered in post-operative period: 
Cardiovascular complications (56%), repiratory failure 
(61%), renal failure (38%). 68% patients required post-oper-
ative ventilatory support and median ICU stay was 9 (0–45 
days). Patients were operated median 32 days (6–104 days) 
after the onset of disease, as the patients were referred late. 
56% of patients developed locoregional complications, in 18 
patients diversion ileostomy was done at time of primary 
surgery. Pancreatic fi stula was the commonest complication, 
followed by entero-cutaneous fi stula, biliary fi stula and sec-
ondary hemorrage. There was overall mortality of 36%.
Conclusions: Necrosectomy and post-operative continuous 
lavage is a safe and effective method for acute necrotizing 
pancreatitis. Two to four weeks is the best time for necrosec-
tomy to be performed for better outcome.
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RUPTURED PSEUDOANEURYSM OF THE 
SPLENIC ARTERY COMPLICATING 
CENTRAL PANCREATECTOMY
L. P. Lefter1,2, D. K. Chang1,2, A. Das1, A. Biankin1,2 
and N. D. Merrett1,2
Lidcombe-Bankstown Hospital1; Garvan Institute for 
Medical Research2, Darlinghurst, Sydney, NSW, Australia
Introduction: Massive arterial hemorrhage is, although 
unusual, a life-threatening complication of major pancreato-
biliary surgery. Splenic artery pseudoaneurysm (SAP) is 
uncommon but a known complication of pancreatitis and 
blunt abdominal trauma.
Method: A 39-year-old female patient was referred to our 
hospital for an elective operation for an isthmus pancreatic 
endocrine tumor. Postoperative course marked by a hypovo-
lemic shock on day 14. On a computed tomography, actively 
bleeding site from a splenic pseudoaneurysm has been identi-
fi ed. On exploratory laparotomy, a ruptured SAP was con-
fi rmed and treated by ligation of the both ends of splenic 
artery.
Results: The successful management of intraperitoneal 
bleeding from a ruptured SAP is reported here. Literature on 
iatrogenic SAP is reviewed.
Conclusion: To our best knowledge, we report herein the 
fi rst case of ruptured SAP following central pancreatectomy 
(CP) for a benign lesion.
P-210
DELAYED GASTRIC EMPTYING AFTER 
MSSPPD: ANTECOLIC VS RETROCOLIC 
ROUTE
T. Oida1, K. Mimatsu1, K. Kano K1, A. Kawasaki1, 
N. Fukino1, K. Kida1, Y. Kuboi1, H. Miyake2 
and S. Amano3
1Department of Surgery, Social Insurance Yokohama 
Central Hospital, Yokohama, Japan; 2Department of 
Surgery, Kasukabe Municipal Hospital, Kasukabe, Japan; 
3Department of Surgery, Nihon University School of 
Medicine, Tokyo, Japan
Introduction: Previously, we developed a modifi ed subtotal 
stomach-preserving pancreaticoduodenectomy for prevent-
ing delayed gastric emptying achieved a decrease in the 
incidence of delayed gastric emptying. In this study, we 
compared the antecolic and retrocolic routes to determine 
which reconstruction route is better for decreasing the inci-
dence of delayed gastric emptying in modifi ed subtotal 
stomach-preserving pancreaticoduodenectomy.
Methods: We retrospectively analyzed 42 patients who 
underwent modifi ed subtotal stomach-preserving pancreati-
coduodenectomy with pancreaticogastrostomy. The patients 
were divided into 2 groups based on type of reconstruction: 
the antecolic reconstruction group and the retrocolic recon-
struction group. The incidence of delayed gastric emptying 
was determined and compared between the 2 groups.
Results: The mean time during nasogastric suction and 
before initiation of a diet after surgery was shorter in the 
retrocolic reconstruction group (without signifi cant differ-
ence); however, the mean time before oral ingestion of solid 
food could be safely resumed was signifi cantly shorter in the 
retrocolic reconstruction group (9.7 ± 1.2 days) than in the 
antecolic reconstruction group AC group (11.4 ± 3.0 days; 
p < 0.0112).
Conclusions: We consider retrocolic reconstruction prefer-
able to antecolic reconstruction for preventing delayed 
gastric emptying in patients who have undergone modifi ed 
subtotal-stomach-preserving pancreaticoduodenectomy with 
pancreaticogastrostomy.
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EFFECT OF PANCREATIC STENT-
REMOVAL TIME ON THE PATENCY OF 
THE REMNANT PANCREATIC DUCT IN 
SOFT PANCREAS
T. Oida1, K. Mimatsu1, H. Kano1, A. Kawasaki1, Y. Kuboi1, 
N. Fukino1, K. Kida1 and S. Amano2
1Department of Surgery, Social Insurance Yokohama 
Central Hospital, Yokohama, Japan; 2Department of 
Surgery, Nihon University School of Medicine, Tokyo, 
Japan
Introduction: Patency of the pancreaticoenteric anastomo-
sis is one of the most important factors affecting the function 
of the remnant pancreas and quality of life of the patients. 
Anastomotic stenosis after pancreaticoduodenectomy (PD) 
along with pancreaticogastrostomy (PG) is observed in some 
patients after approximately 1 to 2 postoperative weeks, and 
the stenosis is attributed to acute infl ammation and fi brosis 
around the anastomosis. Therefore, we evaluated the early 
post-PG changes in the diameter of the remnant pancreatic 
ducts in patients with soft pancreas in terms of the time of 
removal of the pancreatic stents.
Methods: We retrospectively studied 44 patients with soft 
pancreas who has undergone PD along with PG. They were 
divided into 2 groups depending on the time of removal of 
the pancreatic stents: early removal group (Group E) and late 
removal group (Group L).
Results: The pancreatic ducts of the remnant pancreas were 
dilated in all the patients in the both groups, and the mean 
diameter of the duct did not differ between the 2 groups.
Conclusion: Development of post-PG pancreatic anasto-
motic strictures in patients having soft pancreas and a pan-
creatic duct with a small diameter is independent of the time 
of removal of the pancreatic stents.
P-212
HORIZONTAL VERSUS VERTICAL 
INCISION ON THE ANTERIOR GASTRIC 
WALL IN PANCREATICOGASTROSTOMY
T. Oida1, K. Mimatsu1, K. Kano1, A. Kawasaki1, Y. Kuboi1, 
N. Fukino1, K. Kida1 and S. Amano2
1Department of Surgery, Social Insurance Yokohama 
Central Hospital, Yokohama, Japan; 2Department of 
Surgery, Nihon University School of Medicine, Tokyo, 
Japan
Introduction: Pancreaticogastrostomy during pancreatico-
duodenectomy is associated with a very low rate of anasto-
motic leakage. However, gastric peristalsis is disturbed by 
pancreaticogastrostomy, which stabilizes the posterior 
stomach at that point leading to delayed gastric emptying. We 
evaluated which anterior gastrostomy, i.e., horizontal or verti-
cal incision on the anterior gastric wall, is better for maintain-
ing peristaltic movement of the anterior stomach to prevent 
delayed gastric emptying after pancreaticogastrostomy.
Methods: We retrospectively studied 50 patients who 
underwent subtotal stomach-preserving pancreaticoduode-
nectomy with pancreaticogastrostomy. These patients were 
divided into 2 groups depending on the type of anterior 
gastrostomy: horizontal incision (H group) and vertical inci-
sion (V group).
Results: The observed grade of delayed gastric emptying 
was lower in the V group than in the H group; however, the 
difference was not signifi cant.
Conclusions: We conclude that a vertical incision on the 
anterior gastric wall is preferable for preventing delayed 
gastric emptying after a pancreaticogastrostomy.
P-213
LAPAROSCOPIC CYSTOGASTROSTOMY 
BY POSTERIOR APPROACH.
T. Oida1, K. Mimatsu1, A. Kawasaki1, H. Kano1, Y. Kuboi1, 
N. Fukino1, K. Kida1 and S. Amano2
1Department of Surgery, Social Insurance Yokohama 
Central Hospital, Yokohama, Japan; 2 Department of 
Surgery, Nihon University School of Medicine, Tokyo, 
Japan
Introduction: Internal drainage of an acute pancreatic pseu-
docyst is indicated 6 weeks after its fi rst detection. 
Laparoscopic treatment of pancreatic pseudocysts enables 
defi nitive drainage with faster recovery. Pseudocysts located 
adjacent to the posterior gastric wall are best drained by 
pseudocyst gastrostomy. Although the anterior approach for 
drainage has frequently been reported, reports on the poste-
rior approach are rare.
Methods: Seven patients underwent laparoscopic cystogas-
trostomy for pancreatic pseudocysts. The posterior approach 
that enables the direct visualization of the posterior gastric 
wall and pseudocyst was used, and the cyst was drained with 
a needle. After creating a suffi cient drainage orifi ce, the cyst 
was thoroughly debrided. Cystogastrostomy was performed 
using the posterior approach with a stapling device. The 
insertion site of the stapling device closed using a hernia 
stapler.
Results: Cystogastrostomy was performed using the poste-
rior approach with a stapling device in all patients, without 
requiring conversion to the anterior approach or open surgery. 
There were neither operative complications nor late recur-
rences during the follow-up period (median 65 months).
Conclusion: Laparoscopic cystogastrostomy using the pos-
terior approach, which facilitates adequate internal drainage, 
is a safe and feasible procedure for pancreatic pseudocyst, 
and it is not accompanied with a risk of recurrence in the 
long term.
P-214
MODIFIED CATTELL’S 
RECONSTRUCTION FOLLOWING PPPD 
WITH PG FOR GASTROPTOSIS
T. Oida1, K. Mimatsu1, H. Kano1, A. Kawasaki1, Y. Kuboi1, 
N. Fukino1, K. Kida1, H. Miyake2 and S. Amano3
1Department of Surgery, Social Insurance Yokohama 
Central Hospital, Yokohama, Japan; 2Department of 
Surgery, Kasukabe Municipal Hospital, Kauskabe, Japan; 
3Department of Surgery, Nihon University School of 
Medicine, Tokyo, Japan
Introduction: Delayed gastric emptying (DGE) is one of 
the most challenging complications of pylorus-preserving 
pancreaticoduodenectomy (PPPD). Downward displacement 
of the stomach is called gastroptosis. Patients with gastrop-
tosis have equivocal complaints such as nausea, abdominal 
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fullness, abdominal pain, and appetite loss. If PPPD is per-
formed in a patient with gastroptosis, the risk of postsurgical 
DGE may increase. Therefore, we developed a modifi ed 
Cattell’s reconstruction with PG after PPPD to prevent DGE 
in a patient with adenocarcinoma of the ampulla of Vater 
with gastroptosis.
Methods: PG was positioned in the upper area of the 
stomach. The pancreatic stump was inserted into the gastric 
lumen through a suitable posterior gastrostomy performed 
via an anterior gastrostomy. Invagination anastomosis was 
performed with 2 layers of interrupted 4–0 absorbable 
sutures. The pancreatic duct tube was brought out through 
the upper gastric wall and the abdominal wall. The anterior 
gastrostomy was then closed using GIA. Reconstruction 
after PPPD involved the following procedures in the speci-
fi ed order: PG, end-to-side choledochojejunostomy, end-
to-end duodenojejunostomy, and placement of a diverting 
jejuno-jejunostomy between the duodenojejunostomy and 
choledochojejunostomy.
Results: The patient tolerated oral intake of solid diet from 
day 5 after the surgery. She showed good recovery without 
complications and was discharged on day 13 after the 
surgery. The patient was in good health without any equivo-
cal complaints or recurrence for 13 years after the surgery.
Conclusions: This reconstructive technique might have a 
better outcome in terms of operative mortality, morbidity, 
and postoperative nutritional state in patients with 
gastroptosis.
P-215
OPEN METHOD OF PANCREATIC 
STENTING FOR PANCREATIC-DUCT 
OBSTRUCTION AFTER 
PANCREATICOGASTROSTOMY
T. Oida, H. Kano, K. Mimatsu, A. Kawasaki, Y. Kuboi, N. 
Fukino and K. Kida
Department of Surgery, Social Insurance Yokohama 
Central Hospital, Yokohama, Japan
Introduction: Pancreaticodigestive anastomotic stricture 
induces impairment of pancreatic exocrine function after 
pancreaticoduodenectomy (PD). Endoscopic inspection of 
the pancreaticodigestive anastomotic site is easier in PG than 
it is in PJ, and endoscopic dilatation is a treatment option for 
the stenosis of PG. However, surgical procedures are neces-
sitated when the stenosis complicates the catheterization of 
the canal of Wirsung and leads to failure of endoscopic dila-
tation. We have described our technique of open pancreatic 
stenting with a duct-to-mucosa anastomosis for a case which 
the stenosis of pancreaticogastrostomy (PG) could not be 
resolved by endoscopic dilatation.
Methods: A 5-cm anterior gastrostomy was made at the 
opposite site of the posterior gastrostomy. The opening of the 
gastrostomy, revealed a linear scar in the posterior gastric 
wall, and this scar was suggested to be the possible site of 
the pancreaticogastric anastomosis. The orifi ce, which was 
confi rmed by intraoperative ultrasonography, a catheter was 
inserted into the dilated pancreatic duct. A guide-wire 
was inserted into the pancreatic duct through the catheter. A 
pancreatic stent was inserted into the pancreatic duct along 
the guide-wire. Subsequently, pancreatography was per-
formed, and the proper placement of the stent was verifi ed. 
After the placement of the pancreatic stent, a duct-to-mucosa 
anastomosis was added using nonabsorbable sutures.
Results: Three months after the surgery, the patient was 
doing well without recurrence of pancreatic carcinoma, and 
DM had improved.
Conclusions: This technique dose not require re-resected 
PG or side-to-side pancreaticojejunostomy, and the proce-
dure is minimally invasive.
P-216
PANCRATICODUODENECTOMY AFTER 
20 YEARS OBSERVATION FOR 
INTRADUCTAL PAPILLARY 
NEOPLASMA OF THE PANCREAS
T. Oida1, K. Mimatsu1, H. Kano1, A. Kawasaki1, Y. Kuboi1, 
N. Fukino1, K. Kida1 and S. Amano2
1Social Insurance Yokohama Central Hospital, Yokohama, 
Japan; 2Department of Surgery, Nihon University School of 
Medicine, Tokyo, Japan
Here we report a case of branch-duct type of intraductal 
papillary mucinous neoplasm (IPMN) of the heads of the 
pancreas underwent pancreatoduodenectomy after 20 years-
follow-up. A 71-year-old man was pointed out of pancreatic 
cystic tumor at medical health check up 20 years ago. 
Annually examinations by CT and US were performed 
during follow-up, the size of the cyst did not change and 
without symptom for 15 years. The size of the pancreatic cyst 
increased gradually 40 mm in diameter at the 16-years fol-
low-up, however, there were no symptoms, and no developed 
diabetes mellitus nor pancreatitis. Endoscopic retrograde 
cholangiopancreatography was performed, and revealed that 
the main pancreatic duct dilated 5 mm in diameter, however, 
cytology from pancreatic juice revealed class α. The size of 
the pancreatic cyst decreased 15 mm in diameter at the time 
of 19-years follow-up, subsequently cytology revealed class 
β with dsyplasia. However, he has no symptoms and doing 
well, and he rejected the recommendation for surgery, and 
hoped further follow-up. At the time of the 20-years follow-
up, the size of the pancreatic cyst increased 35 mm in diam-
eter, and performed surgery. Histopathological fi ndings 
revealed adenoma, and the patient is doing well without any 
evidence of disease progression nor development of diabetes 
mellitus nor pancreatitis for 5 months. We suggested that 
branch-duct type of IPMN could be followed up under obser-
vation during a long period, even if, those who have small 
papillary protrusions. However, attention should be paid to 
the entire pancreas when performing follow-up examinations 
in patients with branch-duct type IPMN.
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P-217
PREVENTING DELAYED GASTRIC 
EMPTYING IN 
PANCREATICOGASTROSTOMY BY A 
MODIFIED SUBTOTAL-STOMACH-
PRESERVING 
PANCREATICODUODENECTOMY
T. Oida1, M. Mimatsu1, K. Kano1, A. Kawasaki1, Y. Kuboi1, 
N. Fukino1 and S. Amano2
1Department of Surgery, Social Insurance Yokohama 
Central Hospital, Yokohama, Japan; 2Department of 
Surgery, Nihon University School of Medicine, Tokyo, 
Japan
Introduction: Delayed gastric emptying (DGE) is one of 
the most troublesome complications of pylorus -preserving 
pancreaticoduodenectomy (PPPD). In Japan, since the 
1990s, subtotal-stomach-preserving pancreaticoduodenec-
tomy (SSPPD) has been performed as an alternative to 
PPPD. Here, we evaluated the effi cacy of our modifi cation 
of the original SSPPD technique as compared to PPPD with 
an aim to decrease the incidence of DGE.
Methods: We retrospectively analyzed 67 patients who 
underwent PD with pancreaticogastrostomy (PG). They were 
divided into 2 groups on their basis of the surgical treatment: 
the PPPD group and the modifi ed SSPPPD (MSSPPD) 
group. The incidence of DGE was determined and compared 
between the 2 groups.
Results: In the MSSPPD group, 98%, 2%, and 0% of the 
cases developed class A, class B, and class C DGE, respec-
tively; the corresponding values in the PPPD group were 4%, 
52%, and 44%, respectively. The incidence of DGE differed 
signifi cantly between the 2 groups (p < 0.0001).
Conclusions: We consider that our reconstruction proce-
dure is useful for preventing DGE in patients who have 
undergone SSPPD with PG.
P-218
PREVENTION OF MARGINAL ULCERS 
BY PANCREATIC JUICE
T. Oida1, K. Mimatsu1, K. Kano1, A. Kawasaki1, Y. Kuboi1, 
N. Fukino1, K. Kida1, H. Miyake2 and S. Amano3
1Department of Surgery, Social Insurance Yokohama 
Central Hospital, Yokohama, Japan; 2Department of 
Surgery, Kasukabe Municipal Hospital, Kasukabe, Japan; 
3Department of Surgery, Nihon University School of 
Medicine, Tokyo, 173–0023, Japan
Introduction: We observed that an ulcerative scar, without 
the presence of any marginal ulceration developed at the 
pancreaticogastrostomy anastomosis site. Therefore, we 
studied the effect of pancreatic juice secretion into the 
stomach on the induction of marginal ulceration after pan-
creaticoduodenectomy with pancreaticogastrostomy, accord-
ing the type of the pancreaticogastrostomy orifi ce.
Methods: We retrospectively studied 58 patients who 
underwent pancreaticoduodenectomy with pancreaticogas-
trostomy. On the basis of the classifi cation of endoscopic 
fi ndings of the pancreaticogastrostomy orifi ce, these patients 
were divided into 2 groups – A: those with a clear pancreatic 
duct orifi ce with pancreatic juice output, and B: those with 
an unclear pancreatic duct orifi ce with pancreatic juice 
output.
Results: Of the total 58 patients, only 1 (1.7%) developed 
postoperative marginal ulcers without having Helicobacter 
pylori infection; moreover, the patient belonged to group B. 
Three patients in group A were infected with H. pylori; 
although, postoperative marginal ulceration did not develop 
in these 3 patients.
Conclusions: Alkaline pancreatic juice secretion into the 
stomach may help prevent marginal ulcers that may arise 
after pancreaticoduodenectomy with pancreaticogastros-
tomy. Thus, the prevention of anastomotic stenosis is impor-
tant to maintain the output of pancreatic juice into stomach, 
which may reduce the occurrence of postoperative marginal 
ulcers.
P-219
RELATIONSHIP DELAYED GASTRIC 
EMPTYING AND PANCREATIC DUCT 
PATENCY AFTER 
PANCREATICOGASTROSTOMY FOR 
SOFT PANCREAS
T. Oida1, K. Mimatsu1, H. Kano1, A. Kawasaki1, 
N. Fukino1, K. Kida1, Y. Kuboi1, H. Miyake2 and S. Amano3
1Department of Surgery, Social Insurance Yokohama 
Central Hospital, Yokohama, Japan; 2Department of 
Surgery, Kaukabe Municipal Hospital, Kasukabe, Japan; 
3Department of Surgery, Nihon University School of 
Medicine, Tokyo, Japan
Introduction: Pancreatic duct dilatation induced anasto-
motic stenosis of the pancreatic duct is frequently observed 
in patients who have undergone pancreaticoduodenectomy 
(PD) with pancreaticogastrostomy (PG). Patency of the pan-
creaticoenteric anastomosis is one of the most important 
factors affecting the function of the remnant pancreas and 
quality of life. Anastomotic stenosis after PG is observed in 
some patients after approximately 1 to 2 postoperative weeks 
and is attributed to acute infl ammation and fi brosis around 
the anastomosis. We therefore evaluated the early postopera-
tive changes in remnant pancreatic duct diameter after PG in 
patients with soft pancreas in terms of delayed gastric empty-
ing (DGE).
Methods: We retrospectively studied 42 patients with soft 
pancreas who underwent PD with PG. They were divided 
into 2 groups depending on the grade of DGE; without or 
slightly DGE group (WS group) and moderate or severe 
DGE group (MS group).
Results: The mean diameter of the pancreatic duct of the 
remnant pancreas was signifi cantly smaller in the WS group 
than in the MS group.
Conclusion: DGE accelerates pancreatic anastomotic stric-
ture development after PG in patients having soft pancreas 
with a pancreatic duct with a mall diameter. Hence, to main-
tain the pancreatic duct patency, preventing DGE is 
important.
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P-220
TRANSDUODENAL PANCREATIC JUICE 
DRAINAGE FOLLOWING DISTAL 
PANCREATECTOMY
T. Oida1, K. Mimatsu1, H. Kano1, A. Kawasaki1, 
N. Fukino1, K. Kida1, Y. Kuboi1, H. Miyake2 
and S. Amano3
1Department of Surgery, Social Insurance Yokohama 
Central Hospital, Yokohama, Japan; 2Department of 
Surgery, Kasukabe Municipal Hospital, Kasukabe, Japan; 
3Department of Surgery, Nihon University School of 
Medicine, Tokyo, Japan
Introduction: Pancreatic fi stula is the most common and 
troublesome complication after distal pancreatectomy (DP). 
We developed a new surgical technique, transduodenal pan-
creatic juice drainage (TDPD), for preventing pancreatic 
fi stula formation after DP, and evaluated the effi cacy of this 
procedure.
Methods: We retrospectively studied 40 patients who 
underwent DP. These patients were divided into 2 groups: 
the group that underwent conventional DP without pancre-
atic stent insertion (CDP group) (n = 25) and the group that 
underwent DP with TDPD (TDPD group) (n = 15). A pan-
creatic stent was inserted distally into the main pancreatic 
duct from the papilla of Vater via a duodenostomy, and con-
tinuous suction drainage was applied.
Results: This procedure was performed on 15 patients, 
grade-A postoperative pancreatic fi stula (POPF) was revealed 
in 1 patient (6.7%). However none of them developed clini-
cal POPF.
Conclusions: We consider our TDPD technique to be effec-
tive for preventing POPF in patients who have undergone 
DP.
P-221
RISK FACTORS FOR HEPATIC 
STEATOSIS AFTER PANCREATECTOMY 
– A RETROSPECTIVE OBSERVATIONAL 
COHORT STUDY OF THE IMPORTANCE 
OF NUTRITIONAL MANAGEMENT 
INCLUDING INSULIN THERAPY
Y. Okamura, H. Sugimoto, S. Yamada, T. Fujii, S. Nomoto, 
S. Takeda and A. Nakao
Department of Surgery II, Nagoya University Graduate 
School of Medicine, Nagoya, Japan
Objective: The aim of this study is to identify the risk 
factors of hepatic steatosis after pancreatectomy and to 
clarify the impact of this condition on the long-term progno-
sis, and to suggest the prevention method for hepatic 
steatosis.
Summary Background Data: The nonalcoholic fatty liver 
disease (NAFLD) has become widespread with the increas-
ing prevalence of obesity. The progression of NAFLD may 
lead to non-alcoholic steatohepatitis (NASH), sometimes 
followed by end-stage liver failure. The occurrence of 
NAFLD after pancreatectomy has been previously known. 
However, such condition has been neglected for more than 
20 years because its clinical course has been considered 
benign. Several papers have recently showed some risk 
factors of NAFLD, but the precise mechanism has remained 
unclear.
Methods: One hundred and two cases, which were taken 
postoperative computed tomography (CT) image, were 
enrolled. The severity of NAFLD was determined by using 
unenhanced CT. The variables that might infl uence the devel-
opment of NAFLD were compared between the groups with 
and without NAFLD.
Results: The incidence of postoperative NAFLD was 
31.4%. By multivariate analysis showed postoperative no 
use of insulin (P < 0.01) and postoperative BMI decreasing 
>3 kg/m2 (P < 0.01) were the independent risk factors for 
NAFLD. The cumulative disease-free survival rate of the 
group with NAFLD was poorer than that of the group without 
(P = 0.053).
Conclusions: Postoperative NAFLD may affect the long-
term prognosis after pancreatectomy. Surgeon then should 
administer adequate insulin therapy for cases with NAFLD 
after pancreatectomy.
P-222
CLINICAL TRIAL FOR BETTER 
POSTOPERATIVE COURSE OF 
PACREATICODUODENCTOMY
T. Sanada, H. Baba and N. Goseki
Shuwa General Hospital, Kasukabe, Japan
Introduction: In our country, the hospital stay after surgical 
operation tends to be longer than that of other country. 
Especially after pancreaticoduodenectomy, the stay could be 
very long because of various complications or other reasons.
To reduce the length of hospital stay after pancreaticoduode-
nectomy, we introduced a uniform perioperative manage-
ment and reduced the discretion of the attending physician 
variation in postoperative management.
Methods: 29 patients who underwent pancreaticoduodenec-
tomy in our hospital from 2006 to 2010, divided into two 
groups before and after introduction of a uniform treatment 
(14 = conventional group, 15 = recent group). Number of 
days of drain detainment, complication rate, the starting of 
oral intake and enteral nutrition, postoperative hospital stay 
were compared.
Results: In recent group, the days of oral intake and drain 
removal was signifi cantly earlier than that of conventional 
group, the rate of delayed gastric emptying was signifi cantly 
lower. Before the introduction of uniform management the 
average of hospital stay was 40.1 ± 12.3 days, however 
the average of hospital stay was 18.4 ± 3.4 days after the 
introduction.
Conclusion: The introduction of standardized perioperative 
management after pancreaticoduodenectomy reduced the 
hospital stay. We conclude that this has been accomplished 
by the decrease of complications.
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P-223
A RESECTED CASE OF INFLAMMATORY 
PSEUDOTUMOR OF THE PANCREAS
S. Takayuki, K. Takayuki, K. Masato, S. Mitsugi and 
K. Keiichi
Second Department of surgery, Dokkyo Medical University, 
880 Kita Kobayashi, Mibu, Tochigi 321–0293, Japan
Infl ammatory pseudotumor of the pancreats (IPTP) was a rare 
tumor and it was still unclear. We experienced the resected 
case of IPTP with obstructive jaundice. Forty eight year old 
man was presented to a local private clinic with mild jaundice 
and abdominal discomfort at middle of August 2010. 
Immediately, he transferred to our department. CT of the 
abdomen showed isodensity mass, about 30 mm, in the pan-
creas head with mild dilatation of the intrahepatic bile duct. 
Cholangiography revealed the lower biliary obstruction, then 
ENBD was performed, and normal bile juice was discharged. 
The tumor marker, CEA, CA 19–9, DUPAN-2 and SPAN-1, 
were all of within normal limits. Only elastase 1 was elevated 
(810 ng/dl). Serum IgG4 was also within normal limit. 
FDG-PET scan was positive in pancreas head tumor, SUV 
max was 2.29. We diagnosed as the cancer of the pancreas 
head and pancreatoduodenectmy was performed. Pathological 
fi ndings revealed that the tumor had disappearance of pan-
creatic acinus, connective tissue hyperplasia and mild lym-
phocytes and plasma cell infi ltration. Finally, the tumor was 
diagnosed as infl ammatory pseudotumor.
We experienced a resected case of IPTP, and report it in 
addition to the discussion with literatures.
P-224
A RUPTURED SOLID 
PSEUDOPAPILLARY NEOPLASM OF THE 
PANCREAS RESECTED BY THE 
LAPAROSCOPIC SURGERY – A CASE 
REPORT
S. Takamatsu, H. Nagano, S. Ootsukasa, Y. Kawachi and 
H. Maruyama
Department of Surgery, Musashino Red Cross Hospital, 
Tokyo, Japan
Introduction: The solid pseudopapillary neoplasms (SPNs) 
of the pancreas are rare. Although the clinical fi ndings of 
SPNs are various, the rupture of the SPNs are seemed to be 
very rare.
Methods and Results: The patient was a thirteen-year-old 
female. She felt an acute abdominal pain and was carried to 
another hospital by ambulance on March 2010. The abdomi-
nal computed tomography (CT) showed a tumor, which was 
4 cm in diameter and protruded from the pancreatic tail, 
without distant metastases. Moreover, the marked fl uid col-
lection recognized around the tumor, it was suspected to be 
bleeding resulted from the tumor ruptured incidentally. The 
tumor was diagnosed as the SPN of the pancreas. The bleed-
ing stopped spontaneously, the patient was referred to our 
hospital for the surgical treatment about two months later. At 
that moment, the CT showed that the blood around the tumor 
was disappeared completely. On the intraoperative fi ndings, 
there was no adhesion around tumor, and the dissemination 
was not seen, therefore, we performed the laparoscopic 
partial resection of the pancreas on July 2010. The postopera-
tive course was uneventful, and she discharged on the post-
operative day 7. The resected specimen wad examined 
pathologically, it was diagnosed as the SPN of the pancreas. 
The capsule of the tumor was ruptured microscopically, and 
surgical margin was confi rmed to be free.
Conclusions: We reported a rare case of the ruptured SPN 
resected electively by the laparoscopic surgery.
P-225
EXTRAPANCREATIC INFECTIVE 
COMPLICATIONS IN SEVERE ACUTE 
PANCREATITIS
T. D. Yadav, P. K. Sinha PK, R. Kochhar, R. Shah and 
M. Kumar
Postgraduate institute of medical education and research 
Chandigarh India
Introduction: Infective complications account for signifi -
cant morbidity and mortality in severe acute pancreatitis 
(SAP). This study analyzes the incidence, bacterial ecology, 
impact of extrapancreatic infective complications (EPIC) on 
outcome in patients who underwent necrosectomy for SAP.
Patients and Methods: Twenty patients of SAP who under-
went necrosectomy over 1 year were followed up prospec-
tively until discharge or death. Pneumonia, urinary tract 
infection (UTI) and central venous catheter infections 
(CVCI) were evaluated and documented according to stan-
dard protocol, defi nitions. Patients with and without EPICs 
were compared as regards to duration of hospital stay, 
mortality.
Results: Seven out of 20 (35%) patients developed 
EPICs. Pneumonia occurred in 3, UTI, CVCI in 2 patients 
each. Acinetobacter baumanii, E.coli, Staph.aureus and 
Enterococcus fecalis were the isolates. They were sensitive 
to third generation cephalosporins, vancomycin. The mean 
duration of hospital stay was prolonged in patients with 
pneumonia (53 vs. 40 days for no infection), CVCI (72 vs. 
44 days) but not for UTI (43 vs. 47 days). Overall mortality 
in this study group was 40% (8 out of 20). 50% of patients 
(4 out of 8) who died had their course complicated by an 
extrapancreatic infection. All 3 patients with pneumonia, 1 
out of 2 with CVCI died while no patient with UTI died.
Conclusions: EPICs occur in a signifi cant proportion of 
patients undergoing surgery for SAP and contribute to mor-
bidity and mortality. While CVCI prolongs hospital stay, 
pneumonia kills. UTI is manageable and makes no difference 
to the outcome.
P-226
HISTOLOGIC CONFIRMATION OF HUGE 
PANCREATIC LIPOMA: A CASE REPORT
S-P. Yun and H-I. Seo
Department of Surgery, Pusan National University School 
of Medicine, Busan, Republic of Korea
Introduction: Most of the pancreas tumors arise from the 
pancreatic epithelial cells and mesenchymal tumors com-
prise 1% to 2% of all pancreatic tumors. Among these 
tumors, lipoma is considered relatively common, but the 
prevalence is not clearly reported. When the tumors has 
confi rmed as lipoma in diagnostic imaging modalities, surgi-
cal treatment would not be necessary. Therefore histologic 
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confi rmation is extremely rare in radiologically confi rmed 
lipoma. Because similar fi ndings are also visualized in the 
case of well-differentiated liposarcoma, EUS-FNA is recom-
mended to avoid a unnecessary operation. But the operation 
would be needed when the tumor is associated symptoms or 
hard to distinguish from malignancy.
Results: A 54-year-old male patient visited our hospital for 
evaluation of incidental panceatic body tumor in a medical 
examination. The hematologic results and tumor markers 
showed no specifi c fi ndings. In CT scan, the -103 HU density 
of 9 cm-sized well-defi ned pancreas mass was identifi ed 
without infi ltration to adjacent organ and clinically diag-
nosed as a huge lipoma. After 3-month follow-up periods, 
the pancreas tumor has increased to 11 cm and the operation 
was performed to be differentiated from liposarcoma.
Conclusion: Authors report a huge lipoma which was con-
fi rmed with subtotal pancreatectomy.
P-227
INITIAL EXPERIENCE OF DISTAL 
PANCREATECTOMY
S-P. Yun and H.-I. Seo
Department of Surgery, Pusan National University School 
of Medicine, Busan, Republic of Korea
Introduction: To analyze a initial experience with distal 
pancreatectomy, with particular attention to the risk factors, 
outcome, and management of the pancreatic fi stula.
Methods: 28 Patients who underwent elective distal pancre-
atectomy between May 2007 and May 2010. Perioperative 
and postoperative data were analyzed with attention to pan-
creatic fi stula as defi ned by the International Study Group of 
Pancreatic Fistula.
Results: The indications for elective distal pancreatectomy 
were benign disease (n = 16) and malignant disease (n = 12). 
The pancreatic remnant was suture with pancreatic duct liga-
tion (n = 14), stapled alone (n = 2), and both stapled and 
sutured (n = 12). 12 patients (42.9%) developed the pancre-
atic fi stula; fi stula was classifi ed as Grade A 8 (28.6%), B 3 
(10.7%), and C 1 (3.6%). All of the patients with pancreatic 
fi stulae were successfully treated additional treatment with 
no mortality.
Conclusions: On the analysis, perioperative and postopera-
tive data were not affected the risk of pancreatic fi stula. 
Pancreatic fi stulae after distal pancreatectomy can not be 
managed if the location of intra-operative drainages is 
adequate.
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Introduction: Postoperative pancreatic fi stula (POPF) is 
most common and fatal complication after pancreaticoduo-
denectomy (PD). The aim of this study is to analyze the risk 
factor of POPF and to evaluate the signifi cance of the pre-
operative and postoperative laboratory fi nding.
Methods: Fifty-three patients who underwent PD between 
June 2007 and June 2010 were enrolled retrospectively. An 
end-to-side, duct-to-mucosa pancreaticojejunostomy was 
performed for all patients regardless of pancreas texture. 
Computed tomographic scan was performed at postoperative 
day 7 routinely. The patients were divided into two groups 
according to the occurrence of POPF. Preoperative, intraop-
erative and postoperative clinicopathologic data were 
recruited for comparison of two groups.
Results: POPF occurred in 18 patients (31.0%), classifi ed 
as grade A(n = 1, 1.7%), B(n = 14, 24.1%), C(n = 3, 5.2%) 
according new grading system of International Study Group 
for Pancreatic Fistula (ISGPF). Among the three patients 
with grade C, two patients died because of hypovolemic 
shock due to pseudoaneurysm rupture and hemobilia. The 
operative mortality rate was 3.4%(n = 2). General predictive 
factors including gender, body mass index, history of jaun-
dice, diabetes mellitus, type of resection were no statistical 
difference. Whereas, old age was signifi cant risk factor of 
POPF (p = 0.034) and preoperative serum total bilirubin level 
was signifi cantly higher in POPF group (p = 0.012). At post-
operative day 1, serum direct bilirubin and lipase level also 
was signifi cantly higher in POPF group (p = 0.046, p = 
0.048). Finally, serum direct bilirubin level of postoperative 
day 2 was signifi cantly higher in POPF group (p = 0.014).
Conclusion: Old age, pre- and postoperative serum biliru-
bin and lipase level was signifi cant difference between two 
groups. Thus, it may be need to interpret pre- and postopera-
tive laboratory fi nding closely.
